Fidelity National Financial (FNF) 10-Q 7 Nov 24 2024 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2024	Oct. 31, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2024
Document Transition Report	false
Entity File Number	001-32630
Entity Registrant Name	FIDELITY NATIONAL FINANCIAL, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	16-1725106
Entity Address, Address Line One	601 Riverside Avenue
Entity Address, City or Town	Jacksonville
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	32204
City Area Code	904
Local Phone Number	854-8100
Title of 12(b) Security	FNF Common Stock, $0.0001 par value
Trading Symbol	FNF
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		273,639,207
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Entity Central Index Key	0001331875
Current Fiscal Year End Date	--12-31

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) shares in Millions, $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Investments:
Fixed maturity securities available for sale, at fair value, as of September 30, 2024 and December 31, 2023, at an amortized cost of $51,070 and $45,606, respectively, net of allowance for credit losses of $67 and $42, respectively, and includes pledged fixed maturity securities of $502 and $489, respectively, related to secured trust deposits	$ 48,940	$ 42,373
Derivative investments	1,401	797
Mortgage loans, net of allowance for credit losses of $69 and $66 as of September 30, 2024 and December 31, 2023, respectively	5,626	5,336
Investments in unconsolidated affiliates	3,874	3,334
Other long-term investments	780	703
Short-term investments	1,177	2,119
Total investments	62,987	56,049
Cash and cash equivalents, as of September 30, 2024 and December 31, 2023 includes $289 and $262, respectively, of pledged cash related to secured trust deposits	4,970	2,767
Trade and notes receivables, net of allowance for credit losses of $32 as of September 30, 2024 and December 31, 2023	443	442
Reinsurance recoverable, net of allowance for credit losses of $21 as of September 30, 2024 and December 31, 2023	12,409	8,977
Goodwill	5,272	4,830
Prepaid expenses and other assets	1,755	1,900
Market risk benefits asset	134	88
Lease assets	348	348
Other intangible assets, net	5,758	4,627
Title plants	422	418
Property and equipment, net	174	168
Total assets	94,672	80,614
Liabilities:
Contractholder funds	55,468	48,798
Future policy benefits	8,268	7,050
Accounts payable and accrued liabilities	4,375	3,009
Market risk benefits liability	603	403
Notes payable	4,186	3,887
Reserve for title claim losses	1,720	1,770
Funds withheld for reinsurance liabilities	9,980	7,083
Secured trust deposits	766	731
Lease liabilities	383	394
Income taxes payable	21	0
Deferred tax liability	0	29
Total liabilities	85,770	73,154
Equity:
FNF common stock, $0.0001 par value; authorized 600 shares as of September 30, 2024 and December 31, 2023; outstanding of 274 and 273 as of September 30, 2024 and December 31, 2023, respectively	0	0
Preferred stock, $0.0001 par value; authorized 50 shares; issued and outstanding, none	0	0
Additional paid-in capital	5,965	5,913
Retained earnings	5,671	5,244
Accumulated other comprehensive loss	(1,423)	(2,119)
Treasury stock, 56 shares as of September 30, 2024 and December 31, 2023, at cost	(2,131)	(2,130)
Total Fidelity National Financial, Inc. shareholders’ equity	8,082	6,908
Non-controlling interests	820	552
Total equity	8,902	7,460
Total liabilities and equity	$ 94,672	$ 80,614
Common stock, shares, outstanding (in shares)	274	273
Preferred securities
Investments:
Securities, at fair value	$ 460	$ 621
Equity securities
Investments:
Securities, at fair value	$ 729	$ 766

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Fixed maturity securities, available-for-sale securities, amortized cost	$ 51,070	$ 45,606
Fixed maturity securities, available-for-sale securities, allowance for credit losses	67	42
Available-for-sale securities, pledged securities, secured trust deposits	502	489
Allowance for credit loss	69	66
Cash, pledged, secured trust deposits	289	262
Allowance for doubtful accounts, premiums and other receivables	32	32
Expected credit losses on reinsurance recoverable	$ 21	$ 21
Common stock, par or stated value per share (in usd per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	600,000,000	600,000,000
Common stock, shares, outstanding (in shares)	274,000,000	273,000,000
Preferred stock, par or stated value per share (in usd per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	50,000,000	50,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Treasury stock (in shares)	56,000,000	56,000,000

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenues:
Direct title insurance premiums	$ 571	$ 524	$ 1,575	$ 1,493
Agency title insurance premiums	789	728	2,166	1,991
Escrow, title-related and other fees	1,159	1,196	3,555	3,288
Interest and investment income	815	686	2,308	1,915
Recognized gains and losses, net	269	(356)	456	(367)
Total revenues	3,603	2,778	10,060	8,320
Expenses:
Personnel costs	810	734	2,316	2,166
Agent commissions	612	564	1,681	1,534
Other operating expenses	396	380	1,152	1,134
Benefits and other changes in policy reserves	1,095	292	2,864	1,921
Market risk benefit losses (gains)	71	(49)	80	(20)
Depreciation and amortization	189	153	545	438
Provision for title claim losses	61	57	168	157
Interest expense	56	44	152	129
Total expenses	3,290	2,175	8,958	7,459
Earnings before income taxes and equity in earnings of unconsolidated affiliates	313	603	1,102	861
Income tax expense	44	141	223	245
Earnings before equity in earnings of unconsolidated affiliates	269	462	879	616
Equity in earnings of unconsolidated affiliates	2	15	4	16
Net earnings	271	477	883	632
Less: Net earnings attributable to non-controlling interests	5	51	63	46
Net earnings attributable to Fidelity National Financial, Inc. common shareholders	$ 266	$ 426	$ 820	$ 586
Earnings per share
Net earnings per share attributable to common shareholders, basic (in usd per share)	$ 0.98	$ 1.58	$ 3.03	$ 2.17
Net earnings per share attributable to common shareholders, diluted (in usd per share)	$ 0.97	$ 1.57	$ 3	$ 2.16
Weighted average common shares outstanding - basic (in shares)	272	270	271	270
Weighted average common shares outstanding - diluted (in shares)	273	271	273	271

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS - USD ($) $ in Millions		3 Months Ended		9 Months Ended
		Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Statement of Comprehensive Income [Abstract]
Net earnings		$ 271	$ 477	$ 883	$ 632
Other comprehensive earnings (loss):
Unrealized gain (loss) on investments and other financial instruments (excluding investments in unconsolidated affiliates)	[1]	1,082	(676)	913	(505)
Unrealized gain on investments in unconsolidated affiliates	[2]	5	3	23	9
Unrealized gain (loss) on foreign currency translation	[3]	5	(7)	(3)	(1)
Reclassification adjustments for change in unrealized gains and losses included in net earnings	[4]	2	12	(4)	90
Changes in current discount rate - future policy benefits	[5]	(293)	229	(110)	186
Changes in instrument-specific credit risk - market risk benefits	[6]	(25)	(10)	(5)	(7)
Other comprehensive (loss) earnings attributable to non-controlling interest	[7]	(112)	63	(118)	31
Other comprehensive earnings (loss)		664	(386)	696	(197)
Comprehensive earnings		935	91	1,579	435
Less: Comprehensive earnings attributable to non-controlling interests		5	51	63	46
Comprehensive earnings attributable to Fidelity National Financial, Inc. common shareholders		$ 930	$ 40	$ 1,516	$ 389
[1] Net of income tax expense (benefit) of $262 million and $(172) million for the three months ended September 30, 2024 and 2023, respectively, and $220 million and $(126) million for the nine months ended September 30, 2024 and 2023, respectively. Net of income tax expense of $1 million and $1 million for the three months ended September 30, 2024 and 2023, respectively, and $6 million and $2 million for the nine months ended September 30, 2024 and 2023, respectively. Net of income tax expense (benefit) of $2 million and $(2) million for the three months ended September 30, 2024 and 2023, respectively, and $(9) million for the nine months ended September 30, 2023. Net of income tax expense (benefit) of $2 million for the three months ended September 30, 2023, and $(1) million and $22 million for the nine months ended September 30, 2024 and 2023, respectively. Net of income tax (benefit) expense of $(78) million and $61 million for the three months ended September 30, 2024 and 2023, respectively, and $(29) million and $49 million for the nine months ended September 30, 2024 and 2023, respectively. Net of income tax benefit of $6 million and $3 million for the three months ended September 30, 2024 and 2023, respectively, and $1 million and $2 million for the nine months ended September 30, 2024 and 2023, respectively. Net of income tax (benefit) expense of $(28) million and $17 million for the three months ended September 30, 2024 and 2023, respectively, and $(30) million and $9 million for the nine months ended September 30, 2024 and 2023, respectively.

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE EARNINGS (Parenthetical) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Statement of Comprehensive Income [Abstract]
Unrealized gain (loss) on investments and other financial instruments, tax expense (benefit)	$ 262	$ (172)	$ 220	$ (126)
Unrealized gain on investments in unconsolidated affiliates, tax expense	1	1	6	2
Unrealized gain (loss) on foreign currency translation, tax expense (benefit)	2	(2)		(9)
Reclassification adjustments for change in unrealized gains and losses included in net earnings, tax expense (benefit)		2	(1)	22
Changes in current discount rate - future policy benefits , tax (benefit) expense	(78)	61	(29)	49
Changes in instrument-specific credit risk - market risk benefits, tax (benefit)	(6)	(3)	(1)	(2)
Other comprehensive (loss) earnings attributable to non-controlling interest, tax (benefit) expense	$ (28)	$ 17	$ (30)	$ 9

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF EQUITY - USD ($) shares in Millions, $ in Millions	Total		F&G	Common Stock	Additional Paid-in Capital	Additional Paid-in Capital F&G	Retained Earnings	Accumulated Other Comprehensive Earnings (Loss)	Treasury Stock	Non-controlling Interests	Non-controlling Interests F&G
Beginning balance (in shares) at Dec. 31, 2022				328
Beginning balance at Dec. 31, 2022	$ 6,569			$ 0	$ 5,870		$ 5,225	$ (2,870)	$ (2,109)	$ 453
Beginning balance, Treasury stock (in shares) at Dec. 31, 2022									55
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury stock repurchased/F&G purchases of treasury stock	(4)		$ (19)			$ (1)			$ (4)		$ (18)
F&G purchase of FG stock/Purchase of incremental share in consolidated subsidiaries	(21)				(12)					(9)
Other comprehensive (loss) earnings- unrealized (loss) gain on investments and other financial instruments	(505)							(505)
Other comprehensive earnings — unrealized (loss) gain on investments in unconsolidated affiliates	9	[1]						9
Other comprehensive earnings (loss) - unrealized gain (loss) on foreign currency translation	(1)	[2]						(1)
Reclassification adjustments for change in unrealized gains and losses included in net earnings	90	[3]						90
Change in instrument-specific credit risk - market risk benefits	(7)	[4]						(7)
Change in current discount rate — liability for future policy benefits	186	[5]						186
Other comprehensive income (loss) associated with noncontrolling interests	31	[6]			(1)			31		(30)
Stock-based compensation	43				39					4
Shares withheld for taxes and in treasury	(1)								(1)
Dividends declared, per common share	(367)						(367)
Subsidiary dividends declared to non-controlling interests	(20)									(20)
Net earnings	632						586			46
Ending balance (in shares) at Sep. 30, 2023				328
Ending balance at Sep. 30, 2023	6,584			$ 0	5,895		5,444	(3,067)	$ (2,114)	426
Ending balance, Treasury stock (in shares) at Sep. 30, 2023									55
Beginning balance (in shares) at Jun. 30, 2023				328
Beginning balance at Jun. 30, 2023	6,677			$ 0	5,883		5,140	(2,681)	$ (2,113)	448
Beginning balance, Treasury stock (in shares) at Jun. 30, 2023									55
Increase (Decrease) in Stockholders' Equity [Roll Forward]
F&G purchase of FG stock/Purchase of incremental share in consolidated subsidiaries			$ (3)								$ (3)
Other comprehensive (loss) earnings- unrealized (loss) gain on investments and other financial instruments	(676)							(676)
Other comprehensive earnings — unrealized (loss) gain on investments in unconsolidated affiliates	3	[1]						3
Other comprehensive earnings (loss) - unrealized gain (loss) on foreign currency translation	(7)	[2]						(7)
Reclassification adjustments for change in unrealized gains and losses included in net earnings	12	[3]						12
Change in instrument-specific credit risk - market risk benefits	(10)	[4]						(10)
Change in current discount rate — liability for future policy benefits	229	[5]						229
Other comprehensive income (loss) associated with noncontrolling interests	63	[6]						63		(63)
Stock-based compensation	14				12					2
Shares withheld for taxes and in treasury	(1)								$ (1)
Dividends declared, per common share	(122)						(122)
Subsidiary dividends declared to non-controlling interests	(9)									(9)
Net earnings	477						426			51
Ending balance (in shares) at Sep. 30, 2023				328
Ending balance at Sep. 30, 2023	6,584			$ 0	5,895		5,444	(3,067)	$ (2,114)	426
Ending balance, Treasury stock (in shares) at Sep. 30, 2023									55
Beginning balance (in shares) at Dec. 31, 2023				329
Beginning balance at Dec. 31, 2023	$ 7,460			$ 0	5,913		5,244	(2,119)	$ (2,130)	552
Beginning balance, Treasury stock (in shares) at Dec. 31, 2023	56								56
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)				1
Exercise of stock options	$ 17				17
F&G purchase of FG stock/Purchase of incremental share in consolidated subsidiaries	(21)				(12)					(9)
Other comprehensive (loss) earnings- unrealized (loss) gain on investments and other financial instruments	913							913
Other comprehensive earnings — unrealized (loss) gain on investments in unconsolidated affiliates	23	[1]						23
Other comprehensive earnings (loss) - unrealized gain (loss) on foreign currency translation	(3)	[2]						(3)
Reclassification adjustments for change in unrealized gains and losses included in net earnings	(4)	[3]						(4)
Change in instrument-specific credit risk - market risk benefits	(5)	[4]						(5)
Change in current discount rate — liability for future policy benefits	(110)	[5]						(110)
Other comprehensive income (loss) associated with noncontrolling interests	(118)	[6]			(1)			(118)		119
Stock-based compensation	48				47					1
Dilution from share issuance by consolidated sub	0				1					(1)
Shares withheld for taxes and in treasury	(7)								$ (1)	(6)
Noncontrolling interest associated with current period acquisitions	136									136
Dividends declared, per common share	(393)						(393)
Subsidiary dividends declared to non-controlling interests	(35)									(35)
Net earnings	883						820			63
Ending balance (in shares) at Sep. 30, 2024				330
Ending balance at Sep. 30, 2024	$ 8,902			$ 0	5,965		5,671	(1,423)	$ (2,131)	820
Ending balance, Treasury stock (in shares) at Sep. 30, 2024	56								56
Beginning balance (in shares) at Jun. 30, 2024				329
Beginning balance at Jun. 30, 2024	$ 7,981			$ 0	5,942		5,536	(2,087)	$ (2,131)	721
Beginning balance, Treasury stock (in shares) at Jun. 30, 2024									56
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)				1
Exercise of stock options	7				7
Other comprehensive (loss) earnings- unrealized (loss) gain on investments and other financial instruments	1,082							1,082
Other comprehensive earnings — unrealized (loss) gain on investments in unconsolidated affiliates	5	[1]						5
Other comprehensive earnings (loss) - unrealized gain (loss) on foreign currency translation	5	[2]						5
Reclassification adjustments for change in unrealized gains and losses included in net earnings	2	[3]						2
Change in instrument-specific credit risk - market risk benefits	(25)	[4]						(25)
Change in current discount rate — liability for future policy benefits	(293)	[5]						(293)
Other comprehensive income (loss) associated with noncontrolling interests	(112)	[6]						(112)		112
Stock-based compensation	14				15					(1)
Dilution from share issuance by consolidated sub	1				1
Dividends declared, per common share	(131)						(131)
Subsidiary dividends declared to non-controlling interests	(17)									(17)
Net earnings	271						266			5
Ending balance (in shares) at Sep. 30, 2024				330
Ending balance at Sep. 30, 2024	$ 8,902			$ 0	$ 5,965		$ 5,671	$ (1,423)	$ (2,131)	$ 820
Ending balance, Treasury stock (in shares) at Sep. 30, 2024	56								56
[1] Net of income tax expense of $1 million and $1 million for the three months ended September 30, 2024 and 2023, respectively, and $6 million and $2 million for the nine months ended September 30, 2024 and 2023, respectively. Net of income tax expense (benefit) of $2 million and $(2) million for the three months ended September 30, 2024 and 2023, respectively, and $(9) million for the nine months ended September 30, 2023. Net of income tax expense (benefit) of $2 million for the three months ended September 30, 2023, and $(1) million and $22 million for the nine months ended September 30, 2024 and 2023, respectively. Net of income tax benefit of $6 million and $3 million for the three months ended September 30, 2024 and 2023, respectively, and $1 million and $2 million for the nine months ended September 30, 2024 and 2023, respectively. Net of income tax (benefit) expense of $(78) million and $61 million for the three months ended September 30, 2024 and 2023, respectively, and $(29) million and $49 million for the nine months ended September 30, 2024 and 2023, respectively. Net of income tax (benefit) expense of $(28) million and $17 million for the three months ended September 30, 2024 and 2023, respectively, and $(30) million and $9 million for the nine months ended September 30, 2024 and 2023, respectively.

CONDENSED CONSOLIDATED STATEM_5

CONDENSED CONSOLIDATED STATEMENTS OF EQUITY (Parenthetical) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Statement of Stockholders' Equity [Abstract]
Cash dividend per common share (in usd per share)	$ 0.48	$ 0.45	$ 1.44	$ 1.35

CONDENSED CONSOLIDATED STATEM_6

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities:
Net earnings	$ 883	$ 632
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	545	438
Equity in earnings of unconsolidated affiliates	(4)	(16)
(Gain) loss on sales of investments and other assets and asset impairments, net	(132)	481
Interest credited/index credits to contractholder account balances	1,482	607
Change in market risk benefits, net	80	(20)
Deferred policy acquisition costs and deferred sales inducements	(1,061)	(771)
Charges assessed to contractholders for mortality and admin	(209)	(184)
Non-cash lease costs	99	102
Operating lease payments	(112)	(115)
Distributions from unconsolidated affiliates, return on investment	70	142
Stock-based compensation cost	48	43
Change in NAV of limited partnerships, net	(261)	(160)
Change in valuation of derivatives, equity securities, preferred securities, and other assets, net	(372)	(112)
Changes in assets and liabilities, net of effects from acquisitions:
Change in reinsurance recoverable	(28)	105
Change in future policy benefits	1,080	706
Change in funds withheld from reinsurers	2,895	2,418
Net (increase) decrease in trade receivables	(18)	37
Net decrease in reserve for title claim losses	(50)	(41)
Net change in income taxes	25	54
Net change in other assets and other liabilities	360	(131)
Net cash provided by operating activities	5,320	4,215
Cash flows from investing activities:
Proceeds from sales, calls and maturities of investment securities	7,995	4,190
Additions to property and equipment, capitalized software and title plants	(116)	(101)
Purchases of investment securities	(12,642)	(10,660)
Net proceeds from sales and maturities of short-term investment securities	983	1,882
Acquisitions and dispositions	(570)	(299)
Additional investments in unconsolidated affiliates	(903)	(1,061)
Distributions from unconsolidated affiliates, return of investment	224	302
Net other investing activities	13	(13)
Net cash used in investing activities	(5,016)	(5,760)
Cash flows from financing activities:
Debt offering	550	500
Debt service payments	(250)	(8)
F&G Credit Agreement repayments, net	0	(35)
Dividends paid	(391)	(366)
Subsidiary dividends paid to non-controlling interest shareholders	(34)	(24)
Exercise of stock options	17	0
Net change in secured trust deposits	35	(9)
Additional investment in consolidated subsidiaries	(21)	(20)
Payment of contingent consideration for prior period acquisitions	(13)	(6)
Contractholder account deposits	8,574	5,718
Contractholder account withdrawals	(6,568)	(3,258)
F&G repurchases of F&G stock	0	(18)
Purchases of treasury stock	0	(6)
Net cash provided by financing activities	1,899	2,468
Net increase in cash and cash equivalents	2,203	923
Cash and cash equivalents at beginning of period	2,767	2,286
Cash and cash equivalents at end of period	$ 4,970	$ 3,209

Basis of Financial Statements

Basis of Financial Statements	9 Months Ended
	Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Financial Statements	Basis of Financial Statements The financial information in this report presented for interim periods is unaudited and includes the accounts of Fidelity National Financial, Inc. and its subsidiaries (collectively, “we,” “us,” “our,” the "Company" or “FNF”) prepared in accordance with U.S. generally accepted accounting principles ("GAAP") and the instructions to Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All adjustments made were of a normal, recurring nature. This report should be read in conjunction with our Annual Report on Form 10-K (our "Annual Report") for the year ended December 31, 2023. Description of the Business We are a leading provider of (i) title insurance, escrow and other title-related services, including loan sub-servicing, valuations, default services and home warranty, (ii) transaction services to the real estate and mortgage industries and (iii) annuity and life insurance products. FNF is one of the nation’s largest title insurance companies operating through its title insurance underwriters - Fidelity National Title Insurance Company ("FNTIC"), Chicago Title Insurance Company ("Chicago Title"), Commonwealth Land Title Insurance Company ("Commonwealth Title"), Alamo Title Insurance and National Title Insurance of New York Inc. - which collectively issue more title insurance policies than any other title company in the United States. Through our subsidiary, ServiceLink Holdings, LLC ("ServiceLink"), we provide mortgage transaction services, including title-related services and facilitation of production and management of mortgage loans. We are also a leading provider of insurance solutions serving retail annuity and life customers and institutional clients through our majority-owned subsidiary, F&G Annuities & Life ("F&G"). For information about our reportable segments refe r to Note H Segment Information . Recent Developments 6.25% F&G Senior Notes On October 4, 2024, F&G completed its public offering of its 6.25% Senior Notes due 2034 in aggregate principal amount of $500 million (the “6.25% F&G Notes”). The 6.25% F&G Notes are guaranteed on an unsecured, unsubordinated basis by each of F&G’s subsidiaries that are guarantors of F&G’s obligations under its existing credit agreement. A portion of the net proceeds were used to pay off the outstanding balance of $365 million on its revolving credit facility. F&G intends to use the remaining net proceeds of this offering for general corporate purposes, including the support of organic growth opportunities. The 6.25% F&G Notes were registered under the registered under the Securities Act of 1934 (as amended) (the "Securities Act"). Approval of the 2024 Repurchase Program On July 31, 2024, our Board of Directors approved a new three-year stock repurchase program effective July 31, 2024 (the "2024 Repurchase Program") under which we may purchase up to 25 million shares of our FNF common stock through July 31, 2027. We may make repurchases from time to time in the open market, in block purchases or in privately negotiated transactions, depending on market conditions and other factors. Acquisition of PALH On July 18, 2024, F&G acquired 100% of PALH, LLC (“PALH”). PALH markets and sells life insurance and annuity products of various insurance carriers to individuals through a network of agents. Prior to the acquisition date, PALH owned a 70% ownership stake in an operating company of which F&G owned 30% equity. Total consideration to acquire the remaining 70% equity is approximately $314 million, comprised of cash of $215 million, settlement of a prepaid asset of $8 million, acquisition date fair value of the previously held interests of $92 million, net of $1 million cash acquired. 6.50% F&G Senior Notes On June 4, 2024, F&G completed its public offering of $550 million aggregate principal amount of its 6.50% Senior Notes due 2029 (the “6.50% F&G Notes”). The 6.50% F&G Notes are guaranteed on an unsecured, unsubordinated basis by each of F&G’s subsidiaries that are guarantors of F&G’s obligations under its existing credit agreement. A portion of the net proceeds were used to finance a cash tender offer by its wholly owned subsidiary Fidelity & Guaranty Life Holdings, Inc. (“FGLH”) for an aggregate principal amount of $250 million of FGLH’s 5.50% Senior Notes due 2025 (the “5.50% F&G Notes”). F&G intends to use the remaining net proceeds of this offering for general corporate purposes, which may include the repurchase, redemption or repayment at maturity of outstanding indebtedness. The 6.50% F&G Notes were registered under the Securities Act. For further information related to the 6.50% F&G Notes refer to Note O Notes Payable . Consent Solicitation On April 23, 2024, we announced the successful completion of consent solicitations of the holders of each of our 4.50% Senior Notes due 2028 (the “2028 Notes”), 3.40% Senior Notes due 2030 (the “2030 Notes”), 2.45% Senior Notes due 2031 (the “2031 Notes”), and 3.20% Senior Notes due 2051 (the “2051 Notes” and, collectively with the 2028 Notes, 2030 Notes, and the 2031 Notes, the “Notes”; and each a “series of Notes”) to effect a certain amendment (the “Proposed Amendment”) to the indenture governing the Notes (the “Indenture”) with respect to each series of Notes, as described below. A supplemental indenture giving effect to the Proposed Amendment with respect to each series of Notes was executed promptly. Upon its execution, the supplemental indenture was effective and constituted a binding agreement between the Company and the trustee. As described in the Consent Solicitation Statement dated April 16, 2024, we would have paid a consent fee to the holders of each series of Notes who validly delivered their consents at or prior to the Expiration Time immediately prior to the consummation of our proposed redomestication from a corporation organized under the laws of the State of Delaware to a corporation organized under the laws of the State of Nevada (the “Redomestication”). The Redomestication required the affirmative vote of a majority of our outstanding common stock, which we did not receive. Given the Redomestication was not approved by our shareholders, we will not be paying the consent fee to the holders of our Notes and the supplemental indenture was terminated in accordance with its terms. Amendment to our Revolving Credit Facility On February 16, 2024, we entered into a Sixth Amended and Restated Credit Agreement for our $800 million revolving credit facility (the "Amended Revolving Credit Facility") with Bank of America, N.A., as administrative agent and other agents party thereto (the "Sixth Restated Credit Agreement"). Among other changes, the Sixth Amended and Restated Credit Agreement amends the Revolving Credit Facility to extend the maturity date from October 29, 2025, to February 16, 2029. For further information related to the Amended Revolving Credit Facility and the Sixth Restated Credit Agreement refer to Note O Notes Payable . Amendment to the F&G Credit Agreement On February 16, 2024, F&G entered into a Second Amended and Restated F&G Credit Agreement of our $665 million credit agreement, with the guarantors party thereto, the financial institutions party thereto as lenders, and Bank of America, N.A., as administrative agent, swing line lender and an issuing bank (the "Second Amended and Restated F&G Credit Agreement"). Among other changes, the Second Amended and Restated F&G Credit Agreement amends the Amended F&G Credit Agreement to extend the maturity date from November 22, 2025 to November 22, 2027 and increase the aggregate principal amount of commitments under the revolving credit facility to $750 million. For more information related to the Second Amended and Restated F&G Credit Agreement refer to Note O Notes Payable . Acquisition of Roar On January 2, 2024, F&G acquired a 70% majority ownership stake in the equity of Roar Joint Venture, LLC ("Roar"). Roar wholesales life insurance and annuity products to banks and broker dealers through a network of agents. Total initial consideration is comprised of cash of $269 million and $48 million of contingent consideration. Under the terms of the purchase agreement, the Company has agreed to make cash payments of up to $90 million over a three year period upon the achievement by Roar of certain earnings before interest, taxes, depreciation and amortization ("EBITDA") milestones. For further information related to the acquisition of Roar, refer to Note N Acquisitions . Investment of $250 million in F&G On January 12, 2024, we completed a $250 million preferred stock investment in F&G. F&G will use the net proceeds from the investment to support growth of its assets under management. Under the terms of the agreement, we have agreed to invest $250 million in exchange for 5 million shares of F&G's 6.875% Series A Mandatory Convertible Preferred Stock, par value $0.001 per share (the "Mandatory Convertible Preferred Stock"). Each share of Mandatory Convertible Preferred Stock will have a liquidation preference of $50.00 per share. Unless earlier converted at the option of the holder, each outstanding share of the Mandatory Convertible Preferred Stock will automatically convert into shares of common stock of F&G on January 15, 2027 (the "Mandatory Conversion Date"). Upon conversion on the Mandatory Conversion Date, the conversion rate for each share of the Mandatory Convertible Preferred Stock will be no more than 1.1111 shares of common stock and no less than 0.9456 shares of common stock per share of Mandatory Convertible Preferred Stock, depending on the value of F&G's common stock. The preferred stock investment in F&G is eliminated upon consolidation. Income Tax Income tax expense was $44 million and $141 million in the three months ended September 30, 2024 and 2023, respectively, and $223 million and $245 million in the nine months ended September 30, 2024 and 2023, respectively. Income tax expense as a percentage of earnings before income taxes was 14% and 23% in the three months ended September 30, 2024 and 2023, respectively, and 20% and 28% in the nine months ended September 30, 2024 and 2023, respectively. The decreases in income tax expense as a percentage of earnings before taxes in the three and nine months ended September 30, 2024 as compared to the corresponding periods in 2023 are primarily attributable to more valuation allowance being released in the three months ended September 30, 2024 as compared to the corresponding period in 2023, and less valuation allowance being recorded in the nine months ended September 30, 2024 as compared to the corresponding period in 2023. Earnings Per Share Basic earnings per share, as presented on the unaudited Condensed Consolidated Statement of Earnings, is computed by dividing net earnings available to common shareholders in a given period by the weighted average number of common shares outstanding during such period. In periods when earnings are positive, diluted earnings per share is calculated by dividing net earnings available to common shareholders by the weighted average number of common shares outstanding plus assumed conversions of potentially dilutive securities. For periods when we recognize a net loss, diluted loss per share is equal to basic loss per share as the impact of assumed conversions of potentially dilutive securities is considered to be antidilutive. We have granted certain stock options and shares of restricted stock, which have been treated as common share equivalents for purposes of calculating diluted earnings per share for periods in which positive earnings have been reported. Options or other instruments, which provide the ability to purchase shares of our common stock that are antidilutive, are excluded from the computation of diluted earnings per share. There were no antidilutive instruments outstanding during the three and nine months ended September 30, 2024. There were fewer than 1 million antidilutive instruments outstanding during the three and nine months ended September 30, 2023. Unconsolidated Owned Distribution Investments We paid commissions on sales through our unconsolidated funded owned distribution investments and their affiliates of approximately $16 million and $37 million for the three months ended September 30, 2024 and 2023 respectively, and $110 million and $114 million for the nine months ended September 30, 2024 and 2023, respectively. The acquisition expense is deferred and amortized in Depreciation and amortization on the accompanying unaudited Condensed Consolidated Statements of Earnings. Recent Accounting Pronouncements Adopted Pronouncements In March 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2023-02, Accounting for Investments in Tax Credit Structure Using the Proportional Amortization Method (a consensus of the Emerging Issues Task Force). The amendments in this update permit reporting entities to elect to account for their tax equity investments, regardless of the tax credit program from which the income tax credits are received, using the proportional amortization method if certain conditions are met. We adopted this standard on January 1, 2024, as required, and there was no material impact to our unaudited Condensed Consolidated Financial Statements. In June 2022, the FASB issued ASU 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. The amendments in this update affect all entities that have investments in equity securities measured at fair value that are subject to a contractual sale restriction and clarify that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The amendments also clarify that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction. Additionally, the amendments require the following disclosures for equity securities subject to contractual sale restrictions: the fair value of equity securities subject to contractual sale restrictions reflected in the balance sheet, the nature and remaining duration of the restriction(s), and the circumstances that could cause a lapse in the restriction(s). The amendments in this update do not change the principles of fair value measurement, rather, they clarify those principles when measuring the fair value of an equity security subject to a contractual sale restriction and improve current GAAP by reducing diversity in practice, reducing the cost and complexity in measuring fair value, and increasing comparability of financial information across reporting entities that hold those investments. The amendments in this update are effective for public business entities for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. We adopted this standard as of January 1, 2024, and it did not have a material impact on our unaudited Condensed Consolidated Financial Statements and related disclosures upon adoption. Pronouncements Not Yet Adopted In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments in this update improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expense categories that are regularly provided to the chief operating decision maker (CODM) and included in each reported measure of a segment’s profit or loss. In addition, the amendments enhance interim disclosure requirements that are currently required annually, clarify circumstances in which an entity can disclose multiple segment measures of profit or loss, and contain other disclosure requirements. The amendments in this update are incremental to the current requirements of Topic 280 and do not change how a public entity identifies its operating segments, aggregates those operating segments, or applies the quantitative thresholds to determine its reportable segments. The enhanced segment disclosure requirements apply retrospectively to all prior periods presented in the financial statements. The significant segment expense and other segment item amounts disclosed in prior periods shall be based on the significant segment expense categories identified and disclosed in the period of adoption. The amendments in this update are effective for all public entities for fiscal years beginning after December 15, 2023, and interim periods beginning after December 15, 2024. Early adoption is permitted, and the updates must be applied retrospectively to all periods presented in the financial statements. We did not early adopt this standard and are in the process of assessing its impact on our disclosures upon adoption. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amendments in this update enhance the transparency of the income tax disclosures by expanding on the disclosures required annually. The amendments require entities to disclose in their rate reconciliation table additional categories of information about federal, state, and foreign income taxes, in addition to providing details about the reconciling items in some categories if above a quantitative threshold. Additionally, the amendments require annual disclosure of income taxes paid (net of refunds received) disaggregated by jurisdiction based on a quantitative threshold. The amendments in this update are effective for public business entities for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. The amendments should be applied on a prospective basis, however, retrospective application is permitted. We do not currently expect to early adopt this standard and are in the process of assessing its impact on our disclosures upon adoption. In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): The amendment in this update enhances the transparency of certain expense captions by disclosing more granular information of specific expenses within those captions such as personnel cost, depreciation and amortization. The amendment also requires additional qualitative descriptions of such expenses. The amendments in this update are effective for public business entities for annual periods beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. The amendments should be applied either prospectively to financial statements issued for reporting periods after the effective date or retrospectively to all prior periods presented in the financial statements. We are currently evaluating our adoption timing and are in the process of assessing its impact on our disclosures upon adoption. Summary of Updated Significant Accounting Policies Since our Annual Report on Form 10-K for the year ended December 31, 2023, we have updated the following significant accounting policy, which has been followed in preparing the accompanying unaudited Condensed Consolidated Financial Statements: Market Risk Benefits (“MRBs”) MRBs are contracts or contract features that both provide protection to the contract holder from other-than-nominal capital market risk (equity, interest rate, and foreign exchange risk) and expose the Company to other-than-nominal capital market risk. MRBs include certain contract features primarily on fixed index annuity ("FIA") products that provide minimum guarantees to policyholders, such as guaranteed minimum death benefit, guaranteed minimum withdrawal benefit (“GMWB”) riders, and guaranteed minimum accumulation benefit riders. In certain reinsurance transactions, the underlying risks ceded to a reinsurer contain MRBs. MRBs (inclusive of reinsured MRBs) are measured at fair value using an attributed fee measurement approach, where attributed fees are explicit rider charges collectible from the policyholder (or paid to the reinsurer) used to cover the excess benefits, which represent expected benefits in excess of the policyholder’s account value. At contract inception, an attributed fee ratio is calculated equal to rider charges over benefits paid in excess of the account value attributable to the MRBs. The attributed fee ratio remains static over the life of the MRBs and is capped at 100%. Each period subsequent to contract inception, the attributed fee ratio is used to calculate the fair value of the MRBs using a risk neutral valuation method and is based on current net amounts at risk, market data, internal and industry experience, and other factors. The balances are computed using assumptions including mortality, full and partial surrender, GMWB utilization, risk-free rates including non-performance spread and risk margin, market value of options, and economic scenarios. Policyholder behavior assumptions are reviewed at least annually, typically in the third quarter, for any revisions. Reinsured MRBs are valued using a methodology consistent with direct MRBs, with the exception of the non-performance spread, which reflects the credit of the reinsurer. MRBs can either be in an asset or liability position and are presented separately on the unaudited Condensed Consolidated Balance Sheets as the right of setoff criteria are not met. Changes in fair value, net, are recognized in Market risk benefits (gains) losses in the unaudited Condensed Consolidated Statements of Earnings, except for the change in fair value due to a change in our instrument-specific credit risk, which is recognized in the unaudited Condensed Consolidated Statements of Comprehensive Earnings. See a description of the fair value methodology used in Note C Fair Value of Financial Instruments and Note P Market Risk Benefits .

Summary of Reserve for Title Cl

Summary of Reserve for Title Claim Losses	9 Months Ended
	Sep. 30, 2024
Insurance [Abstract]
Summary of Reserve for Title Claim Losses	Summary of Reserve for Title Claim Losses A summary of the reserve for title claim losses follows: Nine months ended September 30, 2024 2023 (In millions) Beginning balance $ 1,770 $ 1,810 Change in insurance recoverable (14) (1) Claim loss provision related to: Current year 168 157 Total title claim loss provision 168 157 Claims paid, net of recoupments related to: Current year (13) (8) Prior years (191) (190) Total title claims paid, net of recoupments (204) (198) Ending balance of claim loss reserve for title insurance $ 1,720 $ 1,768 Provision for title insurance claim losses as a percentage of title insurance premiums 4.5 % 4.5 % Several lawsuits were filed by various parties against Chicago Title Company and Chicago Title Insurance Company as its principal (collectively, the “Named Companies”) by plaintiffs claiming they were investors who were solicited by Gina Champion-Cain through her former company, ANI Development LLC (“ANI”), or other affiliates to provide funds placed in an escrow account that purportedly were to be used for high-interest, short-term loans to parties seeking to acquire California alcoholic beverage licenses. Plaintiffs further alleged that employees of Chicago Title Company assisted Ms. Champion-Cain and her entities in diverting the funds placed into an escrow account maintained by Chicago Title Company into which some of the plaintiffs’ funds were deposited. In connection with the alcoholic beverage license scheme, the SEC filed a civil enforcement proceeding asserting claims for securities fraud against Champion-Cain and ANI in a lawsuit styled, Securities and Exchange Commission v. Gina Champion-Cain and ANI Development, LLC , pending in the United States District Court for the Southern District of California. The receiver, who was appointed by the court to preserve the assets of the defendant affiliated entities, then filed a lawsuit in San Diego County Superior Court against the Named Companies seeking damages in a lawsuit styled, Krista Freitag v. Chicago Title Co. and Chicago Title Ins. Co. The Named Companies reached a global settlement with the receiver and several other investor claimants and jointly sought court approval of the global settlement and entry of an order barring any claims against the Named Companies related to the alcoholic beverage license scheme. On November 23, 2022, the federal court overruled any objections by non-joining investors and entered an order approving the global settlement barring further claims against the Named Companies (“Settlement and Bar Order”). After her receipt of the settlement funds, the receiver dismissed the lawsuit against the Named Companies. Some of the non-joining investor claimants who objected to entry of the Settlement and Bar Order appealed the decision to the United States Court of Appeals for the Ninth Circuit by (Cases 22-56206, 22-56208, and 23-55083). Appellate oral argument was held on August 13, 2024, and a decision is pending with the court. Chicago Title Company has also resolved a number of other pre-suit claims and previously-disclosed lawsuits from both individual and groups of alleged investors under confidential terms. Based on the facts and circumstances of the remaining claims, including the settlements already reached, we have recorded reserves included in our reserve for title claim losses, which we believe are adequate to cover losses related to this matter, and believe that our reserves for title claim losses are adequate. We continually upda te loss reserve estimates as new information becomes known, new loss patterns emerge, or as other contributing factors are considered and incorporated into the analysis of reserve for claim losses. Estimating future title loss payments is difficult because of the complex nature of title claims, the long periods of time over which claims are paid, significantly varying dollar amounts of individual claims, and other factors. Due to the uncertainty inherent in the process and to the judgment used by management, the ultimate liability may be greater or less than our current reserves. If actual claims loss development varies from what is currently expected and is not offset by other factors, additional reserve adjustments may be required in future periods to maintain our recorded reserve within a reasonable range of our actuary's central estimate. Our U.S. insurance subsidiaries, FGL Insurance, FGL NY Insurance, Raven Re and Corbeau Re file financial statements with state insurance regulatory authorities and, with the exception of Raven Re, with the National Association of Insurance Commissioners (“NAIC”) that are prepared in accordance with Statutory Accounting Principles (“SAP”) prescribed or permitted by such authorities, which may vary materially from GAAP. Prescribed SAP includes the Accounting Practices and Procedures Manual of the NAIC as well as state laws, regulations and administrative rules. Permitted SAP encompasses all accounting practices not so prescribed. The principal differences between SAP financial statements and financial statements prepared in accordance with GAAP are that SAP financial statements do not reflect VOBA, DAC, and DSI, some bond portfolios may be carried at amortized cost, assets and liabilities are presented net of reinsurance, contractholder liabilities are generally valued using more conservative assumptions and certain assets are non-admitted. Accordingly, SAP operating results and SAP capital and surplus may differ substantially from amounts reported in the GAAP basis financial statements for comparable items. Our non-U.S. insurance subsidiaries, F&G Cayman Re Ltd (“F&G Cayman Re”) and F&G Life Re Ltd (Bermuda), file financial statements with their respective regulators. U.S. Companies Our principal insurance subsidiaries' statutory financial statements are based on a December 31 year end. Statutory net income for the three and nine months ended September 30, 2024 and September 30, 2023, and statutory capital and surplus as ofSeptember 30, 2024 and December 31, 2023 of our insurance subsidiaries were as follows (in millions): Subsidiary (state of domicile) (a) FGL Insurance FGL NY Insurance (NY) Raven Re Corbeau Re Statutory net income (loss): For the three months ended September 30, 2024 $ (6) $ 1 $ 13 $ 5 For the three months ended September 30, 2023 94 (1) 14 — For the nine months ended September 30, 2024 71 7 41 (394) For the nine months ended September 30, 2023 54 4 42 — Statutory capital and surplus: September 30, 2024 $ 1,704 $ 95 $ 156 $ 139 December 31, 2023 2,009 86 140 171 (a) FGL NY Insurance, Raven Re, and Corbeau Re are subsidiaries of FGL Insurance, and the columns should not be added together. Corbeau Re was incorporated on September 1, 2023. Non-U.S. Companies Our non-U.S. insurance subsidiaries, F&G Cayman Re and F&G Life Re, file financial statements with their respective regulators. As of and for the annual period ended December 31, 2023, F&G Cayman Re began to file financial statements that are prepared in accordance with SAP prescribed or permitted by such authorities, which may vary materially from GAAP. Accordingly, SAP operating results and SAP capital and surplus may differ substantially from amounts reported in the GAAP basis financial statements for comparable items. F&G Cayman Re has two permitted practices which have been approved by the Cayman Islands Monetary Authority (“CIMA”). F&G Cayman Re has a permitted practice approved by CIMA to include, as an admitted asset, the value of the letters of credit (“LOCs”) acquired to support reinsurance transactions. Also, F&G Cayman Re has a permitted practice, approved by CIMA, for PRT reinsurance transactions to use U.S. statutory book value adjusted for best estimate reserve calculations (consistent with GAAP prior to ASU 2018-12, Financial Services-Insurance (Topic 944), Targeted Improvements to the Accounting for Long-Duration Contracts). These reserve calculations will be subject to annual assumption reviews consistent with other GAAP liability balances. If F&G Cayman Re had not been permitted to calculate PRT assumed reserves using best estimate reserve calculations or include the value of the LOCs as an admitted asset, statutory surplus would be $29 million and $102 million as of September 30, 2024 and December 31, 2023, respectively. Without such permitted statutory accounting practices, F&G Cayman Re’s risk-based capital would fall below the minimum regulatory requirements as of September 30, 2024 and December 31, 2023. F&G Life Re files financial statements based on GAAP. Net income and capital and surplus of our wholly owned Cayman Islands and Bermuda regulated insurance subsidiaries under SAP and GAAP, respectively, were as follows (in millions): Subsidiary (country of domicile) F&G Cayman Re (Cayman Islands) F&G Life Re (Bermuda) Statutory net income (loss): For the three months ended September 30, 2024 $ (11) $ 102 For the three months ended September 30, 2023 6 (80) For the nine months ended September 30, 2024 $ (27) $ 181 For the nine months ended September 30, 2023 13 (6) Statutory capital and surplus: September 30, 2024 $ 625 $ 195 December 31, 2023 543 11 There have been no material changes to the prescribed and permitted practices for our U.S. insurance subsidiaries, which were detailed in our Annual Report on Form 10-K, and no other significant changes in the regulatory status of our insurance subsidiaries as of September 30, 2024. The prescribed and permitted statutory accounting practices have no impact on our unaudited Condensed Consolidated Financial Statements, which are prepared in accordance with GAAP.

Fair Value of Financial Instrum

Fair Value of Financial Instruments	9 Months Ended
	Sep. 30, 2024
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments Our measurement of fair value is based on assumptions used by market participants in pricing the asset or liability, which may include inherent risk, restrictions on the sale or use of an asset, or non-performance risk, which may include our own credit risk. We estimate an exchange price is the price in an orderly transaction between market participants to sell the asset or transfer the liability in the principal market, or the most advantageous market for that asset or liability in the absence of a principal market as opposed to the price that would be paid to acquire the asset or assume a liability. We categorize financial instruments carried at fair value into a three-level fair value hierarchy, based on the priority of inputs to the respective valuation technique, along with net asset value. The three-level hierarchy for fair value measurement is defined as follows: Level 1 - Values are unadjusted quoted prices for identical assets and liabilities in active markets accessible at the measurement date. Level 2 - Inputs include quoted prices for similar assets or liabilities in active markets, quoted prices from those willing to trade in markets that are not active, or other inputs that are observable or can be corroborated by market data for the term of the instrument. Such inputs include market interest rates and volatilities, spreads, and yield curves. Level 3 - Certain inputs are unobservable (supported by little or no market activity) and significant to the fair value measurement. Unobservable inputs reflect the Company’s best estimate of what hypothetical market participants would use to determine a transaction price for the asset or liability at the reporting date based on the best information available in the circumstances. Net Asset Value (" NAV ") - Certain equity investments are measured using NAV as a practical expedient in determining fair value. In addition, our unconsolidated affiliates (primarily limited partnerships) are primarily accounted for using the equity method of accounting with fair value determined using NAV as a practical expedient. Our carrying value reflects our pro rata ownership percentage as indicated by NAV in the unconsolidated affiliate's financial statements, which we may adjust if we determine NAV is not calculated consistent with investment company fair value principles. The underlying investments of the unconsolidated affiliates may have significant unobservable inputs, which may include, but are not limited to, comparable multiples and weighted average cost of capital rates applied in valuation models or a discounted cash flow model. Additionally, management inquires quarterly with the general partner to determine whether any credit or other market events have occurred since prior period financial statements to ensure any material events are properly included in current period valuation and investment income. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment’s level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment. When a determination is made to classify an asset or liability within Level 3 of the fair value hierarchy, the determination is based upon the significance of the unobservable inputs to the overall fair value measurement. Because certain securities trade in less liquid or illiquid markets with limited or no pricing information, the determination of fair value for these securities is inherently more difficult. In addition to the unobservable inputs, Level 3 fair value investments may include observable components, which are components that are actively quoted or can be validated to market-based sources. The estimated fair values of our financial instruments for which the disclosure of fair values is required, including financial assets and liabilities measured and carried at fair value on a recurring basis, with the exception of investment contracts, portions of other long-term investments and debt, which are disclosed later within this footnote, was summarized according to the hierarchy previously described, as follows: September 30, 2024 Level 1 Level 2 Level 3 NAV Fair Value Assets (In millions) Cash and cash equivalents $ 4,970 $ — $ — $ — $ 4,970 Fixed maturity securities, available-for-sale: Asset-backed securities ("ABS") — 7,779 8,184 — 15,963 Commercial mortgage-backed securities — 5,179 — — 5,179 Corporates 78 19,166 2,728 — 21,972 Hybrids 37 559 — — 596 Municipals — 1,515 — — 1,515 Residential mortgage-backed securities — 2,597 3 — 2,600 U.S. Government 797 6 — — 803 Foreign Governments — 307 5 — 312 Short term investments 1,013 8 156 — 1,177 Preferred securities 199 253 8 — 460 Equity securities 657 — 13 59 729 Derivative investments — 1,401 — — 1,401 Investment in unconsolidated affiliates — — 272 — 272 Market risk benefits asset — — 134 — 134 Other assets — — 55 — 55 Other long-term investments — — 38 — 38 Total financial assets at fair value $ 7,751 $ 38,770 $ 11,596 $ 59 $ 58,176 Liabilities Derivatives: Indexed annuities/indexed universal life insurance ("IUL") embedded derivatives, included in contractholder funds — — 5,411 — 5,411 Reinsurance related embedded derivative — 34 — — 34 Equity options 5 — — — 5 Contingent consideration obligation — — 69 — 69 Market risk benefits liability — — 603 — 603 Total financial liabilities at fair value $ 5 $ 34 $ 6,083 $ — $ 6,122 December 31, 2023 Level 1 Level 2 Level 3 NAV Fair Value Assets (In millions) Cash and cash equivalents $ 2,767 $ — $ — $ — $ 2,767 Fixed maturity securities, available-for-sale: Asset-backed securities — 7,220 7,122 — 14,342 Commercial mortgage-backed securities — 4,457 18 — 4,475 Corporates 25 15,892 1,979 — 17,896 Hybrids 95 523 — — 618 Municipals — 1,562 49 — 1,611 Residential mortgage-backed securities — 2,426 3 — 2,429 U.S. Government 662 16 — — 678 Foreign Governments — 308 16 — 324 Short term investments 2,111 8 — — 2,119 Preferred securities 214 399 8 — 621 Equity securities 692 — 15 59 766 Derivative investments — 740 57 — 797 Investment in unconsolidated affiliates — — 285 — 285 Reinsurance related embedded derivative, included in other assets — 152 — — 152 Market risk benefits asset — — 88 — 88 Other long-term investments — — 37 — 37 Total financial assets at fair value $ 6,566 $ 33,703 $ 9,677 $ 59 $ 50,005 Liabilities Derivatives: Indexed annuities/IUL embedded derivatives, included in contractholder funds $ — $ — $ 4,258 $ — $ 4,258 Market risk benefits liability — — 403 — 403 Equity options 1 — — 1 Total financial liabilities at fair value $ 1 $ — $ 4,661 $ — $ 4,662 Valuation Methodologies Cash and Cash Equivalents The carrying amounts reported in the unaudited Condensed Consolidated Balance Sheets for these instruments approximate fair value. Fixed Maturity Preferred and Equity Securities We measure the fair value of our securities based on assumptions used by market participants in pricing the security. The most appropriate valuation methodology is selected based on the specific characteristics of the fixed maturity, preferred or equity security, and we will then consistently apply the valuation methodology to measure the security’s fair value. Our fair value measurement is based on a market approach, which utilizes prices and other relevant information generated by market transactions involving identical or comparable securities. Sources of inputs to the market approach include third-party pricing services, independent broker quotations, or pricing matrices. We use observable and unobservable inputs in our valuation methodologies. Observable inputs include benchmark yields, reported trades, broker-dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, and reference data including market research publications. In addition, market indicators and industry and economic events are monitored and further market data will be acquired when certain thresholds are met. For certain security types, additional inputs may be used, or some of the inputs described above may not be applicable. The significant input used in the fair value measurement of equity securities for which the market approach valuation technique is employed is yield for comparable securities. Increases or decreases in the yields would result in lower or higher, respectively, fair value measurements. For broker-quoted only securities, quotes from market makers or broker-dealers are obtained from sources recognized to be market participants. We believe the broker quotes are prices at which trades could be executed based on historical trades executed at broker-quoted or slightly higher prices. We analyze the third-party valuation methodologies and related inputs to perform assessments to determine the appropriate level within the fair value hierarchy. However, we did not adjust prices received from third parties as of September 30, 2024 or December 31, 2023. Certain equity investments are measured using NAV as a practical expedient in determining fair value. Derivative Financial Instruments Our call options and put options (together referred to as “equity options”), futures contracts, and interest rate swaps can either be exchange traded or over the counter. Exchange traded derivatives typically fall within Level 1 of the fair value hierarchy if there is active trading activity. Two methods are used to value over-the-counter derivatives. When required inputs are available, certain derivatives are valued using valuation pricing models, which represent what we would expect to receive or pay at the balance sheet date if we cancelled or exercised the derivative, or entered into offsetting positions. Valuation models require a variety of inputs, which include the use of market-observable inputs, including interest rate, yield curve volatilities, and other factors. These over-the-counter derivatives are typically classified within Level 2 of the fair value hierarchy as the majority trade in liquid markets, we can verify model inputs and model selection does not involve significant management judgment. When inputs aren’t available for valuation models, certain over-the-counter derivatives are valued using independent broker quotes, which are based on unobservable market data and classified within Level 3. Effective September 30, 2024, pricing for certain derivatives was obtained from internal models using substantially all market observable inputs, and those derivatives were transferred out of Level 3 to Level 2. The fair value of the reinsurance-related embedded derivatives in our funds withheld reinsurance agreements are estimated based upon the fair value of the assets supporting the funds withheld from reinsurance liabilities. The fair value of the assets is based on a quoted market price of similar assets (Level 2), and therefore the fair value of the embedded derivative is based on market-observable inputs and classified as Level 2. The fair value measurement of the indexed annuities/IUL embedded derivatives included in contractholder funds is determined through a combination of market observable information and significant unobservable inputs using the option budget method. The market observable inputs are the market value of option and treasury rates. The significant unobservable inputs are the budgeted option cost (i.e., the expected cost to purchase equity options in future periods to fund the equity indexed linked feature), surrender rates, mortality multiplier, and non-performance spread. The mortality multiplier as of September 30, 2024 and December 31, 2023 was applied to the 2012 Individual Annuity mortality tables. Increases or decreases in the market value of an option in isolation would result in a higher or lower, respectively, fair value measurement. Increases or decreases in treasury rates, mortality multiplier, surrender rates, or non-performance spread in isolation would result in a lower or higher fair value measurement, respectively. Generally, a change in any one unobservable input would not directly result in a change in any other unobservable input. Investments in Unconsolidated affiliates We have elected the fair value option (“FVO”) for certain investments in unconsolidated affiliates as we believe this better aligns them with other investments in unconsolidated affiliates that are measured using NAV as a practical expedient in determining fair value. Investments measured using the FVO are included in Level 3 and the fair values of these investments are determined using a multiple of the affiliates’ EBITDA. The EBITDA is based on the affiliates’ financial information. The multiple is derived from market analysis of transactions involving comparable companies. The inputs are considered unobservable, as not all market participants have access to this data. Short-term Investments The carrying amounts reported in the unaudited Condensed Consolidated Balance Sheets for these instruments approximate fair value. Other Long-term Investments We hold a fund-linked note, which provides for an additional payment at maturity based on the value of an embedded derivative based on the actual return of a dedicated return fund. Fair value of the embedded derivative is based on an unobservable input, the NAV of the fund at the balance sheet date. The embedded derivative is similar to an equity option on the NAV of the fund with a strike price of zero since F&G will not be required to make any additional payments at maturity of the fund-linked note in order to receive the NAV of the fund on the maturity date. A Black-Scholes model determines the NAV of the fund as the fair value of the equity option regardless of the values used for the other inputs to the option pricing model. The NAV of the fund is provided by the fund manager at the end of each calendar month and represents the value an investor would receive if it withdrew its investment on the balance sheet date. Therefore, the key unobservable input used in the Black-Scholes model is the value of the fund. As the value of the fund increases or decreases, the fair value of the embedded derivative will increase or decrease. See further discussion on the available-for-sale embedded derivative in Note E Derivative Financial Instruments . The fair value of the credit-linked note is based on a weighted average of a broker quote and a discounted cash flow analysis. The discounted cash flow approach is based on the expected portfolio cash flows and amortization schedule reflecting investment expectations, adjusted for assumptions on the portfolio's default and recovery rates, and the note's discount rate. The fair value of the note is provided by the fund manager at the end of each quarter. Other Assets Mortgage servicing rights are measured at fair value using a discounted cash flow model, which incorporates assumptions that market participants use in estimating future net servicing income cash flows. These assumptions include estimates of prepayment rates, discount rates, cost to service (including delinquency and foreclosure costs), escrow account earnings, contractual servicing fee income, and ancillary income. Contingent Consideration The contingent consideration liability is measured at fair value using a discounted cash flow model applied using a Monte Carlo simulation of estimated EBITDA at each measurement period and for each simulated path relative to contractual EBITDA milestones. The Monte Carlo simulation utilizes a risk-adjusted discount rate, volatility assumption, and risk-free rates to assess the probability Roar's EBITDA trajectory reaches required milestones for the earn out payments to be made. The discounted cash flow approach applies a company-specific discount rate based on F&G credit profile to future expected earn out payments to calculate the estimated fair value based on the average outcome from the simulation. See further discussion on the contingent consideration in Note N Acquisitions. MRBs MRBs (inclusive of reinsured MRBs) are measured at fair value using an attributed fee measurement approach where attributed fees are explicit rider charges collectible from the policyholder (or paid to the reinsurer) used to cover the excess benefits. The fair value is calculated using a risk neutral valuation method and is based on current net amounts at risk, market data, internal and industry experience, and other factors. The balances are computed using assumptions including mortality, full and partial surrender, rider benefit utilization, risk-free rates including non-performance spread and risk margin, market value of options, and economic scenarios. Policyholder behavior assumptions are reviewed at least annually, typically in the third quarter, for any revisions. Reinsured MRBs are valued using a methodology consistent with direct MRBs, with the exception of the non-performance spread, which reflects the credit of the reinsurer. See further discussion on MRBs in Note P Market Risk Benefits . Quantitative information regarding significant unobservable inputs used for recurring Level 3 fair value measurements of financial instruments carried at fair value as of September 30, 2024 and December 31, 2023 are as follows: Fair Value as of Valuation Technique Unobservable Input(s) Range (Weighted average) September 30, 2024 (In millions) September 30, 2024 Assets Asset-backed securities $ 99 Third-Party Valuation Discount Rate 4.82% - 6.71% (5.83%) Corporates 4 Discounted Cash Flow Discount Rate 29.17% - 100.00% (73.00%) Corporates 741 Third-Party Valuation Discount Rate 3.55% - 20.69% (6.47%) Residential mortgage-backed securities 3 Third-Party Valuation Discount Rate 5.19% - 5.19% (5.19%) Foreign Governments 5 Third-Party Valuation Discount Rate 6.91% - 6.91% (6.91%) Investment in unconsolidated affiliates 272 Market Comparable Company Analysis EBITDA Multiple 8.8x - 15.1x (11.7x) Preferred securities 1 Discounted Cash Flow Discount rate 100.00% - 100.00% (100.00%) Equity securities 7 Discounted Cash Flow Discount rate 11.20% - 11.20% (11.20%) Market Comparable Company Analysis EBITDA multiple 5.1x - 5.1x (5.1x) Other assets 55 Discounted Cash Flow Discount Rate 9.27% - 13.40% (11.34%) Conditional Prepayment Rate 6.67% -15.71% (11.19%) Other long-term investments: Available-for-sale embedded derivative 34 Black Scholes Model Market Value of AnchorPath Fund 100.00% Market risk benefits asset 134 Discounted Cash Flow Mortality 80.00% - 115.00% (100.00%) Surrender Rates 0.25% - 30.00% (5.22%) Partial Withdrawal Rates 2.00% - 24.39% (2.48%) Non-Performance Spread 0.30% - 0.98% (0.82%) GMWB Utilization 50.00% - 60.00% (50.57%) Total financial assets at fair value (a) $ 1,355 Liabilities Derivatives: Indexed annuity/ IUL embedded derivatives, included in contractholder funds $ 5,411 Discounted Cash Flow Market Value of Option 0.00% - 30.14% (4.21%) Mortality Multiplier 80.00% - 115.00% (100.00%) Surrender Rates 0.25% - 50.00% (7.23%) Partial Withdrawals 2.00% - 35.71% (2.72%) Non-Performance Spread 0.30% - 0.98% (0.82%) Option Cost 0.07% - 5.70% (2.61%) Contingent consideration 69 Discounted Cash Flow Risk-Adjusted Discount Rate 13.00% - 13.00% (13.00%) EBITDA Volatility 35.00% - 35.00% (35.00%) Counterparty Discount Rate 6.00% - 6.00% (6.00%) Market risk benefits liability 603 Discounted Cash Flow Mortality 80.00% - 115.00% (100.00%) Surrender Rates 0.25% - 30.00% (5.22%) Partial Withdrawal Rates 2.00% - 24.39% (2.48%) Non-Performance Spread 0.30% - 0.98% (0.82%) GMWB Utilization 50.00% - 60.00% (50.57%) Total financial liabilities at fair value $ 6,083 (a) Assets of $10,241 million for which significant quantitative unobservable inputs are not developed internally and not readily available to the Company (primarily those valued using broker quotes and certain third-party pricing services) are excluded from the respective totals in the table above. Fair Value as of Valuation Technique Unobservable Input(s) Range (Weighted average) December 31, 2023 (In millions) December 31, 2023 Assets Asset-backed securities $ 57 Third-Party Valuation Discount Rate 5.09% - 6.95% (6.00%) Corporates 787 Third-Party Valuation Discount Rate 0.00% - 12.87% (6.91%) Corporates 8 Discounted Cash Flow Discount Rate 44.00% - 100.00% (75.20%) Municipals 32 Third-Party Valuation Discount Rate 6.25% - 6.25% (6.25%) Residential mortgage-backed securities 3 Third-Party Valuation Discount Rate 5.46% - 5.46% (5.46%) Foreign Governments 16 Third-Party Valuation Discount Rate 6.94% - 7.68% (7.45%) Investment in unconsolidated affiliates 285 Market Comparable Company Analysis EBITDA Multiple 4.4x - 31.8x (23.2x) Preferred securities 1 Discounted Cash Flow Discount rate 100.00% Equity securities 7 Discounted Cash Flow Discount rate 11.50% - 11.50% (11.50%) Other long-term investments: Available-for-sale embedded derivative 28 Black Scholes Model Market Value of Fund 100.00% Market risk benefits asset 88 Discounted Cash Flow Mortality 100.00% - 100.00% (100.00%) Surrender Rates 0.25% - 10.00% (5.22%) Partial Withdrawal Rates 0.00% -23.26% (2.50%) Non-Performance Spread 0.38% - 1.10% (0.96%) GMWB Utilization 50.00% -60.00% (50.81%) Total financial assets at fair value (a) $ 1,312 Liabilities Derivatives Indexed annuity/ IUL embedded derivatives, included in contractholder funds $ 4,258 Discounted Cash Flow Market Value of Option 0.00% - 18.93% (2.63%) Mortality Multiplier 100.00% - 100.00% (100.00%) Surrender Rates 0.25% - 70.00% (6.83%) Partial Withdrawals 2.00% - 34.48% (2.74%) Non-Performance Spread 0.38% - 1.10% (0.96%) Option Cost 0.07% - 5.48% (2.38%) Market risk benefits liability 403 Discounted Cash Flow Mortality 100.00% - 100.00% (100.00%) Surrender Rates 0.25% - 10.00% (5.22%) Partial Withdrawal Rates 0.00% - 23.26% (2.50%) Non-Performance Spread 0.38% - 1.10% (0.96%) GMWB Utilization 50.00% - 60.00% (50.81%) Total financial liabilities at fair value $ 4,661 (a) Assets of $8,365 million for which significant quantitative unobservable inputs are not developed internally and not readily available to the Company (primarily those valued using broker quotes and certain third-party pricing services) are excluded from the table above. The following tables summarize changes to the Company’s financial instruments carried at fair value and classified within Level 3 of the fair value hierarchy for the three and nine months ended September 30, 2024 and 2023. The gains and losses below may include changes in fair value due in part to observable inputs that are a component of the valuation methodology. Three months ended September 30, 2024 Balance at Beginning Total (Losses) Gains Purchases Sales Settlements Net Transfer Out of Balance at End of Change in Unrealized Included in OCI Included in Included in Assets (In millions) Fixed maturity securities available-for-sale: Asset-backed securities $ 8,042 $ (3) $ 77 $ 515 $ (30) $ (358) $ (59) $ 8,184 $ 77 Commercial mortgage-backed securities 15 — — — — — (15) — — Corporates 2,355 (2) 67 354 — (43) (3) 2,728 64 Residential mortgage-backed securities 3 — — — — — — 3 — Foreign Governments 5 — — — — — — 5 — Preferred securities 8 — — — — — — 8 — Equity securities 13 — — — — — — 13 — Interest Rate Swaps 8 — (1) — — — (7) — — Investment in unconsolidated affiliates (b) 358 6 — — — — (92) 272 — Short term investments 71 — — 85 — — — 156 — Other assets 50 (3) — 8 — — — 55 — Other long-term investments: Available-for-sale embedded derivative 31 — 3 — — — — 34 3 Credit linked note 6 — — — — (2) — 4 — Subtotal Level 3 assets at fair value $ 10,965 $ (2) $ 146 $ 962 $ (30) $ (403) $ (176) $ 11,462 $ 144 Market risk benefits asset (c) 103 134 Total Level 3 assets at fair value $ 11,068 $ 11,596 Liabilities Indexed annuity/ IUL embedded derivatives, included in contractholder funds 4,848 308 — 390 — (135) — 5,411 — Interest rate swaps 28 — — — — — (28) — — Contingent consideration 63 6 — — — — — 69 — Subtotal Level 3 liabilities at fair value $ 4,939 $ 314 $ — $ 390 $ — $ (135) $ (28) $ 5,480 $ — Market risk benefits liability (c) 459 603 Total Level 3 liabilities at fair value $ 5,398 $ 6,083 (a) The net transfers out of Level 3 during the three months ended September 30, 2024 were exclusively to Level 2. (b) The transfer out of investments in unconsolidated affiliates represents F&G’s 30% ownership of PALH prior to the majority acquisition on July 18, 2024. Refer to Note N Acquisitions for details of the PALH majority acquisition. (c) Refer to Note P Market Risk Benefits for roll forward activity of the net Market risk benefits asset and liability. Three months ended September 30, 2023 Balance at Beginning Total (Losses) Gains Purchases Sales Settlements Net Transfer Out of Balance at End of Change in Unrealized Included in OCI Included in Included in Assets (In millions) Fixed maturity securities available-for-sale: Asset-backed securities $ 6,510 $ (45) $ 75 $ 536 $ (27) $ (171) $ (121) $ 6,757 $ 75 Commercial mortgage-backed securities 17 — — 10 — — — 27 — Corporates 1,628 — (21) 162 — (24) (1) 1,744 (21) Municipals 49 — (2) — — — — 47 (2) Residential mortgage-backed securities 28 — (1) — — (1) (23) 3 (1) Foreign Governments 16 — — — — — — 16 — Investment in unconsolidated affiliates 197 — — 75 — — — 272 — Short term investments 126 — — 65 (19) (103) — 69 — Preferred securities 7 — 1 — — — — 8 1 Equity securities 14 1 — — — — — 15 — Other long-term investments: Available-for-sale embedded derivative 26 — (3) — — — — 23 (3) Credit linked note 13 — — — — (1) — 12 — Secured borrowing receivable 10 — — — — — — 10 — Subtotal Level 3 assets at fair value $ 8,641 $ (44) $ 49 $ 848 $ (46) $ (300) $ (145) $ 9,003 $ 49 Market risk benefits asset (b) 118 118 Total Level 3 assets at fair value $ 8,759 $ 9,121 Liabilities Indexed annuity/IUL embedded derivatives, included in contractholder funds 3,821 (796) — 576 — (45) — 3,556 — Interest rate swaps — 16 — — — — — 16 Subtotal Level 3 liabilities at fair value $ 3,821 $ (780) $ — $ 576 $ — $ (45) $ — $ 3,572 $ — Market risk benefits liability (b) 313 278 Total Level 3 liabilities at fair value $ 4,134 $ 3,850 (a) The net transfers out of Level 3 during the three months ended September 30, 2023 were exclusively to Level 2. (b) Refer to Note P Market Risk Benefits for roll forward activity of the net Market risk benefits asset and liability. Nine months ended September 30, 2024 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Change in Unrealized Included in OCI Included in Included in Assets (In millions) Fixed maturity securities available-for-sale: Asset-backed securities $ 7,122 $ 12 $ 187 $ 1,981 $ (109) $ (904) $ (105) $ 8,184 $ 184 Commercial mortgage-backed securities 18 — — 58 — — (76) — — Corporates 1,979 (2) 79 873 (96) (85) (20) 2,728 77 Municipals 49 — 1 — (50) — — — 1 Residential mortgage-backed securities 3 — — 1 — — (1) 3 — Foreign Governments 16 — — — — (11) — 5 — Preferred securities 8 — — — — — — 8 — Equity securities 15 (2) — — — — — 13 — Interest Rate Swaps 57 (50) — — — — (7) — 1 Investment in unconsolidated affiliates (b) 285 79 — — — — (92) 272 — Other assets — (3) — 58 — — — 55 — Short term investments — — — 156 — — — 156 — Other long-term investments: Available-for-sale embedded derivative 27 — 7 — — — — 34 7 Credit linked note 10 1 — — — (7) — 4 — Subtotal Level 3 assets at fair value $ 9,589 $ 35 $ 274 $ 3,127 $ (255) $ (1,007) $ (301) $ 11,462 $ 270 Market risk benefits asset (c) 88 134 Total Level 3 assets at fair value $ 9,677 $ 11,596 Liabilities Indexed annuity/ IUL embedded derivatives, included in contractholder funds $ 4,258 $ 452 $ — $ 1,011 $ — $ (310) $ — $ 5,411 $ — Interest rate swaps — 28 — — — — (28) — — Contingent consideration (d) — 21 — 48 — — — 69 — Subtotal Level 3 liabilities at fair value $ 4,258 $ 501 $ — $ 1,059 $ — $ (310) $ (28) $ 5,480 $ — Market risk benefits liability (c) 403 603 Total Level 3 liabilities at fair value $ 4,661 $ 6,083 (a) The net transfers out of Level 3 during the three months ended September 30, 2024 were exclusively to Level 2. (b) The transfer out of investments in unconsolidated affiliates represents F&G’s 30% ownership of PALH prior to the majority acquisition on July 18, 2024. Refer to Note N Acquisitions for details of the PALH majority acquisition. (c) Refer to Note P Market Risk Benefits for roll forward activity of the net Market risk benefits asset and liability. (d) The initial contingent consideration recorded in the Roar transaction is included in purchases in the table above. Refer to Note N Acquisition for more information. Nine months ended September 30, 2023 Balance at Beginning Total (Losses) Gain Purchases Sales Settlements Net Transfer (Out) In of Balance at End of Change in Unrealized Included in OCI Included in Included in Assets (In millions) Fixed maturity securities available-for-sale: Asset-backed securities $ 6,263 $ (56) $ 108 $ 1,331 $ (125) $ (557) $ (207) $ 6,757 $ 107 Commercial mortgage-backed securities 37 — 1 22 — — (33) 27 1 Corporates 1,440 (1) (77) 423 (1) (43) 3 1,744 (77) Municipals 29 — 18 — — — — 47 18 Residential mortgage-backed securities 302 1 7 32 — (9) (330) 3 7 Foreign Governments 16 — — — — — — 16 — Investment in unconsolidated affiliates 23 — — 249 — — — 272 — Short term investments — — — 191 (19) (103) — 69 — Preferred securities 1 — 1 — — — 6 8 1 Equity securities 10 1 — — — — 4 15 — Other long-term investments: Available-for-sale embedded derivative 23 — — — — — — 23 — Credit linked note 15 — — — — (3) — 12 — Secured borrowing receivable 10 — — — — — — 10 — Subtotal Level 3 assets at fair value $ 8,169 $ (55) $ 58 $ 2,248 $ (145) $ (715) $ (557) $ 9,003 $ 57 Market risk benefits asset (b) 117 118 Total Level 3 assets at fair value $ 8,286 $ 9,121 Liabilities Indexed annuity/IUL embedded derivatives, included in contractholder funds 3,115 (214) — 765 — (110) — 3,556 — Interest rate swaps — 16 — — — — — 16 — Subtotal Level 3 liabilities at fair value $ 3,115 $ (198) $ — $ 765 $ — $ (110) $ — $ 3,572 $ — Market risk benefits liability (b) 282 278 Total Level 3 liabilities at fair value $ 3,397 $ 3,850 (a) The net transfers out of Level 3 during the nine months ended September 30, 2023 were exclusively to Level 2 (b) Refer to Note P Market Risk Benefits for roll forward activity of the net Market risk benefits asset and liability. Valuation Methodologies and Associated Inputs for Financial Instruments Not Carried at Fair Value The following discussion outlines the methodologies and assumptions used to determine the fair value of our financial instruments not carried at fair value. Considerable judgment is required to develop these assumptions used to measure fair value. Accordingly, the estimates shown are not necessarily indicative of the amounts that would be realized in a one-time, current market exchange of all of our financial instruments. Mortgage Loans The fair value of mortgage loans is established using a discounted cash flow method based on internal credit rating, maturity, and future income. This yield-based approach is sourced from our third-party vendor. The internal ratings for mortgages in good standing are based on property type, location, market conditions, occupancy, debt service coverage, loan-to-value, quality of tenancy, borrower, and payment record. The inputs used to measure the fair value of our mortgage loans are classified as Level 3 within the fair value hierarchy. Investments in Unconsolidated affiliates In our F&G segment, the carrying value of Investments in unconsolidated affiliates is primarily determined using NAV as a practical expedient and are included in the NAV column in the table below. Recognition of income and adjustments to the carrying amount are delayed due to the availability of the related financial statements, which are obtained from the general partner typically on a one to three-month delay. In our title segment, Investments in unconsolidated affiliates are accounted for under the equity method of accounting were $208 million and $263 million as of September 30, 2024 and December 31, 2023, respectively. Policy Loans (included within Other long-term investments) Policy loans are reported at the unpaid principal balance and are fully collateralized by the cash surrender value of underlying insurance policies. The carrying value of the policy loans approximates the fair value and are classified as Le

Investments

Investments	9 Months Ended
	Sep. 30, 2024
Investments, Debt and Equity Securities [Abstract]
Investments	1.25 1.00 - 1.25 <1.00 September 30, 2024 (In millions) LTV Ratios: Less than 50.00% $ 499 $ 8 $ 9 $ 516 20 % $ 501 21 % 50.00% to 59.99% 749 59 12 820 31 752 32 60.00% to 74.99% 1,182 57 — 1,239 48 1,074 46 75.00% to 84.99% — 6 9 15 1 15 1 CMLs $ 2,430 $ 130 $ 30 $ 2,590 100 % $ 2,342 100 % December 31, 2023 LTV Ratios: Less than 50.00% $ 519 $ 4 $ 10 $ 533 21 % $ 510 23 % 50.00% to 59.99% 764 — — 764 30 679 30 60.00% to 74.99% 1,160 56 — 1,216 48 1,028 46 75.00% to 84.99% — 6 9 15 1 14 1 CMLs (a) $ 2,443 $ 66 $ 19 $ 2,528 100 % $ 2,231 100 % (a) Excludes loans under development with an amortized cost and estimated fair value of $22 million. September 30, 2024 Amortized Cost by Origination Year 2024 2023 2022 2021 2020 Prior Total Commercial mortgages (In millions) LTV Less than 50.00% $ 58 $ 93 $ 18 $ 74 $ 189 $ 84 $ 516 50.00% to 59.99% 59 53 149 267 158 134 820 60.00% to 74.99% 23 69 113 912 122 — 1,239 75.00% to 84.99% — 6 9 — — — 15 Total CMLs $ 140 $ 221 $ 289 $ 1,253 $ 469 $ 218 $ 2,590 Commercial mortgages DSCR Greater than 1.25x $ 72 $ 161 $ 278 $ 1,241 $ 469 $ 209 $ 2,430 1.00x - 1.25x 67 60 3 — — — 130 Less than 1.00x 1 — 8 12 — 9 30 Total CMLs $ 140 $ 221 $ 289 $ 1,253 $ 469 $ 218 $ 2,590 December 31, 2023 Amortized Cost by Origination Year 2023 2022 2021 2020 2019 Prior Total Commercial mortgages (In millions) LTV Less than 50.00% $ 85 $ 17 $ 77 $ 232 $ — $ 122 $ 533 50.00% to 59.99% 53 149 267 158 — 137 764 60.00% to 74.99% 69 113 912 122 — — 1,216 75.00% to 84.99% 6 9 — — — — 15 Total CMLs (a) $ 213 $ 288 $ 1,256 $ 512 $ — $ 259 $ 2,528 Commercial mortgages DSCR Greater than 1.25x $ 154 $ 276 $ 1,256 $ 512 $ — $ 245 $ 2,443 1.00x - 1.25x 59 3 — — — 4 66 Less than 1.00x — 9 — — — 10 19 Total CMLs (a) $ 213 $ 288 $ 1,256 $ 512 $ — $ 259 $ 2,528 (a) Excludes loans under development with an amortized cost and estimated fair value of $22 million. We recognize a mortgage loan as delinquent when payments on the loan are greater than 30 days past due. At September 30, 2024, we had one CML that was delinquent in principal or interest payments as shown in the risk rating exposure table above compared to none at December 31, 2023. Residential Mortgage Loans Residential mortgage loans (“RMLs”) represented approximately 5% of our total investments as of September 30, 2024 and December 31, 2023. Our RMLs are primarily closed end, amortizing loans and 100% of the properties are located in the United States. We diversify our RML portfolio by state to attempt to reduce concentration risk. The distribution of RMLs by state with highest-to-lowest concentration are reflected in the following tables, gross of valuation allowances: September 30, 2024 Amortized Cost % of Total U.S. State: (In millions) Florida $ 160 5 % All other states (a) 2,945 95 Total RMLs, gross of valuation allowance 3,105 100 % Allowance for expected credit loss (51) Total RMLs, net of valuation allowance $ 3,054 (a) The individual concentration of each state is less than 5% as of September 30, 2024. December 31, 2023 Amortized Cost % of Total U.S. State: (In millions) Florida $ 163 6 % New York 129 5 Texas 129 5 All other states (a) 2,431 84 Total RMLs, gross of valuation allowance 2,852 100 % Allowance for expected credit loss (54) Total RMLs, net of valuation allowance $ 2,798 (a) The individual concentration of each state is less than 5% as of December 31, 2023. RMLs have a primary credit quality indicator of either a performing or nonperforming loan. We define non-performing RMLs as those that are 90 or more days past due or in non-accrual status, which is assessed monthly. The credit quality of RMLs as of September 30, 2024 and December 31, 2023, was as follows: September 30, 2024 December 31, 2023 Amortized Cost % of Total Amortized Cost % of Total Performance indicators: (In millions) (In millions) Performing $ 3,031 98 % $ 2,795 98 % Non-performing 74 2 57 2 Total RMLs, gross of valuation allowance 3,105 100 % 2,852 100 % Allowance for expected loan loss (51) (54) Total RMLs, net of valuation allowance $ 3,054 $ 2,798 There were no charge offs recorded by RMLs during the nine months ended September 30, 2024 or during the year ended December 31, 2023. RMLs segregated by aging of the loans (by year of origination) as of September 30, 2024 and December 31, 2023, were as follows, gross of valuation allowances: September 30, 2024 Amortized Cost by Origination Year 2024 2023 2022 2021 2020 Prior Total Residential mortgages (In millions) Current (less than 30 days past due) $ 387 $ 372 $ 928 $ 822 $ 168 $ 317 $ 2,994 30-89 days past due 6 3 9 8 4 7 37 90 days or more past due — 2 9 28 10 25 74 Total residential mortgages $ 393 $ 377 $ 946 $ 858 $ 182 $ 349 $ 3,105 December 31, 2023 Amortized Cost by Origination Year 2023 2022 2021 2020 2019 Prior Total Residential mortgages (In millions) Current (less than 30 days past due) $ 373 $ 985 $ 854 $ 192 $ 183 $ 192 $ 2,779 30-89 days past due — 4 7 3 — 2 16 90 days or more past due — 6 16 13 21 1 57 Total residential mortgages $ 373 $ 995 $ 877 $ 208 $ 204 $ 195 $ 2,852 Non-accrual loans by amortized cost as of September 30, 2024 and December 31, 2023, were as follows: September 30, 2024 December 31, 2023 Amortized cost of loans on non-accrual (In millions) Residential mortgage: $ 74 $ 57 Commercial mortgage: — — Total non-accrual mortgages $ 74 $ 57 Immaterial interest income was recognized on non-accrual financing receivables for the three and nine months ended September 30, 2024 and 2023. It is our policy to cease to accrue interest on loans that are delinquent for 90 days or more. For loans less than 90 days delinquent, interest is accrued unless it is determined that the accrued interest is not collectible. If a loan becomes 90 days or more delinquent, it is our general policy to initiate foreclosure proceedings unless a workout arrangement to bring the loan current is in place. As of September 30, 2024 and December 31, 2023, we had $74 million and $57 million, respectively, of mortgage loans that were over 90 days past due. As of September 30, 2024 and December 31, 2023, we had $73 million and $41 million, respectively, of residential mortgage loans that were in the process of foreclosure. Under certain circumstances, modifications are granted to mortgage loans. Generally, the types of concessions may include interest rate reduction, term extension, payment deferrals, principal forgiveness, or a combination of these concessions. We had an immaterial amount of mortgage loans modified during the three and nine month periods ended September 30, 2024 and 2023. Allowance for Expected Credit Loss We estimate expected credit losses for our commercial and residential mortgage loan portfolios using a probability of default/loss given default model. Significant inputs to this model include, where applicable, the loans' current performance, underlying collateral type, location, contractual life, LTV, DSC and Debt to Income or FICO. The model projects losses using a two year reasonable and supportable forecast and then reverts over a three year period to market-wide historical loss experience. Changes in our allowance for expected credit losses on mortgage loans are recognized in Recognized gains and losses, net in the accompanying unaudited Condensed Consolidated Statements of Earnings. The allowances for our mortgage loan portfolio are summarized as follows: Three months ended September 30, 2024 Nine months ended September 30, 2024 (In millions) (In millions) Residential Mortgage Commercial Mortgage Total Residential Mortgage Commercial Mortgage Total Beginning Balance $ (50) $ (14) $ (64) $ (54) $ (12) $ (66) Provision (expense) benefit for loan losses (1) (4) (5) 3 (6) (3) Ending Balance $ (51) $ (18) $ (69) $ (51) $ (18) $ (69) Three months ended September 30, 2023 Nine months ended September 30, 2023 (In millions) (In millions) Residential Mortgage Commercial Mortgage Total Residential Mortgage Commercial Mortgage Total Beginning Balance $ (51) $ (13) $ (64) $ (32) $ (10) $ (42) Provision (expense) benefit for loan losses 2 (2) — (17) (5) (22) Ending Balance $ (49) $ (15) $ (64) $ (49) $ (15) $ (64) An allowance for expected credit loss is not measured on accrued interest income for CMLs as we have a process to write-off interest on loans that enter into non-accrual status (90 days or more past due). Allowances for expected credit losses are measured on accrued interest income for RMLs and were immaterial for the three and nine months ended September 30, 2024 and 2023. Interest and Investment Income The major sources of Interest and investment income reported on the accompanying unaudited Condensed Consolidated Statements of Earnings were as follows: Three months ended September 30, Nine months ended September 30, 2024 2023 2024 2023 (In millions) (In millions) Fixed maturity securities, available-for-sale $ 583 $ 493 $ 1,679 $ 1,405 Equity securities 8 8 26 24 Preferred securities 7 12 25 39 Mortgage loans 69 59 200 167 Invested cash and short-term investments 72 39 172 106 Limited partnerships 84 69 234 171 Tax deferred property exchange income 36 44 102 128 Other investments 32 25 88 63 Gross investment income 891 749 2,526 2,103 Investment expense (76) (63) (218) (188) Interest and investment income $ 815 $ 686 $ 2,308 $ 1,915 Interest and investment income is shown net of amounts attributable to certain funds withheld reinsurance agreements, which is passed along to the reinsurer in accordance with the terms of these agreements. Interest and investment income attributable to these agreements, and thus excluded from the totals in the table above, was $181 million and $102 million for the three months ended September 30, 2024 and 2023, respectively, and $463 million and $236 million for the nine months ended September 30, 2024 and 2023, respectively. Recognized Gains and Losses, Net Details underlying Recognized gains and losses, net reported on the accompanying unaudited Condensed Consolidated Statements of Earnings were as follows: Three months ended September 30, Nine months ended September 30, 2024 2023 2024 2023 (In millions) (In millions) Net realized (losses) gains on fixed maturity available-for-sale securities $ (1) $ (32) $ 3 $ (137) Net realized/unrealized gains (losses) on equity securities (1) 48 (33) 48 (37) Net realized/unrealized gains (losses) on preferred securities (2) 17 1 29 (7) Net realized/unrealized gains (losses) on other invested assets 3 9 73 (20) Change in allowance for expected credit losses — (7) (32) (30) Derivatives and embedded derivatives: Realized gains (losses) on certain derivative instruments 30 (30) 65 (184) Unrealized gains (losses) on certain derivative instruments 347 (297) 450 14 Change in fair value of reinsurance related embedded derivatives (3) (178) 36 (186) 34 Change in fair value of other derivatives and embedded derivatives 3 (3) 6 — Realized gains (losses) on derivatives and embedded derivatives 202 (294) 335 (136) Recognized gains and losses, net $ 269 $ (356) $ 456 $ (367) (1) Includes net valuation gains (losses) of $31 million and $(22) million for the three months ended September 30, 2024 and 2023, respectively, and net valuation losses of $(42) million and $(12) million for the nine months ended September 30, 2024 and 2023, respectively. (2) Includes net valuation gains of $18 million and $2 million for the three months ended September 30, 2024 and 2023, respectively, and net valuation gains of $30 million and $52 million for the nine months ended September 30, 2024 and 2023, respectively. (3) Change in fair value of reinsurance related embedded derivatives is due to activity related to the reinsurance treaties. Recognized gains and losses, net is shown net of amounts attributable to certain funds withheld reinsurance agreements, which are passed along to the reinsurer in accordance with the terms of these agreements. Recognized gains and (losses) attributable to these agreements, and thus excluded from the totals in the table above, were $177 million and $(186) million for the three and nine months ended September 30, 2024, respectively, and $43 million and $42 million for the three and nine months ended September 30, 2023. The proceeds from the sale of fixed-maturity securities and the gross gains and losses associated with those transactions were as follows: Three months ended September 30, Nine months ended September 30, 2024 2023 2024 2023 (In millions) Proceeds $ 1,476 $ 880 $ 2,638 $ 1,978 Gross gains 18 — 36 7 Gross losses (20) (27) (52) (109) Unconsolidated Variable Interest Entities We own investments in variable interest entities ("VIEs") that are not consolidated within our financial statements. A VIE is an entity that does not have sufficient equity to finance its own activities without additional financial support, where investors lack certain characteristics of a controlling financial interest, or where the entity is structured with non-substantive voting rights. VIEs are consolidated by their ‘primary beneficiary,’ a designation given to an entity that receives both the benefits from the VIE as well as the substantive power to make its key economic decisions. While we participate in the benefits from VIEs in which we invest, but do not consolidate, the substantive power to make the key economic decisions for each respective VIE resides with entities not under our common control. It is for this reason that we are not considered the primary beneficiary for the VIE investments that are not consolidated. We invest in various limited partnerships and limited liability companies primarily as a passive investor. These investments are primarily in credit funds with a bias towards current income, real assets, or private equity. Limited partnership and limited liability company interests are accounted for under the equity method and are included in Investments in unconsolidated affiliates on our unaudited Condensed Consolidated Balance Sheets. In addition, we invest in structured investments, which may be VIEs, but for which we are not the primary beneficiary. These structured investments typically invest in fixed income investments and are managed by third parties and include asset-backed securities, commercial mortgage-backed securities, and residential mortgage-backed securities included in fixed maturity securities available for sale on our unaudited Condensed Consolidated Balance Sheets. Our maximum loss exposure with respect to these VIEs is limited to the investment carrying amounts reported in our unaudited Condensed Consolidated Balance Sheets for limited partnerships and the amortized costs of our fixed maturity securities, in addition to any required unfunded commitments (also refer to Note F Commitments and Contingencies ). The following table summarizes the carrying value and the maximum loss exposure of our unconsolidated VIEs as of September 30, 2024 and December 31, 2023: September 30, 2024 December 31, 2023 (In millions) (In millions) Carrying Value Maximum Loss Exposure Carrying Value Maximum Loss Exposure Investment in unconsolidated affiliates $ 3,666 $ 4,814 $ 3,071 $ 4,806 Fixed maturity securities 23,343 24,120 20,837 22,346 Total unconsolidated VIE investments $ 27,009 $ 28,934 $ 23,908 $ 27,152 " id="sjs-B4" xml:space="preserve">Investments Our fixed maturity securities investments have been designated as available-for-sale ("AFS"), and are carried at fair value, net of allowance for expected credit losses, with unrealized gains and losses included in Accumulated Other Comprehensive Income ("AOCI"), net of deferred income taxes. Our preferred and equity securities investments are carried at fair value with unrealized gains and losses included in net earnings. The Company’s consolidated investments as of September 30, 2024 and December 31, 2023 are summarized as follows: September 30, 2024 Amortized Cost Allowance for Expected Credit Losses Gross Unrealized Gains Gross Unrealized Losses Fair Value Available-for-sale securities (In millions) Asset-backed securities $ 15,986 $ (12) $ 264 $ (275) $ 15,963 Commercial mortgage-backed securities 5,359 (49) 61 (192) 5,179 Corporates 23,673 (5) 396 (2,092) 21,972 Hybrids 609 — 6 (19) 596 Municipals 1,682 — 20 (187) 1,515 Residential mortgage-backed securities 2,617 (1) 61 (77) 2,600 U.S. Government 800 — 9 (6) 803 Foreign Governments 344 — 5 (37) 312 Total available-for-sale securities $ 51,070 $ (67) $ 822 $ (2,885) $ 48,940 December 31, 2023 Amortized Cost Allowance for Expected Credit Losses Gross Unrealized Gains Gross Unrealized Losses Fair Value Available-for-sale securities (In millions) Asset-backed securities $ 14,631 $ (11) $ 191 $ (469) $ 14,342 Commercial mortgage-backed/asset-backed securities 4,797 (22) 23 (323) 4,475 Corporates 20,133 (6) 186 (2,417) 17,896 Hybrids 668 — 3 (53) 618 Municipals 1,826 — 14 (229) 1,611 Residential mortgage-backed securities 2,507 (3) 29 (104) 2,429 U.S. Government 679 — 8 (9) 678 Foreign Governments 365 — 3 (44) 324 Total available-for-sale securities $ 45,606 $ (42) $ 457 $ (3,648) $ 42,373 Securities held on deposit with various state regulatory authorities had a fair value of $150 million and $141 million as of September 30, 2024 and December 31, 2023, respectively. As of September 30, 2024 and December 31, 2023, the Company held $29 million and $47 million, respectively, of investments that were non-income producing for a period greater than twelve months. As of September 30, 2024 and December 31, 2023, the Company's accrued interest receivable balance was $531 million and $481 million, respectively. Accrued interest receivable is classified within Prepaid expenses and other assets within the unaudited Condensed Consolidated Balance Sheets. In accordance with our FHLB agreements, the investments supporting the funding agreement liabilities are pledged as collateral to secure the FHLB funding agreement liabilities and are not available to us for general purposes. The collateral investments had a fair value of $5,123 million and $4,345 million as of September 30, 2024 and December 31, 2023, respectively. The amortized cost and fair value of fixed maturity securities by contractual maturities, as applicable, are shown below. Actual maturities may differ from contractual maturities because issuers may have the right to call or prepay obligations. September 30, 2024 December 31, 2023 (In millions) (In millions) Amortized Cost Fair Value Amortized Cost Fair Value Corporates, Non-structured Hybrids, Municipal and Government securities: Due in one year or less $ 890 $ 885 $ 703 $ 687 Due after one year through five years 4,996 4,985 4,320 4,209 Due after five years through ten years 4,975 4,981 3,195 3,048 Due after ten years 16,247 14,347 15,453 13,183 Subtotal 27,108 25,198 23,671 21,127 Other securities, which provide for periodic payments: Asset-backed securities 15,986 15,963 14,631 14,342 Commercial mortgage-backed securities 5,359 5,179 4,797 4,475 Residential mortgage-backed securities 2,617 2,600 2,507 2,429 Subtotal 23,962 23,742 21,935 21,246 Total fixed maturity available-for-sale securities $ 51,070 $ 48,940 $ 45,606 $ 42,373 Allowance for Expected Credit Loss We regularly review AFS securities for declines in fair value that we determine to be credit related. For our fixed maturity securities, we generally consider the following in determining whether our unrealized losses are credit related, and if so, the magnitude of the credit loss: • The extent to which the fair value is less than the amortized cost basis; • The reasons for the decline in value (credit event, currency or interest-rate related, including general credit spread widening); • The financial condition of and near-term prospects of the issuer (including issuer's current credit rating and the probability of full recovery of principal based upon the issuer's financial strength); • Current delinquencies and nonperforming assets of underlying collateral; • Expected future default rates; • Collateral value by vintage, geographic region, industry concentration or property type; • Subordination levels or other credit enhancements as of the balance sheet date as compared to origination; and • Contractual and regulatory cash obligations and the issuer's plans to meet such obligations. We recognize an allowance for current expected credit losses on fixed maturity securities in an unrealized loss position when it is determined, using the factors discussed above, a component of the unrealized loss is related to credit. We measure the credit loss using a discounted cash flow model that utilizes the single best estimate cash flow and the recognized credit loss is limited to the total unrealized loss on the security (i.e., the fair value floor). Cash flows are discounted using the implicit yield of bonds at their time of purchase and the current book yield for asset and mortgage-backed securities as well as variable rate securities. We recognize the expected credit losses in Recognized gains and losses, net in the unaudited Condensed Consolidated Statements of Earnings, with an offset for the amount of non-credit impairments recognized in AOCI. We do not measure a credit loss allowance on accrued investment income because we write-off accrued interest through Interest and investment income when collectability concerns arise. We consider the following in determining whether write-offs of a security’s amortized cost are necessary: • We believe amounts related to securities have become uncollectible; • We intend to sell a security; or • It is more likely than not that we will be required to sell a security prior to recovery. If we intend to sell a fixed maturity security or it is more likely than not that we will be required to sell the security before recovery of its amortized cost basis and the fair value of the security is below amortized cost, we will write down the security to current fair value, with a corresponding charge, net of any amount previously recognized as an allowance for expected credit loss, to Recognized gains and losses, net in the accompanying unaudited Condensed Consolidated Statements of Earnings. If we do not intend to sell a fixed maturity security or it is more likely than not that we will not be required to sell a fixed maturity security before recovery of its amortized cost basis but believe amounts related to a security are uncollectible (generally based on proximity to expected credit loss), an impairment is deemed to have occurred and the amortized cost is written down to the estimated recovery value with a corresponding charge, net of any amount previously recognized as an allowance for expected credit loss, to Recognized gains and losses, net in the accompanying unaudited Condensed Consolidated Statements of Earnings. The remainder of unrealized loss is held in AOCI. As of September 30, 2024 and December 31, 2023, our allowance for expected credit losses for AFS securities was $67 million and $42 million, respectively. The fair value and gross unrealized losses of AFS securities, excluding securities in an unrealized loss position with an allowance for expected credit loss, aggregated by investment category and duration of fair value below amortized cost as of September 30, 2024 and December 31, 2023 were as follows: September 30, 2024 Less than 12 months 12 months or longer Total Fair Value Gross Unrealized Fair Value Gross Unrealized Fair Value Gross Unrealized Available-for-sale securities (In millions) Asset-backed securities $ 583 $ (19) $ 3,447 $ (237) $ 4,030 $ (256) Commercial mortgage-backed securities 209 (5) 1,682 (168) 1,891 (173) Corporates 1,382 (8) 10,698 (2,084) 12,080 (2,092) Hybrids 47 (1) 393 (18) 440 (19) Municipals 82 (1) 1,089 (186) 1,171 (187) Residential mortgage-backed securities 188 (3) 447 (68) 635 (71) U.S. Government 268 (1) 130 (5) 398 (6) Foreign Government 23 (2) 170 (36) 193 (38) Total available-for-sale securities $ 2,782 $ (40) $ 18,056 $ (2,802) $ 20,838 $ (2,842) Total number of available-for-sale securities in an unrealized loss position less than twelve months 585 Total number of available-for-sale securities in an unrealized loss position twelve months or longer 2,393 Total number of available-for-sale securities in an unrealized loss position 2,978 December 31, 2023 Less than 12 months 12 months or longer Total Fair Value Gross Unrealized Fair Value Gross Unrealized Fair Value Gross Unrealized Available-for-sale securities (In millions) Asset-backed securities $ 1,707 $ (56) $ 5,835 $ (404) $ 7,542 $ (460) Commercial mortgage-backed securities 819 (53) 1,922 (235) 2,741 (288) Corporates 2,387 (134) 10,739 (2,283) 13,126 (2,417) Hybrids 60 (2) 483 (51) 543 (53) Municipals 399 (49) 920 (179) 1,319 (228) Residential mortgage-backed securities 336 (5) 662 (89) 998 (94) U.S. Government 84 — 159 (9) 243 (9) Foreign Government 49 (3) 188 (41) 237 (44) Total available-for-sale securities $ 5,841 $ (302) $ 20,908 $ (3,291) $ 26,749 $ (3,593) Total number of available-for-sale securities in an unrealized loss position less than twelve months 1,035 Total number of available-for-sale securities in an unrealized loss position twelve months or longer 2,846 Total number of available-for-sale securities in an unrealized loss position 3,881 The unrealized losses as of September 30, 2024 and December 31, 2023 were caused by higher treasury rates compared to those at the time of the F&G acquisition or purchase of the security if later. For securities in an unrealized loss position as of September 30, 2024, our allowance for expected credit loss was $67 million. We believe the unrealized loss position for which we have not recorded an allowance for expected credit loss as of September 30, 2024 was primarily attributable to interest rate increases, near-term illiquidity, and other macroeconomic uncertainties as opposed to issuer specific credit concerns. Mortgage Loans Our mortgage loans are collateralized by commercial and residential properties. Commercial Mortgage Loans Commercial mortgage loans (“CMLs”) represented approximately 4% and 5% of our total investments as of September 30, 2024 and December 31, 2023, respectively. The mortgage loans in our investment portfolio are generally comprised of high quality commercial first lien and mezzanine real estate loans. Mortgage loans are primarily on income producing properties including industrial properties, retail buildings, multifamily properties, and office buildings. We diversify our CML portfolio by geographic region and property type to attempt to reduce concentration risk. We continuously evaluate CMLs based on relevant current information to ensure properties are performing at a consistent and acceptable level to secure the related debt. The distribution of CMLs, gross of valuation allowances, by property type and geographic region is reflected in the following tables: September 30, 2024 December 31, 2023 Gross Carrying Value % of Total Gross Carrying Value % of Total Property Type: (In millions) (In millions) Hotel $ 17 1 % $ 18 1 % Industrial 617 24 616 24 Mixed Use 11 — 11 — Multifamily 1,006 39 1,012 40 Office 356 14 316 13 Retail 99 4 102 4 Student Housing 83 3 83 3 Other 401 15 392 15 Total commercial mortgage loans, gross of valuation allowance $ 2,590 100 % $ 2,550 100 % Allowance for expected credit loss (18) (12) Total commercial mortgage loans, net of valuation allowance $ 2,572 $ 2,538 U.S. Region: East North Central $ 98 4 % $ 151 6 % East South Central 75 3 75 3 Middle Atlantic 354 14 354 14 Mountain 409 16 352 14 New England 164 6 168 6 Pacific 713 27 766 30 South Atlantic 595 23 563 22 West North Central 22 1 4 — West South Central 160 6 117 5 Total commercial mortgage loans, gross of valuation allowance $ 2,590 100 % $ 2,550 100 % Allowance for expected credit loss (18) (12) Total commercial mortgage loans, net of valuation allowance $ 2,572 $ 2,538 CMLs segregated by aging of the loans and charge offs (by year of origination) as of September 30, 2024 and December 31, 2023, were as follows, gross of valuation allowances: September 30, 2024 Amortized Cost by Origination Year 2024 2023 2022 2021 2020 Prior Total Commercial mortgages (In millions) Current (less than 30 days past due) $ 140 $ 221 $ 289 $ 1,253 $ 469 $ 209 $ 2,581 30-89 days past due — — — — — 9 9 90 days or more past due — — — — — — — Total CMLs $ 140 $ 221 $ 289 $ 1,253 $ 469 $ 218 $ 2,590 Charge offs $ — $ — $ — $ — $ — $ — $ — December 31, 2023 Amortized Cost by Origination Year 2023 2022 2021 2020 2019 Prior Total Commercial mortgages (In millions) Current (less than 30 days past due) $ 213 $ 288 $ 1,256 $ 512 $ — $ 259 $ 2,528 30-89 days past due — — — — — — — 90 days or more past due — — — — — — — Total CMLs (a) $ 213 $ 288 $ 1,256 $ 512 $ — $ 259 $ 2,528 Charge offs $ — $ — $ — $ — $ — $ 3 $ 3 (a) Excludes loans under development with an amortized cost and estimated fair value of $22 million. Loan-to-value (“LTV”) and debt service coverage (“DSC”) ratios are measures commonly used to assess the risk and quality of mortgage loans. The LTV ratio is expressed as a percentage of the amount of the loan relative to the value of the underlying property. A LTV ratio in excess of 100% indicates the unpaid loan amount exceeds the underlying collateral. The DSC ratio, based upon the most recently received financial statements, is expressed as a percentage of the amount of a property’s net income to its debt service payments. A DSC ratio of less than 1.00 indicates that a property’s operations do not generate sufficient income to cover debt payments. We normalize our DSC ratios to a 25 year amortization period for purposes of our general loan allowance evaluation. The following tables present the recorded investment in CMLs by LTV and DSC ratio categories and estimated fair value by the indicated LTV ratios, gross of valuation allowances as of September 30, 2024 and December 31, 2023 : Debt-Service Coverage Ratios Total Amount % of Total Estimated Fair Value % of Total >1.25 1.00 - 1.25 <1.00 September 30, 2024 (In millions) LTV Ratios: Less than 50.00% $ 499 $ 8 $ 9 $ 516 20 % $ 501 21 % 50.00% to 59.99% 749 59 12 820 31 752 32 60.00% to 74.99% 1,182 57 — 1,239 48 1,074 46 75.00% to 84.99% — 6 9 15 1 15 1 CMLs $ 2,430 $ 130 $ 30 $ 2,590 100 % $ 2,342 100 % December 31, 2023 LTV Ratios: Less than 50.00% $ 519 $ 4 $ 10 $ 533 21 % $ 510 23 % 50.00% to 59.99% 764 — — 764 30 679 30 60.00% to 74.99% 1,160 56 — 1,216 48 1,028 46 75.00% to 84.99% — 6 9 15 1 14 1 CMLs (a) $ 2,443 $ 66 $ 19 $ 2,528 100 % $ 2,231 100 % (a) Excludes loans under development with an amortized cost and estimated fair value of $22 million. September 30, 2024 Amortized Cost by Origination Year 2024 2023 2022 2021 2020 Prior Total Commercial mortgages (In millions) LTV Less than 50.00% $ 58 $ 93 $ 18 $ 74 $ 189 $ 84 $ 516 50.00% to 59.99% 59 53 149 267 158 134 820 60.00% to 74.99% 23 69 113 912 122 — 1,239 75.00% to 84.99% — 6 9 — — — 15 Total CMLs $ 140 $ 221 $ 289 $ 1,253 $ 469 $ 218 $ 2,590 Commercial mortgages DSCR Greater than 1.25x $ 72 $ 161 $ 278 $ 1,241 $ 469 $ 209 $ 2,430 1.00x - 1.25x 67 60 3 — — — 130 Less than 1.00x 1 — 8 12 — 9 30 Total CMLs $ 140 $ 221 $ 289 $ 1,253 $ 469 $ 218 $ 2,590 December 31, 2023 Amortized Cost by Origination Year 2023 2022 2021 2020 2019 Prior Total Commercial mortgages (In millions) LTV Less than 50.00% $ 85 $ 17 $ 77 $ 232 $ — $ 122 $ 533 50.00% to 59.99% 53 149 267 158 — 137 764 60.00% to 74.99% 69 113 912 122 — — 1,216 75.00% to 84.99% 6 9 — — — — 15 Total CMLs (a) $ 213 $ 288 $ 1,256 $ 512 $ — $ 259 $ 2,528 Commercial mortgages DSCR Greater than 1.25x $ 154 $ 276 $ 1,256 $ 512 $ — $ 245 $ 2,443 1.00x - 1.25x 59 3 — — — 4 66 Less than 1.00x — 9 — — — 10 19 Total CMLs (a) $ 213 $ 288 $ 1,256 $ 512 $ — $ 259 $ 2,528 (a) Excludes loans under development with an amortized cost and estimated fair value of $22 million. We recognize a mortgage loan as delinquent when payments on the loan are greater than 30 days past due. At September 30, 2024, we had one CML that was delinquent in principal or interest payments as shown in the risk rating exposure table above compared to none at December 31, 2023. Residential Mortgage Loans Residential mortgage loans (“RMLs”) represented approximately 5% of our total investments as of September 30, 2024 and December 31, 2023. Our RMLs are primarily closed end, amortizing loans and 100% of the properties are located in the United States. We diversify our RML portfolio by state to attempt to reduce concentration risk. The distribution of RMLs by state with highest-to-lowest concentration are reflected in the following tables, gross of valuation allowances: September 30, 2024 Amortized Cost % of Total U.S. State: (In millions) Florida $ 160 5 % All other states (a) 2,945 95 Total RMLs, gross of valuation allowance 3,105 100 % Allowance for expected credit loss (51) Total RMLs, net of valuation allowance $ 3,054 (a) The individual concentration of each state is less than 5% as of September 30, 2024. December 31, 2023 Amortized Cost % of Total U.S. State: (In millions) Florida $ 163 6 % New York 129 5 Texas 129 5 All other states (a) 2,431 84 Total RMLs, gross of valuation allowance 2,852 100 % Allowance for expected credit loss (54) Total RMLs, net of valuation allowance $ 2,798 (a) The individual concentration of each state is less than 5% as of December 31, 2023. RMLs have a primary credit quality indicator of either a performing or nonperforming loan. We define non-performing RMLs as those that are 90 or more days past due or in non-accrual status, which is assessed monthly. The credit quality of RMLs as of September 30, 2024 and December 31, 2023, was as follows: September 30, 2024 December 31, 2023 Amortized Cost % of Total Amortized Cost % of Total Performance indicators: (In millions) (In millions) Performing $ 3,031 98 % $ 2,795 98 % Non-performing 74 2 57 2 Total RMLs, gross of valuation allowance 3,105 100 % 2,852 100 % Allowance for expected loan loss (51) (54) Total RMLs, net of valuation allowance $ 3,054 $ 2,798 There were no charge offs recorded by RMLs during the nine months ended September 30, 2024 or during the year ended December 31, 2023. RMLs segregated by aging of the loans (by year of origination) as of September 30, 2024 and December 31, 2023, were as follows, gross of valuation allowances: September 30, 2024 Amortized Cost by Origination Year 2024 2023 2022 2021 2020 Prior Total Residential mortgages (In millions) Current (less than 30 days past due) $ 387 $ 372 $ 928 $ 822 $ 168 $ 317 $ 2,994 30-89 days past due 6 3 9 8 4 7 37 90 days or more past due — 2 9 28 10 25 74 Total residential mortgages $ 393 $ 377 $ 946 $ 858 $ 182 $ 349 $ 3,105 December 31, 2023 Amortized Cost by Origination Year 2023 2022 2021 2020 2019 Prior Total Residential mortgages (In millions) Current (less than 30 days past due) $ 373 $ 985 $ 854 $ 192 $ 183 $ 192 $ 2,779 30-89 days past due — 4 7 3 — 2 16 90 days or more past due — 6 16 13 21 1 57 Total residential mortgages $ 373 $ 995 $ 877 $ 208 $ 204 $ 195 $ 2,852 Non-accrual loans by amortized cost as of September 30, 2024 and December 31, 2023, were as follows: September 30, 2024 December 31, 2023 Amortized cost of loans on non-accrual (In millions) Residential mortgage: $ 74 $ 57 Commercial mortgage: — — Total non-accrual mortgages $ 74 $ 57 Immaterial interest income was recognized on non-accrual financing receivables for the three and nine months ended September 30, 2024 and 2023. It is our policy to cease to accrue interest on loans that are delinquent for 90 days or more. For loans less than 90 days delinquent, interest is accrued unless it is determined that the accrued interest is not collectible. If a loan becomes 90 days or more delinquent, it is our general policy to initiate foreclosure proceedings unless a workout arrangement to bring the loan current is in place. As of September 30, 2024 and December 31, 2023, we had $74 million and $57 million, respectively, of mortgage loans that were over 90 days past due. As of September 30, 2024 and December 31, 2023, we had $73 million and $41 million, respectively, of residential mortgage loans that were in the process of foreclosure. Under certain circumstances, modifications are granted to mortgage loans. Generally, the types of concessions may include interest rate reduction, term extension, payment deferrals, principal forgiveness, or a combination of these concessions. We had an immaterial amount of mortgage loans modified during the three and nine month periods ended September 30, 2024 and 2023. Allowance for Expected Credit Loss We estimate expected credit losses for our commercial and residential mortgage loan portfolios using a probability of default/loss given default model. Significant inputs to this model include, where applicable, the loans' current performance, underlying collateral type, location, contractual life, LTV, DSC and Debt to Income or FICO. The model projects losses using a two year reasonable and supportable forecast and then reverts over a three year period to market-wide historical loss experience. Changes in our allowance for expected credit losses on mortgage loans are recognized in Recognized gains and losses, net in the accompanying unaudited Condensed Consolidated Statements of Earnings. The allowances for our mortgage loan portfolio are summarized as follows: Three months ended September 30, 2024 Nine months ended September 30, 2024 (In millions) (In millions) Residential Mortgage Commercial Mortgage Total Residential Mortgage Commercial Mortgage Total Beginning Balance $ (50) $ (14) $ (64) $ (54) $ (12) $ (66) Provision (expense) benefit for loan losses (1) (4) (5) 3 (6) (3) Ending Balance $ (51) $ (18) $ (69) $ (51) $ (18) $ (69) Three months ended September 30, 2023 Nine months ended September 30, 2023 (In millions) (In millions) Residential Mortgage Commercial Mortgage Total Residential Mortgage Commercial Mortgage Total Beginning Balance $ (51) $ (13) $ (64) $ (32) $ (10) $ (42) Provision (expense) benefit for loan losses 2 (2) — (17) (5) (22) Ending Balance $ (49) $ (15) $ (64) $ (49) $ (15) $ (64) An allowance for expected credit loss is not measured on accrued interest income for CMLs as we have a process to write-off interest on loans that enter into non-accrual status (90 days or more past due). Allowances for expected credit losses are measured on accrued interest income for RMLs and were immaterial for the three and nine months ended September 30, 2024 and 2023. Interest and Investment Income The major sources of Interest and investment income reported on the accompanying unaudited Condensed Consolidated Statements of Earnings were as follows: Three months ended September 30, Nine months ended September 30, 2024 2023 2024 2023 (In millions) (In millions) Fixed maturity securities, available-for-sale $ 583 $ 493 $ 1,679 $ 1,405 Equity securities 8 8 26 24 Preferred securities 7 12 25 39 Mortgage loans 69 59 200 167 Invested cash and short-term investments 72 39 172 106 Limited partnerships 84 69 234 171 Tax deferred property exchange income 36 44 102 128 Other investments 32 25 88 63 Gross investment income 891 749 2,526 2,103 Investment expense (76) (63) (218) (188) Interest and investment income $ 815 $ 686 $ 2,308 $ 1,915 Interest and investment income is shown net of amounts attributable to certain funds withheld reinsurance agreements, which is passed along to the reinsurer in accordance with the terms of these agreements. Interest and investment income attributable to these agreements, and thus excluded from the totals in the table above, was $181 million and $102 million for the three months ended September 30, 2024 and 2023, respectively, and $463 million and $236 million for the nine months ended September 30, 2024 and 2023, respectively. Recognized Gains and Losses, Net Details underlying Recognized gains and losses, net reported on the accompanying unaudited Condensed Consolidated Statements of Earnings were as follows: Three months ended September 30, Nine months ended September 30, 2024 2023 2024 2023 (In millions) (In millions) Net realized (losses) gains on fixed maturity available-for-sale securities $ (1) $ (32) $ 3 $ (137) Net realized/unrealized gains (losses) on equity securities (1) 48 (33) 48 (37) Net realized/unrealized gains (losses) on preferred securities (2) 17 1 29 (7) Net realized/unrealized gains (losses) on other invested assets 3 9 73 (20) Change in allowance for expected credit losses — (7) (32) (30) Derivatives and embedded derivatives: Realized gains (losses) on certain derivative instruments 30 (30) 65 (184) Unrealized gains (losses) on certain derivative instruments 347 (297) 450 14 Change in fair value of reinsurance related embedded derivatives (3) (178) 36 (186) 34 Change in fair value of other derivatives and embedded derivatives 3 (3) 6 — Realized gains (losses) on derivatives and embedded derivatives 202 (294) 335 (136) Recognized gains and losses, net $ 269 $ (356) $ 456 $ (367) (1) Includes net valuation gains (losses) of $31 million and $(22) million for the three months ended September 30, 2024 and 2023, respectively, and net valuation losses of $(42) million and $(12) million for the nine months ended September 30, 2024 and 2023, respectively. (2) Includes net valuation gains of $18 million and $2 million for the three months ended September 30, 2024 and 2023, respectively, and net valuation gains of $30 million and $52 million for the nine months ended September 30, 2024 and 2023, respectively. (3) Change in fair value of reinsurance related embedded derivatives is due to activity related to the reinsurance treaties. Recognized gains and losses, net is shown net of amounts attributable to certain funds withheld reinsurance agreements, which are passed along to the reinsurer in accordance with the terms of these agreements. Recognized gains and (losses) attributable to these agreements, and thus excluded from the totals in the table above, were $177 million and $(186) million for the three and nine months ended September 30, 2024, respectively, and $43 million and $42 million for the three and nine months ended September 30, 2023. The proceeds from the sale of fixed-maturity securities and the gross gains and losses associated with those transactions were as follows: Three months ended September 30, Nine months ended September 30, 2024 2023 2024 2023 (In millions) Proceeds $ 1,476 $ 880 $ 2,638 $ 1,978 Gross gains 18 — 36 7 Gross losses (20) (27) (52) (109) Unconsolidated Variable Interest Entities We own investments in variable interest entities ("VIEs") that are not consolidated within our financial statements. A VIE is an entity that does not have sufficient equity to finance its own activities without additional financial support, where investors lack certain characteristics of a controlling financial interest, or where the entity is structured with non-substantive voting rights. VIEs are consolidated by their ‘primary beneficiary,’ a designation given to an entity that receives both the benefits from the VIE as well as the substantive power to make its key economic decisions. While we participate in the benefits from VIEs in which we invest, but do not consolidate, the substantive power to make the key economic decisions for each respective VIE resides with entities not under our common control. It is for this reason that we are not considered the primary beneficiary for the VIE investments that are not consolidated. We invest in various limited partnerships and limited liability companies primarily as a passive investor. These investments are primarily in credit funds with a bias towards current income, real assets, or private equity. Limited partnership and limited liability company interests are accounted for under the equity method and are included in Investments in unconsolidated affiliates on our unaudited Condensed Consolidated Balance Sheets. In addition, we invest in structured investments, which may be VIEs, but for which we are not the primary beneficiary. These structured investments typically invest in fixed income investments and are managed by third parties and include asset-backed securities, commercial mortgage-backed securities, and residential mortgage-backed securities included in fixed maturity securities available for sale on our unaudited Condensed Consolidated Balance Sheets. Our maximum loss exposure with respect to these VIEs is limited to the investment carrying amounts reported in our unaudited Condensed Consolidated Balance Sheets for limited partnerships and the amortized costs of our fixed maturity securities, in addition to any required unfunded commitments (also refer to Note F Commitments and Contingencies ). The following table summarizes the carrying value and the maximum loss exposure of our unconsolidated VIEs as of September 30, 2024 and December 31, 2023: September 30, 2024 December 31, 2023 (In millions) (In millions) Carrying Value Maximum Loss Exposure Carrying Value Maximum Loss Exposure Investment in unconsolidated affiliates $ 3,666 $ 4,814 $ 3,071 $ 4,806 Fixed maturity securities 23,343 24,120 20,837 22,346 Total unconsolidated VIE investments $ 27,009 $ 28,934 $ 23,908 $ 27,152

Derivative Financial Instrument

Derivative Financial Instruments	9 Months Ended
	Sep. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments The carrying amounts of derivative instruments, including derivative instruments embedded in indexed annuities and IUL contracts, and reinsurance are as follows: September 30, 2024 December 31, 2023 (In millions) Assets: Derivative investments: Equity options $ 1,293 $ 739 Interest rate swaps 108 57 Other derivative investments — 1 Other long-term investments: Other embedded derivatives 34 28 Prepaid expenses and other assets: Reinsurance related embedded derivatives — 152 Total $ 1,435 $ 977 Liabilities Contractholder funds: Indexed annuities/IUL embedded derivatives $ 5,411 $ 4,258 Accounts payable and accrued liabilities: Reinsurance related embedded derivative 34 — Equity Options 4 1 Total $ 5,449 $ 4,259 The change in fair value of derivative instruments included within Recognized gains and losses, net in the accompanying unaudited Condensed Consolidated Statements of Earnings is as follows: Three months ended September 30, Nine months ended September 30, 2024 2023 2024 2023 (In millions) (In millions) Net investment gains (losses): Equity options $ 260 $ (308) $ 487 $ (155) Interest rate swaps 114 (19) 9 (19) Futures contracts 7 (4) 18 1 Other derivative investments (4) 4 1 3 Other embedded derivatives 3 (3) 6 — Reinsurance related embedded derivatives (178) 36 (186) 34 Total net investment gains (losses) $ 202 $ (294) $ 335 $ (136) Benefits and other changes in policy reserves: Indexed annuities/IUL embedded derivatives increase $ 563 $ (265) $ 1,153 $ 441 Additional Disclosures See descriptions of the fair value methodologies used for derivative financial instruments in Note C Fair Value of Financial Instruments . Indexed Annuities/IUL Embedded Derivative, Equity Options and Futures We have indexed annuities and IUL contracts that permit the holder to elect an interest rate return or an equity index linked component, where interest credited to the contracts is linked to the performance of various equity indices, for example the S&P 500 Index. This feature represents an embedded derivative under GAAP. The indexed annuities/IUL embedded derivatives are valued at fair value and included in the liability for contractholder funds in the accompanying unaudited Condensed Consolidated Balance Sheets with changes in fair value included as a component of Benefits and other changes in policy reserves in the unaudited Condensed Consolidated Statements of Earnings. We purchase derivatives consisting of a combination of equity options and futures contracts (specifically for indexed annuity contracts) on the applicable market indices to fund the index credits due to indexed annuity/IUL contractholders. The equity options are one two three five six Other market exposures are hedged periodically depending on market conditions and our risk tolerance. Our indexed annuities/IUL hedging strategy economically hedges the equity returns and exposes us to the risk that unhedged market exposures result in divergence between changes in the fair value of the liabilities and the hedging assets. We use a variety of techniques, including direct estimation of market sensitivities, to monitor this risk daily. We intend to continue to adjust the hedging strategy as market conditions and our risk tolerance changes. Interest Rate Swaps We utilize interest rate swaps to reduce market risks from interest rate changes on our earnings associated with our floating rate investments. With an interest rate swap, we agree with another party to exchange the difference between fixed-rate and floating-rate interest amounts tied to an agreed upon notional principal at specified intervals. The interest rate swaps are marked to fair value with the change in fair value, including accrued interest and related periodic cash flows received or paid, included as a component of Recognized gains and (losses), net, in the accompanying unaudited Condensed Consolidated Statements of Earnings. Reinsurance Related Embedded Derivatives F&G cedes certain business on a coinsurance funds withheld basis. Investment results for the assets that support the coinsurance that are segregated within the funds withheld account are passed directly to the reinsurer pursuant to the contractual terms of the reinsurance agreement, which creates embedded derivatives considered to be total return swaps. These total return swaps are not clearly and closely related to the underlying reinsurance contract and thus require bifurcation. The fair value of the total return swaps is based on the change in fair value of the underlying assets held in the funds withheld account. These embedded derivatives are reported in Prepaid expenses and other assets if in a net gain position, or Accounts payable and accrued liabilities, if in a net loss position on the unaudited Condensed Consolidated Balance Sheets and the related gains or losses are reported in Recognized gains and (losses), net, on the unaudited Condensed Consolidated Statements of Earnings. Credit Risk We are exposed to credit loss in the event of non-performance by our counterparties and reflect assumptions regarding this non-performance risk in the fair value of our derivatives. The non-performance risk is the net counterparty exposure based on the fair value of the open contracts less collateral held. We maintain a policy of requiring all derivative contracts to be governed by an International Swaps and Derivatives Association (“ISDA”) Master Agreement. We manage credit risk related to non-performance by our counterparties by (i) entering into derivative transactions with creditworthy counterparties; (ii) obtaining collateral, such as cash and securities when appropriate; (iii) establishing counterparty exposure limits, which are subject to periodic management review. Information regarding our exposure to credit loss on the derivative instruments we hold, excluding futures contracts, is presented below: Notional Amount Fair Value Collateral Net Credit Risk (In millions) September 30, 2024 $ 35,561 $ 1,393 $ 1,351 $ 53 December 31, 2023 29,968 796 775 39 Collateral Agreements We are required to maintain minimum ratings as a matter of routine practice as part of our over-the-counter derivative agreements on ISDA forms. Under some ISDA agreements, we have agreed to maintain certain financial strength ratings. A downgrade below these levels provides the counterparty under the agreement the right to terminate the open derivative contracts between the parties, at which time any amounts payable by us or the counterparty would be dependent on the market value of the underlying contracts. Our current rating does not allow any counterparty the right to terminate ISDA agreements. In certain transactions, both us and the counterparty have entered into a collateral support agreement requiring either party to post collateral when the net exposures exceed pre-determined thresholds. For all counterparties, except one, the threshold is set to zero. As of September 30, 2024 and December 31, 2023 counterparties posted collateral of $1,351 million and $775 million, respectively, of which $1,133 million and $588 million, respectively, is included in Cash and cash equivalents with an associated payable for this collateral included in Accounts payable and accrued liabilities on the unaudited Condensed Consolidated Balance Sheets. Accordingly, the maximum amount of loss due to credit risk that we would incur if parties to the derivatives failed completely to perform according to the terms of the contracts was $53 million as of September 30, 2024 and $39 million as of December 31, 2023. We are required to pay our counterparties the effective federal funds interest rate each day for cash collateral posted to us. Cash collateral is reinvested in overnight investment sweep products, which are included in Cash and cash equivalents in the accompanying unaudited Condensed Consolidated Balance Sheets, to reduce the interest cost.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Legal and Regulatory Contingencies In the ordinary course of business, we are involved in various pending and threatened litigation matters related to our operations, some of which include claims for punitive or exemplary damages. With respect to our title insurance operations, this customary litigation includes but is not limited to a wide variety of cases arising out of or related to title and escrow claims, for which we make provisions through our loss reserves. See Note B Summary of Reserve for Title Claim Losses for further discussion. Additionally, like other companies, our ordinary course litigation includes a number of class action and purported class action lawsuits, which make allegations related to aspects of our operations. We believe that no actions, other than the matters discussed below, if any, depart from customary litigation incidental to our business. We review lawsuits and other legal and regulatory matters (collectively “legal proceedings”) on an ongoing basis when making accrual and disclosure decisions. When assessing reasonably possible and probable outcomes, management bases its decision on its assessment of the ultimate outcome assuming all appeals have been exhausted. For legal proceedings in which it has been determined that a loss is both probable and reasonably estimable, a liability based on known facts and that represents our best estimate has been recorded. Our accrual for legal and regulatory matters was $17 million and $10 million as of September 30, 2024 and December 31, 2023, respectively. None of the amounts we have currently recorded are considered to be material to our financial condition individually or in the aggregate. Actual losses may materially differ from the amounts recorded and the ultimate outcome of our pending legal proceedings is generally not yet determinable. While some of these matters could be material to our operating results or cash flows for any particular period if an unfavorable outcome results, at present we do not believe that the ultimate resolution of currently pending legal proceedings, either individually or in the aggregate, will have a material adverse effect on our financial condition. F&G is a defendant in two putative class action lawsuits related to the alleged compromise of certain of F&G’s customers’ personal information resulting from an alleged vulnerability in the MOVEit file transfer software. F&G’s vendor, Pension Benefit Information, LLC (“PBI”), used the MOVEit software in the course of providing audit and address research services to F&G and many other corporate customers. Miller v. F&G , No. 4:23-cv-00326, was filed against F&G in the Southern District of Iowa on August 31, 2023. Miller alleges that he is an F&G customer whose information was impacted in the MOVEit incident and brings common law tort and implied contract claims. Plaintiff seeks injunctive relief and damages. Cooper v. Progress Software Corp. , No. 1:23-cv-12067, was filed against F&G and five other defendants in the District of Massachusetts on September 7, 2023. Cooper also alleges that he is an F&G customer and brings similar common law tort claims and alleges claims as a purported third-party beneficiary of an alleged contract. Plaintiff seeks declaratory and injunctive relief and damages. Well over 150 similar lawsuits have been filed against other entities impacted by the MOVEit incident including a number of such lawsuits related to PBI’s use of MOVEit. On October 4, 2023, the U.S. Judicial Panel on Multidistrict Litigation (JPML) created a multidistrict litigation (MDL) pursuant to 28 U.S.C. § 1407 to handle all litigation brought by individuals whose information was potentially compromised in connection with the alleged MOVEit vulnerability. Both Miller and Cooper have been transferred to the MDL and are proceeding under MDL Case No. 1:23-md-03083-ADB-PGL. Plaintiffs filed amendments to their complaints, and Defendants filed their omnibus motion to dismiss for lack of Article III standing on July 23, 2024. The case is proceeding under a modified bellweather structure to decide critical issues and facilitate reciprocal discovery. At this time, F&G does not believe the incident will have a material impact on its business, operations, or financial results. In connection with the cybersecurity incident initially reported on November 21, 2023, the Company and/or its subsidiaries is a party to a consolidated putative nationwide class action, In Re: LoanCare Data Security Breach Litigation , Case No. 3:23cv1508, pending in the U.S. District Court for the Middle District of Florida and originating from the consolidation of putative class actions filed in the U.S. District Courts for the Middle District of Florida, the Central District of California, and the Western District of Missouri. On March 19, 2024, plaintiffs filed their consolidated class action complaint on behalf of a nationwide class, along with a California subclass and a Florida subclass, alleging common law tort and contract claims and certain state statutory claims. The parties mediated the case on July 25, 2024, and reached an agreement in principle to resolve the case on a class-wide basis. The parties have sought preliminary court approval of the class-wide settlement. If approved, once the settlement administrator disburses all the funds, final court approval of the settlement will be sought, and the case dismissed. On May 28, 2024, a lawsuit styled Roofers Local 149 Pension Fund v. Fidelity National Financial Inc., William P. Foley, F&G Annuities & Life Inc ., C.A. No. 2024-0562-LWW, was filed in the Chancery Court of the State of Delaware against Fidelity National Financial, Inc. (“FNF”), in its capacity as F&G Annuities & Life Inc.’s (“F&G”) controlling stockholder, and William P. Foley, Executive Chairman of F&G and Chairman of FNF, alleging breach of fiduciary duty related to F&G’s January 11, 2024 sale of $250 million of 6.875% Series A Mandatory Convertible Preferred Stock to FNF. Plaintiff alleges that, based upon an unfair process and unfair price, the preferred stock investment was advantageous to FNF and unfair to F&G. Plaintiff seeks to recover damages on behalf of F&G for the alleged unfair preferred stock investment and the adoption of certain corporate governance measures. On July 24, 2024, F&G filed its answer, and the remaining defendants, including FNF, filed their motion to dismiss Plaintiff’s complaint. On September 23, 2024, Plaintiff voluntarily dismissed its action against William P. Foley, leaving FNF’s motion to dismiss fully briefed and a decision pending with the court. The remaining defendants will vigorously contest the Plaintiff’s claims in the action. From time to time, we receive inquiries and requests for information from state insurance departments, attorneys general, and other regulatory agencies about various matters relating to our business. Sometimes these take the form of civil investigative demands or subpoenas. We cooperate with all such inquiries, and we have responded to or are currently responding to inquiries from multiple governmental agencies. Also, regulators and courts have been dealing with issues arising from foreclosures and related processes and documentation. Various governmental entities are studying the title insurance product, market, pricing, and business practices, and potential regulatory and legislative changes, which may materially affect our business and operations. From time to time, we are assessed fines for violations of regulations or other matters or enter into settlements with such authorities, which may require us to pay fines or claims or take other actions. We do not anticipate such fines and settlements, either individually or in the aggregate, will have a material adverse effect on our business, operations, or financial results. F&G Commitments In our F&G segment, we have unfunded commitments as of September 30, 2024 based upon the timing of when investments and agreements are executed or signed compared to when the actual investments and agreements are funded or closed. Some investments require that funding occur over a period of months or years. A summary of unfunded commitments by commitment type as of September 30, 2024 is included below: September 30, 2024 Commitment Type (In millions) Unconsolidated VIEs: Limited partnerships $ 1,148 Whole loans 949 Fixed maturity securities, ABS 359 Direct Lending 273 Other fixed maturity securities, AFS 43 Commercial mortgage loans 79 Other assets 145 Other invested assets 109 Total $ 3,105 Concurrent with the Roar purchase agreement, we executed a separate loan agreement with the sellers of Roar for us to lend up to $40 million. The loan matures on August 5, 2027. There was a $6 million balance outstanding as of September 30, 2024, and the unfunded loan commitment is included in the unfunded commitments table above in the “Other assets” line item. Refer to Note N Acquisitions for more information on the Roar acquisition.

Dividends

Dividends	9 Months Ended
	Sep. 30, 2024
Equity [Abstract]
Dividends	Dividends On November 6, 2024, our Board of Directors declared cash dividends of $0.50 per share, payable on December 31, 2024, to FNF common shareholders of record as of December 17, 2024.

Segment Information

Segment Information	9 Months Ended
	Sep. 30, 2024
Segment Reporting [Abstract]
Segment Information	Segment Information Summarized financial information concerning our reportable segments is shown in the following tables. As of and for the three months ended September 30, 2024: Title F&G Corporate and Other Elimination Total (In millions) Title premiums $ 1,360 $ — $ — $ — $ 1,360 Other revenues 581 526 52 — 1,159 Revenues from external customers 1,941 526 52 — 2,519 Interest and investment income, including recognized gains and losses, net 155 918 37 (26) 1,084 Total revenues 2,096 1,444 89 (26) 3,603 Depreciation and amortization 35 147 7 — 189 Interest expense — 36 20 — 56 Earnings (loss) before income taxes and equity in earnings of unconsolidated affiliates 372 (30) (3) (26) 313 Income tax expense (benefit) 73 (25) (4) — 44 Earnings (loss) before equity in earnings of unconsolidated affiliates 299 (5) 1 (26) 269 Equity in earnings of unconsolidated affiliates 2 — — — 2 Net earnings (loss) from continuing operations $ 301 $ (5) $ 1 $ (26) $ 271 Assets $ 8,046 $ 84,110 $ 2,516 $ — $ 94,672 Goodwill 2,800 2,179 293 — 5,272 As of and for the three months ended September 30, 2023: Title F&G Corporate and Other Elimination Total (In millions) Title premiums $ 1,252 $ — $ — $ — $ 1,252 Other revenues 577 582 37 — 1,196 Revenues from external customers 1,829 582 37 — 2,448 Interest and investment income, including recognized gains and losses, net 46 269 37 (22) 330 Total revenues 1,875 851 74 (22) 2,778 Depreciation and amortization 39 108 6 — 153 Interest expense — 24 20 — 44 Earnings (loss) before income taxes and equity in earnings of unconsolidated affiliates 248 380 (3) (22) 603 Income tax expense (benefit) 73 74 (6) — 141 Earnings (loss) before equity in earnings of unconsolidated affiliates 175 306 3 (22) 462 Equity in earnings of unconsolidated affiliates 15 — — — 15 Net earnings (loss) from continuing operations $ 190 $ 306 $ 3 $ (22) $ 477 Assets $ 8,136 $ 63,596 $ 2,270 $ — $ 74,002 Goodwill 2,789 1,749 292 — 4,830 As of and for the nine months ended September 30, 2024: Title F&G Corporate and Other Elimination Total (In millions) Title premiums $ 3,741 $ — $ — $ — $ 3,741 Other revenues 1,636 1,772 147 — 3,555 Revenues from external customers 5,377 1,772 147 — 7,296 Interest and investment income, including recognized gains and losses, net 313 2,413 118 (80) 2,764 Total revenues 5,690 4,185 265 (80) 10,060 Depreciation and amortization 106 417 22 — 545 Interest expense — 94 58 — 152 Earnings (loss) from continuing operations before income taxes and equity in earnings of unconsolidated affiliates 825 366 (9) (80) 1,102 Income tax expense (benefit) 190 51 (18) — 223 Earnings (loss) from continuing operations before equity in earnings (loss) of unconsolidated affiliates 635 315 9 (80) 879 Equity in earnings of unconsolidated affiliates 4 — — — 4 Net earnings (loss) from continuing operations $ 639 $ 315 $ 9 $ (80) $ 883 Assets $ 8,046 $ 84,110 $ 2,516 $ — $ 94,672 Goodwill 2,800 2,179 293 — 5,272 As of and for the nine months ended September 30, 2023: Title F&G Corporate and Other Elimination Total (In millions) Title premiums $ 3,484 $ — $ — $ — $ 3,484 Other revenues 1,629 1,523 136 — 3,288 Revenues from external customers 5,113 1,523 136 — 6,772 Interest and investment income, including recognized gains and losses, net 178 1,365 48 (43) 1,548 Total revenues 5,291 2,888 184 (43) 8,320 Depreciation and amortization 115 302 21 — 438 Interest expense — 71 58 — 129 Earnings (loss) from continuing operations before income taxes and equity in earnings of unconsolidated affiliates 638 340 (74) (43) 861 Income tax expense (benefit) 165 99 (19) — 245 Earnings (loss) from continuing operations before equity in earnings of unconsolidated affiliates 473 241 (55) (43) 616 Equity in earnings of unconsolidated affiliates 16 — — — 16 Net earnings (loss) from continuing operations $ 489 $ 241 $ (55) $ (43) $ 632 Assets $ 8,136 $ 63,596 $ 2,270 $ — $ 74,002 Goodwill 2,789 1,749 292 — 4,830 The activities in our segments include the following: • Title. This segment consists of the operations of our title insurance underwriters and related businesses. This segment provides core title insurance and escrow and other title-related services including loan sub-servicing, valuations, default services, and home warranty. • F&G . This segment primarily consists of the operations of our annuities and life insurance related businesses. This segment issues a broad portfolio of annuity and life products, including deferred annuities (indexed annuities and fixed rate annuities), immediate annuities and IUL. This segment also provides funding agreements and PRT solutions. • Corporate and Other. This segment consists of the operations of the parent holding company, our real estate technology subsidiaries, and our remaining real estate brokerage businesses. This segment also includes certain other unallocated corporate overhead expenses and eliminations of revenues and expenses between it and our Title segment. • Elimination. This segment consists of the elimination of dividends paid from F&G to FNF, which are included in the Corporate and Other segment.

Supplemental Cash Flow Informat

Supplemental Cash Flow Information	9 Months Ended
	Sep. 30, 2024
Supplemental Cash Flow Elements [Abstract]
Supplemental Cash Flow Information	Supplemental Cash Flow Information The following supplemental cash flow information is provided with respect to certain cash payment and non-cash investing and financing activities: Nine months ended September 30, 2024 2023 Cash paid for: (In millions) Interest $ 154 $ 122 Income taxes 153 140 Deferred sales inducements 219 113 Non-cash investing and financing activities: Change in proceeds of sales of investments available for sale receivable in period (69) 53 Change in purchases of investments available for sale payable in period 639 145 Lease liabilities recognized in exchange for lease right-of-use assets 35 29 Remeasurement of lease liabilities 55 53 Liabilities assumed in connection with acquisitions Fair value of assets acquired 771 304 Less: Total Purchase price 570 299 Liabilities and noncontrolling interests assumed $ 201 $ 5

Revenue Recognition

Revenue Recognition	9 Months Ended
	Sep. 30, 2024
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition Disaggregation of Revenue Our revenue consists of: Three months ended September 30, Nine months ended September 30, 2024 2023 2024 2023 Revenue Stream Income Statement Classification Segment Total Revenue Revenue from insurance contracts: (In millions) Direct title insurance premiums Direct title insurance premiums Title $ 571 $ 524 $ 1,575 $ 1,493 Agency title insurance premiums Agency title insurance premiums Title 789 728 2,166 1,991 Life insurance premiums, insurance and investment product fees, and other Escrow, title-related and other fees F&G 526 582 1,772 1,523 Home warranty Escrow, title-related and other fees Title 42 43 114 110 Total revenue from insurance contracts 1,928 1,877 5,627 5,117 Revenue from contracts with customers: Escrow fees Escrow, title-related and other fees Title 219 211 609 590 Other title-related fees and income Escrow, title-related and other fees Title 169 167 479 482 ServiceLink, excluding title premiums, escrow fees, and subservicing fees Escrow, title-related and other fees Title 83 85 237 247 Real estate technology Escrow, title-related and other fees Corporate and other 35 38 106 114 Total revenue from contracts with customers 506 501 1,431 1,433 Other revenue: Loan subservicing revenue Escrow, title-related and other fees Title 68 71 197 200 Other Escrow, title-related and other fees Corporate and other 17 (1) 41 22 Interest and investment income Interest and investment income Various 815 686 2,308 1,915 Recognized gains and losses, net Recognized gains and losses, net Various 269 (356) 456 (367) Total revenues Total revenues $ 3,603 $ 2,778 $ 10,060 $ 8,320 Our Direct title insurance premiums are recognized as revenue at the time of closing of the underlying transaction as the earnings process is then considered complete. Regulation of title insurance rates varies by state. Premiums are charged to customers based on rates predetermined in coordination with each states' respective Department of Insurance. Cash associated with such revenue is typically collected at closing of the underlying real estate transaction. Premium revenues from agency title operations are recognized when the underlying title order and transaction closing, if applicable, are complete. Revenues from our home warranty business are generated from contracts with customers to provide warranty for major home appliances. Substantially all of our home warranty contracts are one year in length and revenue is recognized ratably over the term of the contract. Escrow fees and other title-related fees and income in our Title segment are closely related to Direct title insurance premiums and are primarily associated with managing the closing of real estate transactions, including the processing of funds on behalf of the transaction participants, gathering and recording the required closing documents, providing notary and home inspection services, and other real estate or title-related activities. Revenue is primarily recognized upon closing of the underlying real estate transaction or completion of services. Cash associated with such revenue is typically collected at closing. Revenues from ServiceLink, excluding its title premiums, escrow fees and loan subservicing fees primarily include revenues from real estate appraisal services and foreclosure processing and facilitation services. Revenues from real estate appraisal services are recognized when all appraisal work is complete, a final report is issued to the client and the client is billed. Revenues from foreclosure processing and facilitation services are primarily recognized upon completion of the services and when billing to the client is complete. Life insurance premiums in our F&G segment reflect premiums for life-contingent PRT, traditional life insurance products, and life-contingent immediate annuity products, which are recognized as revenue when due from the policyholder. We have ceded the majority of our traditional life business to unaffiliated third party reinsurers. While the base contract has been reinsured, we continue to retain the return of premium rider. Insurance and investment product fees and other consist primarily of the cost of insurance on IUL policies, unearned revenue liabilities ("URL") on IUL policies, policy rider fees primarily on FIA policies and surrender charges assessed against policy withdrawals in excess of the policyholder's allowable penalty-free amounts. Premium and annuity deposit collections for indexed annuities, fixed rate annuities, immediate annuities and PRT without life contingency, and amounts received for funding agreements are reported in the financial statements as deposit liabilities (i.e., contractholder funds) instead of as sales or revenues. Similarly, cash payments to customers are reported as decreases in the liability for contractholder funds and not as expenses. Sources of revenues for products accounted for as deposit liabilities include net investment income, surrender, cost of insurance and other charges deducted from contractholder funds, and net realized gains (losses) on investments. Components of expenses for products accounted for as deposit liabilities are interest-sensitive and index product benefits (primarily interest credited to account balances or the hedging cost of providing index credits to the policyholder), amortization of value of business acquired ("VOBA"), deferred acquisition costs ("DAC") and deferred sales inducements ("DSI"), other operating costs and expenses, and income taxes. Real estate technology revenues are primarily comprised of subscription fees for use of software provided to real estate professionals. Subscriptions are only offered on a month-by-month basis and fees are billed monthly. Revenue is recognized in the month services are provided. Loan subservicing revenues are generated by certain subsidiaries of ServiceLink and are associated with the servicing of mortgage loans on behalf of its customers. Revenue is recognized when the underlying work is performed and billed. Loan subservicing revenues are subject to the recognition requirements of ASC Topic 860. Interest and investment income consists primarily of interest payments received on fixed maturity security holdings and dividends received on equity and preferred security holdings along with the investment income of limited partnerships. We do not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less, primarily related to revenue from our home warranty business, and (ii) contracts for which we recognize revenue at the amount to which we have the right to invoice for services performed. Contract Balances The following table provides information about trade receivables and deferred revenue: September 30, 2024 December 31, 2023 (In millions) Trade receivables $ 336 $ 317 Deferred revenue (contract liabilities) 94 91 Deferred revenue is recorded primarily for our home warranty contracts. Revenues from home warranty products are recognized over the life of the policy, which is primarily one year. The unrecognized portion is recorded as deferred revenue in Accounts payable and other accrued liabilities in the unaudited Condensed Consolidated Balance Sheets. During the three and nine months ended September 30, 2024, we recognized $40 million a nd $76 million of revenue, respectively, which was included in deferred revenue at the beginning of the respective period. URL As of September 30, 2024 and December 31, 2023, the total URL balance of $366 million and $270 million, respectively, is included in Accounts payable and accrued liabilities on the unaudited Condensed Consolidated Balance Sheets. The following tables roll forward URL for our universal life product for the nine months ended September 30, 2024 and September 30, 2023: Nine Months Ended September 30, 2024 2023 (In millions) Balance at January 1, $ 270 $ 166 Capitalization 110 87 Amortization (14) (12) Balance at September 30, $ 366 $ 241

Value of Business Acquired, Def

Value of Business Acquired, Deferred Acquisition Costs and Deferred Sales Inducements	9 Months Ended
	Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Value of Business Acquired, Deferred Acquisition Costs and Deferred Sales Inducements	Value of Business Acquired, Deferred Acquisition Costs and Deferred Sales Inducements The following table reconciles to Other intangible assets, net, on the unaudited Condensed Consolidated Balance Sheets as of September 30, 2024 and December 31, 2023. September 30, 2024 December 31, 2023 (In millions) Customer relationships and contracts $ 440 $ 174 Value of business acquired 1,389 1,446 Deferred acquisition costs 2,857 2,215 Deferred sales inducements 538 346 Value of distribution asset 76 86 Computer software 282 266 Trademarks, tradenames, and other 176 94 Total Other intangible assets, net $ 5,758 $ 4,627 The following tables roll forward VOBA by product for the nine months ended September 30, 2024 and 2023. Indexed Annuities Fixed Rate Annuities Immediate Annuities Universal Life Traditional Life Total (In millions) Balance as of January 1, 2024 $ 1,025 $ 27 $ 191 $ 134 $ 69 $ 1,446 Amortization (101) (4) (5) (5) (5) (120) Actuarial model updates and refinements (a) — — — — 63 63 Balance as of September 30, 2024 $ 924 $ 23 $ 186 $ 129 $ 127 $ 1,389 (a) net of amortization of ($15 million). Indexed Annuities Fixed Rate Annuities Immediate Annuities Universal Life Traditional Life Total (In millions) Balance as of January 1, 2023 $ 1,166 $ 32 $ 201 $ 143 $ 73 $ 1,615 Amortization (106) (4) (8) (7) (3) (128) Balance as of September 30, 2023 $ 1,060 $ 28 $ 193 $ 136 $ 70 $ 1,487 VOBA amortization expense of $135 million and $128 million was recorded in Depreciation and amortization on the unaudited Condensed Consolidated Statements of Earnings for the nine months ended September 30, 2024 and 2023, respectively. The following tables roll forward DAC by product for the nine months ended September 30, 2024 and 2023. Indexed Annuities Fixed Rate Annuities Universal Life Total (a) (In millions) Balance as of January 1, 2024 $ 1,378 $ 288 $ 545 $ 2,211 Capitalization 496 147 199 842 Amortization (112) (61) (27) (200) Balance as of September 30, 2024 $ 1,762 $ 374 $ 717 $ 2,853 Indexed Annuities Fixed Rate Annuities Universal Life Total (a) (In millions) Balance as of January 1, 2023 $ 971 $ 83 $ 348 $ 1,402 Capitalization 371 119 167 657 Amortization (75) (35) (25) (135) Reinsurance related adjustments — 79 — 79 Balance as of September 30, 2023 $ 1,267 $ 246 $ 490 $ 2,003 (a) Excludes insignificant amounts of DAC related to Funding Agreement Backed Note (“FABN”). DAC amortization expense of $200 million and $135 million was recorded in Depreciation and amortization on the unaudited Condensed Consolidated Statements of Earnings for the nine months ended September 30, 2024 and 2023, respectively, excluding insignificant amounts related to FABN. The following table presents a reconciliation of DAC to the table above, which is reconciled to the unaudited Condensed Consolidated Balance Sheets as of September 30, 2024 and December 31, 2023: September 30, 2024 December 31, 2023 (In millions) Indexed Annuities $ 1,762 $ 1,378 Fixed Rate Annuities 374 288 Universal Life 717 545 Funding Agreements 4 4 Total $ 2,857 $ 2,215 The following table rolls forward DSI for our indexed annuity products for the nine months ended September 30, 2024 and 2023: Nine Months Ended September 30, 2024 2023 (In millions) Balance as of January 1, $ 346 $ 200 Capitalization 219 112 Amortization (27) (15) Balance as of September 30, $ 538 $ 297 DSI amortization expense of $27 million and $15 million was recorded in Depreciation and amortization on the unaudited Condensed Consolidated Statements of Earnings for the nine months ended September 30, 2024 and 2023, respectively. The cash flow assumptions used to amortize VOBA and DAC were consistent with the assumptions used to estimate the future policy benefits (“FPB”) for life contingent immediate annuities, and will be reviewed and unlocked, if applicable, in the same period as those balances. For nonparticipating traditional life contracts, the VOBA amortization is straight-line, without the use of cash flow assumptions. For indexed annuity contracts, the cash flow assumptions used to amortize VOBA, DAC, and DSI were consistent with the assumptions used to estimate the value of the embedded derivative and MRBs, and will be reviewed and unlocked, if applicable, in the same period as those balances. For fixed rate annuities and IUL the cash flow assumptions used to amortize VOBA, DAC and DSI reflect the Company’s best estimates for policyholder behavior, consistent with the development of assumptions for indexed annuities and immediate annuities. We review cash flow assumptions annually, generally in the third quarter. In 2024 and 2023, F&G undertook a review of all significant assumptions and revised several assumptions relating to our deferred annuity (indexed annuity and fixed rate annuity) and IUL products. For the nine months ended September 30, 2024, we updated assumptions including surrender rates, GMWB election timing, premium persistency, and option budgets. For the nine months ended September 30, 2023, we updated assumptions including surrender rates, partial withdrawal rates, mortality improvement, and option budgets. All updates to these assumptions brought us more in line with our company and overall industry experience since the prior assumption update. For the in-force liabilities as of September 30, 2024, the estimated amortization expense for VOBA in future fiscal periods is as follows: Estimated Amortization Expense Fiscal Year (In millions) 2024 $ 38 2025 143 2026 130 2027 119 2028 108 Thereafter 851 Total $ 1,389

F&G Reinsurance

F&G Reinsurance	9 Months Ended
	Sep. 30, 2024
Reinsurance Disclosures [Abstract]
F&G Reinsurance	F&G Reinsurance The Company reinsures portions of its policy risks with other insurance companies. The use of indemnity reinsurance does not discharge an insurer from liability on the insurance ceded. The insurer is required to pay in full the amount of its insurance liability regardless of whether it is entitled to or able to receive payment from the reinsurer. The portion of risks exceeding the Company's retention limit is reinsured. The Company primarily seeks reinsurance coverage in order to manage loss exposures, to enhance our capital position, to diversify risks and earnings, and to manage new business volume. The Company follows reinsurance accounting when the treaty adequately transfers insurance risk and any acquisition cost reimbursements reduce policy acquisition costs deferred and maintenance expense reimbursements reduce direct expenses incurred. Otherwise, the Company follows deposit accounting if there is inadequate transfer of insurance risk or if the underlying policy for which risk is being transferred is an investment contract that does not contain insurance risk. The effects of reinsurance on net premiums earned and net benefits incurred (benefits paid and reserve changes) for the three and nine months ended September 30, 2024 and 2023 were as follows: Three months ended September 30, Nine months ended September 30, 2024 2023 2024 2023 (In millions) Net Premiums Earned Net Benefits Incurred Net Premiums Earned Net Benefits Incurred Net Premiums Earned Net Benefits Incurred Net Premiums Earned Net Benefits Incurred Direct $ 363 $ 1,127 $ 508 $ 323 $ 1,340 $ 2,999 $ 1,319 $ 2,057 Ceded (23) (32) (26) (31) (71) (135) (79) (136) Net $ 340 $ 1,095 $ 482 $ 292 $ 1,269 $ 2,864 $ 1,240 $ 1,921 Amounts payable or recoverable for reinsurance on paid and unpaid claims are not subject to periodic or maximum limits. No policies issued by the Company have been reinsured with any foreign company, which is controlled, either directly or indirectly, by a party not primarily engaged in the business of insurance. The Company has not entered into any reinsurance agreements in which the reinsurer may unilaterally cancel any reinsurance for reasons other than non-payment of premiums or other similar credit issues. Reinsurance Transactions The following summarizes significant changes to a third-party reinsurance agreement for the period ended September 30, 2024: Somerset: Effective July 1, 2024, F&G amended the existing flow reinsurance agreement with Somerset Reinsurance Ltd. (“Somerset”), a third-party reinsurer, to additionally cede the base contract benefits and GMWB riders attached under certain FIA policies on a coinsurance funds withheld quota share basis. There have been no other significant changes to third party reinsurance agreements for the three and nine months ended September 30, 2024. The following summarizes our reinsurance recoverable as of September 30, 2024 and December 31, 2023: Parent Company/ Reinsurance Recoverable (a) Agreement Type Products Accounting September 30, 2024 December 31, 2023 (In millions) Aspida Life Re Ltd $ 7,543 $ 6,128 Coinsurance Funds Withheld Certain MYGA (b) Deposit Somerset Reinsurance Ltd (c) 2,181 716 Coinsurance Funds Withheld Certain MYGA (b) and deferred annuities Deposit Coinsurance Funds Withheld Certain FIA Reinsurance Everlake Life Insurance Company 1,120 509 Coinsurance (d) Certain MYGA (b) (d) Deposit Wilton Reassurance Company 1,073 1,092 Coinsurance Block of traditional, IUL and UL (e) Reinsurance Other (f) 508 536 Reinsurance recoverable, gross of allowance for credit losses 12,425 8,981 Allowance for expected credit loss (21) (21) Reinsurance recoverable, net of allowance for credit losses $ 12,404 $ 8,960 (a) Reinsurance recoverables do not include unearned ceded premiums that would be recovered in the event of early termination of certain traditional life policies. (b) The combined quota share flow reinsurance amongst all reinsurers for 2024 was 90% through May 31, 2024, decreased to 30% in June and July 2024, and increased to 90% in August and September 2024. As of December 31, 2023, the combined quota share flow reinsurance amongst all reinsurers was 90%. (c) The balance represents the total reinsurance recoverable for all reinsurance agreements with Somerset. (d) Reinsurance recoverable is collateralized by assets placed in a statutory comfort trust by the reinsurer and maintained for our sole benefit. (e) Also includes certain FGL Insurance life insurance policies that are subject to redundant reserves, reported on a statutory basis, under Regulation XXX and Guideline AXXX. (f) Represents all other reinsurers, with no single reinsurer having a carrying value in excess of 5% of total reinsurance recoverable. As of September 30, 2024, and December 31, 2023, F&G had a deposit asset of $10.5 billion and $7.5 billion, respectively, which is reported in the Reinsurance recoverable, net of allowance for credit losses on the unaudited Condensed Consolidated Balance Sheet. The Company incurred risk charge fees of $10 million and $10 million during the three months ended September 30, 2024 and 2023, respectively, and $32 million and $30 million during the nine months ended September 30, 2024, and 2023, respectively, in relation to reinsurance agreements. Credit Losses The Company estimates expected credit losses on reinsurance recoverables using a probability of default/loss given default model. Significant inputs to the model include the reinsurer's credit risk, expected timing of recovery, industry-wide historical default experience, senior unsecured bond recovery rates, and credit enhancement features. The expected credit loss reserves were as follows: Three months ended September 30, Nine months ended September 30, 2024 2023 2024 2023 (In millions) Balance at beginning of period $ (21) $ (9) $ (21) $ (10) Changes in the expected credit loss reserve — (1) — — Balance at end of period $ (21) $ (10) $ (21) $ (10) Concentration of Reinsurance Risk As indicated above, F&G has a significant concentration of reinsurance risk with third party reinsurers, ASPIDA Life Re Ltd. (“Aspida Re”), Somerset, Everlake Life Insurance Company (“Everlake”), and Wilton Reinsurance (“Wilton Re”) that could have a material impact on our financial position in the event that any of these reinsurers fails to perform its obligations under the various reinsurance treaties. We monitor the financial condition and financial strength of individual reinsurers using public ratings (refer to table below) and ratings reports of individual reinsurers to attempt to reduce the risk of default by such reinsurers. In addition, the risk of non-performance is further mitigated with various forms of collateral or collateral arrangements, including secured trusts, funds withheld accounts, and irrevocable letters of credit. We believe that all amounts due from Aspida Re, Somerset, Everlake, and Wilton Re for periodic treaty settlements, net of any applicable credit loss reserves, are collectible as of September 30, 2024. The following table presents financial strength ratings as of September 30, 2024: Parent Company/Principal Reinsurers Financial Strength Rating AM Best S&P Fitch Moody's Aspida Re A- — — — Somerset A- BBB+ — — Everlake A — — — Wilton Re A+ — A —

F&G Insurance Subsidiary Financ

F&G Insurance Subsidiary Financial Information and Regulatory Matters	9 Months Ended
	Sep. 30, 2024
Insurance [Abstract]
F&G Insurance Subsidiary Financial Information and Regulatory Matters	Summary of Reserve for Title Claim Losses A summary of the reserve for title claim losses follows: Nine months ended September 30, 2024 2023 (In millions) Beginning balance $ 1,770 $ 1,810 Change in insurance recoverable (14) (1) Claim loss provision related to: Current year 168 157 Total title claim loss provision 168 157 Claims paid, net of recoupments related to: Current year (13) (8) Prior years (191) (190) Total title claims paid, net of recoupments (204) (198) Ending balance of claim loss reserve for title insurance $ 1,720 $ 1,768 Provision for title insurance claim losses as a percentage of title insurance premiums 4.5 % 4.5 % Several lawsuits were filed by various parties against Chicago Title Company and Chicago Title Insurance Company as its principal (collectively, the “Named Companies”) by plaintiffs claiming they were investors who were solicited by Gina Champion-Cain through her former company, ANI Development LLC (“ANI”), or other affiliates to provide funds placed in an escrow account that purportedly were to be used for high-interest, short-term loans to parties seeking to acquire California alcoholic beverage licenses. Plaintiffs further alleged that employees of Chicago Title Company assisted Ms. Champion-Cain and her entities in diverting the funds placed into an escrow account maintained by Chicago Title Company into which some of the plaintiffs’ funds were deposited. In connection with the alcoholic beverage license scheme, the SEC filed a civil enforcement proceeding asserting claims for securities fraud against Champion-Cain and ANI in a lawsuit styled, Securities and Exchange Commission v. Gina Champion-Cain and ANI Development, LLC , pending in the United States District Court for the Southern District of California. The receiver, who was appointed by the court to preserve the assets of the defendant affiliated entities, then filed a lawsuit in San Diego County Superior Court against the Named Companies seeking damages in a lawsuit styled, Krista Freitag v. Chicago Title Co. and Chicago Title Ins. Co. The Named Companies reached a global settlement with the receiver and several other investor claimants and jointly sought court approval of the global settlement and entry of an order barring any claims against the Named Companies related to the alcoholic beverage license scheme. On November 23, 2022, the federal court overruled any objections by non-joining investors and entered an order approving the global settlement barring further claims against the Named Companies (“Settlement and Bar Order”). After her receipt of the settlement funds, the receiver dismissed the lawsuit against the Named Companies. Some of the non-joining investor claimants who objected to entry of the Settlement and Bar Order appealed the decision to the United States Court of Appeals for the Ninth Circuit by (Cases 22-56206, 22-56208, and 23-55083). Appellate oral argument was held on August 13, 2024, and a decision is pending with the court. Chicago Title Company has also resolved a number of other pre-suit claims and previously-disclosed lawsuits from both individual and groups of alleged investors under confidential terms. Based on the facts and circumstances of the remaining claims, including the settlements already reached, we have recorded reserves included in our reserve for title claim losses, which we believe are adequate to cover losses related to this matter, and believe that our reserves for title claim losses are adequate. We continually upda te loss reserve estimates as new information becomes known, new loss patterns emerge, or as other contributing factors are considered and incorporated into the analysis of reserve for claim losses. Estimating future title loss payments is difficult because of the complex nature of title claims, the long periods of time over which claims are paid, significantly varying dollar amounts of individual claims, and other factors. Due to the uncertainty inherent in the process and to the judgment used by management, the ultimate liability may be greater or less than our current reserves. If actual claims loss development varies from what is currently expected and is not offset by other factors, additional reserve adjustments may be required in future periods to maintain our recorded reserve within a reasonable range of our actuary's central estimate. Our U.S. insurance subsidiaries, FGL Insurance, FGL NY Insurance, Raven Re and Corbeau Re file financial statements with state insurance regulatory authorities and, with the exception of Raven Re, with the National Association of Insurance Commissioners (“NAIC”) that are prepared in accordance with Statutory Accounting Principles (“SAP”) prescribed or permitted by such authorities, which may vary materially from GAAP. Prescribed SAP includes the Accounting Practices and Procedures Manual of the NAIC as well as state laws, regulations and administrative rules. Permitted SAP encompasses all accounting practices not so prescribed. The principal differences between SAP financial statements and financial statements prepared in accordance with GAAP are that SAP financial statements do not reflect VOBA, DAC, and DSI, some bond portfolios may be carried at amortized cost, assets and liabilities are presented net of reinsurance, contractholder liabilities are generally valued using more conservative assumptions and certain assets are non-admitted. Accordingly, SAP operating results and SAP capital and surplus may differ substantially from amounts reported in the GAAP basis financial statements for comparable items. Our non-U.S. insurance subsidiaries, F&G Cayman Re Ltd (“F&G Cayman Re”) and F&G Life Re Ltd (Bermuda), file financial statements with their respective regulators. U.S. Companies Our principal insurance subsidiaries' statutory financial statements are based on a December 31 year end. Statutory net income for the three and nine months ended September 30, 2024 and September 30, 2023, and statutory capital and surplus as ofSeptember 30, 2024 and December 31, 2023 of our insurance subsidiaries were as follows (in millions): Subsidiary (state of domicile) (a) FGL Insurance FGL NY Insurance (NY) Raven Re Corbeau Re Statutory net income (loss): For the three months ended September 30, 2024 $ (6) $ 1 $ 13 $ 5 For the three months ended September 30, 2023 94 (1) 14 — For the nine months ended September 30, 2024 71 7 41 (394) For the nine months ended September 30, 2023 54 4 42 — Statutory capital and surplus: September 30, 2024 $ 1,704 $ 95 $ 156 $ 139 December 31, 2023 2,009 86 140 171 (a) FGL NY Insurance, Raven Re, and Corbeau Re are subsidiaries of FGL Insurance, and the columns should not be added together. Corbeau Re was incorporated on September 1, 2023. Non-U.S. Companies Our non-U.S. insurance subsidiaries, F&G Cayman Re and F&G Life Re, file financial statements with their respective regulators. As of and for the annual period ended December 31, 2023, F&G Cayman Re began to file financial statements that are prepared in accordance with SAP prescribed or permitted by such authorities, which may vary materially from GAAP. Accordingly, SAP operating results and SAP capital and surplus may differ substantially from amounts reported in the GAAP basis financial statements for comparable items. F&G Cayman Re has two permitted practices which have been approved by the Cayman Islands Monetary Authority (“CIMA”). F&G Cayman Re has a permitted practice approved by CIMA to include, as an admitted asset, the value of the letters of credit (“LOCs”) acquired to support reinsurance transactions. Also, F&G Cayman Re has a permitted practice, approved by CIMA, for PRT reinsurance transactions to use U.S. statutory book value adjusted for best estimate reserve calculations (consistent with GAAP prior to ASU 2018-12, Financial Services-Insurance (Topic 944), Targeted Improvements to the Accounting for Long-Duration Contracts). These reserve calculations will be subject to annual assumption reviews consistent with other GAAP liability balances. If F&G Cayman Re had not been permitted to calculate PRT assumed reserves using best estimate reserve calculations or include the value of the LOCs as an admitted asset, statutory surplus would be $29 million and $102 million as of September 30, 2024 and December 31, 2023, respectively. Without such permitted statutory accounting practices, F&G Cayman Re’s risk-based capital would fall below the minimum regulatory requirements as of September 30, 2024 and December 31, 2023. F&G Life Re files financial statements based on GAAP. Net income and capital and surplus of our wholly owned Cayman Islands and Bermuda regulated insurance subsidiaries under SAP and GAAP, respectively, were as follows (in millions): Subsidiary (country of domicile) F&G Cayman Re (Cayman Islands) F&G Life Re (Bermuda) Statutory net income (loss): For the three months ended September 30, 2024 $ (11) $ 102 For the three months ended September 30, 2023 6 (80) For the nine months ended September 30, 2024 $ (27) $ 181 For the nine months ended September 30, 2023 13 (6) Statutory capital and surplus: September 30, 2024 $ 625 $ 195 December 31, 2023 543 11 There have been no material changes to the prescribed and permitted practices for our U.S. insurance subsidiaries, which were detailed in our Annual Report on Form 10-K, and no other significant changes in the regulatory status of our insurance subsidiaries as of September 30, 2024. The prescribed and permitted statutory accounting practices have no impact on our unaudited Condensed Consolidated Financial Statements, which are prepared in accordance with GAAP.

Acquisitions

Acquisitions	9 Months Ended
	Sep. 30, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Acquisitions	Acquisitions Owned Distribution - Acquisition of Roar On January 2, 2024, F&G acquired a 70% majority ownership stake in the equity of Roar. Roar wholesales life insurance and annuity products to banks and broker dealers through a network of agents. Under the terms of the purchase agreement, the Company has agreed to make cash payments of up to $90 million over a three-year period upon the achievement of certain EBITDA milestones of Roar. The initial purchase price is as follows (in millions): Cash paid for 70% majority interest of Roar shares $ 269 Less: Cash acquired net of noncontrolling interests 1 Net cash paid for 70% majority interest of Roar 268 Initial fair value of contingent consideration 48 Total initial consideration $ 316 The following table summarizes the fair value amounts recognized for the assets acquired and liabilities assumed as of the acquisition date: Fair value as of (In millions) Goodwill $ 268 Prepaid expenses and other assets 3 Other intangible assets 183 Total assets acquired 454 Accounts payable and accrued liabilities 2 Total liabilities assumed 2 Noncontrolling interests (fair value determined using income approach) 136 Total liabilities assumed and non-controlling interests 138 Net assets acquired $ 316 The gross carrying value and weighted average estimated useful lives of Other intangible assets acquired in the Roar acquisition consist of the following: Gross Carrying Value Estimated Useful Life Other intangible assets: (In millions) (In years) Customer relationships $ 179 12 Definite lived trademarks, tradenames, and other 4 10 Total Other intangible assets $ 183 Goodwill consists primarily of intangible assets that do not qualify for separate recognition, such as the assembled workforce and synergies between the entities. The total amount of goodwill recorded is expected to be deductible for tax purposes. Roar’s revenues of $19 million and $60 million and net earnings of $2 million and $6 million are included in the unaudited Condensed Consolidated Statement of Earnings for the three and nine months ended September 30, 2024, respectively. Contingent Consideration Under the terms of the purchase agreement for Roar, we have agreed to make cash payments of up to $90 million over a three-year period upon the achievement by Roar of certain EBITDA milestones. The contingent consideration is recorded at fair value in Accounts payable and accrued liabilities. Refer to Note A Basis of Financial Statements for more information on the Roar purchase and refer to Note C Fair Value of Financial Instruments for more information regarding the fair value of the contingent consideration. Owned Distribution - Acquisition of PALH, LLC On July 18, 2024, F&G acquired a 100% ownership stake in the equity of PALH. PALH markets and sells life insurance and annuity products of various insurance carriers to individuals through a network of agents. Prior to the acquisition date, PALH owned a 70% ownership stake in an operating company of which F&G owned 30% equity. Immediately before the acquisition date, the fair value of F&G’s minority stake in the operating company was approximately $92 million, derived from the transaction value. The transaction value contemplates measures such as EBITDA margin, revenue growth over time periods and growth opportunities. This remeasurement resulted in a realized gain of $2 million recorded in Recognized gains and losses, net in the unaudited Condensed Consolidated Statements of Earnings during the three and nine months ended September 30, 2024 . The initial purchase price was as follows (in millions): Cash consideration $ 215 Less: Cash acquired 1 Net cash paid 214 Settlement of prepaid asset 8 Acquisition date fair value of previously held interests 92 Total consideration $ 314 The following table summarizes the fair value amounts recognized for the assets acquired and liabilities assumed as of the acquisition date (in millions): Fair value as of Goodwill $ 162 Prepaid expenses and other assets 5 Other intangible assets 149 Total assets acquired 316 Accounts payable and accrued liabilities 2 Total liabilities assumed 2 Net assets acquired $ 314 The gross carrying value and weighted average estimated useful lives of Other intangible assets acquired in the PALH acquisition consist of the following: Gross Carrying Value Estimated Useful Life Other intangible assets: (In millions) (In years) Customer relationships $ 131 20 Definite lived trademarks, tradenames, and other 18 5 to 10 Total Other intangible assets $ 149

Notes Payable

Notes Payable	9 Months Ended
	Sep. 30, 2024
Debt Disclosure [Abstract]
Notes Payable	Notes Payable Notes payable consists of the following: September 30, 2024 December 31, 2023 (In millions) 4.50% Notes, net of discount $ 446 $ 446 3.40% Notes, net of discount 645 644 2.45% Notes, net of discount 595 594 3.20% Notes, net of discount 444 444 Revolving Credit Facility (4) (2) F&G Credit Agreement 358 362 6.50% F&G Notes, net of discount 544 — 7.40% F&G Notes, net of discount 496 495 5.50% F&G Notes, net of discount 304 561 7.95% F&G Notes, net of discount 336 336 Other 22 7 $ 4,186 $ 3,887 On June 4, 2024, F&G completed its public offering of $550 million aggregate principal amount of its 6.50% F&G Notes due 2029. The 6.50% F&G Notes were issued at 99.74% of face value net of deferred issuance costs of approximately $6 million. The 6.50% F&G Notes are guaranteed on an unsecured, unsubordinated basis by each of F&G’s subsidiaries that are guarantors of F&G’s obligations under its existing credit agreement. The 6.50% F&G Notes mature on June 4, 2029, and become callable on May 4, 2029. Interest is payable semi-annually at a fixed rate of 6.50%, and, if the 6.50% F&G Notes are downgraded, the interest rate payable is subject to adjustment from time to time per the terms of the indenture. F&G used a portion of the net proceeds from the offering to repay an aggregate principal amount of $250 million of the 5.50% F&G Notes. The balance of the 5.50% F&G Notes was $304 million as of September 30, 2024 compared to $561 million at December 31, 2023. F&G intends to use the remaining net proceeds for general corporate purposes, which may include the repurchase, redemption, or repayment at maturity of outstanding indebtedness. On December 6, 2023, F&G issued $345 million of its 7.95% Senior Notes due 2053 ("7.95% F&G Notes"). The 7.95% F&G Notes were issued at par, net of deferred issuance costs of approximately $9 million. The 7.95% F&G Notes are senior unsecured, unsubordinated obligations of F&G and are guaranteed by each of F&G’s subsidiaries that are guarantors of F&G’s obligations under its existing credit agreement. The 7.95% F&G Notes mature on December 15, 2053, and become callable on December 15, 2028. Interest is payable quarterly at a fixed rate of 7.95%, and, if the 7.95% F&G Notes are downgraded, the interest rate payable is subject to adjustment from time to time per the terms of the indenture. F&G used a portion of the net proceeds from the offering to repay borrowings under its revolving credit facility as discussed below and for general corporate purposes, including the support of organic growth opportunities. On January 13, 2023, F&G completed its issuance and sale of $500 million aggregate amount of its 7.40% Notes due 2028 ("the 7.40% F&G Notes"), pursuant to Rule 144A and Regulation S under the Securities Act of 1933, as amended. The 7.40% F&G Notes are the senior unsecured, unsubordinated obligations of F&G and are guaranteed on an unsecured, unsubordinated basis by each of F&G's subsidiaries that are guarantors of its obligations under the F&G Credit Agreement (the “Guarantors”). The interest rate payable on the 7.40% F&G Notes will be subject to adjustment from time to time if either S&P or Fitch (or a substitute rating agency therefor) downgrades (or downgrades and subsequently upgrades) the credit ratings assigned to the 7.40% F&G Notes. F&G intends to use the net proceeds from the offering for general corporate purposes, including to support the growth of assets under management and for F&G's future liquidity requirements. The Senior notes were registered under the Securities Act of 1933 (as amended). On November 22, 2022, F&G entered into a Credit Agreement (the "F&G Credit Agreement") with certain lenders (the "Lenders") and Bank of America, N.A. as administrative agent (the "Administrative Agent"), swing line lender and issuing bank, pursuant to which the Lenders have made available to F&G an unsecured revolving credit facility (the "F&G Credit Facility") in an aggregate principal amount of $550 million to be used for working capital and general corporate purposes. The F&G Credit Agreement matures on the earlier to occur of November 22, 2025 or 91 days prior to May 1, 2025, the stated maturity date of the 5.50% F&G Notes, unless the principal amount of the 5.50% F&G Notes is $150 million or less at such time, the 5.50% F&G Notes have been redeemed or defeased in full, and any refinancing indebtedness incurred in connection therewith matures at least 91 days after the date that is 3 years from the Effective Date, as defined in the F&G Credit Agreement, or certain other conditions are met. Revolving loans under the F&G Credit Agreement generally bear interest at a variable rate based on either (i) the base rate (which is the highest of (a) one-half of one percent in excess of the federal funds rate, (b) the Administrative Agent’s “prime rate”, or (c) the sum of one percent plus the term Secured Overnight Financing Rate (“SOFR”) plus a margin of between 30.0 and 80.0 basis points depending on the non-credit-enhanced, senior unsecured long-term debt ratings of F&G or (ii) SOFR plus a margin of between 130.0 and 180.0 basis points depending on the non-credit-enhanced, senior unsecured long-term debt ratings of F&G). On February 21, 2023, F&G amended the F&G Credit Agreement with the Lenders and the Administrative Agent, swing line lender and issuing bank. The amendment to the F&G Credit Agreement increased the aggregate principal amount of commitments under the F&G Credit Facility by $115 million to $665 million. On February 16, 2024, we entered into a Second Amended and Restated F&G Credit Agreement. Among other changes, the Second Amended and Restated F&G Credit Agreement amends the Amended F&G Credit Agreement to extend the maturity date to November 22, 2027 and increase the aggregate principal amount of commitments under the revolving credit facility to $750 million. On September 17, 2021, we completed our underwritten public offering of $450 million aggregate principal amount of our 3.20% Notes due 2051 ("the 3.20% Notes"), pursuant to our registration statement on Form S-3 ASR (File No. 333-239002) and the related prospectus supplement. The net proceeds from the registered offering of the 3.20% Notes were approximately $443 million, after deducting underwriting discounts, commissions and offering expenses. We plan to use the net proceeds from the offering for general corporate purposes. On October 29, 2020, we entered into the Fifth Restated Credit Agreement for our Amended Revolving Credit Facility with Bank of America, N.A., as administrative agent and the other agents party thereto. Among other changes, the Fifth Restated Credit Agreement amends the Fourth Restated Credit Agreement to extend the maturity date from April 27, 2022 to October 29, 2025. The material terms of the Fourth Restated Credit Agreement are set forth in our Annual Report on Form 10-K for the year ended December 31, 2019. On February 16, 2024, we entered into a Sixth Amended and Restated Credit Agreement for our $800 million revolving credit facility (the "Amended Revolving Credit Facility") with Bank of America, N.A., as administrative agent and other agents party thereto (the "Sixth Restated Credit Agreement"). Among other changes, the Sixth Restated Credit Agreement amends the Amended Revolving Credit Facility to extend the maturity date from October 29, 2025, to February 16, 2029. As of September 30, 2024, there was no principal outstanding, $4 million of unamortized debt issuance costs, and $800 million of available borrowing capacity under the Amended Revolving Credit Facility. On September 15, 2020, we completed our underwritten public offering of $600 million aggregate principal amount of our 2.45% Notes due March 15, 2031 (the "2.45% Notes") pursuant to an effective registration statement filed with the SEC. The net proceeds from the registered offering of the 2.45% Notes were approximately $593 million, after deducting underwriting discounts and commissions and offering expenses. We used the net proceeds from the offering (i) to repay all our $260 million outstanding indebtedness under the Term Loan, and (ii) for general corporate purposes. On June 12, 2020, we completed our underwritten public offering of $650 million aggregate principal amount of the 3.40% Notes due June 15, 2030 (the “3.40% Notes”) pursuant to an effective registration statement filed with the SEC. The net proceeds from the registered offering of the 3.40% Notes were approximately $642 million, after deducting underwriting discounts, and commissions and offering expenses. We used the net proceeds from the offering (i) to repay $640 million of the outstanding principal amount under the Term Loan, and (ii) for general corporate purposes. On June 1, 2020, as a result of the F&G acquisition, we assumed $550 million aggregate principal amount of 5.50% senior notes due 2025 (the "5.50% F&G Notes"), originally issued on April 20, 2018 at 99.5% of face value for proceeds of $547 million. In 2024, F&G used a portion of the net proceeds from the offering of $550 million aggregate principal amount of its 6.50% F&G Notes to repay an aggregate principal amount of $250 million of the 5.50% F&G Notes. On August 13, 2018, we completed an offering of $450 million in aggregate principal amount of 4.50% notes due August 2028 (the "4.50% Notes"), pursuant to Rule 144A and Regulation S under the Securities Act of 1933, as amended. The 4.50% Notes were priced at 99.252% of par to yield 4.594% annual interest. We pay interest on the 4.50% Notes semi-annually on the 15th of February and August, beginning February 15, 2019. The 4.50% Notes contain customary covenants and events of default for investment grade public debt, which primarily relate to failure to make principal or interest payments. On May 16, 2019, we completed an offering to exchange the 4.50% Notes for substantially identical notes registered pursuant to Rule 424 under the Securities Act of 1933 (the "4.50% Notes Exchange"). There were no material changes to the terms of the 4.50% Notes as a result of the 4.50% Notes Exchange and all holders of the 4.50% Notes accepted the offer to exchange. Gross principal maturities of notes payable as of September 30, 2024 are as follows: (In millions) 2024 (remaining) $ 365 2025 303 2026 22 2027 — 2028 950 Thereafter 2,595 $ 4,235

Market Risk Benefits

Market Risk Benefits	9 Months Ended
	Sep. 30, 2024
Insurance [Abstract]
Market Risk Benefits	Market Risk Benefits The following table presents the balances of and changes in MRBs associated with indexed annuities and fixed rate annuities for the nine months ended September 30, 2024 and the year ended December 31, 2023: September 30, 2024 December 31, 2023 Indexed Fixed rate annuities Indexed Fixed rate annuities (In millions) Balance, beginning of period, net liability $ 314 $ 1 $ 164 $ 1 Balance, beginning of period, before effect of changes in the instrument-specific credit risk $ 209 $ 1 $ 102 $ 1 Issuances and benefit payments 78 — (10) — Attributed fees collected and interest accrual 103 — 131 — Actual policyholder behavior different from expected 8 — 27 — Changes in assumptions and other 32 — 29 — Effects of market related movements (31) — (70) — Balance, end of period, before effect of changes in the instrument-specific credit risk 399 1 209 1 Effect of changes in the instrument-specific credit risk 112 — 105 — Balance, end of period, net liability 511 1 314 1 Less: reinsured market risk benefits 43 — — — Balance, end of period, net of reinsurance $ 468 $ 1 $ 314 $ 1 Weighted-average attained age of policyholders weighted by total AV (years) 68.04 72.47 68.28 72.59 Net amount at risk $ 1,390 $ 2 $ 1,059 $ 2 The following table reconciles MRBs by amounts in an asset position and amounts in a liability position to the MRBs amounts in the accompanying unaudited Condensed Consolidated Balance Sheets: September 30, 2024 December 31, 2023 Direct Reinsured Net Direct Reinsured Net (In millions) MRB asset Indexed annuities $ 91 $ 43 $ 134 $ 88 $ — $ 88 Total MRB asset $ 91 $ 43 $ 134 $ 88 $ — $ 88 MRB liability Indexed annuities $ 602 $ — $ 602 $ 402 $ — $ 402 Fixed rate annuities 1 — 1 1 — 1 Total MRB liability $ 603 $ — $ 603 $ 403 $ — $ 403 The net MRB liability increased for the nine months ended September 30, 2024, primarily as a result of collection of attributed fees, interest accrual, MRB reserves for contracts issued within the period, and changes in actuarial assumptions. These increases were partially offset by the effects of market related movements, including the impacts of higher risk-free rates and increases in the equity market related projections. For the nine months ended September 30, 2024, notable changes made to the inputs to the fair value estimates of MRBs calculations included an increase in risk-free rates leading to a favorable change in the MRBs associated with indexed annuities and fixed rate annuities; increases in the equity market related projections resulted in a decrease in the net amount at risk associated with indexed annuities, leading to a favorable change in the value of the associated MRBs; and an increase in the rider benefit utilization assumption, leading to an unfavorable change in the value of the associated MRBs. The net MRB liability increased for the year ended December 31, 2023, primarily as a result of attributed fees collected, increases as a result of actual policyholder behavior different than expected and changes in assumptions as discussed below. These increases were partially offset by the effects of market related movements, including the impacts of higher risk-free rates and increases in the equity market related projections. For the year ended December 31, 2023, notable changes made to the inputs to the fair value estimates of MRBs calculations included a significant increase in risk-free rates leading to a favorable change in the MRBs associated with indexed annuities and fixed rate annuities; increases in the equity market related projections resulted in a decrease in the net amount at risk associated with indexed annuities, leading to a favorable change in the value of the associated MRBs; and F&G’s credit spread decreased, lead to a corresponding unfavorable change in the MRBs associated with both indexed annuities and fixed rate annuities. In 2024 and 2023, F&G undertook a review of all significant assumptions and revised several assumptions relating to our deferred annuities (indexed annuities and fixed rate annuities) with MRBs. For the nine months ended September 30, 2024, we updated assumptions including surrender rates, rider benefit election utilization and option budgets. For the year ended December 31, 2023,we updated assumptions including surrender rates, partial withdrawal rates, mortality improvement, and option budgets. All updates to these assumptions brought us more in line with our Company and overall industry experience since the prior assumption updates. These updates, in total, led to increases in the net MRB liability for the nine months ended September 30, 2024 and for the year ended December 31, 2023. The following tables summarize balances of and changes in contractholder funds’ account balances: September 30, 2024 Indexed annuities Fixed rate annuities Universal Life FABN (b) FHLB (b) (Dollars in millions) Balance, beginning of year $ 27,164 $ 13,443 $ 2,391 $ 2,613 $ 2,539 Issuances 4,829 4,476 157 599 1,803 Premiums received 85 1 361 — — Policy charges (a) (140) — (231) — — Surrenders and withdrawals (2,807) (1,184) (75) — — Benefit payments (368) (233) (13) (791) (1,576) Interest credited 488 476 108 51 89 Other 5 — — (1) (2) Balance, end of period 29,256 16,979 2,698 2,471 2,853 Embedded derivative adjustment (c) 790 — 119 — — Gross Liability, end of period 30,046 16,979 2,817 2,471 2,853 Less: Reinsurance 410 10,471 883 — — Net Liability, after Reinsurance $ 29,636 $ 6,508 $ 1,934 $ 2,471 $ 2,853 Weighted-average crediting rate 2.33 % 4.26 % 5.84 % N/A N/A Net amount at risk (d) N/A N/A $ 70,859 N/A N/A Cash surrender value (e) $ 26,985 $ 15,815 $ 2,088 N/A N/A (a) Contracts included in the contractholder funds are generally charged a premium and/or monthly assessment on the basis of the account balance. (b) FABN and FHLB are considered funding agreements that are investment contracts, which follow the interest method of accounting, and therefore are not subject to ASU 2018-12 disclosure requirements. However, the Company has elected to present the liability for these agreements within the disaggregated roll forward as we believe it will provide meaningful information for users of the financials. (c) The embedded derivative adjustment reconciles the account balance to the gross GAAP liability and represents the combination of the host contract and the fair value of the embedded derivatives. (d) For those guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date. (e) These amounts are gross of reinsurance. December 31, 2023 Indexed annuities Fixed rate annuities Universal Life FABN (b) FHLB (b) (Dollars in millions) Balance, beginning of year $ 24,766 $ 9,358 $ 2,112 $ 2,613 $ 1,982 Issuances 4,722 5,061 199 — 1,256 Premiums received 103 1 382 — — Policy charges (a) (182) — (261) — — Surrenders and withdrawals (2,005) (1,142) (90) — — Benefit payments (526) (240) (27) (53) (763) Interest credited 270 405 76 54 64 Other 16 — — (1) — Balance, end of period 27,164 13,443 2,391 2,613 2,539 Embedded derivative adjustment (c) 243 — 84 — — Gross Liability, end of period 27,407 13,443 2,475 2,613 2,539 Less: Reinsurance 17 7,520 894 — — Net Liability, after Reinsurance $ 27,390 $ 5,923 $ 1,581 $ 2,613 $ 2,539 Weighted-average crediting rate 1.40 % 4.85 % 3.44 % N/A N/A Net amount at risk (d) N/A N/A $ 60,389 N/A N/A Cash surrender value (e) $ 25,099 $ 12,505 $ 1,872 N/A N/A (a) Contracts included in the contractholder funds are generally charged a premium and/or monthly assessment on the basis of the account balance. (b) FABN and FHLB are considered funding agreements that are investment contracts, which follow the interest method of accounting, and therefore are not subject to ASU 2018-12 disclosure requirements. However, the Company has elected to present the liability for these agreements within the disaggregated roll forward as we believe it will provide meaningful information for users of the financials. (c) The embedded derivative adjustment reconciles the account balance to the gross GAAP liability and represents the combination of the host contract and the fair value of the embedded derivatives. (d) For those guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date. (e) These amounts are gross of reinsurance. The following table reconciles contractholder funds’ account balances to the contractholder funds liability in the accompanying unaudited Condensed Consolidated Balance Sheets: September 30, 2024 December 31, 2023 (In millions) Indexed annuities $ 30,046 $ 27,407 Fixed rate annuities 16,979 13,443 Immediate annuities 292 311 Universal life 2,817 2,475 Traditional life 5 5 Funding Agreement-FABN 2,471 2,613 FHLB 2,853 2,539 PRT 5 5 Total $ 55,468 $ 48,798 Annually, typically in the third quarter, we review assumptions associated with reserves for policy benefits and product guarantees. For the nine months ended September 30, 2024, based on policyholder behavior, experience and interest rate movements, we reflected updates to surrender assumptions for recent and expected near term policyholder behavior, as well as updated certain FIA assumptions used to calculate the fair value of the embedded derivative component within contractholder funds. These changes resulted in a decrease in total benefits and other changes in policy reserves of approximately $79 million for the nine months ended September 30, 2024. For the year ended December 31, 2023, based on increases in interest rates and pricing changes, we updated certain FIA assumptions used to calculate the fair value of the embedded derivative component within contractholder funds and also aligned reserves to actual policyholder behavior. These changes resulted in an increase in total benefits and other changes in policy reserves of approximately $73 million for the year ended December 31, 2023. The following tables present the account values by range of guaranteed minimum crediting rates and the related range of difference, in basis points, between rates being credited to policyholders and the respective guaranteed minimums: September 30, 2024 Range of guaranteed minimum crediting rate At Guaranteed Minimum 1 Basis Point-50 Basis Points Above 51 Basis Points-150 Basis Points Above Greater Than 150 Basis Points Above Total Indexed Annuities (In millions) 0.00%-1.50% $ 23,095 $ 1,285 $ 502 $ 1,847 $ 26,729 1.51%-2.50% 700 1 460 1,046 2,207 Greater than 2.50% 317 2 — 1 320 Total $ 24,112 $ 1,288 $ 962 $ 2,894 $ 29,256 Fixed Rate Annuities 0.00%-1.50% $ 46 $ 21 $ 925 $ 13,855 $ 14,847 1.51%-2.50% 4 7 20 460 491 Greater than 2.50% 826 2 3 810 1,641 Total $ 876 $ 30 $ 948 $ 15,125 $ 16,979 Universal Life 0.00%-1.50% $ 2,303 $ 6 $ — $ 22 $ 2,331 Greater than 2.50% 366 — 1 — 367 Total $ 2,669 $ 6 $ 1 $ 22 $ 2,698 December 31, 2023 Range of guaranteed minimum crediting rate At Guaranteed Minimum 1 Basis Point-50 Basis Points Above 51 Basis Points-150 Basis Points Above Greater Than 150 Basis Points Above Total Indexed Annuities (In millions) 0.00%-1.50% $ 22,392 $ 1,444 $ 526 $ 1,953 $ 26,315 1.51%-2.50% 196 1 24 250 471 Greater than 2.50% 377 1 — — 378 Total $ 22,965 $ 1,446 $ 550 $ 2,203 $ 27,164 Fixed Rate Annuities 0.00%-1.50% $ 23 $ 25 $ 1,532 $ 10,271 $ 11,851 1.51%-2.50% 5 8 23 453 489 Greater than 2.50% 893 2 4 204 1,103 Total $ 921 $ 35 $ 1,559 $ 10,928 $ 13,443 Universal Life 0.00%-1.50% $ 1,987 $ 5 $ — $ 21 $ 2,013 Greater than 2.50% 361 16 1 — 378 Total $ 2,348 $ 21 $ 1 $ 21 $ 2,391

Contractholder Funds

Contractholder Funds	9 Months Ended
	Sep. 30, 2024
Insurance [Abstract]
Contractholder Funds	Market Risk Benefits The following table presents the balances of and changes in MRBs associated with indexed annuities and fixed rate annuities for the nine months ended September 30, 2024 and the year ended December 31, 2023: September 30, 2024 December 31, 2023 Indexed Fixed rate annuities Indexed Fixed rate annuities (In millions) Balance, beginning of period, net liability $ 314 $ 1 $ 164 $ 1 Balance, beginning of period, before effect of changes in the instrument-specific credit risk $ 209 $ 1 $ 102 $ 1 Issuances and benefit payments 78 — (10) — Attributed fees collected and interest accrual 103 — 131 — Actual policyholder behavior different from expected 8 — 27 — Changes in assumptions and other 32 — 29 — Effects of market related movements (31) — (70) — Balance, end of period, before effect of changes in the instrument-specific credit risk 399 1 209 1 Effect of changes in the instrument-specific credit risk 112 — 105 — Balance, end of period, net liability 511 1 314 1 Less: reinsured market risk benefits 43 — — — Balance, end of period, net of reinsurance $ 468 $ 1 $ 314 $ 1 Weighted-average attained age of policyholders weighted by total AV (years) 68.04 72.47 68.28 72.59 Net amount at risk $ 1,390 $ 2 $ 1,059 $ 2 The following table reconciles MRBs by amounts in an asset position and amounts in a liability position to the MRBs amounts in the accompanying unaudited Condensed Consolidated Balance Sheets: September 30, 2024 December 31, 2023 Direct Reinsured Net Direct Reinsured Net (In millions) MRB asset Indexed annuities $ 91 $ 43 $ 134 $ 88 $ — $ 88 Total MRB asset $ 91 $ 43 $ 134 $ 88 $ — $ 88 MRB liability Indexed annuities $ 602 $ — $ 602 $ 402 $ — $ 402 Fixed rate annuities 1 — 1 1 — 1 Total MRB liability $ 603 $ — $ 603 $ 403 $ — $ 403 The net MRB liability increased for the nine months ended September 30, 2024, primarily as a result of collection of attributed fees, interest accrual, MRB reserves for contracts issued within the period, and changes in actuarial assumptions. These increases were partially offset by the effects of market related movements, including the impacts of higher risk-free rates and increases in the equity market related projections. For the nine months ended September 30, 2024, notable changes made to the inputs to the fair value estimates of MRBs calculations included an increase in risk-free rates leading to a favorable change in the MRBs associated with indexed annuities and fixed rate annuities; increases in the equity market related projections resulted in a decrease in the net amount at risk associated with indexed annuities, leading to a favorable change in the value of the associated MRBs; and an increase in the rider benefit utilization assumption, leading to an unfavorable change in the value of the associated MRBs. The net MRB liability increased for the year ended December 31, 2023, primarily as a result of attributed fees collected, increases as a result of actual policyholder behavior different than expected and changes in assumptions as discussed below. These increases were partially offset by the effects of market related movements, including the impacts of higher risk-free rates and increases in the equity market related projections. For the year ended December 31, 2023, notable changes made to the inputs to the fair value estimates of MRBs calculations included a significant increase in risk-free rates leading to a favorable change in the MRBs associated with indexed annuities and fixed rate annuities; increases in the equity market related projections resulted in a decrease in the net amount at risk associated with indexed annuities, leading to a favorable change in the value of the associated MRBs; and F&G’s credit spread decreased, lead to a corresponding unfavorable change in the MRBs associated with both indexed annuities and fixed rate annuities. In 2024 and 2023, F&G undertook a review of all significant assumptions and revised several assumptions relating to our deferred annuities (indexed annuities and fixed rate annuities) with MRBs. For the nine months ended September 30, 2024, we updated assumptions including surrender rates, rider benefit election utilization and option budgets. For the year ended December 31, 2023,we updated assumptions including surrender rates, partial withdrawal rates, mortality improvement, and option budgets. All updates to these assumptions brought us more in line with our Company and overall industry experience since the prior assumption updates. These updates, in total, led to increases in the net MRB liability for the nine months ended September 30, 2024 and for the year ended December 31, 2023. The following tables summarize balances of and changes in contractholder funds’ account balances: September 30, 2024 Indexed annuities Fixed rate annuities Universal Life FABN (b) FHLB (b) (Dollars in millions) Balance, beginning of year $ 27,164 $ 13,443 $ 2,391 $ 2,613 $ 2,539 Issuances 4,829 4,476 157 599 1,803 Premiums received 85 1 361 — — Policy charges (a) (140) — (231) — — Surrenders and withdrawals (2,807) (1,184) (75) — — Benefit payments (368) (233) (13) (791) (1,576) Interest credited 488 476 108 51 89 Other 5 — — (1) (2) Balance, end of period 29,256 16,979 2,698 2,471 2,853 Embedded derivative adjustment (c) 790 — 119 — — Gross Liability, end of period 30,046 16,979 2,817 2,471 2,853 Less: Reinsurance 410 10,471 883 — — Net Liability, after Reinsurance $ 29,636 $ 6,508 $ 1,934 $ 2,471 $ 2,853 Weighted-average crediting rate 2.33 % 4.26 % 5.84 % N/A N/A Net amount at risk (d) N/A N/A $ 70,859 N/A N/A Cash surrender value (e) $ 26,985 $ 15,815 $ 2,088 N/A N/A (a) Contracts included in the contractholder funds are generally charged a premium and/or monthly assessment on the basis of the account balance. (b) FABN and FHLB are considered funding agreements that are investment contracts, which follow the interest method of accounting, and therefore are not subject to ASU 2018-12 disclosure requirements. However, the Company has elected to present the liability for these agreements within the disaggregated roll forward as we believe it will provide meaningful information for users of the financials. (c) The embedded derivative adjustment reconciles the account balance to the gross GAAP liability and represents the combination of the host contract and the fair value of the embedded derivatives. (d) For those guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date. (e) These amounts are gross of reinsurance. December 31, 2023 Indexed annuities Fixed rate annuities Universal Life FABN (b) FHLB (b) (Dollars in millions) Balance, beginning of year $ 24,766 $ 9,358 $ 2,112 $ 2,613 $ 1,982 Issuances 4,722 5,061 199 — 1,256 Premiums received 103 1 382 — — Policy charges (a) (182) — (261) — — Surrenders and withdrawals (2,005) (1,142) (90) — — Benefit payments (526) (240) (27) (53) (763) Interest credited 270 405 76 54 64 Other 16 — — (1) — Balance, end of period 27,164 13,443 2,391 2,613 2,539 Embedded derivative adjustment (c) 243 — 84 — — Gross Liability, end of period 27,407 13,443 2,475 2,613 2,539 Less: Reinsurance 17 7,520 894 — — Net Liability, after Reinsurance $ 27,390 $ 5,923 $ 1,581 $ 2,613 $ 2,539 Weighted-average crediting rate 1.40 % 4.85 % 3.44 % N/A N/A Net amount at risk (d) N/A N/A $ 60,389 N/A N/A Cash surrender value (e) $ 25,099 $ 12,505 $ 1,872 N/A N/A (a) Contracts included in the contractholder funds are generally charged a premium and/or monthly assessment on the basis of the account balance. (b) FABN and FHLB are considered funding agreements that are investment contracts, which follow the interest method of accounting, and therefore are not subject to ASU 2018-12 disclosure requirements. However, the Company has elected to present the liability for these agreements within the disaggregated roll forward as we believe it will provide meaningful information for users of the financials. (c) The embedded derivative adjustment reconciles the account balance to the gross GAAP liability and represents the combination of the host contract and the fair value of the embedded derivatives. (d) For those guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date. (e) These amounts are gross of reinsurance. The following table reconciles contractholder funds’ account balances to the contractholder funds liability in the accompanying unaudited Condensed Consolidated Balance Sheets: September 30, 2024 December 31, 2023 (In millions) Indexed annuities $ 30,046 $ 27,407 Fixed rate annuities 16,979 13,443 Immediate annuities 292 311 Universal life 2,817 2,475 Traditional life 5 5 Funding Agreement-FABN 2,471 2,613 FHLB 2,853 2,539 PRT 5 5 Total $ 55,468 $ 48,798 Annually, typically in the third quarter, we review assumptions associated with reserves for policy benefits and product guarantees. For the nine months ended September 30, 2024, based on policyholder behavior, experience and interest rate movements, we reflected updates to surrender assumptions for recent and expected near term policyholder behavior, as well as updated certain FIA assumptions used to calculate the fair value of the embedded derivative component within contractholder funds. These changes resulted in a decrease in total benefits and other changes in policy reserves of approximately $79 million for the nine months ended September 30, 2024. For the year ended December 31, 2023, based on increases in interest rates and pricing changes, we updated certain FIA assumptions used to calculate the fair value of the embedded derivative component within contractholder funds and also aligned reserves to actual policyholder behavior. These changes resulted in an increase in total benefits and other changes in policy reserves of approximately $73 million for the year ended December 31, 2023. The following tables present the account values by range of guaranteed minimum crediting rates and the related range of difference, in basis points, between rates being credited to policyholders and the respective guaranteed minimums: September 30, 2024 Range of guaranteed minimum crediting rate At Guaranteed Minimum 1 Basis Point-50 Basis Points Above 51 Basis Points-150 Basis Points Above Greater Than 150 Basis Points Above Total Indexed Annuities (In millions) 0.00%-1.50% $ 23,095 $ 1,285 $ 502 $ 1,847 $ 26,729 1.51%-2.50% 700 1 460 1,046 2,207 Greater than 2.50% 317 2 — 1 320 Total $ 24,112 $ 1,288 $ 962 $ 2,894 $ 29,256 Fixed Rate Annuities 0.00%-1.50% $ 46 $ 21 $ 925 $ 13,855 $ 14,847 1.51%-2.50% 4 7 20 460 491 Greater than 2.50% 826 2 3 810 1,641 Total $ 876 $ 30 $ 948 $ 15,125 $ 16,979 Universal Life 0.00%-1.50% $ 2,303 $ 6 $ — $ 22 $ 2,331 Greater than 2.50% 366 — 1 — 367 Total $ 2,669 $ 6 $ 1 $ 22 $ 2,698 December 31, 2023 Range of guaranteed minimum crediting rate At Guaranteed Minimum 1 Basis Point-50 Basis Points Above 51 Basis Points-150 Basis Points Above Greater Than 150 Basis Points Above Total Indexed Annuities (In millions) 0.00%-1.50% $ 22,392 $ 1,444 $ 526 $ 1,953 $ 26,315 1.51%-2.50% 196 1 24 250 471 Greater than 2.50% 377 1 — — 378 Total $ 22,965 $ 1,446 $ 550 $ 2,203 $ 27,164 Fixed Rate Annuities 0.00%-1.50% $ 23 $ 25 $ 1,532 $ 10,271 $ 11,851 1.51%-2.50% 5 8 23 453 489 Greater than 2.50% 893 2 4 204 1,103 Total $ 921 $ 35 $ 1,559 $ 10,928 $ 13,443 Universal Life 0.00%-1.50% $ 1,987 $ 5 $ — $ 21 $ 2,013 Greater than 2.50% 361 16 1 — 378 Total $ 2,348 $ 21 $ 1 $ 21 $ 2,391

Future Policy Benefits

Future Policy Benefits	9 Months Ended
	Sep. 30, 2024
Insurance [Abstract]
Future Policy Benefits	Future Policy Benefits The following table summarizes balances and changes in the present value of expected net premiums and the present value of the expected FPB for nonparticipating traditional contracts: Traditional Life September 30, 2024 December 31, 2023 Expected net premiums (Dollars in millions) Balance, beginning of year $ 722 $ 797 Beginning balance at original discount rate 874 974 Effect of actual variances from expected experience (4) (1) Balance adjusted for variances from expectation 870 973 Interest accrual 13 19 Net premiums collected (82) (118) Ending Balance at original discount rate 801 874 Effect of changes in discount rate assumptions (128) (152) Balance, end of period $ 673 $ 722 Expected FPB Balance, beginning of year $ 2,071 $ 2,151 Beginning balance at original discount rate 2,492 2,665 Effect of actual variances from expected experience 48 (24) Balance adjusted for variances from expectation 2,540 2,641 Interest accrual 41 56 Benefits payments (165) (205) Ending Balance at original discount rate 2,416 2,492 Effect of changes in discount rate assumptions (358) (421) Balance, end of period $ 2,058 $ 2,071 Net liability for future policy benefits $ 1,385 $ 1,349 Less: Reinsurance recoverable 525 413 Net liability for future policy benefits, after reinsurance recoverable $ 860 $ 936 Weighted-average duration of liability for future policyholder benefits (years) 6.87 7.36 The following tables summarize balances and changes in the present value of the expected FPB for limited-payment contracts: September 30, 2024 Immediate annuities PRT (Dollars in millions) Balance, beginning of year $ 1,415 $ 4,189 Beginning balance at original discount rate 1,788 4,351 Effect of changes in cash flow assumptions — 4 Effect of actual variances from expected experience (26) (20) Balance adjusted for variances from expectation 1,762 4,335 Issuances 27 1,300 Interest accrual 46 168 Benefits payments (88) (346) Ending Balance at original discount rate 1,747 5,457 Effect of changes in discount rate assumptions (354) (63) Balance, end of period $ 1,393 $ 5,394 Net liability for future policy benefits $ 1,393 $ 5,394 Less: Reinsurance recoverable 115 — Net liability for future policy benefits, after reinsurance recoverable $ 1,278 $ 5,394 Weighted-average duration of liability for future policyholder benefits (years) 12.89 8.03 December 31, 2023 Immediate annuities PRT (Dollars in millions) Balance, beginning of year $ 1,429 $ 2,165 Beginning balance at original discount rate 1,858 2,475 Effect of changes in cash flow assumptions — (9) Effect of actual variances from expected experience (15) (7) Balance adjusted for variances from expectation $ 1,843 $ 2,459 Issuances 22 2,041 Interest accrual 51 109 Benefits payments (128) (258) Ending Balance at original discount rate $ 1,788 $ 4,351 Effect of changes in discount rate assumptions (373) (162) Balance, end of period $ 1,415 $ 4,189 Net liability for future policy benefits $ 1,415 $ 4,189 Less: Reinsurance recoverable 116 — Net liability for future policy benefits, after reinsurance recoverable $ 1,299 $ 4,189 Weighted-average duration of liability for future policyholder benefits (years) 12.47 8.23 The following tables summarize balances and changes in the liability for DPL for limited-payment contracts: September 30, 2024 December 31, 2023 Immediate annuities PRT Immediate annuities PRT (In millions) Balance, beginning of year $ 87 $ 10 $ 69 $ 4 Effect of modeling changes — — 4 — Effect of changes in cash flow assumptions — (7) — 1 Effect of actual variances from expected experience 6 — 16 5 Balance adjusted for variances from expectation 93 3 89 10 Issuances 2 — 3 — Interest accrual 1 4 2 1 Amortization (6) (1) (7) (1) Balance, end of period $ 90 $ 6 $ 87 $ 10 The following table reconciles the net FPB to the FPB in the unaudited Condensed Consolidated Balance Sheets. The DPL for Immediate Annuities and PRT is presented together with the FPB in the unaudited Condensed Consolidated Balance Sheets and has been included as a reconciling item in the table below: September 30, 2024 December 31, 2023 (In millions) Traditional Life $ 1,385 $ 1,349 Immediate annuities 1,393 1,415 PRT 5,394 4,189 Immediate annuities DPL 90 87 PRT DPL 6 10 Total $ 8,268 $ 7,050 The following table provides the amount of undiscounted and discounted expected gross premiums and expected future benefits and expenses for nonparticipating traditional and limited-payment contracts: Undiscounted Discounted September 30, 2024 September 30, 2023 September 30, 2024 September 30, 2023 Traditional Life (In millions) Expected future benefit payments $ 2,843 $ 2,996 $ 2,073 $ 1,984 Expected future gross premiums 978 1,116 728 772 Immediate annuities Expected future benefit payments $ 3,212 $ 3,227 $ 1,392 $ 1,313 Expected future gross premiums — — — — PRT Expected future benefit payments $ 8,449 $ 5,445 $ 5,470 $ 3,605 Expected future gross premiums — — — — The following table summarizes the amount of revenue and interest related to nonparticipating traditional and limited-payment contracts recognized in the unaudited Condensed Consolidated Statements of Earnings: Gross Premiums (a) Interest Expense (b) September 30, 2024 September 30, 2023 September 30, 2024 September 30, 2023 (In millions) Traditional Life $ 84 $ 94 $ 28 $ 28 Immediate annuities 16 18 46 42 PRT 1,240 1,207 168 79 Total $ 1,340 $ 1,319 $ 242 $ 149 (a) Included in Life insurance premiums and other fees on the unaudited Condensed Consolidated Statements of Earnings. (b) Included in Benefits and other changes in policy reserves (remeasurement gains (losses) (a)) on the unaudited Condensed Consolidated Statements of Earnings. The following table presents the weighted-average interest rate: September 30, 2024 December 31, 2023 Traditional Life Interest accretion rate 2.34 % 2.33 % Current discount rate 4.95 5.03 Immediate annuities Interest accretion rate 3.17 % 3.14 % Current discount rate 4.90 4.98 PRT Interest accretion rate 4.70 % 4.61 % Current discount rate 4.85 5.03 The following tables summarize the actual experience and expected experience for mortality and lapses of the FPB: September 30, 2024 Traditional Life Immediate annuities PRT Mortality Actual experience 1.4 % 2.7 % 3.0 % Expected experience 1.5 1.9 2.5 Lapses Actual experience 0.1 % — % — % Expected experience 0.5 — — December 31, 2023 Traditional Life Immediate annuities PRT Mortality Actual experience 1.7 % 3.2 % 3.2 % Expected experience 1.4 1.8 2.3 Lapses Actual experience — % — % — % Expected experience 0.3 — — The following table provides additional information for periods in which a cohort has an net premium ratio ("NPR") greater than 100% (and therefore capped at 100%) (dollars in millions): September 30, 2024 Cohort X Description NPR before capping 109 % Term with return of premium Non-NY Cohort Reserves before NPR capping $ 1,219 Term with return of premium Non-NY Cohort Reserves after NPR capping 1,250 Term with return of premium Non-NY Cohort Loss Expense 31 Term with return of premium Non-NY Cohort Premium deficiency testing F&G conducts annual premium deficiency testing for its long-duration contracts except for the FPB for nonparticipating traditional and limited-payment contracts. F&G also conducts annual premium deficiency testing for the VOBA of all long-duration contracts. Premium deficiency testing is performed by reviewing assumptions used to calculate the insurance liabilities and determining whether the sum of the existing contract liabilities and the present value of future gross premiums is sufficient to cover the present value of future benefits to be paid to or on behalf of policyholders and settlement costs and recover unamortized present value of future profits. Anticipated investment income, based on F&G’s experience, is considered when performing premium deficiency testing for long-duration contracts. During 2024, F&G was not required to establish any additional liabilities as a result of premium deficiency testing. F&G made changes to assumptions during the nine months ended September 30, 2024 and the year ended December 31, 2023. Significant assumption inputs used in the calculation of our FPB are described below. Refer to the tables above for further details on changes to our FPB. Traditional life Significant assumption inputs to the calculation of the FPB for traditional life include mortality, lapses (including lapses due to nonpayment of premium and surrenders for cash surrender value), and discount rates (both accretion and current). We review the cash flow assumptions annually, typically in the third quarter. In 2023, F&G undertook a review of all significant assumptions and revised the lapse assumption, resulting in a slight decrease to the FPB. In 2024, F&G made an adjustment to the calculation to reflect additional actuarial precision, unrelated to the assumptions, driving an increase to the FPB liability. There have been no other significant changes. Market data that underlies current discount rates was updated in 2024 from that utilized in 2023 resulting in decreased discount rates that drove a material increase to the FPB. Immediate annuities (life contingent) Significant assumption inputs to the calculation of the FPB for immediate annuities (life contingent) include mortality and discount rates (both accretion and current). We review the cash flow assumptions annually, typically in the third quarter. In 2024 and 2023, F&G undertook a review of the significant cash flow assumptions and did not make any changes to mortality. Market data that underlies current discount rates was updated in 2024 from that utilized in 2023, resulting in decreased discount rates that drove a material increase to the FPB. PRT (life contingent) Significant assumption inputs to the calculation of the FPB for PRT (life contingent) include mortality and discount rates (both accretion and current). We review the cash flow assumptions annually, typically in the third quarter. In 2024 and 2023, F&G undertook a review of the significant cash flow assumptions and did not make any changes to mortality. Market data that underlies current discount rates was updated in 2024 from 2023 resulting in decreased discount rates that drove a material increase to the FPB.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ 266	$ 426	$ 820	$ 586

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	9 Months Ended
	Sep. 30, 2024 shares	Sep. 30, 2024 shares
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Sandra D. Morgan [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		On September 24, 2024, Sandra D. Morgan, a Director on our Board of Directors, adopted a Rule 10b5-1 trading arrangement (the "Morgan Rule 10b5-1 trading agreement") that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c). The Morgan Rule 10b5-1 trading agreement was entered into during an open trading window and in accordance with our insider trading policies. Ms. Morgan was not aware of any material, nonpublic information concerning us or our securities upon adoption of the Morgan Rule 10b5-1 trading arrangement. The Morgan Rule 10b5-1 trading arrangement provides for the sale, on December 24, 2024, of 35% of an aggregate 5,979 of FNF common stock, or 2,093 shares, to be received by Ms. Morgan upon the vesting of restricted stock awards in November 2024. The Morgan Rule 10b5-1 trading arrangement will terminate on the earlier of (a) September 12, 2025, (b) execution of all trades or expirations of all the orders relating to such trades, or (c) upon other conditions as defined in the Morgan Rule 10b5-1 trading arrangement.
Name	Sandra D. Morgan
Title	Director on our Board of Directors
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	September 24, 2024
Expiration Date	September 12, 2025
Arrangement Duration	353 days
Ms. Sandra D. Morgan , Trading Arrangement, 35% Of Common Stock [Member] | Sandra D. Morgan [Member]
Trading Arrangements, by Individual
Aggregate Available	5,979	5,979
Ms. Sandra D. Morgan, Trading Arrangement, Common Stock [Member] | Sandra D. Morgan [Member]
Trading Arrangements, by Individual
Aggregate Available	2,093	2,093

Basis of Financial Statements (

Basis of Financial Statements (Policies)	9 Months Ended
	Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Financial Statements	The financial information in this report presented for interim periods is unaudited and includes the accounts of Fidelity National Financial, Inc. and its subsidiaries (collectively, “we,” “us,” “our,” the "Company" or “FNF”) prepared in accordance with U.S. generally accepted accounting principles ("GAAP") and the instructions to Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. All adjustments made were of a normal, recurring nature. This report should be read in conjunction with our Annual Report on Form 10-K (our "Annual Report") for the year ended December 31, 2023.
Earnings Per Share	Earnings Per Share Basic earnings per share, as presented on the unaudited Condensed Consolidated Statement of Earnings, is computed by dividing net earnings available to common shareholders in a given period by the weighted average number of common shares outstanding during such period. In periods when earnings are positive, diluted earnings per share is calculated by dividing net earnings available to common shareholders by the weighted average number of common shares outstanding plus assumed conversions of potentially dilutive securities. For periods when we recognize a net loss, diluted loss per share is equal to basic loss per share as the impact of assumed conversions of potentially dilutive securities is considered to be antidilutive. We have granted certain stock options and shares of restricted stock, which have been treated as common share equivalents for purposes of calculating diluted earnings per share for periods in which positive earnings have been reported. Options or other instruments, which provide the ability to purchase shares of our common stock that are antidilutive, are excluded from the computation of diluted earnings per share. There were no antidilutive instruments outstanding during the three and nine months ended September 30, 2024. There were fewer than 1 million antidilutive instruments outstanding during the three and nine months ended September 30, 2023.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Adopted Pronouncements In March 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2023-02, Accounting for Investments in Tax Credit Structure Using the Proportional Amortization Method (a consensus of the Emerging Issues Task Force). The amendments in this update permit reporting entities to elect to account for their tax equity investments, regardless of the tax credit program from which the income tax credits are received, using the proportional amortization method if certain conditions are met. We adopted this standard on January 1, 2024, as required, and there was no material impact to our unaudited Condensed Consolidated Financial Statements. In June 2022, the FASB issued ASU 2022-03, Fair Value Measurement (Topic 820): Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions. The amendments in this update affect all entities that have investments in equity securities measured at fair value that are subject to a contractual sale restriction and clarify that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The amendments also clarify that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction. Additionally, the amendments require the following disclosures for equity securities subject to contractual sale restrictions: the fair value of equity securities subject to contractual sale restrictions reflected in the balance sheet, the nature and remaining duration of the restriction(s), and the circumstances that could cause a lapse in the restriction(s). The amendments in this update do not change the principles of fair value measurement, rather, they clarify those principles when measuring the fair value of an equity security subject to a contractual sale restriction and improve current GAAP by reducing diversity in practice, reducing the cost and complexity in measuring fair value, and increasing comparability of financial information across reporting entities that hold those investments. The amendments in this update are effective for public business entities for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. We adopted this standard as of January 1, 2024, and it did not have a material impact on our unaudited Condensed Consolidated Financial Statements and related disclosures upon adoption. Pronouncements Not Yet Adopted In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments in this update improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expense categories that are regularly provided to the chief operating decision maker (CODM) and included in each reported measure of a segment’s profit or loss. In addition, the amendments enhance interim disclosure requirements that are currently required annually, clarify circumstances in which an entity can disclose multiple segment measures of profit or loss, and contain other disclosure requirements. The amendments in this update are incremental to the current requirements of Topic 280 and do not change how a public entity identifies its operating segments, aggregates those operating segments, or applies the quantitative thresholds to determine its reportable segments. The enhanced segment disclosure requirements apply retrospectively to all prior periods presented in the financial statements. The significant segment expense and other segment item amounts disclosed in prior periods shall be based on the significant segment expense categories identified and disclosed in the period of adoption. The amendments in this update are effective for all public entities for fiscal years beginning after December 15, 2023, and interim periods beginning after December 15, 2024. Early adoption is permitted, and the updates must be applied retrospectively to all periods presented in the financial statements. We did not early adopt this standard and are in the process of assessing its impact on our disclosures upon adoption. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amendments in this update enhance the transparency of the income tax disclosures by expanding on the disclosures required annually. The amendments require entities to disclose in their rate reconciliation table additional categories of information about federal, state, and foreign income taxes, in addition to providing details about the reconciling items in some categories if above a quantitative threshold. Additionally, the amendments require annual disclosure of income taxes paid (net of refunds received) disaggregated by jurisdiction based on a quantitative threshold. The amendments in this update are effective for public business entities for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. The amendments should be applied on a prospective basis, however, retrospective application is permitted. We do not currently expect to early adopt this standard and are in the process of assessing its impact on our disclosures upon adoption. In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): The amendment in this update enhances the transparency of certain expense captions by disclosing more granular information of specific expenses within those captions such as personnel cost, depreciation and amortization. The amendment also requires additional qualitative descriptions of such expenses. The amendments in this update are effective for public business entities for annual periods beginning after December 15, 2026 and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. The amendments should be applied either prospectively to financial statements issued for reporting periods after the effective date or retrospectively to all prior periods presented in the financial statements. We are currently evaluating our adoption timing and are in the process of assessing its impact on our disclosures upon adoption.
Market Risk Benefits (“MRBs”)	Market Risk Benefits (“MRBs”) MRBs are contracts or contract features that both provide protection to the contract holder from other-than-nominal capital market risk (equity, interest rate, and foreign exchange risk) and expose the Company to other-than-nominal capital market risk. MRBs include certain contract features primarily on fixed index annuity ("FIA") products that provide minimum guarantees to policyholders, such as guaranteed minimum death benefit, guaranteed minimum withdrawal benefit (“GMWB”) riders, and guaranteed minimum accumulation benefit riders. In certain reinsurance transactions, the underlying risks ceded to a reinsurer contain MRBs. MRBs (inclusive of reinsured MRBs) are measured at fair value using an attributed fee measurement approach, where attributed fees are explicit rider charges collectible from the policyholder (or paid to the reinsurer) used to cover the excess benefits, which represent expected benefits in excess of the policyholder’s account value. At contract inception, an attributed fee ratio is calculated equal to rider charges over benefits paid in excess of the account value attributable to the MRBs. The attributed fee ratio remains static over the life of the MRBs and is capped at 100%. Each period subsequent to contract inception, the attributed fee ratio is used to calculate the fair value of the MRBs using a risk neutral valuation method and is based on current net amounts at risk, market data, internal and industry experience, and other factors. The balances are computed using assumptions including mortality, full and partial surrender, GMWB utilization, risk-free rates including non-performance spread and risk margin, market value of options, and economic scenarios. Policyholder behavior assumptions are reviewed at least annually, typically in the third quarter, for any revisions. Reinsured MRBs are valued using a methodology consistent with direct MRBs, with the exception of the non-performance spread, which reflects the credit of the reinsurer. MRBs can either be in an asset or liability position and are presented separately on the unaudited Condensed Consolidated Balance Sheets as the right of setoff criteria are not met. Changes in fair value, net, are recognized in Market risk benefits (gains) losses in the unaudited Condensed Consolidated Statements of Earnings, except for the change in fair value due to a change in our instrument-specific credit risk, which is recognized in the unaudited Condensed Consolidated Statements of Comprehensive Earnings. See a description of the fair value methodology used in Note C Fair Value of Financial Instruments and Note P Market Risk Benefits .
Revenue Recognition	Our Direct title insurance premiums are recognized as revenue at the time of closing of the underlying transaction as the earnings process is then considered complete. Regulation of title insurance rates varies by state. Premiums are charged to customers based on rates predetermined in coordination with each states' respective Department of Insurance. Cash associated with such revenue is typically collected at closing of the underlying real estate transaction. Premium revenues from agency title operations are recognized when the underlying title order and transaction closing, if applicable, are complete.
Revenue Recognition, Services, Real Estate Transactions	Escrow fees and other title-related fees and income in our Title segment are closely related to Direct title insurance premiums and are primarily associated with managing the closing of real estate transactions, including the processing of funds on behalf of the transaction participants, gathering and recording the required closing documents, providing notary and home inspection services, and other real estate or title-related activities. Revenue is primarily recognized upon closing of the underlying real estate transaction or completion of services. Cash associated with such revenue is typically collected at closing. Revenues from ServiceLink, excluding its title premiums, escrow fees and loan subservicing fees primarily include revenues from real estate appraisal services and foreclosure processing and facilitation services. Revenues from real estate appraisal services are recognized when all appraisal work is complete, a final report is issued to the client and the client is billed. Revenues from foreclosure processing and facilitation services are primarily recognized upon completion of the services and when billing to the client is complete. Life insurance premiums in our F&G segment reflect premiums for life-contingent PRT, traditional life insurance products, and life-contingent immediate annuity products, which are recognized as revenue when due from the policyholder. We have ceded the majority of our traditional life business to unaffiliated third party reinsurers. While the base contract has been reinsured, we continue to retain the return of premium rider. Insurance and investment product fees and other consist primarily of the cost of insurance on IUL policies, unearned revenue liabilities ("URL") on IUL policies, policy rider fees primarily on FIA policies and surrender charges assessed against policy withdrawals in excess of the policyholder's allowable penalty-free amounts. Premium and annuity deposit collections for indexed annuities, fixed rate annuities, immediate annuities and PRT without life contingency, and amounts received for funding agreements are reported in the financial statements as deposit liabilities (i.e., contractholder funds) instead of as sales or revenues. Similarly, cash payments to customers are reported as decreases in the liability for contractholder funds and not as expenses. Sources of revenues for products accounted for as deposit liabilities include net investment income, surrender, cost of insurance and other charges deducted from contractholder funds, and net realized gains (losses) on investments. Components of expenses for products accounted for as deposit liabilities are interest-sensitive and index product benefits (primarily interest credited to account balances or the hedging cost of providing index credits to the policyholder), amortization of value of business acquired ("VOBA"), deferred acquisition costs ("DAC") and deferred sales inducements ("DSI"), other operating costs and expenses, and income taxes. Real estate technology revenues are primarily comprised of subscription fees for use of software provided to real estate professionals. Subscriptions are only offered on a month-by-month basis and fees are billed monthly. Revenue is recognized in the month services are provided. Loan subservicing revenues are generated by certain subsidiaries of ServiceLink and are associated with the servicing of mortgage loans on behalf of its customers. Revenue is recognized when the underlying work is performed and billed. Loan subservicing revenues are subject to the recognition requirements of ASC Topic 860.
Revenue Recognition, Other	We do not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less, primarily related to revenue from our home warranty business, and (ii) contracts for which we recognize revenue at the amount to which we have the right to invoice for services performed.

Summary of Reserve for Title _2

Summary of Reserve for Title Claim Losses (Tables)	9 Months Ended
	Sep. 30, 2024
Insurance [Abstract]
Summary of the Reserve for Claim Losses	A summary of the reserve for title claim losses follows: Nine months ended September 30, 2024 2023 (In millions) Beginning balance $ 1,770 $ 1,810 Change in insurance recoverable (14) (1) Claim loss provision related to: Current year 168 157 Total title claim loss provision 168 157 Claims paid, net of recoupments related to: Current year (13) (8) Prior years (191) (190) Total title claims paid, net of recoupments (204) (198) Ending balance of claim loss reserve for title insurance $ 1,720 $ 1,768 Provision for title insurance claim losses as a percentage of title insurance premiums 4.5 % 4.5 %

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2024
Fair Value Disclosures [Abstract]
Schedule of Carrying Amount and Estimated Fair Value of Assets and Liabilities on Recurring Basis	The estimated fair values of our financial instruments for which the disclosure of fair values is required, including financial assets and liabilities measured and carried at fair value on a recurring basis, with the exception of investment contracts, portions of other long-term investments and debt, which are disclosed later within this footnote, was summarized according to the hierarchy previously described, as follows: September 30, 2024 Level 1 Level 2 Level 3 NAV Fair Value Assets (In millions) Cash and cash equivalents $ 4,970 $ — $ — $ — $ 4,970 Fixed maturity securities, available-for-sale: Asset-backed securities ("ABS") — 7,779 8,184 — 15,963 Commercial mortgage-backed securities — 5,179 — — 5,179 Corporates 78 19,166 2,728 — 21,972 Hybrids 37 559 — — 596 Municipals — 1,515 — — 1,515 Residential mortgage-backed securities — 2,597 3 — 2,600 U.S. Government 797 6 — — 803 Foreign Governments — 307 5 — 312 Short term investments 1,013 8 156 — 1,177 Preferred securities 199 253 8 — 460 Equity securities 657 — 13 59 729 Derivative investments — 1,401 — — 1,401 Investment in unconsolidated affiliates — — 272 — 272 Market risk benefits asset — — 134 — 134 Other assets — — 55 — 55 Other long-term investments — — 38 — 38 Total financial assets at fair value $ 7,751 $ 38,770 $ 11,596 $ 59 $ 58,176 Liabilities Derivatives: Indexed annuities/indexed universal life insurance ("IUL") embedded derivatives, included in contractholder funds — — 5,411 — 5,411 Reinsurance related embedded derivative — 34 — — 34 Equity options 5 — — — 5 Contingent consideration obligation — — 69 — 69 Market risk benefits liability — — 603 — 603 Total financial liabilities at fair value $ 5 $ 34 $ 6,083 $ — $ 6,122 December 31, 2023 Level 1 Level 2 Level 3 NAV Fair Value Assets (In millions) Cash and cash equivalents $ 2,767 $ — $ — $ — $ 2,767 Fixed maturity securities, available-for-sale: Asset-backed securities — 7,220 7,122 — 14,342 Commercial mortgage-backed securities — 4,457 18 — 4,475 Corporates 25 15,892 1,979 — 17,896 Hybrids 95 523 — — 618 Municipals — 1,562 49 — 1,611 Residential mortgage-backed securities — 2,426 3 — 2,429 U.S. Government 662 16 — — 678 Foreign Governments — 308 16 — 324 Short term investments 2,111 8 — — 2,119 Preferred securities 214 399 8 — 621 Equity securities 692 — 15 59 766 Derivative investments — 740 57 — 797 Investment in unconsolidated affiliates — — 285 — 285 Reinsurance related embedded derivative, included in other assets — 152 — — 152 Market risk benefits asset — — 88 — 88 Other long-term investments — — 37 — 37 Total financial assets at fair value $ 6,566 $ 33,703 $ 9,677 $ 59 $ 50,005 Liabilities Derivatives: Indexed annuities/IUL embedded derivatives, included in contractholder funds $ — $ — $ 4,258 $ — $ 4,258 Market risk benefits liability — — 403 — 403 Equity options 1 — — 1 Total financial liabilities at fair value $ 1 $ — $ 4,661 $ — $ 4,662 The following tables provide the carrying value and estimated fair value of our financial instruments that are carried on the unaudited Condensed Consolidated Balance Sheets at amounts other than fair value, summarized according to the fair value hierarchy previously described. September 30, 2024 Level 1 Level 2 Level 3 NAV Total Estimated Fair Value Carrying Amount Assets (In millions) FHLB common stock $ — $ 153 $ — $ — $ 153 $ 153 Commercial mortgage loans — — 2,342 — 2,342 2,572 Residential mortgage loans — — 2,830 — 2,830 3,054 Investments in unconsolidated affiliates — — 4 3,390 3,394 3,394 Policy loans — — 94 — 94 94 Other invested assets 22 — — 47 69 69 Company-owned life insurance — — 426 — 426 426 Trade and notes receivables, net of allowance — — 443 — 443 443 Total $ 22 $ 153 $ 6,139 $ 3,437 $ 9,751 $ 10,205 Liabilities Investment contracts, included in contractholder funds $ — $ — $ 44,762 $ — $ 44,762 $ 55,057 Debt — 3,986 — — 3,986 4,186 Total $ — $ 3,986 $ 44,762 $ — $ 48,748 $ 59,243 December 31, 2023 Level 1 Level 2 Level 3 NAV Total Estimated Fair Value Carrying Amount Assets (In millions) FHLB common stock $ — $ 138 $ — $ — $ 138 $ 138 Commercial mortgage loans — — 2,253 — 2,253 2,538 Residential mortgage loans — — 2,545 — 2,545 2,798 Investments in unconsolidated affiliates — — 7 2,779 2,786 2,786 Policy loans — — 71 — 71 71 Other invested assets 17 — — 42 59 59 Company-owned life insurance — — 397 — 397 397 Trade and notes receivables, net of allowance — — 442 — 442 442 Total $ 17 $ 138 $ 5,715 $ 2,821 $ 8,691 $ 9,229 Liabilities Investment contracts, included in contractholder funds $ — $ — $ 40,229 $ — $ 40,229 $ 44,540 Debt — 3,568 — — 3,568 3,887 Total $ — $ 3,568 $ 40,229 $ — $ 43,797 $ 48,427
Schedule of Quantitative Information Regarding Significant Unobservable Inputs Used for Recurring Level Three Fair Value Measurements of Financial Instruments	Quantitative information regarding significant unobservable inputs used for recurring Level 3 fair value measurements of financial instruments carried at fair value as of September 30, 2024 and December 31, 2023 are as follows: Fair Value as of Valuation Technique Unobservable Input(s) Range (Weighted average) September 30, 2024 (In millions) September 30, 2024 Assets Asset-backed securities $ 99 Third-Party Valuation Discount Rate 4.82% - 6.71% (5.83%) Corporates 4 Discounted Cash Flow Discount Rate 29.17% - 100.00% (73.00%) Corporates 741 Third-Party Valuation Discount Rate 3.55% - 20.69% (6.47%) Residential mortgage-backed securities 3 Third-Party Valuation Discount Rate 5.19% - 5.19% (5.19%) Foreign Governments 5 Third-Party Valuation Discount Rate 6.91% - 6.91% (6.91%) Investment in unconsolidated affiliates 272 Market Comparable Company Analysis EBITDA Multiple 8.8x - 15.1x (11.7x) Preferred securities 1 Discounted Cash Flow Discount rate 100.00% - 100.00% (100.00%) Equity securities 7 Discounted Cash Flow Discount rate 11.20% - 11.20% (11.20%) Market Comparable Company Analysis EBITDA multiple 5.1x - 5.1x (5.1x) Other assets 55 Discounted Cash Flow Discount Rate 9.27% - 13.40% (11.34%) Conditional Prepayment Rate 6.67% -15.71% (11.19%) Other long-term investments: Available-for-sale embedded derivative 34 Black Scholes Model Market Value of AnchorPath Fund 100.00% Market risk benefits asset 134 Discounted Cash Flow Mortality 80.00% - 115.00% (100.00%) Surrender Rates 0.25% - 30.00% (5.22%) Partial Withdrawal Rates 2.00% - 24.39% (2.48%) Non-Performance Spread 0.30% - 0.98% (0.82%) GMWB Utilization 50.00% - 60.00% (50.57%) Total financial assets at fair value (a) $ 1,355 Liabilities Derivatives: Indexed annuity/ IUL embedded derivatives, included in contractholder funds $ 5,411 Discounted Cash Flow Market Value of Option 0.00% - 30.14% (4.21%) Mortality Multiplier 80.00% - 115.00% (100.00%) Surrender Rates 0.25% - 50.00% (7.23%) Partial Withdrawals 2.00% - 35.71% (2.72%) Non-Performance Spread 0.30% - 0.98% (0.82%) Option Cost 0.07% - 5.70% (2.61%) Contingent consideration 69 Discounted Cash Flow Risk-Adjusted Discount Rate 13.00% - 13.00% (13.00%) EBITDA Volatility 35.00% - 35.00% (35.00%) Counterparty Discount Rate 6.00% - 6.00% (6.00%) Market risk benefits liability 603 Discounted Cash Flow Mortality 80.00% - 115.00% (100.00%) Surrender Rates 0.25% - 30.00% (5.22%) Partial Withdrawal Rates 2.00% - 24.39% (2.48%) Non-Performance Spread 0.30% - 0.98% (0.82%) GMWB Utilization 50.00% - 60.00% (50.57%) Total financial liabilities at fair value $ 6,083 (a) Assets of $10,241 million for which significant quantitative unobservable inputs are not developed internally and not readily available to the Company (primarily those valued using broker quotes and certain third-party pricing services) are excluded from the respective totals in the table above. Fair Value as of Valuation Technique Unobservable Input(s) Range (Weighted average) December 31, 2023 (In millions) December 31, 2023 Assets Asset-backed securities $ 57 Third-Party Valuation Discount Rate 5.09% - 6.95% (6.00%) Corporates 787 Third-Party Valuation Discount Rate 0.00% - 12.87% (6.91%) Corporates 8 Discounted Cash Flow Discount Rate 44.00% - 100.00% (75.20%) Municipals 32 Third-Party Valuation Discount Rate 6.25% - 6.25% (6.25%) Residential mortgage-backed securities 3 Third-Party Valuation Discount Rate 5.46% - 5.46% (5.46%) Foreign Governments 16 Third-Party Valuation Discount Rate 6.94% - 7.68% (7.45%) Investment in unconsolidated affiliates 285 Market Comparable Company Analysis EBITDA Multiple 4.4x - 31.8x (23.2x) Preferred securities 1 Discounted Cash Flow Discount rate 100.00% Equity securities 7 Discounted Cash Flow Discount rate 11.50% - 11.50% (11.50%) Other long-term investments: Available-for-sale embedded derivative 28 Black Scholes Model Market Value of Fund 100.00% Market risk benefits asset 88 Discounted Cash Flow Mortality 100.00% - 100.00% (100.00%) Surrender Rates 0.25% - 10.00% (5.22%) Partial Withdrawal Rates 0.00% -23.26% (2.50%) Non-Performance Spread 0.38% - 1.10% (0.96%) GMWB Utilization 50.00% -60.00% (50.81%) Total financial assets at fair value (a) $ 1,312 Liabilities Derivatives Indexed annuity/ IUL embedded derivatives, included in contractholder funds $ 4,258 Discounted Cash Flow Market Value of Option 0.00% - 18.93% (2.63%) Mortality Multiplier 100.00% - 100.00% (100.00%) Surrender Rates 0.25% - 70.00% (6.83%) Partial Withdrawals 2.00% - 34.48% (2.74%) Non-Performance Spread 0.38% - 1.10% (0.96%) Option Cost 0.07% - 5.48% (2.38%) Market risk benefits liability 403 Discounted Cash Flow Mortality 100.00% - 100.00% (100.00%) Surrender Rates 0.25% - 10.00% (5.22%) Partial Withdrawal Rates 0.00% - 23.26% (2.50%) Non-Performance Spread 0.38% - 1.10% (0.96%) GMWB Utilization 50.00% - 60.00% (50.81%) Total financial liabilities at fair value $ 4,661 (a) Assets of $8,365 million for which significant quantitative unobservable inputs are not developed internally and not readily available to the Company (primarily those valued using broker quotes and certain third-party pricing services) are excluded from the table above.
Schedule of Changes in Fair Value of Financial Instruments - Assets	The following tables summarize changes to the Company’s financial instruments carried at fair value and classified within Level 3 of the fair value hierarchy for the three and nine months ended September 30, 2024 and 2023. The gains and losses below may include changes in fair value due in part to observable inputs that are a component of the valuation methodology. Three months ended September 30, 2024 Balance at Beginning Total (Losses) Gains Purchases Sales Settlements Net Transfer Out of Balance at End of Change in Unrealized Included in OCI Included in Included in Assets (In millions) Fixed maturity securities available-for-sale: Asset-backed securities $ 8,042 $ (3) $ 77 $ 515 $ (30) $ (358) $ (59) $ 8,184 $ 77 Commercial mortgage-backed securities 15 — — — — — (15) — — Corporates 2,355 (2) 67 354 — (43) (3) 2,728 64 Residential mortgage-backed securities 3 — — — — — — 3 — Foreign Governments 5 — — — — — — 5 — Preferred securities 8 — — — — — — 8 — Equity securities 13 — — — — — — 13 — Interest Rate Swaps 8 — (1) — — — (7) — — Investment in unconsolidated affiliates (b) 358 6 — — — — (92) 272 — Short term investments 71 — — 85 — — — 156 — Other assets 50 (3) — 8 — — — 55 — Other long-term investments: Available-for-sale embedded derivative 31 — 3 — — — — 34 3 Credit linked note 6 — — — — (2) — 4 — Subtotal Level 3 assets at fair value $ 10,965 $ (2) $ 146 $ 962 $ (30) $ (403) $ (176) $ 11,462 $ 144 Market risk benefits asset (c) 103 134 Total Level 3 assets at fair value $ 11,068 $ 11,596 Liabilities Indexed annuity/ IUL embedded derivatives, included in contractholder funds 4,848 308 — 390 — (135) — 5,411 — Interest rate swaps 28 — — — — — (28) — — Contingent consideration 63 6 — — — — — 69 — Subtotal Level 3 liabilities at fair value $ 4,939 $ 314 $ — $ 390 $ — $ (135) $ (28) $ 5,480 $ — Market risk benefits liability (c) 459 603 Total Level 3 liabilities at fair value $ 5,398 $ 6,083 (a) The net transfers out of Level 3 during the three months ended September 30, 2024 were exclusively to Level 2. (b) The transfer out of investments in unconsolidated affiliates represents F&G’s 30% ownership of PALH prior to the majority acquisition on July 18, 2024. Refer to Note N Acquisitions for details of the PALH majority acquisition. (c) Refer to Note P Market Risk Benefits for roll forward activity of the net Market risk benefits asset and liability. Three months ended September 30, 2023 Balance at Beginning Total (Losses) Gains Purchases Sales Settlements Net Transfer Out of Balance at End of Change in Unrealized Included in OCI Included in Included in Assets (In millions) Fixed maturity securities available-for-sale: Asset-backed securities $ 6,510 $ (45) $ 75 $ 536 $ (27) $ (171) $ (121) $ 6,757 $ 75 Commercial mortgage-backed securities 17 — — 10 — — — 27 — Corporates 1,628 — (21) 162 — (24) (1) 1,744 (21) Municipals 49 — (2) — — — — 47 (2) Residential mortgage-backed securities 28 — (1) — — (1) (23) 3 (1) Foreign Governments 16 — — — — — — 16 — Investment in unconsolidated affiliates 197 — — 75 — — — 272 — Short term investments 126 — — 65 (19) (103) — 69 — Preferred securities 7 — 1 — — — — 8 1 Equity securities 14 1 — — — — — 15 — Other long-term investments: Available-for-sale embedded derivative 26 — (3) — — — — 23 (3) Credit linked note 13 — — — — (1) — 12 — Secured borrowing receivable 10 — — — — — — 10 — Subtotal Level 3 assets at fair value $ 8,641 $ (44) $ 49 $ 848 $ (46) $ (300) $ (145) $ 9,003 $ 49 Market risk benefits asset (b) 118 118 Total Level 3 assets at fair value $ 8,759 $ 9,121 Liabilities Indexed annuity/IUL embedded derivatives, included in contractholder funds 3,821 (796) — 576 — (45) — 3,556 — Interest rate swaps — 16 — — — — — 16 Subtotal Level 3 liabilities at fair value $ 3,821 $ (780) $ — $ 576 $ — $ (45) $ — $ 3,572 $ — Market risk benefits liability (b) 313 278 Total Level 3 liabilities at fair value $ 4,134 $ 3,850 (a) The net transfers out of Level 3 during the three months ended September 30, 2023 were exclusively to Level 2. (b) Refer to Note P Market Risk Benefits for roll forward activity of the net Market risk benefits asset and liability. Nine months ended September 30, 2024 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Change in Unrealized Included in OCI Included in Included in Assets (In millions) Fixed maturity securities available-for-sale: Asset-backed securities $ 7,122 $ 12 $ 187 $ 1,981 $ (109) $ (904) $ (105) $ 8,184 $ 184 Commercial mortgage-backed securities 18 — — 58 — — (76) — — Corporates 1,979 (2) 79 873 (96) (85) (20) 2,728 77 Municipals 49 — 1 — (50) — — — 1 Residential mortgage-backed securities 3 — — 1 — — (1) 3 — Foreign Governments 16 — — — — (11) — 5 — Preferred securities 8 — — — — — — 8 — Equity securities 15 (2) — — — — — 13 — Interest Rate Swaps 57 (50) — — — — (7) — 1 Investment in unconsolidated affiliates (b) 285 79 — — — — (92) 272 — Other assets — (3) — 58 — — — 55 — Short term investments — — — 156 — — — 156 — Other long-term investments: Available-for-sale embedded derivative 27 — 7 — — — — 34 7 Credit linked note 10 1 — — — (7) — 4 — Subtotal Level 3 assets at fair value $ 9,589 $ 35 $ 274 $ 3,127 $ (255) $ (1,007) $ (301) $ 11,462 $ 270 Market risk benefits asset (c) 88 134 Total Level 3 assets at fair value $ 9,677 $ 11,596 Liabilities Indexed annuity/ IUL embedded derivatives, included in contractholder funds $ 4,258 $ 452 $ — $ 1,011 $ — $ (310) $ — $ 5,411 $ — Interest rate swaps — 28 — — — — (28) — — Contingent consideration (d) — 21 — 48 — — — 69 — Subtotal Level 3 liabilities at fair value $ 4,258 $ 501 $ — $ 1,059 $ — $ (310) $ (28) $ 5,480 $ — Market risk benefits liability (c) 403 603 Total Level 3 liabilities at fair value $ 4,661 $ 6,083 (a) The net transfers out of Level 3 during the three months ended September 30, 2024 were exclusively to Level 2. (b) The transfer out of investments in unconsolidated affiliates represents F&G’s 30% ownership of PALH prior to the majority acquisition on July 18, 2024. Refer to Note N Acquisitions for details of the PALH majority acquisition. (c) Refer to Note P Market Risk Benefits for roll forward activity of the net Market risk benefits asset and liability. (d) The initial contingent consideration recorded in the Roar transaction is included in purchases in the table above. Refer to Note N Acquisition for more information. Nine months ended September 30, 2023 Balance at Beginning Total (Losses) Gain Purchases Sales Settlements Net Transfer (Out) In of Balance at End of Change in Unrealized Included in OCI Included in Included in Assets (In millions) Fixed maturity securities available-for-sale: Asset-backed securities $ 6,263 $ (56) $ 108 $ 1,331 $ (125) $ (557) $ (207) $ 6,757 $ 107 Commercial mortgage-backed securities 37 — 1 22 — — (33) 27 1 Corporates 1,440 (1) (77) 423 (1) (43) 3 1,744 (77) Municipals 29 — 18 — — — — 47 18 Residential mortgage-backed securities 302 1 7 32 — (9) (330) 3 7 Foreign Governments 16 — — — — — — 16 — Investment in unconsolidated affiliates 23 — — 249 — — — 272 — Short term investments — — — 191 (19) (103) — 69 — Preferred securities 1 — 1 — — — 6 8 1 Equity securities 10 1 — — — — 4 15 — Other long-term investments: Available-for-sale embedded derivative 23 — — — — — — 23 — Credit linked note 15 — — — — (3) — 12 — Secured borrowing receivable 10 — — — — — — 10 — Subtotal Level 3 assets at fair value $ 8,169 $ (55) $ 58 $ 2,248 $ (145) $ (715) $ (557) $ 9,003 $ 57 Market risk benefits asset (b) 117 118 Total Level 3 assets at fair value $ 8,286 $ 9,121 Liabilities Indexed annuity/IUL embedded derivatives, included in contractholder funds 3,115 (214) — 765 — (110) — 3,556 — Interest rate swaps — 16 — — — — — 16 — Subtotal Level 3 liabilities at fair value $ 3,115 $ (198) $ — $ 765 $ — $ (110) $ — $ 3,572 $ — Market risk benefits liability (b) 282 278 Total Level 3 liabilities at fair value $ 3,397 $ 3,850 (a) The net transfers out of Level 3 during the nine months ended September 30, 2023 were exclusively to Level 2 (b) Refer to Note P Market Risk Benefits for roll forward activity of the net Market risk benefits asset and liability.
Schedule of Changes in Fair Value of Financial Instruments - Liabilities	The following tables summarize changes to the Company’s financial instruments carried at fair value and classified within Level 3 of the fair value hierarchy for the three and nine months ended September 30, 2024 and 2023. The gains and losses below may include changes in fair value due in part to observable inputs that are a component of the valuation methodology. Three months ended September 30, 2024 Balance at Beginning Total (Losses) Gains Purchases Sales Settlements Net Transfer Out of Balance at End of Change in Unrealized Included in OCI Included in Included in Assets (In millions) Fixed maturity securities available-for-sale: Asset-backed securities $ 8,042 $ (3) $ 77 $ 515 $ (30) $ (358) $ (59) $ 8,184 $ 77 Commercial mortgage-backed securities 15 — — — — — (15) — — Corporates 2,355 (2) 67 354 — (43) (3) 2,728 64 Residential mortgage-backed securities 3 — — — — — — 3 — Foreign Governments 5 — — — — — — 5 — Preferred securities 8 — — — — — — 8 — Equity securities 13 — — — — — — 13 — Interest Rate Swaps 8 — (1) — — — (7) — — Investment in unconsolidated affiliates (b) 358 6 — — — — (92) 272 — Short term investments 71 — — 85 — — — 156 — Other assets 50 (3) — 8 — — — 55 — Other long-term investments: Available-for-sale embedded derivative 31 — 3 — — — — 34 3 Credit linked note 6 — — — — (2) — 4 — Subtotal Level 3 assets at fair value $ 10,965 $ (2) $ 146 $ 962 $ (30) $ (403) $ (176) $ 11,462 $ 144 Market risk benefits asset (c) 103 134 Total Level 3 assets at fair value $ 11,068 $ 11,596 Liabilities Indexed annuity/ IUL embedded derivatives, included in contractholder funds 4,848 308 — 390 — (135) — 5,411 — Interest rate swaps 28 — — — — — (28) — — Contingent consideration 63 6 — — — — — 69 — Subtotal Level 3 liabilities at fair value $ 4,939 $ 314 $ — $ 390 $ — $ (135) $ (28) $ 5,480 $ — Market risk benefits liability (c) 459 603 Total Level 3 liabilities at fair value $ 5,398 $ 6,083 (a) The net transfers out of Level 3 during the three months ended September 30, 2024 were exclusively to Level 2. (b) The transfer out of investments in unconsolidated affiliates represents F&G’s 30% ownership of PALH prior to the majority acquisition on July 18, 2024. Refer to Note N Acquisitions for details of the PALH majority acquisition. (c) Refer to Note P Market Risk Benefits for roll forward activity of the net Market risk benefits asset and liability. Three months ended September 30, 2023 Balance at Beginning Total (Losses) Gains Purchases Sales Settlements Net Transfer Out of Balance at End of Change in Unrealized Included in OCI Included in Included in Assets (In millions) Fixed maturity securities available-for-sale: Asset-backed securities $ 6,510 $ (45) $ 75 $ 536 $ (27) $ (171) $ (121) $ 6,757 $ 75 Commercial mortgage-backed securities 17 — — 10 — — — 27 — Corporates 1,628 — (21) 162 — (24) (1) 1,744 (21) Municipals 49 — (2) — — — — 47 (2) Residential mortgage-backed securities 28 — (1) — — (1) (23) 3 (1) Foreign Governments 16 — — — — — — 16 — Investment in unconsolidated affiliates 197 — — 75 — — — 272 — Short term investments 126 — — 65 (19) (103) — 69 — Preferred securities 7 — 1 — — — — 8 1 Equity securities 14 1 — — — — — 15 — Other long-term investments: Available-for-sale embedded derivative 26 — (3) — — — — 23 (3) Credit linked note 13 — — — — (1) — 12 — Secured borrowing receivable 10 — — — — — — 10 — Subtotal Level 3 assets at fair value $ 8,641 $ (44) $ 49 $ 848 $ (46) $ (300) $ (145) $ 9,003 $ 49 Market risk benefits asset (b) 118 118 Total Level 3 assets at fair value $ 8,759 $ 9,121 Liabilities Indexed annuity/IUL embedded derivatives, included in contractholder funds 3,821 (796) — 576 — (45) — 3,556 — Interest rate swaps — 16 — — — — — 16 Subtotal Level 3 liabilities at fair value $ 3,821 $ (780) $ — $ 576 $ — $ (45) $ — $ 3,572 $ — Market risk benefits liability (b) 313 278 Total Level 3 liabilities at fair value $ 4,134 $ 3,850 (a) The net transfers out of Level 3 during the three months ended September 30, 2023 were exclusively to Level 2. (b) Refer to Note P Market Risk Benefits for roll forward activity of the net Market risk benefits asset and liability. Nine months ended September 30, 2024 Balance at Beginning Total Gains (Losses) Purchases Sales Settlements Net transfer In (Out) of Balance at End of Change in Unrealized Included in OCI Included in Included in Assets (In millions) Fixed maturity securities available-for-sale: Asset-backed securities $ 7,122 $ 12 $ 187 $ 1,981 $ (109) $ (904) $ (105) $ 8,184 $ 184 Commercial mortgage-backed securities 18 — — 58 — — (76) — — Corporates 1,979 (2) 79 873 (96) (85) (20) 2,728 77 Municipals 49 — 1 — (50) — — — 1 Residential mortgage-backed securities 3 — — 1 — — (1) 3 — Foreign Governments 16 — — — — (11) — 5 — Preferred securities 8 — — — — — — 8 — Equity securities 15 (2) — — — — — 13 — Interest Rate Swaps 57 (50) — — — — (7) — 1 Investment in unconsolidated affiliates (b) 285 79 — — — — (92) 272 — Other assets — (3) — 58 — — — 55 — Short term investments — — — 156 — — — 156 — Other long-term investments: Available-for-sale embedded derivative 27 — 7 — — — — 34 7 Credit linked note 10 1 — — — (7) — 4 — Subtotal Level 3 assets at fair value $ 9,589 $ 35 $ 274 $ 3,127 $ (255) $ (1,007) $ (301) $ 11,462 $ 270 Market risk benefits asset (c) 88 134 Total Level 3 assets at fair value $ 9,677 $ 11,596 Liabilities Indexed annuity/ IUL embedded derivatives, included in contractholder funds $ 4,258 $ 452 $ — $ 1,011 $ — $ (310) $ — $ 5,411 $ — Interest rate swaps — 28 — — — — (28) — — Contingent consideration (d) — 21 — 48 — — — 69 — Subtotal Level 3 liabilities at fair value $ 4,258 $ 501 $ — $ 1,059 $ — $ (310) $ (28) $ 5,480 $ — Market risk benefits liability (c) 403 603 Total Level 3 liabilities at fair value $ 4,661 $ 6,083 (a) The net transfers out of Level 3 during the three months ended September 30, 2024 were exclusively to Level 2. (b) The transfer out of investments in unconsolidated affiliates represents F&G’s 30% ownership of PALH prior to the majority acquisition on July 18, 2024. Refer to Note N Acquisitions for details of the PALH majority acquisition. (c) Refer to Note P Market Risk Benefits for roll forward activity of the net Market risk benefits asset and liability. (d) The initial contingent consideration recorded in the Roar transaction is included in purchases in the table above. Refer to Note N Acquisition for more information. Nine months ended September 30, 2023 Balance at Beginning Total (Losses) Gain Purchases Sales Settlements Net Transfer (Out) In of Balance at End of Change in Unrealized Included in OCI Included in Included in Assets (In millions) Fixed maturity securities available-for-sale: Asset-backed securities $ 6,263 $ (56) $ 108 $ 1,331 $ (125) $ (557) $ (207) $ 6,757 $ 107 Commercial mortgage-backed securities 37 — 1 22 — — (33) 27 1 Corporates 1,440 (1) (77) 423 (1) (43) 3 1,744 (77) Municipals 29 — 18 — — — — 47 18 Residential mortgage-backed securities 302 1 7 32 — (9) (330) 3 7 Foreign Governments 16 — — — — — — 16 — Investment in unconsolidated affiliates 23 — — 249 — — — 272 — Short term investments — — — 191 (19) (103) — 69 — Preferred securities 1 — 1 — — — 6 8 1 Equity securities 10 1 — — — — 4 15 — Other long-term investments: Available-for-sale embedded derivative 23 — — — — — — 23 — Credit linked note 15 — — — — (3) — 12 — Secured borrowing receivable 10 — — — — — — 10 — Subtotal Level 3 assets at fair value $ 8,169 $ (55) $ 58 $ 2,248 $ (145) $ (715) $ (557) $ 9,003 $ 57 Market risk benefits asset (b) 117 118 Total Level 3 assets at fair value $ 8,286 $ 9,121 Liabilities Indexed annuity/IUL embedded derivatives, included in contractholder funds 3,115 (214) — 765 — (110) — 3,556 — Interest rate swaps — 16 — — — — — 16 — Subtotal Level 3 liabilities at fair value $ 3,115 $ (198) $ — $ 765 $ — $ (110) $ — $ 3,572 $ — Market risk benefits liability (b) 282 278 Total Level 3 liabilities at fair value $ 3,397 $ 3,850 (a) The net transfers out of Level 3 during the nine months ended September 30, 2023 were exclusively to Level 2 (b) Refer to Note P Market Risk Benefits for roll forward activity of the net Market risk benefits asset and liability.

Investments (Tables)

Investments (Tables)	9 Months Ended
	Sep. 30, 2024
Investments, Debt and Equity Securities [Abstract]
Schedule of Consolidated Investments	The Company’s consolidated investments as of September 30, 2024 and December 31, 2023 are summarized as follows: September 30, 2024 Amortized Cost Allowance for Expected Credit Losses Gross Unrealized Gains Gross Unrealized Losses Fair Value Available-for-sale securities (In millions) Asset-backed securities $ 15,986 $ (12) $ 264 $ (275) $ 15,963 Commercial mortgage-backed securities 5,359 (49) 61 (192) 5,179 Corporates 23,673 (5) 396 (2,092) 21,972 Hybrids 609 — 6 (19) 596 Municipals 1,682 — 20 (187) 1,515 Residential mortgage-backed securities 2,617 (1) 61 (77) 2,600 U.S. Government 800 — 9 (6) 803 Foreign Governments 344 — 5 (37) 312 Total available-for-sale securities $ 51,070 $ (67) $ 822 $ (2,885) $ 48,940 December 31, 2023 Amortized Cost Allowance for Expected Credit Losses Gross Unrealized Gains Gross Unrealized Losses Fair Value Available-for-sale securities (In millions) Asset-backed securities $ 14,631 $ (11) $ 191 $ (469) $ 14,342 Commercial mortgage-backed/asset-backed securities 4,797 (22) 23 (323) 4,475 Corporates 20,133 (6) 186 (2,417) 17,896 Hybrids 668 — 3 (53) 618 Municipals 1,826 — 14 (229) 1,611 Residential mortgage-backed securities 2,507 (3) 29 (104) 2,429 U.S. Government 679 — 8 (9) 678 Foreign Governments 365 — 3 (44) 324 Total available-for-sale securities $ 45,606 $ (42) $ 457 $ (3,648) $ 42,373
Schedule of Investments Classified by Contractual Maturity Date	The amortized cost and fair value of fixed maturity securities by contractual maturities, as applicable, are shown below. Actual maturities may differ from contractual maturities because issuers may have the right to call or prepay obligations. September 30, 2024 December 31, 2023 (In millions) (In millions) Amortized Cost Fair Value Amortized Cost Fair Value Corporates, Non-structured Hybrids, Municipal and Government securities: Due in one year or less $ 890 $ 885 $ 703 $ 687 Due after one year through five years 4,996 4,985 4,320 4,209 Due after five years through ten years 4,975 4,981 3,195 3,048 Due after ten years 16,247 14,347 15,453 13,183 Subtotal 27,108 25,198 23,671 21,127 Other securities, which provide for periodic payments: Asset-backed securities 15,986 15,963 14,631 14,342 Commercial mortgage-backed securities 5,359 5,179 4,797 4,475 Residential mortgage-backed securities 2,617 2,600 2,507 2,429 Subtotal 23,962 23,742 21,935 21,246 Total fixed maturity available-for-sale securities $ 51,070 $ 48,940 $ 45,606 $ 42,373
Schedule of Fair Value and Gross Unrealized Losses of Available-for-sale Securities	The fair value and gross unrealized losses of AFS securities, excluding securities in an unrealized loss position with an allowance for expected credit loss, aggregated by investment category and duration of fair value below amortized cost as of September 30, 2024 and December 31, 2023 were as follows: September 30, 2024 Less than 12 months 12 months or longer Total Fair Value Gross Unrealized Fair Value Gross Unrealized Fair Value Gross Unrealized Available-for-sale securities (In millions) Asset-backed securities $ 583 $ (19) $ 3,447 $ (237) $ 4,030 $ (256) Commercial mortgage-backed securities 209 (5) 1,682 (168) 1,891 (173) Corporates 1,382 (8) 10,698 (2,084) 12,080 (2,092) Hybrids 47 (1) 393 (18) 440 (19) Municipals 82 (1) 1,089 (186) 1,171 (187) Residential mortgage-backed securities 188 (3) 447 (68) 635 (71) U.S. Government 268 (1) 130 (5) 398 (6) Foreign Government 23 (2) 170 (36) 193 (38) Total available-for-sale securities $ 2,782 $ (40) $ 18,056 $ (2,802) $ 20,838 $ (2,842) Total number of available-for-sale securities in an unrealized loss position less than twelve months 585 Total number of available-for-sale securities in an unrealized loss position twelve months or longer 2,393 Total number of available-for-sale securities in an unrealized loss position 2,978 December 31, 2023 Less than 12 months 12 months or longer Total Fair Value Gross Unrealized Fair Value Gross Unrealized Fair Value Gross Unrealized Available-for-sale securities (In millions) Asset-backed securities $ 1,707 $ (56) $ 5,835 $ (404) $ 7,542 $ (460) Commercial mortgage-backed securities 819 (53) 1,922 (235) 2,741 (288) Corporates 2,387 (134) 10,739 (2,283) 13,126 (2,417) Hybrids 60 (2) 483 (51) 543 (53) Municipals 399 (49) 920 (179) 1,319 (228) Residential mortgage-backed securities 336 (5) 662 (89) 998 (94) U.S. Government 84 — 159 (9) 243 (9) Foreign Government 49 (3) 188 (41) 237 (44) Total available-for-sale securities $ 5,841 $ (302) $ 20,908 $ (3,291) $ 26,749 $ (3,593) Total number of available-for-sale securities in an unrealized loss position less than twelve months 1,035 Total number of available-for-sale securities in an unrealized loss position twelve months or longer 2,846 Total number of available-for-sale securities in an unrealized loss position 3,881
Schedule of Distribution of CMLs, Gross Valuation by Property Type and Geographic Region	The distribution of CMLs, gross of valuation allowances, by property type and geographic region is reflected in the following tables: September 30, 2024 December 31, 2023 Gross Carrying Value % of Total Gross Carrying Value % of Total Property Type: (In millions) (In millions) Hotel $ 17 1 % $ 18 1 % Industrial 617 24 616 24 Mixed Use 11 — 11 — Multifamily 1,006 39 1,012 40 Office 356 14 316 13 Retail 99 4 102 4 Student Housing 83 3 83 3 Other 401 15 392 15 Total commercial mortgage loans, gross of valuation allowance $ 2,590 100 % $ 2,550 100 % Allowance for expected credit loss (18) (12) Total commercial mortgage loans, net of valuation allowance $ 2,572 $ 2,538 U.S. Region: East North Central $ 98 4 % $ 151 6 % East South Central 75 3 75 3 Middle Atlantic 354 14 354 14 Mountain 409 16 352 14 New England 164 6 168 6 Pacific 713 27 766 30 South Atlantic 595 23 563 22 West North Central 22 1 4 — West South Central 160 6 117 5 Total commercial mortgage loans, gross of valuation allowance $ 2,590 100 % $ 2,550 100 % Allowance for expected credit loss (18) (12) Total commercial mortgage loans, net of valuation allowance $ 2,572 $ 2,538
Schedule of Loans Segregated by Risk Rating Exposure	CMLs segregated by aging of the loans and charge offs (by year of origination) as of September 30, 2024 and December 31, 2023, were as follows, gross of valuation allowances: September 30, 2024 Amortized Cost by Origination Year 2024 2023 2022 2021 2020 Prior Total Commercial mortgages (In millions) Current (less than 30 days past due) $ 140 $ 221 $ 289 $ 1,253 $ 469 $ 209 $ 2,581 30-89 days past due — — — — — 9 9 90 days or more past due — — — — — — — Total CMLs $ 140 $ 221 $ 289 $ 1,253 $ 469 $ 218 $ 2,590 Charge offs $ — $ — $ — $ — $ — $ — $ — December 31, 2023 Amortized Cost by Origination Year 2023 2022 2021 2020 2019 Prior Total Commercial mortgages (In millions) Current (less than 30 days past due) $ 213 $ 288 $ 1,256 $ 512 $ — $ 259 $ 2,528 30-89 days past due — — — — — — — 90 days or more past due — — — — — — — Total CMLs (a) $ 213 $ 288 $ 1,256 $ 512 $ — $ 259 $ 2,528 Charge offs $ — $ — $ — $ — $ — $ 3 $ 3 (a) Excludes loans under development with an amortized cost and estimated fair value of $22 million. September 30, 2024 Amortized Cost by Origination Year 2024 2023 2022 2021 2020 Prior Total Residential mortgages (In millions) Current (less than 30 days past due) $ 387 $ 372 $ 928 $ 822 $ 168 $ 317 $ 2,994 30-89 days past due 6 3 9 8 4 7 37 90 days or more past due — 2 9 28 10 25 74 Total residential mortgages $ 393 $ 377 $ 946 $ 858 $ 182 $ 349 $ 3,105 December 31, 2023 Amortized Cost by Origination Year 2023 2022 2021 2020 2019 Prior Total Residential mortgages (In millions) Current (less than 30 days past due) $ 373 $ 985 $ 854 $ 192 $ 183 $ 192 $ 2,779 30-89 days past due — 4 7 3 — 2 16 90 days or more past due — 6 16 13 21 1 57 Total residential mortgages $ 373 $ 995 $ 877 $ 208 $ 204 $ 195 $ 2,852
Schedule of Investment in Mortgage Loans by Loan to Value and Debt Service Coverage Ratios	The following tables present the recorded investment in CMLs by LTV and DSC ratio categories and estimated fair value by the indicated LTV ratios, gross of valuation allowances as of September 30, 2024 and December 31, 2023 : Debt-Service Coverage Ratios Total Amount % of Total Estimated Fair Value % of Total >1.25 1.00 - 1.25 <1.00 September 30, 2024 (In millions) LTV Ratios: Less than 50.00% $ 499 $ 8 $ 9 $ 516 20 % $ 501 21 % 50.00% to 59.99% 749 59 12 820 31 752 32 60.00% to 74.99% 1,182 57 — 1,239 48 1,074 46 75.00% to 84.99% — 6 9 15 1 15 1 CMLs $ 2,430 $ 130 $ 30 $ 2,590 100 % $ 2,342 100 % December 31, 2023 LTV Ratios: Less than 50.00% $ 519 $ 4 $ 10 $ 533 21 % $ 510 23 % 50.00% to 59.99% 764 — — 764 30 679 30 60.00% to 74.99% 1,160 56 — 1,216 48 1,028 46 75.00% to 84.99% — 6 9 15 1 14 1 CMLs (a) $ 2,443 $ 66 $ 19 $ 2,528 100 % $ 2,231 100 % (a) Excludes loans under development with an amortized cost and estimated fair value of $22 million. September 30, 2024 Amortized Cost by Origination Year 2024 2023 2022 2021 2020 Prior Total Commercial mortgages (In millions) LTV Less than 50.00% $ 58 $ 93 $ 18 $ 74 $ 189 $ 84 $ 516 50.00% to 59.99% 59 53 149 267 158 134 820 60.00% to 74.99% 23 69 113 912 122 — 1,239 75.00% to 84.99% — 6 9 — — — 15 Total CMLs $ 140 $ 221 $ 289 $ 1,253 $ 469 $ 218 $ 2,590 Commercial mortgages DSCR Greater than 1.25x $ 72 $ 161 $ 278 $ 1,241 $ 469 $ 209 $ 2,430 1.00x - 1.25x 67 60 3 — — — 130 Less than 1.00x 1 — 8 12 — 9 30 Total CMLs $ 140 $ 221 $ 289 $ 1,253 $ 469 $ 218 $ 2,590 December 31, 2023 Amortized Cost by Origination Year 2023 2022 2021 2020 2019 Prior Total Commercial mortgages (In millions) LTV Less than 50.00% $ 85 $ 17 $ 77 $ 232 $ — $ 122 $ 533 50.00% to 59.99% 53 149 267 158 — 137 764 60.00% to 74.99% 69 113 912 122 — — 1,216 75.00% to 84.99% 6 9 — — — — 15 Total CMLs (a) $ 213 $ 288 $ 1,256 $ 512 $ — $ 259 $ 2,528 Commercial mortgages DSCR Greater than 1.25x $ 154 $ 276 $ 1,256 $ 512 $ — $ 245 $ 2,443 1.00x - 1.25x 59 3 — — — 4 66 Less than 1.00x — 9 — — — 10 19 Total CMLs (a) $ 213 $ 288 $ 1,256 $ 512 $ — $ 259 $ 2,528
Schedule of Residential Mortgage Loans by State	The distribution of RMLs by state with highest-to-lowest concentration are reflected in the following tables, gross of valuation allowances: September 30, 2024 Amortized Cost % of Total U.S. State: (In millions) Florida $ 160 5 % All other states (a) 2,945 95 Total RMLs, gross of valuation allowance 3,105 100 % Allowance for expected credit loss (51) Total RMLs, net of valuation allowance $ 3,054 (a) The individual concentration of each state is less than 5% as of September 30, 2024. December 31, 2023 Amortized Cost % of Total U.S. State: (In millions) Florida $ 163 6 % New York 129 5 Texas 129 5 All other states (a) 2,431 84 Total RMLs, gross of valuation allowance 2,852 100 % Allowance for expected credit loss (54) Total RMLs, net of valuation allowance $ 2,798 (a) The individual concentration of each state is less than 5% as of December 31, 2023.
Schedule of Loans with Credit Quality Indicators, Performing or Nonperforming	The credit quality of RMLs as of September 30, 2024 and December 31, 2023, was as follows: September 30, 2024 December 31, 2023 Amortized Cost % of Total Amortized Cost % of Total Performance indicators: (In millions) (In millions) Performing $ 3,031 98 % $ 2,795 98 % Non-performing 74 2 57 2 Total RMLs, gross of valuation allowance 3,105 100 % 2,852 100 % Allowance for expected loan loss (51) (54) Total RMLs, net of valuation allowance $ 3,054 $ 2,798
Schedule of Nonaccrual Loans by Amortized Cost	Non-accrual loans by amortized cost as of September 30, 2024 and December 31, 2023, were as follows: September 30, 2024 December 31, 2023 Amortized cost of loans on non-accrual (In millions) Residential mortgage: $ 74 $ 57 Commercial mortgage: — — Total non-accrual mortgages $ 74 $ 57
Schedule of Allowance for Expected Credit Losses on Loans	The allowances for our mortgage loan portfolio are summarized as follows: Three months ended September 30, 2024 Nine months ended September 30, 2024 (In millions) (In millions) Residential Mortgage Commercial Mortgage Total Residential Mortgage Commercial Mortgage Total Beginning Balance $ (50) $ (14) $ (64) $ (54) $ (12) $ (66) Provision (expense) benefit for loan losses (1) (4) (5) 3 (6) (3) Ending Balance $ (51) $ (18) $ (69) $ (51) $ (18) $ (69) Three months ended September 30, 2023 Nine months ended September 30, 2023 (In millions) (In millions) Residential Mortgage Commercial Mortgage Total Residential Mortgage Commercial Mortgage Total Beginning Balance $ (51) $ (13) $ (64) $ (32) $ (10) $ (42) Provision (expense) benefit for loan losses 2 (2) — (17) (5) (22) Ending Balance $ (49) $ (15) $ (64) $ (49) $ (15) $ (64)
Schedule of Sources of Net Investment Income Reported	The major sources of Interest and investment income reported on the accompanying unaudited Condensed Consolidated Statements of Earnings were as follows: Three months ended September 30, Nine months ended September 30, 2024 2023 2024 2023 (In millions) (In millions) Fixed maturity securities, available-for-sale $ 583 $ 493 $ 1,679 $ 1,405 Equity securities 8 8 26 24 Preferred securities 7 12 25 39 Mortgage loans 69 59 200 167 Invested cash and short-term investments 72 39 172 106 Limited partnerships 84 69 234 171 Tax deferred property exchange income 36 44 102 128 Other investments 32 25 88 63 Gross investment income 891 749 2,526 2,103 Investment expense (76) (63) (218) (188) Interest and investment income $ 815 $ 686 $ 2,308 $ 1,915
Schedule of Recognized Gains and Losses, net	Details underlying Recognized gains and losses, net reported on the accompanying unaudited Condensed Consolidated Statements of Earnings were as follows: Three months ended September 30, Nine months ended September 30, 2024 2023 2024 2023 (In millions) (In millions) Net realized (losses) gains on fixed maturity available-for-sale securities $ (1) $ (32) $ 3 $ (137) Net realized/unrealized gains (losses) on equity securities (1) 48 (33) 48 (37) Net realized/unrealized gains (losses) on preferred securities (2) 17 1 29 (7) Net realized/unrealized gains (losses) on other invested assets 3 9 73 (20) Change in allowance for expected credit losses — (7) (32) (30) Derivatives and embedded derivatives: Realized gains (losses) on certain derivative instruments 30 (30) 65 (184) Unrealized gains (losses) on certain derivative instruments 347 (297) 450 14 Change in fair value of reinsurance related embedded derivatives (3) (178) 36 (186) 34 Change in fair value of other derivatives and embedded derivatives 3 (3) 6 — Realized gains (losses) on derivatives and embedded derivatives 202 (294) 335 (136) Recognized gains and losses, net $ 269 $ (356) $ 456 $ (367) (1) Includes net valuation gains (losses) of $31 million and $(22) million for the three months ended September 30, 2024 and 2023, respectively, and net valuation losses of $(42) million and $(12) million for the nine months ended September 30, 2024 and 2023, respectively. (2) Includes net valuation gains of $18 million and $2 million for the three months ended September 30, 2024 and 2023, respectively, and net valuation gains of $30 million and $52 million for the nine months ended September 30, 2024 and 2023, respectively. (3) Change in fair value of reinsurance related embedded derivatives is due to activity related to the reinsurance treaties.
Schedule of Proceeds from Sale of Fixed Maturity Available-for-sale Securities	The proceeds from the sale of fixed-maturity securities and the gross gains and losses associated with those transactions were as follows: Three months ended September 30, Nine months ended September 30, 2024 2023 2024 2023 (In millions) Proceeds $ 1,476 $ 880 $ 2,638 $ 1,978 Gross gains 18 — 36 7 Gross losses (20) (27) (52) (109)
Schedule of Carrying Value and Maximum Loss Exposure, Unconsolidated VIEs	The following table summarizes the carrying value and the maximum loss exposure of our unconsolidated VIEs as of September 30, 2024 and December 31, 2023: September 30, 2024 December 31, 2023 (In millions) (In millions) Carrying Value Maximum Loss Exposure Carrying Value Maximum Loss Exposure Investment in unconsolidated affiliates $ 3,666 $ 4,814 $ 3,071 $ 4,806 Fixed maturity securities 23,343 24,120 20,837 22,346 Total unconsolidated VIE investments $ 27,009 $ 28,934 $ 23,908 $ 27,152

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Carrying Amount of Derivative Instruments	The carrying amounts of derivative instruments, including derivative instruments embedded in indexed annuities and IUL contracts, and reinsurance are as follows: September 30, 2024 December 31, 2023 (In millions) Assets: Derivative investments: Equity options $ 1,293 $ 739 Interest rate swaps 108 57 Other derivative investments — 1 Other long-term investments: Other embedded derivatives 34 28 Prepaid expenses and other assets: Reinsurance related embedded derivatives — 152 Total $ 1,435 $ 977 Liabilities Contractholder funds: Indexed annuities/IUL embedded derivatives $ 5,411 $ 4,258 Accounts payable and accrued liabilities: Reinsurance related embedded derivative 34 — Equity Options 4 1 Total $ 5,449 $ 4,259
Schedule of Change in Fair Value of Derivative Instruments	The change in fair value of derivative instruments included within Recognized gains and losses, net in the accompanying unaudited Condensed Consolidated Statements of Earnings is as follows: Three months ended September 30, Nine months ended September 30, 2024 2023 2024 2023 (In millions) (In millions) Net investment gains (losses): Equity options $ 260 $ (308) $ 487 $ (155) Interest rate swaps 114 (19) 9 (19) Futures contracts 7 (4) 18 1 Other derivative investments (4) 4 1 3 Other embedded derivatives 3 (3) 6 — Reinsurance related embedded derivatives (178) 36 (186) 34 Total net investment gains (losses) $ 202 $ (294) $ 335 $ (136) Benefits and other changes in policy reserves: Indexed annuities/IUL embedded derivatives increase $ 563 $ (265) $ 1,153 $ 441
Schedule of Exposure to Credit Loss on Call Options Held	Information regarding our exposure to credit loss on the derivative instruments we hold, excluding futures contracts, is presented below: Notional Amount Fair Value Collateral Net Credit Risk (In millions) September 30, 2024 $ 35,561 $ 1,393 $ 1,351 $ 53 December 31, 2023 29,968 796 775 39

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Schedule of Unfunded Commitments	A summary of unfunded commitments by commitment type as of September 30, 2024 is included below: September 30, 2024 Commitment Type (In millions) Unconsolidated VIEs: Limited partnerships $ 1,148 Whole loans 949 Fixed maturity securities, ABS 359 Direct Lending 273 Other fixed maturity securities, AFS 43 Commercial mortgage loans 79 Other assets 145 Other invested assets 109 Total $ 3,105

Segment Information (Tables)

Segment Information (Tables)	9 Months Ended
	Sep. 30, 2024
Segment Reporting [Abstract]
Schedule of Segment Reporting Information	Summarized financial information concerning our reportable segments is shown in the following tables. As of and for the three months ended September 30, 2024: Title F&G Corporate and Other Elimination Total (In millions) Title premiums $ 1,360 $ — $ — $ — $ 1,360 Other revenues 581 526 52 — 1,159 Revenues from external customers 1,941 526 52 — 2,519 Interest and investment income, including recognized gains and losses, net 155 918 37 (26) 1,084 Total revenues 2,096 1,444 89 (26) 3,603 Depreciation and amortization 35 147 7 — 189 Interest expense — 36 20 — 56 Earnings (loss) before income taxes and equity in earnings of unconsolidated affiliates 372 (30) (3) (26) 313 Income tax expense (benefit) 73 (25) (4) — 44 Earnings (loss) before equity in earnings of unconsolidated affiliates 299 (5) 1 (26) 269 Equity in earnings of unconsolidated affiliates 2 — — — 2 Net earnings (loss) from continuing operations $ 301 $ (5) $ 1 $ (26) $ 271 Assets $ 8,046 $ 84,110 $ 2,516 $ — $ 94,672 Goodwill 2,800 2,179 293 — 5,272 As of and for the three months ended September 30, 2023: Title F&G Corporate and Other Elimination Total (In millions) Title premiums $ 1,252 $ — $ — $ — $ 1,252 Other revenues 577 582 37 — 1,196 Revenues from external customers 1,829 582 37 — 2,448 Interest and investment income, including recognized gains and losses, net 46 269 37 (22) 330 Total revenues 1,875 851 74 (22) 2,778 Depreciation and amortization 39 108 6 — 153 Interest expense — 24 20 — 44 Earnings (loss) before income taxes and equity in earnings of unconsolidated affiliates 248 380 (3) (22) 603 Income tax expense (benefit) 73 74 (6) — 141 Earnings (loss) before equity in earnings of unconsolidated affiliates 175 306 3 (22) 462 Equity in earnings of unconsolidated affiliates 15 — — — 15 Net earnings (loss) from continuing operations $ 190 $ 306 $ 3 $ (22) $ 477 Assets $ 8,136 $ 63,596 $ 2,270 $ — $ 74,002 Goodwill 2,789 1,749 292 — 4,830 As of and for the nine months ended September 30, 2024: Title F&G Corporate and Other Elimination Total (In millions) Title premiums $ 3,741 $ — $ — $ — $ 3,741 Other revenues 1,636 1,772 147 — 3,555 Revenues from external customers 5,377 1,772 147 — 7,296 Interest and investment income, including recognized gains and losses, net 313 2,413 118 (80) 2,764 Total revenues 5,690 4,185 265 (80) 10,060 Depreciation and amortization 106 417 22 — 545 Interest expense — 94 58 — 152 Earnings (loss) from continuing operations before income taxes and equity in earnings of unconsolidated affiliates 825 366 (9) (80) 1,102 Income tax expense (benefit) 190 51 (18) — 223 Earnings (loss) from continuing operations before equity in earnings (loss) of unconsolidated affiliates 635 315 9 (80) 879 Equity in earnings of unconsolidated affiliates 4 — — — 4 Net earnings (loss) from continuing operations $ 639 $ 315 $ 9 $ (80) $ 883 Assets $ 8,046 $ 84,110 $ 2,516 $ — $ 94,672 Goodwill 2,800 2,179 293 — 5,272 As of and for the nine months ended September 30, 2023: Title F&G Corporate and Other Elimination Total (In millions) Title premiums $ 3,484 $ — $ — $ — $ 3,484 Other revenues 1,629 1,523 136 — 3,288 Revenues from external customers 5,113 1,523 136 — 6,772 Interest and investment income, including recognized gains and losses, net 178 1,365 48 (43) 1,548 Total revenues 5,291 2,888 184 (43) 8,320 Depreciation and amortization 115 302 21 — 438 Interest expense — 71 58 — 129 Earnings (loss) from continuing operations before income taxes and equity in earnings of unconsolidated affiliates 638 340 (74) (43) 861 Income tax expense (benefit) 165 99 (19) — 245 Earnings (loss) from continuing operations before equity in earnings of unconsolidated affiliates 473 241 (55) (43) 616 Equity in earnings of unconsolidated affiliates 16 — — — 16 Net earnings (loss) from continuing operations $ 489 $ 241 $ (55) $ (43) $ 632 Assets $ 8,136 $ 63,596 $ 2,270 $ — $ 74,002 Goodwill 2,789 1,749 292 — 4,830

Supplemental Cash Flow Inform_2

Supplemental Cash Flow Information (Tables)	9 Months Ended
	Sep. 30, 2024
Supplemental Cash Flow Elements [Abstract]
Schedule of Supplemental Cash Flow Information	The following supplemental cash flow information is provided with respect to certain cash payment and non-cash investing and financing activities: Nine months ended September 30, 2024 2023 Cash paid for: (In millions) Interest $ 154 $ 122 Income taxes 153 140 Deferred sales inducements 219 113 Non-cash investing and financing activities: Change in proceeds of sales of investments available for sale receivable in period (69) 53 Change in purchases of investments available for sale payable in period 639 145 Lease liabilities recognized in exchange for lease right-of-use assets 35 29 Remeasurement of lease liabilities 55 53 Liabilities assumed in connection with acquisitions Fair value of assets acquired 771 304 Less: Total Purchase price 570 299 Liabilities and noncontrolling interests assumed $ 201 $ 5

Revenue Recognition (Tables)

Revenue Recognition (Tables)	9 Months Ended
	Sep. 30, 2024
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue	Our revenue consists of: Three months ended September 30, Nine months ended September 30, 2024 2023 2024 2023 Revenue Stream Income Statement Classification Segment Total Revenue Revenue from insurance contracts: (In millions) Direct title insurance premiums Direct title insurance premiums Title $ 571 $ 524 $ 1,575 $ 1,493 Agency title insurance premiums Agency title insurance premiums Title 789 728 2,166 1,991 Life insurance premiums, insurance and investment product fees, and other Escrow, title-related and other fees F&G 526 582 1,772 1,523 Home warranty Escrow, title-related and other fees Title 42 43 114 110 Total revenue from insurance contracts 1,928 1,877 5,627 5,117 Revenue from contracts with customers: Escrow fees Escrow, title-related and other fees Title 219 211 609 590 Other title-related fees and income Escrow, title-related and other fees Title 169 167 479 482 ServiceLink, excluding title premiums, escrow fees, and subservicing fees Escrow, title-related and other fees Title 83 85 237 247 Real estate technology Escrow, title-related and other fees Corporate and other 35 38 106 114 Total revenue from contracts with customers 506 501 1,431 1,433 Other revenue: Loan subservicing revenue Escrow, title-related and other fees Title 68 71 197 200 Other Escrow, title-related and other fees Corporate and other 17 (1) 41 22 Interest and investment income Interest and investment income Various 815 686 2,308 1,915 Recognized gains and losses, net Recognized gains and losses, net Various 269 (356) 456 (367) Total revenues Total revenues $ 3,603 $ 2,778 $ 10,060 $ 8,320
Schedule of Information about Trade Receivables and Deferred Revenue	The following table provides information about trade receivables and deferred revenue: September 30, 2024 December 31, 2023 (In millions) Trade receivables $ 336 $ 317 Deferred revenue (contract liabilities) 94 91
Schedule of Rollforward of Unearned Revenue Liabilities (URL)	The following tables roll forward URL for our universal life product for the nine months ended September 30, 2024 and September 30, 2023: Nine Months Ended September 30, 2024 2023 (In millions) Balance at January 1, $ 270 $ 166 Capitalization 110 87 Amortization (14) (12) Balance at September 30, $ 366 $ 241

Value of Business Acquired, D_2

Value of Business Acquired, Deferred Acquisition Costs and Deferred Sales Inducements (Tables)	9 Months Ended
	Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Other Intangible Assets, Finite	The following table reconciles to Other intangible assets, net, on the unaudited Condensed Consolidated Balance Sheets as of September 30, 2024 and December 31, 2023. September 30, 2024 December 31, 2023 (In millions) Customer relationships and contracts $ 440 $ 174 Value of business acquired 1,389 1,446 Deferred acquisition costs 2,857 2,215 Deferred sales inducements 538 346 Value of distribution asset 76 86 Computer software 282 266 Trademarks, tradenames, and other 176 94 Total Other intangible assets, net $ 5,758 $ 4,627
Schedule of Other Intangible Assets, Indefinite	The following table reconciles to Other intangible assets, net, on the unaudited Condensed Consolidated Balance Sheets as of September 30, 2024 and December 31, 2023. September 30, 2024 December 31, 2023 (In millions) Customer relationships and contracts $ 440 $ 174 Value of business acquired 1,389 1,446 Deferred acquisition costs 2,857 2,215 Deferred sales inducements 538 346 Value of distribution asset 76 86 Computer software 282 266 Trademarks, tradenames, and other 176 94 Total Other intangible assets, net $ 5,758 $ 4,627
Schedule of Rollforward of Value of Business Acquired	The following tables roll forward VOBA by product for the nine months ended September 30, 2024 and 2023. Indexed Annuities Fixed Rate Annuities Immediate Annuities Universal Life Traditional Life Total (In millions) Balance as of January 1, 2024 $ 1,025 $ 27 $ 191 $ 134 $ 69 $ 1,446 Amortization (101) (4) (5) (5) (5) (120) Actuarial model updates and refinements (a) — — — — 63 63 Balance as of September 30, 2024 $ 924 $ 23 $ 186 $ 129 $ 127 $ 1,389 (a) net of amortization of ($15 million). Indexed Annuities Fixed Rate Annuities Immediate Annuities Universal Life Traditional Life Total (In millions) Balance as of January 1, 2023 $ 1,166 $ 32 $ 201 $ 143 $ 73 $ 1,615 Amortization (106) (4) (8) (7) (3) (128) Balance as of September 30, 2023 $ 1,060 $ 28 $ 193 $ 136 $ 70 $ 1,487
Schedule of Rollforward of Deferred Policy Acquisition Costs	The following tables roll forward DAC by product for the nine months ended September 30, 2024 and 2023. Indexed Annuities Fixed Rate Annuities Universal Life Total (a) (In millions) Balance as of January 1, 2024 $ 1,378 $ 288 $ 545 $ 2,211 Capitalization 496 147 199 842 Amortization (112) (61) (27) (200) Balance as of September 30, 2024 $ 1,762 $ 374 $ 717 $ 2,853 Indexed Annuities Fixed Rate Annuities Universal Life Total (a) (In millions) Balance as of January 1, 2023 $ 971 $ 83 $ 348 $ 1,402 Capitalization 371 119 167 657 Amortization (75) (35) (25) (135) Reinsurance related adjustments — 79 — 79 Balance as of September 30, 2023 $ 1,267 $ 246 $ 490 $ 2,003 (a) Excludes insignificant amounts of DAC related to Funding Agreement Backed Note (“FABN”).
Schedule of Reconciliation of DAC to Condensed Consolidated Balance Sheets	The following table presents a reconciliation of DAC to the table above, which is reconciled to the unaudited Condensed Consolidated Balance Sheets as of September 30, 2024 and December 31, 2023: September 30, 2024 December 31, 2023 (In millions) Indexed Annuities $ 1,762 $ 1,378 Fixed Rate Annuities 374 288 Universal Life 717 545 Funding Agreements 4 4 Total $ 2,857 $ 2,215
Schedule of Rollforward of Deferred Sale Inducement Cost	The following table rolls forward DSI for our indexed annuity products for the nine months ended September 30, 2024 and 2023: Nine Months Ended September 30, 2024 2023 (In millions) Balance as of January 1, $ 346 $ 200 Capitalization 219 112 Amortization (27) (15) Balance as of September 30, $ 538 $ 297
Schedule of Estimated Amortization Expense for VOBA in Future Fiscal Periods	For the in-force liabilities as of September 30, 2024, the estimated amortization expense for VOBA in future fiscal periods is as follows: Estimated Amortization Expense Fiscal Year (In millions) 2024 $ 38 2025 143 2026 130 2027 119 2028 108 Thereafter 851 Total $ 1,389

F&G Reinsurance (Tables)

F&G Reinsurance (Tables)	9 Months Ended
	Sep. 30, 2024
Reinsurance Disclosures [Abstract]
Schedule of Effect of Reinsurance on Premiums Earned, Benefits Incurred and Reserve Changes	The effects of reinsurance on net premiums earned and net benefits incurred (benefits paid and reserve changes) for the three and nine months ended September 30, 2024 and 2023 were as follows: Three months ended September 30, Nine months ended September 30, 2024 2023 2024 2023 (In millions) Net Premiums Earned Net Benefits Incurred Net Premiums Earned Net Benefits Incurred Net Premiums Earned Net Benefits Incurred Net Premiums Earned Net Benefits Incurred Direct $ 363 $ 1,127 $ 508 $ 323 $ 1,340 $ 2,999 $ 1,319 $ 2,057 Ceded (23) (32) (26) (31) (71) (135) (79) (136) Net $ 340 $ 1,095 $ 482 $ 292 $ 1,269 $ 2,864 $ 1,240 $ 1,921
Schedule of Reinsurance Recoverable	The following summarizes our reinsurance recoverable as of September 30, 2024 and December 31, 2023: Parent Company/ Reinsurance Recoverable (a) Agreement Type Products Accounting September 30, 2024 December 31, 2023 (In millions) Aspida Life Re Ltd $ 7,543 $ 6,128 Coinsurance Funds Withheld Certain MYGA (b) Deposit Somerset Reinsurance Ltd (c) 2,181 716 Coinsurance Funds Withheld Certain MYGA (b) and deferred annuities Deposit Coinsurance Funds Withheld Certain FIA Reinsurance Everlake Life Insurance Company 1,120 509 Coinsurance (d) Certain MYGA (b) (d) Deposit Wilton Reassurance Company 1,073 1,092 Coinsurance Block of traditional, IUL and UL (e) Reinsurance Other (f) 508 536 Reinsurance recoverable, gross of allowance for credit losses 12,425 8,981 Allowance for expected credit loss (21) (21) Reinsurance recoverable, net of allowance for credit losses $ 12,404 $ 8,960 (a) Reinsurance recoverables do not include unearned ceded premiums that would be recovered in the event of early termination of certain traditional life policies. (b) The combined quota share flow reinsurance amongst all reinsurers for 2024 was 90% through May 31, 2024, decreased to 30% in June and July 2024, and increased to 90% in August and September 2024. As of December 31, 2023, the combined quota share flow reinsurance amongst all reinsurers was 90%. (c) The balance represents the total reinsurance recoverable for all reinsurance agreements with Somerset. (d) Reinsurance recoverable is collateralized by assets placed in a statutory comfort trust by the reinsurer and maintained for our sole benefit. (e) Also includes certain FGL Insurance life insurance policies that are subject to redundant reserves, reported on a statutory basis, under Regulation XXX and Guideline AXXX. (f) Represents all other reinsurers, with no single reinsurer having a carrying value in excess of 5% of total reinsurance recoverable.
Schedule of Reinsurance Recoverable Expected Credit Loss	The expected credit loss reserves were as follows: Three months ended September 30, Nine months ended September 30, 2024 2023 2024 2023 (In millions) Balance at beginning of period $ (21) $ (9) $ (21) $ (10) Changes in the expected credit loss reserve — (1) — — Balance at end of period $ (21) $ (10) $ (21) $ (10)
Schedule of Financial Strength Ratings of Principal Reinsurers	Parent Company/Principal Reinsurers Financial Strength Rating AM Best S&P Fitch Moody's Aspida Re A- — — — Somerset A- BBB+ — — Everlake A — — — Wilton Re A+ — A —

F&G Insurance Subsidiary Fina_2

F&G Insurance Subsidiary Financial Information and Regulatory Matters (Tables)	9 Months Ended
	Sep. 30, 2024
Insurance [Abstract]
Schedule of Statutory Accounting Practices	Subsidiary (state of domicile) (a) FGL Insurance FGL NY Insurance (NY) Raven Re Corbeau Re Statutory net income (loss): For the three months ended September 30, 2024 $ (6) $ 1 $ 13 $ 5 For the three months ended September 30, 2023 94 (1) 14 — For the nine months ended September 30, 2024 71 7 41 (394) For the nine months ended September 30, 2023 54 4 42 — Statutory capital and surplus: September 30, 2024 $ 1,704 $ 95 $ 156 $ 139 December 31, 2023 2,009 86 140 171 (a) FGL NY Insurance, Raven Re, and Corbeau Re are subsidiaries of FGL Insurance, and the columns should not be added together. Corbeau Re was incorporated on September 1, 2023. Subsidiary (country of domicile) F&G Cayman Re (Cayman Islands) F&G Life Re (Bermuda) Statutory net income (loss): For the three months ended September 30, 2024 $ (11) $ 102 For the three months ended September 30, 2023 6 (80) For the nine months ended September 30, 2024 $ (27) $ 181 For the nine months ended September 30, 2023 13 (6) Statutory capital and surplus: September 30, 2024 $ 625 $ 195 December 31, 2023 543 11

Acquisitions (Tables)

Acquisitions (Tables)	9 Months Ended
	Sep. 30, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Schedule of Initial Purchase Price	The initial purchase price is as follows (in millions): Cash paid for 70% majority interest of Roar shares $ 269 Less: Cash acquired net of noncontrolling interests 1 Net cash paid for 70% majority interest of Roar 268 Initial fair value of contingent consideration 48 Total initial consideration $ 316 The initial purchase price was as follows (in millions): Cash consideration $ 215 Less: Cash acquired 1 Net cash paid 214 Settlement of prepaid asset 8 Acquisition date fair value of previously held interests 92 Total consideration $ 314
Schedule of Fair Value Amounts Expected to be Recognized for Assets Acquired and Liabilities Assumed	The following table summarizes the fair value amounts recognized for the assets acquired and liabilities assumed as of the acquisition date: Fair value as of (In millions) Goodwill $ 268 Prepaid expenses and other assets 3 Other intangible assets 183 Total assets acquired 454 Accounts payable and accrued liabilities 2 Total liabilities assumed 2 Noncontrolling interests (fair value determined using income approach) 136 Total liabilities assumed and non-controlling interests 138 Net assets acquired $ 316 The following table summarizes the fair value amounts recognized for the assets acquired and liabilities assumed as of the acquisition date (in millions): Fair value as of Goodwill $ 162 Prepaid expenses and other assets 5 Other intangible assets 149 Total assets acquired 316 Accounts payable and accrued liabilities 2 Total liabilities assumed 2 Net assets acquired $ 314
Schedule of Gross Carrying Value and Weighted Average Estimated Useful Lives of Other Intangible Assets Acquired	The gross carrying value and weighted average estimated useful lives of Other intangible assets acquired in the Roar acquisition consist of the following: Gross Carrying Value Estimated Useful Life Other intangible assets: (In millions) (In years) Customer relationships $ 179 12 Definite lived trademarks, tradenames, and other 4 10 Total Other intangible assets $ 183 The gross carrying value and weighted average estimated useful lives of Other intangible assets acquired in the PALH acquisition consist of the following: Gross Carrying Value Estimated Useful Life Other intangible assets: (In millions) (In years) Customer relationships $ 131 20 Definite lived trademarks, tradenames, and other 18 5 to 10 Total Other intangible assets $ 149

Notes Payable (Tables)

Notes Payable (Tables)	9 Months Ended
	Sep. 30, 2024
Debt Disclosure [Abstract]
Schedule of Notes Payable	Notes payable consists of the following: September 30, 2024 December 31, 2023 (In millions) 4.50% Notes, net of discount $ 446 $ 446 3.40% Notes, net of discount 645 644 2.45% Notes, net of discount 595 594 3.20% Notes, net of discount 444 444 Revolving Credit Facility (4) (2) F&G Credit Agreement 358 362 6.50% F&G Notes, net of discount 544 — 7.40% F&G Notes, net of discount 496 495 5.50% F&G Notes, net of discount 304 561 7.95% F&G Notes, net of discount 336 336 Other 22 7 $ 4,186 $ 3,887
Schedule of Principal Maturities of Notes Payable	Gross principal maturities of notes payable as of September 30, 2024 are as follows: (In millions) 2024 (remaining) $ 365 2025 303 2026 22 2027 — 2028 950 Thereafter 2,595 $ 4,235

Market Risk Benefits (Tables)

Market Risk Benefits (Tables)	9 Months Ended
	Sep. 30, 2024
Insurance [Abstract]
Schedule of Balances and Changes in Market Risk Benefit	The following table presents the balances of and changes in MRBs associated with indexed annuities and fixed rate annuities for the nine months ended September 30, 2024 and the year ended December 31, 2023: September 30, 2024 December 31, 2023 Indexed Fixed rate annuities Indexed Fixed rate annuities (In millions) Balance, beginning of period, net liability $ 314 $ 1 $ 164 $ 1 Balance, beginning of period, before effect of changes in the instrument-specific credit risk $ 209 $ 1 $ 102 $ 1 Issuances and benefit payments 78 — (10) — Attributed fees collected and interest accrual 103 — 131 — Actual policyholder behavior different from expected 8 — 27 — Changes in assumptions and other 32 — 29 — Effects of market related movements (31) — (70) — Balance, end of period, before effect of changes in the instrument-specific credit risk 399 1 209 1 Effect of changes in the instrument-specific credit risk 112 — 105 — Balance, end of period, net liability 511 1 314 1 Less: reinsured market risk benefits 43 — — — Balance, end of period, net of reinsurance $ 468 $ 1 $ 314 $ 1 Weighted-average attained age of policyholders weighted by total AV (years) 68.04 72.47 68.28 72.59 Net amount at risk $ 1,390 $ 2 $ 1,059 $ 2
Schedule of Reconciliation of Asset and Liability	The following table reconciles MRBs by amounts in an asset position and amounts in a liability position to the MRBs amounts in the accompanying unaudited Condensed Consolidated Balance Sheets: September 30, 2024 December 31, 2023 Direct Reinsured Net Direct Reinsured Net (In millions) MRB asset Indexed annuities $ 91 $ 43 $ 134 $ 88 $ — $ 88 Total MRB asset $ 91 $ 43 $ 134 $ 88 $ — $ 88 MRB liability Indexed annuities $ 602 $ — $ 602 $ 402 $ — $ 402 Fixed rate annuities 1 — 1 1 — 1 Total MRB liability $ 603 $ — $ 603 $ 403 $ — $ 403

Contractholder Funds (Tables)

Contractholder Funds (Tables)	9 Months Ended
	Sep. 30, 2024
Insurance [Abstract]
Schedule of Balances and Changes in Contractholder Funds	The following tables summarize balances of and changes in contractholder funds’ account balances: September 30, 2024 Indexed annuities Fixed rate annuities Universal Life FABN (b) FHLB (b) (Dollars in millions) Balance, beginning of year $ 27,164 $ 13,443 $ 2,391 $ 2,613 $ 2,539 Issuances 4,829 4,476 157 599 1,803 Premiums received 85 1 361 — — Policy charges (a) (140) — (231) — — Surrenders and withdrawals (2,807) (1,184) (75) — — Benefit payments (368) (233) (13) (791) (1,576) Interest credited 488 476 108 51 89 Other 5 — — (1) (2) Balance, end of period 29,256 16,979 2,698 2,471 2,853 Embedded derivative adjustment (c) 790 — 119 — — Gross Liability, end of period 30,046 16,979 2,817 2,471 2,853 Less: Reinsurance 410 10,471 883 — — Net Liability, after Reinsurance $ 29,636 $ 6,508 $ 1,934 $ 2,471 $ 2,853 Weighted-average crediting rate 2.33 % 4.26 % 5.84 % N/A N/A Net amount at risk (d) N/A N/A $ 70,859 N/A N/A Cash surrender value (e) $ 26,985 $ 15,815 $ 2,088 N/A N/A (a) Contracts included in the contractholder funds are generally charged a premium and/or monthly assessment on the basis of the account balance. (b) FABN and FHLB are considered funding agreements that are investment contracts, which follow the interest method of accounting, and therefore are not subject to ASU 2018-12 disclosure requirements. However, the Company has elected to present the liability for these agreements within the disaggregated roll forward as we believe it will provide meaningful information for users of the financials. (c) The embedded derivative adjustment reconciles the account balance to the gross GAAP liability and represents the combination of the host contract and the fair value of the embedded derivatives. (d) For those guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date. (e) These amounts are gross of reinsurance. December 31, 2023 Indexed annuities Fixed rate annuities Universal Life FABN (b) FHLB (b) (Dollars in millions) Balance, beginning of year $ 24,766 $ 9,358 $ 2,112 $ 2,613 $ 1,982 Issuances 4,722 5,061 199 — 1,256 Premiums received 103 1 382 — — Policy charges (a) (182) — (261) — — Surrenders and withdrawals (2,005) (1,142) (90) — — Benefit payments (526) (240) (27) (53) (763) Interest credited 270 405 76 54 64 Other 16 — — (1) — Balance, end of period 27,164 13,443 2,391 2,613 2,539 Embedded derivative adjustment (c) 243 — 84 — — Gross Liability, end of period 27,407 13,443 2,475 2,613 2,539 Less: Reinsurance 17 7,520 894 — — Net Liability, after Reinsurance $ 27,390 $ 5,923 $ 1,581 $ 2,613 $ 2,539 Weighted-average crediting rate 1.40 % 4.85 % 3.44 % N/A N/A Net amount at risk (d) N/A N/A $ 60,389 N/A N/A Cash surrender value (e) $ 25,099 $ 12,505 $ 1,872 N/A N/A (a) Contracts included in the contractholder funds are generally charged a premium and/or monthly assessment on the basis of the account balance. (b) FABN and FHLB are considered funding agreements that are investment contracts, which follow the interest method of accounting, and therefore are not subject to ASU 2018-12 disclosure requirements. However, the Company has elected to present the liability for these agreements within the disaggregated roll forward as we believe it will provide meaningful information for users of the financials. (c) The embedded derivative adjustment reconciles the account balance to the gross GAAP liability and represents the combination of the host contract and the fair value of the embedded derivatives. (d) For those guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date. (e) These amounts are gross of reinsurance.
Schedule of Reconciliation of Policyholder Account Balances to Statement of Financial Position	The following table reconciles contractholder funds’ account balances to the contractholder funds liability in the accompanying unaudited Condensed Consolidated Balance Sheets: September 30, 2024 December 31, 2023 (In millions) Indexed annuities $ 30,046 $ 27,407 Fixed rate annuities 16,979 13,443 Immediate annuities 292 311 Universal life 2,817 2,475 Traditional life 5 5 Funding Agreement-FABN 2,471 2,613 FHLB 2,853 2,539 PRT 5 5 Total $ 55,468 $ 48,798
Schedule of Policyholder Account Balance, Guaranteed Minimum Crediting Rate	The following tables present the account values by range of guaranteed minimum crediting rates and the related range of difference, in basis points, between rates being credited to policyholders and the respective guaranteed minimums: September 30, 2024 Range of guaranteed minimum crediting rate At Guaranteed Minimum 1 Basis Point-50 Basis Points Above 51 Basis Points-150 Basis Points Above Greater Than 150 Basis Points Above Total Indexed Annuities (In millions) 0.00%-1.50% $ 23,095 $ 1,285 $ 502 $ 1,847 $ 26,729 1.51%-2.50% 700 1 460 1,046 2,207 Greater than 2.50% 317 2 — 1 320 Total $ 24,112 $ 1,288 $ 962 $ 2,894 $ 29,256 Fixed Rate Annuities 0.00%-1.50% $ 46 $ 21 $ 925 $ 13,855 $ 14,847 1.51%-2.50% 4 7 20 460 491 Greater than 2.50% 826 2 3 810 1,641 Total $ 876 $ 30 $ 948 $ 15,125 $ 16,979 Universal Life 0.00%-1.50% $ 2,303 $ 6 $ — $ 22 $ 2,331 Greater than 2.50% 366 — 1 — 367 Total $ 2,669 $ 6 $ 1 $ 22 $ 2,698 December 31, 2023 Range of guaranteed minimum crediting rate At Guaranteed Minimum 1 Basis Point-50 Basis Points Above 51 Basis Points-150 Basis Points Above Greater Than 150 Basis Points Above Total Indexed Annuities (In millions) 0.00%-1.50% $ 22,392 $ 1,444 $ 526 $ 1,953 $ 26,315 1.51%-2.50% 196 1 24 250 471 Greater than 2.50% 377 1 — — 378 Total $ 22,965 $ 1,446 $ 550 $ 2,203 $ 27,164 Fixed Rate Annuities 0.00%-1.50% $ 23 $ 25 $ 1,532 $ 10,271 $ 11,851 1.51%-2.50% 5 8 23 453 489 Greater than 2.50% 893 2 4 204 1,103 Total $ 921 $ 35 $ 1,559 $ 10,928 $ 13,443 Universal Life 0.00%-1.50% $ 1,987 $ 5 $ — $ 21 $ 2,013 Greater than 2.50% 361 16 1 — 378 Total $ 2,348 $ 21 $ 1 $ 21 $ 2,391

Future Policy Benefits (Tables)

Future Policy Benefits (Tables)	9 Months Ended
	Sep. 30, 2024
Insurance [Abstract]
Schedule of Balances and Changes in the Present Value of Expected Net Premiums and Present Value	The following table summarizes balances and changes in the present value of expected net premiums and the present value of the expected FPB for nonparticipating traditional contracts: Traditional Life September 30, 2024 December 31, 2023 Expected net premiums (Dollars in millions) Balance, beginning of year $ 722 $ 797 Beginning balance at original discount rate 874 974 Effect of actual variances from expected experience (4) (1) Balance adjusted for variances from expectation 870 973 Interest accrual 13 19 Net premiums collected (82) (118) Ending Balance at original discount rate 801 874 Effect of changes in discount rate assumptions (128) (152) Balance, end of period $ 673 $ 722 Expected FPB Balance, beginning of year $ 2,071 $ 2,151 Beginning balance at original discount rate 2,492 2,665 Effect of actual variances from expected experience 48 (24) Balance adjusted for variances from expectation 2,540 2,641 Interest accrual 41 56 Benefits payments (165) (205) Ending Balance at original discount rate 2,416 2,492 Effect of changes in discount rate assumptions (358) (421) Balance, end of period $ 2,058 $ 2,071 Net liability for future policy benefits $ 1,385 $ 1,349 Less: Reinsurance recoverable 525 413 Net liability for future policy benefits, after reinsurance recoverable $ 860 $ 936 Weighted-average duration of liability for future policyholder benefits (years) 6.87 7.36 The following tables summarize balances and changes in the present value of the expected FPB for limited-payment contracts: September 30, 2024 Immediate annuities PRT (Dollars in millions) Balance, beginning of year $ 1,415 $ 4,189 Beginning balance at original discount rate 1,788 4,351 Effect of changes in cash flow assumptions — 4 Effect of actual variances from expected experience (26) (20) Balance adjusted for variances from expectation 1,762 4,335 Issuances 27 1,300 Interest accrual 46 168 Benefits payments (88) (346) Ending Balance at original discount rate 1,747 5,457 Effect of changes in discount rate assumptions (354) (63) Balance, end of period $ 1,393 $ 5,394 Net liability for future policy benefits $ 1,393 $ 5,394 Less: Reinsurance recoverable 115 — Net liability for future policy benefits, after reinsurance recoverable $ 1,278 $ 5,394 Weighted-average duration of liability for future policyholder benefits (years) 12.89 8.03 December 31, 2023 Immediate annuities PRT (Dollars in millions) Balance, beginning of year $ 1,429 $ 2,165 Beginning balance at original discount rate 1,858 2,475 Effect of changes in cash flow assumptions — (9) Effect of actual variances from expected experience (15) (7) Balance adjusted for variances from expectation $ 1,843 $ 2,459 Issuances 22 2,041 Interest accrual 51 109 Benefits payments (128) (258) Ending Balance at original discount rate $ 1,788 $ 4,351 Effect of changes in discount rate assumptions (373) (162) Balance, end of period $ 1,415 $ 4,189 Net liability for future policy benefits $ 1,415 $ 4,189 Less: Reinsurance recoverable 116 — Net liability for future policy benefits, after reinsurance recoverable $ 1,299 $ 4,189 Weighted-average duration of liability for future policyholder benefits (years) 12.47 8.23
Schedule of Changes in Liability for Deferred Profit Liability	The following tables summarize balances and changes in the liability for DPL for limited-payment contracts: September 30, 2024 December 31, 2023 Immediate annuities PRT Immediate annuities PRT (In millions) Balance, beginning of year $ 87 $ 10 $ 69 $ 4 Effect of modeling changes — — 4 — Effect of changes in cash flow assumptions — (7) — 1 Effect of actual variances from expected experience 6 — 16 5 Balance adjusted for variances from expectation 93 3 89 10 Issuances 2 — 3 — Interest accrual 1 4 2 1 Amortization (6) (1) (7) (1) Balance, end of period $ 90 $ 6 $ 87 $ 10
Schedule of Reconciliation of Future Policy Benefits to Statement of Financial Position	The following table reconciles the net FPB to the FPB in the unaudited Condensed Consolidated Balance Sheets. The DPL for Immediate Annuities and PRT is presented together with the FPB in the unaudited Condensed Consolidated Balance Sheets and has been included as a reconciling item in the table below: September 30, 2024 December 31, 2023 (In millions) Traditional Life $ 1,385 $ 1,349 Immediate annuities 1,393 1,415 PRT 5,394 4,189 Immediate annuities DPL 90 87 PRT DPL 6 10 Total $ 8,268 $ 7,050
Schedule of Liability for Future Policy Benefit Expected Future Policy Benefit Undiscounted Before Reinsurance	The following table provides the amount of undiscounted and discounted expected gross premiums and expected future benefits and expenses for nonparticipating traditional and limited-payment contracts: Undiscounted Discounted September 30, 2024 September 30, 2023 September 30, 2024 September 30, 2023 Traditional Life (In millions) Expected future benefit payments $ 2,843 $ 2,996 $ 2,073 $ 1,984 Expected future gross premiums 978 1,116 728 772 Immediate annuities Expected future benefit payments $ 3,212 $ 3,227 $ 1,392 $ 1,313 Expected future gross premiums — — — — PRT Expected future benefit payments $ 8,449 $ 5,445 $ 5,470 $ 3,605 Expected future gross premiums — — — —
Schedule of Revenue from External Customers by Products and Services	The following table summarizes the amount of revenue and interest related to nonparticipating traditional and limited-payment contracts recognized in the unaudited Condensed Consolidated Statements of Earnings: Gross Premiums (a) Interest Expense (b) September 30, 2024 September 30, 2023 September 30, 2024 September 30, 2023 (In millions) Traditional Life $ 84 $ 94 $ 28 $ 28 Immediate annuities 16 18 46 42 PRT 1,240 1,207 168 79 Total $ 1,340 $ 1,319 $ 242 $ 149 (a) Included in Life insurance premiums and other fees on the unaudited Condensed Consolidated Statements of Earnings. (b) Included in Benefits and other changes in policy reserves (remeasurement gains (losses) (a)) on the unaudited Condensed Consolidated Statements of Earnings.
Schedule of Liability for Future Policy Benefit, Weighted Average Discount Rates	The following table presents the weighted-average interest rate: September 30, 2024 December 31, 2023 Traditional Life Interest accretion rate 2.34 % 2.33 % Current discount rate 4.95 5.03 Immediate annuities Interest accretion rate 3.17 % 3.14 % Current discount rate 4.90 4.98 PRT Interest accretion rate 4.70 % 4.61 % Current discount rate 4.85 5.03
Schedule of Liability for Future Policy Benefit, Mortality and Lapse, Actual and Expected Experience	The following tables summarize the actual experience and expected experience for mortality and lapses of the FPB: September 30, 2024 Traditional Life Immediate annuities PRT Mortality Actual experience 1.4 % 2.7 % 3.0 % Expected experience 1.5 1.9 2.5 Lapses Actual experience 0.1 % — % — % Expected experience 0.5 — — December 31, 2023 Traditional Life Immediate annuities PRT Mortality Actual experience 1.7 % 3.2 % 3.2 % Expected experience 1.4 1.8 2.3 Lapses Actual experience — % — % — % Expected experience 0.3 — —
Schedule of Liability for Future Policy Benefits, Additional Information	The following table provides additional information for periods in which a cohort has an net premium ratio ("NPR") greater than 100% (and therefore capped at 100%) (dollars in millions): September 30, 2024 Cohort X Description NPR before capping 109 % Term with return of premium Non-NY Cohort Reserves before NPR capping $ 1,219 Term with return of premium Non-NY Cohort Reserves after NPR capping 1,250 Term with return of premium Non-NY Cohort Loss Expense 31 Term with return of premium Non-NY Cohort

Basis of Financial Statements -

Basis of Financial Statements - Recent Developments (Details)

Oct. 04, 2024 USD ($)

Jul. 31, 2024 shares

Jul. 18, 2024 USD ($)

Jul. 17, 2024 USD ($)

Jan. 12, 2024 USD ($) $ / shares shares

Jan. 11, 2024

Jan. 02, 2024 USD ($)

Sep. 30, 2024 $ / shares

Jun. 04, 2024 USD ($)

Apr. 23, 2024

Feb. 16, 2024 USD ($)

Feb. 15, 2024 USD ($)

Dec. 31, 2023 $ / shares

Feb. 21, 2023 USD ($)

Nov. 22, 2022 USD ($)

Sep. 17, 2021 USD ($)

Sep. 15, 2020 USD ($)

Jun. 12, 2020 USD ($)

Aug. 13, 2018 USD ($)

Business Acquisition [Line Items]

Preferred stock, par or stated value per share (in usd per share) | $ / shares

$ 0.0001

$ 0.0001

6.875% Series A Mandatory Convertible Preferred Stock

Business Acquisition [Line Items]

Preferred stock, dividend rate, percentage

6.875%

F&G | 6.875% Series A Mandatory Convertible Preferred Stock

Business Acquisition [Line Items]

Investment in preferred stock

$ 250,000,000

Preferred stock investment, shares issued in transaction (in shares) | shares

5,000,000

Preferred stock, dividend rate, percentage

6.875%

Preferred stock, par or stated value per share (in usd per share) | $ / shares

$ 0.001

Preferred stock, liquidation preference (in usd per share) | $ / shares

$ 50

F&G | 6.875% Series A Mandatory Convertible Preferred Stock | Maximum

Business Acquisition [Line Items]

Preferred stock, conversion ratio

1.1111

F&G | 6.875% Series A Mandatory Convertible Preferred Stock | Minimum

Business Acquisition [Line Items]

Preferred stock, conversion ratio

0.9456

6.25% Senior Notes Due 2034 | Senior Notes | F&G | Subsequent Event

Business Acquisition [Line Items]

Debt instrument, interest rate, stated percentage

6.25%

Aggregate principal amount

$ 500,000,000

6.25% Senior Notes Due 2034 | Senior Notes | Revolving Credit Facility | F&G | Subsequent Event

Business Acquisition [Line Items]

Repayments of debt

$ 365,000,000

6.50% F&G Notes, net of discount | Senior Notes

Business Acquisition [Line Items]

Debt instrument, interest rate, stated percentage

6.50%

6.50%

Aggregate principal amount

$ 550,000,000

5.50% Senior Notes due 2025 | Senior Notes

Business Acquisition [Line Items]

Debt instrument, interest rate, stated percentage

5.50%

Aggregate principal amount

$ 250,000,000

4.50% Notes, net of discount

Business Acquisition [Line Items]

Debt instrument, interest rate, stated percentage

4.50%

4.50% Notes, net of discount | Senior Notes

Business Acquisition [Line Items]

Debt instrument, interest rate, stated percentage

4.50%

4.50%

4.50%

Aggregate principal amount

$ 450,000,000

3.40% Senior Notes due 2030

Business Acquisition [Line Items]

Debt instrument, interest rate, stated percentage

3.40%

Aggregate principal amount

$ 650,000,000

3.40% Senior Notes due 2030 | Senior Notes

Business Acquisition [Line Items]

Debt instrument, interest rate, stated percentage

3.40%

3.40%

2.45% Senior Notes due 2031

Business Acquisition [Line Items]

Debt instrument, interest rate, stated percentage

2.45%

Aggregate principal amount

$ 600,000,000

2.45% Senior Notes due 2031 | Senior Notes

Business Acquisition [Line Items]

Debt instrument, interest rate, stated percentage

2.45%

2.45%

3.20% Senior Notes due 2051

Business Acquisition [Line Items]

Debt instrument, interest rate, stated percentage

3.20%

Aggregate principal amount

$ 450,000,000

3.20% Senior Notes due 2051 | Senior Notes

Business Acquisition [Line Items]

Debt instrument, interest rate, stated percentage

3.20%

3.20%

Revolving Credit Facility | Line of Credit | Revolving Credit Facility

Business Acquisition [Line Items]

Line of credit facility

$ 800,000,000

F&G Credit Agreement | Line of Credit | Revolving Credit Facility

Business Acquisition [Line Items]

Line of credit facility

$ 750,000,000

$ 665,000,000

$ 665,000,000

$ 550,000,000

PALH LLC

Business Acquisition [Line Items]

Ownership interest including subsequent acquisition, percentage

100%

Ownership interest prior to acquisition

30%

Ownership interests acquired

70%

Total consideration

$ 314,000,000

Cash consideration

215,000,000

Settlement of prepaid asset

8,000,000

Acquisition date fair value of previously held interests

92,000,000

$ 92,000,000

Cash acquired

$ 1,000,000

PALH LLC | PALH LLC

Business Acquisition [Line Items]

Ownership percentage, of acquiree prior to acquisition

70%

Roar

Business Acquisition [Line Items]

Ownership interests acquired

70%

Total consideration

$ 316,000,000

Cash consideration

269,000,000

Cash acquired

1,000,000

Contingent consideration arrangements, payments (up to)

$ 90,000,000

Contingent consideration liability payment period

3 years

Roar | F&G

Business Acquisition [Line Items]

Ownership interests acquired

70%

Cash consideration

$ 269,000,000

Contingent consideration obligation

48,000,000

Contingent consideration arrangements, payments (up to)

$ 90,000,000

Contingent consideration liability payment period

3 years

2024 Repurchase Program

Business Acquisition [Line Items]

Stock repurchase plan period in force

3 years

Stock repurchase program, number of shares authorized to be repurchased (in shares) | shares

25,000,000

Basis of Financial Statements_2

Basis of Financial Statements - Income Tax (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Income tax expense	$ 44	$ 141	$ 223	$ 245
Income tax expense as percentage of earnings before income taxes, percent	14%	23%	20%	28%

Basis of Financial Statements_3

Basis of Financial Statements - Earnings Per Share (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Accounting Policies [Abstract]
Antidilutive securities excluded from computation of EPS, less than in 2023 (in shares)	0	1,000,000	0	1,000,000

Basis of Financial Statements_4

Basis of Financial Statements - Owned Distribution Investments (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Distribution Investments And Affiliates | Commission Fees Paid
Business Acquisition [Line Items]
Payments for commissions	$ 16	$ 37	$ 110	$ 114

Basis of Financial Statements_5

Basis of Financial Statements - Additional Information (Details)	Sep. 30, 2024
Accounting Policies [Abstract]
MRB, attributed fee ratio capped percentage	100%

Summary of Reserve for Title _3

Summary of Reserve for Title Claim Losses - Claim Loss Reserve (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]
Change in insurance recoverable	$ 28	$ (105)
Title
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]
Beginning balance	1,770	1,810
Change in insurance recoverable	(14)	(1)
Claim loss provision related to:
Current year	168	157
Total title claim loss provision	168	157
Claims paid, net of recoupments related to:
Current year	(13)	(8)
Prior years	(191)	(190)
Total title claims paid, net of recoupments	(204)	(198)
Ending balance of claim loss reserve for title insurance	$ 1,720	$ 1,768
Provision for title insurance claim losses as a percentage of title insurance premiums	4.50%	4.50%

Fair Value of Financial Instr_3

Fair Value of Financial Instruments - Schedule of Carrying Amounts of Assets and Liabilities at Estimated Fair Value Measured on a Recurring Basis (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Assets
Fixed maturity securities available for sale	$ 48,940	$ 42,373
Derivative investments and reinsurance related embedded derivative, included in other assets	1,401	797
Market risk benefits asset	134	88
Total financial assets at fair value	1,355	1,312
Derivatives:
Market risk benefits liability	603	403
Level 1
Assets
Cash and cash equivalents	4,970	2,767
Short term investments	1,013	2,111
Derivative investments and reinsurance related embedded derivative, included in other assets	0	0
Investment in unconsolidated affiliates	0	0
Market risk benefits asset	0	0
Other assets	0
Total financial assets at fair value	7,751	6,566
Derivatives:
Contingent consideration obligation	0
Market risk benefits liability	0	0
Total financial liabilities at fair value	5	1
Level 2
Assets
Cash and cash equivalents	0	0
Short term investments	8	8
Derivative investments and reinsurance related embedded derivative, included in other assets	1,401	740
Investment in unconsolidated affiliates	0	0
Market risk benefits asset	0	0
Other assets	0
Total financial assets at fair value	38,770	33,703
Derivatives:
Contingent consideration obligation	0
Market risk benefits liability	0	0
Total financial liabilities at fair value	34	0
Level 3
Assets
Cash and cash equivalents	0	0
Short term investments	156	0
Derivative investments and reinsurance related embedded derivative, included in other assets	0	57
Investment in unconsolidated affiliates	272	285
Market risk benefits asset	134	88
Other assets	55
Total financial assets at fair value	11,596	9,677
Derivatives:
Contingent consideration obligation	69
Market risk benefits liability	603	403
Total financial liabilities at fair value	6,083	4,661
NAV
Assets
Total financial assets at fair value	59	59
Fair Value
Assets
Cash and cash equivalents	4,970	2,767
Short term investments	1,177	2,119
Derivative investments and reinsurance related embedded derivative, included in other assets	1,401	797
Investment in unconsolidated affiliates	272	285
Market risk benefits asset	134	88
Other assets	55
Total financial assets at fair value	58,176	50,005
Derivatives:
Contingent consideration obligation	69
Market risk benefits liability	603	403
Total financial liabilities at fair value	6,122	4,662
Reinsurance related embedded derivative, included in other assets | Level 1
Assets
Derivative investments and reinsurance related embedded derivative, included in other assets		0
Reinsurance related embedded derivative, included in other assets | Level 2
Assets
Derivative investments and reinsurance related embedded derivative, included in other assets		152
Reinsurance related embedded derivative, included in other assets | Level 3
Assets
Derivative investments and reinsurance related embedded derivative, included in other assets		0
Reinsurance related embedded derivative, included in other assets | Fair Value
Assets
Derivative investments and reinsurance related embedded derivative, included in other assets		152
Indexed annuities/indexed universal life insurance ("IUL") embedded derivatives, included in contractholder funds | Level 1
Derivatives:
Derivative liability	0	0
Indexed annuities/indexed universal life insurance ("IUL") embedded derivatives, included in contractholder funds | Level 2
Derivatives:
Derivative liability	0	0
Indexed annuities/indexed universal life insurance ("IUL") embedded derivatives, included in contractholder funds | Level 3
Derivatives:
Derivative liability	5,411	4,258
Indexed annuities/indexed universal life insurance ("IUL") embedded derivatives, included in contractholder funds | Fair Value
Derivatives:
Derivative liability	5,411	4,258
Reinsurance related embedded derivative | Level 1
Derivatives:
Derivative liability	0
Reinsurance related embedded derivative | Level 2
Derivatives:
Derivative liability	34
Reinsurance related embedded derivative | Level 3
Derivatives:
Derivative liability	0
Reinsurance related embedded derivative | Fair Value
Derivatives:
Derivative liability	34
Equity options | Level 1
Derivatives:
Derivative liability	5	1
Equity options | Level 2
Derivatives:
Derivative liability	0	0
Equity options | Level 3
Derivatives:
Derivative liability	0	0
Equity options | Fair Value
Derivatives:
Derivative liability	5	1
Asset-backed securities ("ABS")
Assets
Fixed maturity securities available for sale	15,963	14,342
Asset-backed securities ("ABS") | Level 1
Assets
Fixed maturity securities available for sale	0	0
Asset-backed securities ("ABS") | Level 2
Assets
Fixed maturity securities available for sale	7,779	7,220
Asset-backed securities ("ABS") | Level 3
Assets
Fixed maturity securities available for sale	8,184	7,122
Asset-backed securities ("ABS") | Fair Value
Assets
Fixed maturity securities available for sale	15,963	14,342
Commercial mortgage-backed securities
Assets
Fixed maturity securities available for sale	5,179	4,475
Commercial mortgage-backed securities | Level 1
Assets
Fixed maturity securities available for sale	0	0
Commercial mortgage-backed securities | Level 2
Assets
Fixed maturity securities available for sale	5,179	4,457
Commercial mortgage-backed securities | Level 3
Assets
Fixed maturity securities available for sale	0	18
Commercial mortgage-backed securities | Fair Value
Assets
Fixed maturity securities available for sale	5,179	4,475
Corporates
Assets
Fixed maturity securities available for sale	21,972	17,896
Corporates | Level 1
Assets
Fixed maturity securities available for sale	78	25
Corporates | Level 2
Assets
Fixed maturity securities available for sale	19,166	15,892
Corporates | Level 3
Assets
Fixed maturity securities available for sale	2,728	1,979
Corporates | Fair Value
Assets
Fixed maturity securities available for sale	21,972	17,896
Hybrids
Assets
Fixed maturity securities available for sale	596	618
Hybrids | Level 1
Assets
Fixed maturity securities available for sale	37	95
Hybrids | Level 2
Assets
Fixed maturity securities available for sale	559	523
Hybrids | Level 3
Assets
Fixed maturity securities available for sale	0	0
Hybrids | Fair Value
Assets
Fixed maturity securities available for sale	596	618
Municipals
Assets
Fixed maturity securities available for sale	1,515	1,611
Municipals | Level 1
Assets
Fixed maturity securities available for sale	0	0
Municipals | Level 2
Assets
Fixed maturity securities available for sale	1,515	1,562
Municipals | Level 3
Assets
Fixed maturity securities available for sale	0	49
Municipals | Fair Value
Assets
Fixed maturity securities available for sale	1,515	1,611
Residential mortgage-backed securities
Assets
Fixed maturity securities available for sale	2,600	2,429
Residential mortgage-backed securities | Level 1
Assets
Fixed maturity securities available for sale	0	0
Residential mortgage-backed securities | Level 2
Assets
Fixed maturity securities available for sale	2,597	2,426
Residential mortgage-backed securities | Level 3
Assets
Fixed maturity securities available for sale	3	3
Residential mortgage-backed securities | Fair Value
Assets
Fixed maturity securities available for sale	2,600	2,429
U.S. Government
Assets
Fixed maturity securities available for sale	803	678
U.S. Government | Level 1
Assets
Fixed maturity securities available for sale	797	662
U.S. Government | Level 2
Assets
Fixed maturity securities available for sale	6	16
U.S. Government | Level 3
Assets
Fixed maturity securities available for sale	0	0
U.S. Government | Fair Value
Assets
Fixed maturity securities available for sale	803	678
Foreign Governments
Assets
Fixed maturity securities available for sale	312	324
Foreign Governments | Level 1
Assets
Fixed maturity securities available for sale	0	0
Foreign Governments | Level 2
Assets
Fixed maturity securities available for sale	307	308
Foreign Governments | Level 3
Assets
Fixed maturity securities available for sale	5	16
Foreign Governments | Fair Value
Assets
Fixed maturity securities available for sale	312	324
Preferred securities
Assets
Equity and preferred securities	460	621
Preferred securities | Level 1
Assets
Equity and preferred securities	199	214
Preferred securities | Level 2
Assets
Equity and preferred securities	253	399
Preferred securities | Level 3
Assets
Equity and preferred securities	8	8
Preferred securities | Fair Value
Assets
Equity and preferred securities	460	621
Equity securities | Level 1
Assets
Equity and preferred securities	657	692
Equity securities | Level 2
Assets
Equity and preferred securities	0	0
Equity securities | Level 3
Assets
Equity and preferred securities	13	15
Equity securities | NAV
Assets
Equity and preferred securities	59	59
Equity securities | Fair Value
Assets
Equity and preferred securities	729	766
Other long-term investments | Level 1
Assets
Other long-term investments	0	0
Other long-term investments | Level 2
Assets
Other long-term investments	0	0
Other long-term investments | Level 3
Assets
Other long-term investments	38	37
Other long-term investments | Fair Value
Assets
Other long-term investments	$ 38	$ 37

Fair Value of Financial Instr_4

Fair Value of Financial Instruments - Narrative (Details) $ in Millions	Sep. 30, 2024 USD ($) $ / Contract	Dec. 31, 2023 USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments in unconsolidated affiliates	$ 3,874	$ 3,334
Title
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments in unconsolidated affiliates	$ 208	$ 263
Credit linked note | Valuation, Income Approach
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative, strike price | $ / Contract	0

Fair Value of Financial Instr_5

Fair Value of Financial Instruments - Schedule of Quantitative Information Regarding Significant Unobservable Inputs Used for Recurring Level 3 Fair Value Measurements of Financial Instruments (Details) $ in Millions	Sep. 30, 2024 USD ($)	Dec. 31, 2023 USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	$ 1,355	$ 1,312
Liabilities, fair value	6,083	4,661
Third-Party Valuation | Offered Quotes
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	10,241	8,365
Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Liabilities, fair value	$ 5,411	$ 4,258
Minimum | Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Surrender Rates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability	0.0025	0.0025
Minimum | Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Partial Withdrawals
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability	0.0200	0.0200
Minimum | Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Non-Performance Spread
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability	0.0030	0.0038
Minimum | Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Market Value of Option
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability	0	0
Minimum | Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Mortality Multiplier
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability	0.8000	1
Minimum | Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Option Cost
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability	0.0007	0.0007
Maximum | Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Surrender Rates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability	0.5000	0.7000
Maximum | Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Partial Withdrawals
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability	0.3571	0.3448
Maximum | Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Non-Performance Spread
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability	0.0098	0.0110
Maximum | Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Market Value of Option
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability	0.3014	0.1893
Maximum | Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Mortality Multiplier
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability	1.1500	1
Maximum | Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Option Cost
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability	0.0570	0.0548
Weighted Average | Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Surrender Rates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability	0.0723	0.0683
Weighted Average | Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Partial Withdrawals
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability	0.0272	0.0274
Weighted Average | Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Non-Performance Spread
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability	0.0082	0.0096
Weighted Average | Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Market Value of Option
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability	0.0421	0.0263
Weighted Average | Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Mortality Multiplier
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability	1	1
Weighted Average | Indexed annuity/ IUL embedded derivatives, included in contractholder funds | Discounted Cash Flow | Option Cost
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative liability	0.0261	0.0238
Asset-backed securities | Third-Party Valuation
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	$ 99	$ 57
Asset-backed securities | Minimum | Third-Party Valuation | Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt securities	0.0482	0.0509
Asset-backed securities | Maximum | Third-Party Valuation | Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt securities	0.0671	0.0695
Asset-backed securities | Weighted Average | Third-Party Valuation | Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt securities	0.0583	0.0600
Corporates | Third-Party Valuation
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	$ 741	$ 787
Corporates | Discounted Cash Flow
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	$ 4	$ 8
Corporates | Minimum | Third-Party Valuation | Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt securities	0.0355	0
Corporates | Minimum | Discounted Cash Flow | Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt securities	0.2917	0.4400
Corporates | Maximum | Third-Party Valuation | Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt securities	0.2069	0.1287
Corporates | Maximum | Discounted Cash Flow | Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt securities	1	1
Corporates | Weighted Average | Third-Party Valuation | Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt securities	0.0647	0.0691
Corporates | Weighted Average | Discounted Cash Flow | Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt securities	0.7300	0.7520
Municipals | Third-Party Valuation
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value		$ 32
Municipals | Minimum | Third-Party Valuation | Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt securities		0.0625
Municipals | Maximum | Third-Party Valuation | Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt securities		0.0625
Municipals | Weighted Average | Third-Party Valuation | Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt securities		0.0625
Residential mortgage-backed securities | Third-Party Valuation
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	$ 3	$ 3
Residential mortgage-backed securities | Minimum | Third-Party Valuation | Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt securities	0.0519	0.0546
Residential mortgage-backed securities | Maximum | Third-Party Valuation | Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt securities	0.0519	0.0546
Residential mortgage-backed securities | Weighted Average | Third-Party Valuation | Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt securities	0.0519	0.0546
Foreign Governments | Third-Party Valuation
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	$ 5	$ 16
Foreign Governments | Minimum | Third-Party Valuation | Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt securities	0.0691	0.0694
Foreign Governments | Maximum | Third-Party Valuation | Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt securities	0.0691	0.0768
Foreign Governments | Weighted Average | Third-Party Valuation | Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Debt securities	0.0691	0.0745
Investment in unconsolidated affiliates | Broker quoted/Market Comparable
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	$ 272	$ 285
Investment in unconsolidated affiliates | Minimum | Broker quoted/Market Comparable | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment in unconsolidated affiliate	8.8	4.4
Investment in unconsolidated affiliates | Maximum | Broker quoted/Market Comparable | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment in unconsolidated affiliate	15.1	31.8
Investment in unconsolidated affiliates | Weighted Average | Broker quoted/Market Comparable | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Investment in unconsolidated affiliate	11.7	23.2
Preferred securities | Discounted Cash Flow
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value		$ 1
Preferred securities | Affiliated Entity | Discounted Cash Flow
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	$ 1
Preferred securities | Affiliated Entity | Discounted Cash Flow | Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Preferred/Equity securities		1
Preferred securities | Affiliated Entity | Minimum | Discounted Cash Flow | Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Preferred/Equity securities	1
Preferred securities | Affiliated Entity | Maximum | Discounted Cash Flow | Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Preferred/Equity securities	1
Preferred securities | Affiliated Entity | Weighted Average | Discounted Cash Flow | Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Preferred/Equity securities	1
Equity securities | Discounted Cash Flow
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value		$ 7
Equity securities | Minimum | Broker quoted/Market Comparable | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Preferred/Equity securities	5.1
Equity securities | Maximum | Broker quoted/Market Comparable | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Preferred/Equity securities	5.1
Equity securities | Weighted Average | Broker quoted/Market Comparable | EBITDA Multiple
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Preferred/Equity securities	5.1
Equity securities | Affiliated Entity | Discounted Cash Flow
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	$ 7
Equity securities | Affiliated Entity | Minimum | Discounted Cash Flow | Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Preferred/Equity securities	0.1120	0.1150
Equity securities | Affiliated Entity | Maximum | Discounted Cash Flow | Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Preferred/Equity securities	0.1120	0.1150
Equity securities | Affiliated Entity | Weighted Average | Discounted Cash Flow | Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Preferred/Equity securities	0.1120	0.1150
Other assets | Discounted Cash Flow
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	$ 55
Other assets | Minimum | Discounted Cash Flow | Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Other assets	0.0927
Other assets | Minimum | Discounted Cash Flow | Conditional Prepayment Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Other assets	0.0667
Other assets | Maximum | Discounted Cash Flow | Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Other assets	0.1340
Other assets | Maximum | Discounted Cash Flow | Conditional Prepayment Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Other assets	0.1571
Other assets | Weighted Average | Discounted Cash Flow | Discount rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Other assets	0.1134
Other assets | Weighted Average | Discounted Cash Flow | Conditional Prepayment Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Other assets	0.1119
Available-for-sale embedded derivative | Black Scholes model
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	$ 34	$ 28
Available-for-sale embedded derivative | Black Scholes model | Market Value of AnchorPath Fund
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Embedded derivative asset	1	1
Market risk benefits asset | Discounted Cash Flow
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	$ 134	$ 88
Market risk benefits asset | Minimum | Discounted Cash Flow | Mortality
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.8000	1
Market risk benefits asset | Minimum | Discounted Cash Flow | Surrender Rates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.0025	0.0025
Market risk benefits asset | Minimum | Discounted Cash Flow | Partial Withdrawals
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.0200	0
Market risk benefits asset | Minimum | Discounted Cash Flow | Non-Performance Spread
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.0030	0.0038
Market risk benefits asset | Minimum | Discounted Cash Flow | GMWB Utilization
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.5000	0.5000
Market risk benefits asset | Maximum | Discounted Cash Flow | Mortality
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	1.1500	1
Market risk benefits asset | Maximum | Discounted Cash Flow | Surrender Rates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.3000	0.1000
Market risk benefits asset | Maximum | Discounted Cash Flow | Partial Withdrawals
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.2439	0.2326
Market risk benefits asset | Maximum | Discounted Cash Flow | Non-Performance Spread
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.0098	0.0110
Market risk benefits asset | Maximum | Discounted Cash Flow | GMWB Utilization
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.6000	0.6000
Market risk benefits asset | Weighted Average | Discounted Cash Flow | Mortality
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	1	1
Market risk benefits asset | Weighted Average | Discounted Cash Flow | Surrender Rates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.0522	0.0522
Market risk benefits asset | Weighted Average | Discounted Cash Flow | Partial Withdrawals
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.0248	0.0250
Market risk benefits asset | Weighted Average | Discounted Cash Flow | Non-Performance Spread
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.0082	0.0096
Market risk benefits asset | Weighted Average | Discounted Cash Flow | GMWB Utilization
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.5057	0.5081
Contingent Consideration | Discounted Cash Flow
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Liabilities, fair value	$ 69
Contingent Consideration | Minimum | Discounted Cash Flow | Risk-Adjusted Discount Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contingent consideration	0.1300
Contingent Consideration | Minimum | Discounted Cash Flow | EBITDA Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contingent consideration	0.3500
Contingent Consideration | Minimum | Discounted Cash Flow | Counterparty Discount Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contingent consideration	0.0600
Contingent Consideration | Maximum | Discounted Cash Flow | Risk-Adjusted Discount Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contingent consideration	0.1300
Contingent Consideration | Maximum | Discounted Cash Flow | EBITDA Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contingent consideration	0.3500
Contingent Consideration | Maximum | Discounted Cash Flow | Counterparty Discount Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contingent consideration	0.0600
Contingent Consideration | Weighted Average | Discounted Cash Flow | Risk-Adjusted Discount Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contingent consideration	0.1300
Contingent Consideration | Weighted Average | Discounted Cash Flow | EBITDA Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contingent consideration	0.3500
Contingent Consideration | Weighted Average | Discounted Cash Flow | Counterparty Discount Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Contingent consideration	0.0600
Market risk benefits liability | Discounted Cash Flow
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Liabilities, fair value	$ 603	$ 403
Market risk benefits liability | Minimum | Discounted Cash Flow | Mortality
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.8000	1
Market risk benefits liability | Minimum | Discounted Cash Flow | Surrender Rates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.0025	0.0025
Market risk benefits liability | Minimum | Discounted Cash Flow | Partial Withdrawals
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.0200	0
Market risk benefits liability | Minimum | Discounted Cash Flow | Non-Performance Spread
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.0030	0.0038
Market risk benefits liability | Minimum | Discounted Cash Flow | GMWB Utilization
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.5000	0.5000
Market risk benefits liability | Maximum | Discounted Cash Flow | Mortality
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	1.1500	1
Market risk benefits liability | Maximum | Discounted Cash Flow | Surrender Rates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.3000	0.1000
Market risk benefits liability | Maximum | Discounted Cash Flow | Partial Withdrawals
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.2439	0.2326
Market risk benefits liability | Maximum | Discounted Cash Flow | Non-Performance Spread
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.0098	0.0110
Market risk benefits liability | Maximum | Discounted Cash Flow | GMWB Utilization
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.6000	0.6000
Market risk benefits liability | Weighted Average | Discounted Cash Flow | Mortality
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	1	1
Market risk benefits liability | Weighted Average | Discounted Cash Flow | Surrender Rates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.0522	0.0522
Market risk benefits liability | Weighted Average | Discounted Cash Flow | Partial Withdrawals
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.0248	0.0250
Market risk benefits liability | Weighted Average | Discounted Cash Flow | Non-Performance Spread
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.0082	0.0096
Market risk benefits liability | Weighted Average | Discounted Cash Flow | GMWB Utilization
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Market risk benefit	0.5057	0.5081

Fair Value of Financial Instr_6

Fair Value of Financial Instruments - Schedule of Changes to Fair Value of Financial Instruments Level 3 (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Jul. 17, 2024
Liabilities
Liabilities, Total (Losses) Gains Included in Earnings	$ 314	$ (780)	$ 501	$ (198)
Liabilities, Total (Losses) Gains Included in AOCI	0	0	0	0
Liabilities, Purchases	390	576	1,059	765
Liabilities, Sales	0	0	0	0
Liabilities, Settlements	(135)	(45)	(310)	(110)
Liabilities, Net transfer In (Out) of Level 3	$ (28)	$ 0	$ (28)	$ 0
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Recognized gains and losses, net	Recognized gains and losses, net	Recognized gains and losses, net	Recognized gains and losses, net
Fair Value, Asset, Recurring Basis, Unobservable Input Reconciliation, Asset, Gain (Loss), Statement of Other Comprehensive Income or Comprehensive Income [Extensible Enumeration]	Unrealized gain (loss) on investments and other financial instruments (excluding investments in unconsolidated affiliates)	Unrealized gain (loss) on investments and other financial instruments (excluding investments in unconsolidated affiliates)	Unrealized gain (loss) on investments and other financial instruments (excluding investments in unconsolidated affiliates)	Unrealized gain (loss) on investments and other financial instruments (excluding investments in unconsolidated affiliates)
PALH LLC
Liabilities
Ownership interest prior to acquisition					30%
Level 3
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	$ 11,068	$ 8,759	$ 9,677	$ 8,286
Balance at End of Period	11,596	9,121	11,596	9,121
Liabilities
Balance at Beginning of Period	5,398	4,134	4,661	3,397
Balance at End of Period	6,083	3,850	6,083	3,850
Indexed annuities/indexed universal life insurance ("IUL") embedded derivatives, included in contractholder funds
Liabilities
Balance at Beginning of Period	4,848	3,821	4,258	3,115
Liabilities, Total (Losses) Gains Included in Earnings	308	(796)	452	(214)
Liabilities, Total (Losses) Gains Included in AOCI	0	0	0	0
Liabilities, Purchases	390	576	1,011	765
Liabilities, Sales	0	0	0	0
Liabilities, Settlements	(135)	(45)	(310)	(110)
Liabilities, Net transfer In (Out) of Level 3	0	0	0	0
Balance at End of Period	5,411	3,556	5,411	3,556
Change in Unrealized Gains (Losses) Included in OCI	0	0	0	0
Interest rate swaps
Liabilities
Balance at Beginning of Period	28	0	0	0
Liabilities, Total (Losses) Gains Included in Earnings	0	16	28	16
Liabilities, Total (Losses) Gains Included in AOCI	0	0	0	0
Liabilities, Purchases	0	0	0	0
Liabilities, Sales	0	0	0	0
Liabilities, Settlements	0	0	0	0
Liabilities, Net transfer In (Out) of Level 3	(28)	0	(28)	0
Balance at End of Period	0	16	0	16
Change in Unrealized Gains (Losses) Included in OCI	0		0	0
Contingent consideration
Liabilities
Balance at Beginning of Period	63		0
Liabilities, Total (Losses) Gains Included in Earnings	6		21
Liabilities, Total (Losses) Gains Included in AOCI	0		0
Liabilities, Purchases	0		48
Liabilities, Sales	0		0
Liabilities, Settlements	0		0
Liabilities, Net transfer In (Out) of Level 3	0		0
Balance at End of Period	69		69
Change in Unrealized Gains (Losses) Included in OCI	0		0
Asset-backed securities
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	8,042	6,510	7,122	6,263
Assets, Total (Losses) Gains Included in Earnings	(3)	(45)	12	(56)
Assets, Total (Losses) Gains Included in AOCI	77	75	187	108
Assets, Purchases	515	536	1,981	1,331
Assets, Sales	(30)	(27)	(109)	(125)
Assets, Settlements	(358)	(171)	(904)	(557)
Assets, Net transfer In (Out) of Level 3	(59)	(121)	(105)	(207)
Balance at End of Period	8,184	6,757	8,184	6,757
Change in Unrealized Included in OCI	77	75	184	107
Commercial mortgage-backed securities
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	15	17	18	37
Assets, Total (Losses) Gains Included in Earnings	0	0	0	0
Assets, Total (Losses) Gains Included in AOCI	0	0	0	1
Assets, Purchases	0	10	58	22
Assets, Sales	0	0	0	0
Assets, Settlements	0	0	0	0
Assets, Net transfer In (Out) of Level 3	(15)	0	(76)	(33)
Balance at End of Period	0	27	0	27
Change in Unrealized Included in OCI	0	0	0	1
Corporates
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	2,355	1,628	1,979	1,440
Assets, Total (Losses) Gains Included in Earnings	(2)	0	(2)	(1)
Assets, Total (Losses) Gains Included in AOCI	67	(21)	79	(77)
Assets, Purchases	354	162	873	423
Assets, Sales	0	0	(96)	(1)
Assets, Settlements	(43)	(24)	(85)	(43)
Assets, Net transfer In (Out) of Level 3	(3)	(1)	(20)	3
Balance at End of Period	2,728	1,744	2,728	1,744
Change in Unrealized Included in OCI	64	(21)	77	(77)
Municipals
Fixed maturity securities available-for-sale:
Balance at Beginning of Period		49	49	29
Assets, Total (Losses) Gains Included in Earnings		0	0	0
Assets, Total (Losses) Gains Included in AOCI		(2)	1	18
Assets, Purchases		0	0	0
Assets, Sales		0	(50)	0
Assets, Settlements		0	0	0
Assets, Net transfer In (Out) of Level 3		0	0	0
Balance at End of Period	0	47	0	47
Change in Unrealized Included in OCI		(2)	1	18
Residential mortgage-backed securities
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	3	28	3	302
Assets, Total (Losses) Gains Included in Earnings	0	0	0	1
Assets, Total (Losses) Gains Included in AOCI	0	(1)	0	7
Assets, Purchases	0	0	1	32
Assets, Sales	0	0	0	0
Assets, Settlements	0	(1)	0	(9)
Assets, Net transfer In (Out) of Level 3	0	(23)	(1)	(330)
Balance at End of Period	3	3	3	3
Change in Unrealized Included in OCI	0	(1)	0	7
Foreign Governments
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	5	16	16	16
Assets, Total (Losses) Gains Included in Earnings	0	0	0	0
Assets, Total (Losses) Gains Included in AOCI	0	0	0	0
Assets, Purchases	0	0	0	0
Assets, Sales	0	0	0	0
Assets, Settlements	0	0	(11)	0
Assets, Net transfer In (Out) of Level 3	0	0	0	0
Balance at End of Period	5	16	5	16
Change in Unrealized Included in OCI	0	0	0	0
Preferred securities
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	8	7	8	1
Assets, Total (Losses) Gains Included in Earnings	0	0	0	0
Assets, Total (Losses) Gains Included in AOCI	0	1	0	1
Assets, Purchases	0	0	0	0
Assets, Sales	0	0	0	0
Assets, Settlements	0	0	0	0
Assets, Net transfer In (Out) of Level 3	0	0	0	6
Balance at End of Period	8	8	8	8
Change in Unrealized Included in OCI	0	1	0	1
Equity securities
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	13	14	15	10
Assets, Total (Losses) Gains Included in Earnings	0	1	(2)	1
Assets, Total (Losses) Gains Included in AOCI	0	0	0	0
Assets, Purchases	0	0	0	0
Assets, Sales	0	0	0	0
Assets, Settlements	0	0	0	0
Assets, Net transfer In (Out) of Level 3	0	0	0	4
Balance at End of Period	13	15	13	15
Change in Unrealized Included in OCI	0	0	0	0
Interest rate swaps
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	8		57
Assets, Total (Losses) Gains Included in Earnings	0		(50)
Assets, Total (Losses) Gains Included in AOCI	(1)		0
Assets, Purchases	0		0
Assets, Sales	0		0
Assets, Settlements	0		0
Assets, Net transfer In (Out) of Level 3	(7)		(7)
Balance at End of Period	0		0
Change in Unrealized Included in OCI	0		1
Investment in unconsolidated affiliates
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	358	197	285	23
Assets, Total (Losses) Gains Included in Earnings	6	0	79	0
Assets, Total (Losses) Gains Included in AOCI	0	0	0	0
Assets, Purchases	0	75	0	249
Assets, Sales	0	0	0	0
Assets, Settlements	0	0	0	0
Assets, Net transfer In (Out) of Level 3	(92)	0	(92)	0
Balance at End of Period	272	272	272	272
Change in Unrealized Included in OCI	0	0	0	0
Short term investments
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	71	126	0	0
Assets, Total (Losses) Gains Included in Earnings	0	0	0	0
Assets, Total (Losses) Gains Included in AOCI	0	0	0	0
Assets, Purchases	85	65	156	191
Assets, Sales	0	(19)	0	(19)
Assets, Settlements	0	(103)	0	(103)
Assets, Net transfer In (Out) of Level 3	0	0	0	0
Balance at End of Period	156	69	156	69
Change in Unrealized Included in OCI	0	0	0	0
Other assets
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	50		0
Assets, Total (Losses) Gains Included in Earnings	(3)		(3)
Assets, Total (Losses) Gains Included in AOCI	0		0
Assets, Purchases	8		58
Assets, Sales	0		0
Assets, Settlements	0		0
Assets, Net transfer In (Out) of Level 3	0		0
Balance at End of Period	55		55
Change in Unrealized Included in OCI	0		0
Available-for-sale embedded derivative
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	31	26	27	23
Assets, Total (Losses) Gains Included in Earnings	0	0	0	0
Assets, Total (Losses) Gains Included in AOCI	3	(3)	7	0
Assets, Purchases	0	0	0	0
Assets, Sales	0	0	0	0
Assets, Settlements	0	0	0	0
Assets, Net transfer In (Out) of Level 3	0	0	0	0
Balance at End of Period	34	23	34	23
Change in Unrealized Included in OCI	3	(3)	7	0
Credit linked note
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	6	13	10	15
Assets, Total (Losses) Gains Included in Earnings	0	0	1	0
Assets, Total (Losses) Gains Included in AOCI	0	0	0	0
Assets, Purchases	0	0	0	0
Assets, Sales	0	0	0	0
Assets, Settlements	(2)	(1)	(7)	(3)
Assets, Net transfer In (Out) of Level 3	0	0	0	0
Balance at End of Period	4	12	4	12
Change in Unrealized Included in OCI	0	0	0	0
Secured borrowing receivable
Fixed maturity securities available-for-sale:
Balance at Beginning of Period		10		10
Assets, Total (Losses) Gains Included in Earnings		0		0
Assets, Total (Losses) Gains Included in AOCI		0		0
Assets, Purchases		0		0
Assets, Sales		0		0
Assets, Settlements		0		0
Assets, Net transfer In (Out) of Level 3		0		0
Balance at End of Period		10		10
Change in Unrealized Included in OCI		0		0
Subtotal Level 3 assets at fair value | Level 3
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	10,965	8,641	9,589	8,169
Assets, Total (Losses) Gains Included in Earnings	(2)	(44)	35	(55)
Assets, Total (Losses) Gains Included in AOCI	146	49	274	58
Assets, Purchases	962	848	3,127	2,248
Assets, Sales	(30)	(46)	(255)	(145)
Assets, Settlements	(403)	(300)	(1,007)	(715)
Assets, Net transfer In (Out) of Level 3	(176)	(145)	(301)	(557)
Balance at End of Period	11,462	9,003	11,462	9,003
Change in Unrealized Included in OCI	144	49	270	57
Market risk benefits asset | Level 3
Fixed maturity securities available-for-sale:
Balance at Beginning of Period	103	118	88	117
Balance at End of Period	134	118	134	118
Subtotal Level 3 liabilities at fair value
Liabilities
Change in Unrealized Gains (Losses) Included in OCI	0	0	0	0
Subtotal Level 3 liabilities at fair value | Level 3
Liabilities
Balance at Beginning of Period	4,939	3,821	4,258	3,115
Balance at End of Period	5,480	3,572	5,480	3,572
Market risk benefits liability | Level 3
Liabilities
Balance at Beginning of Period	459	313	403	282
Balance at End of Period	$ 603	$ 278	$ 603	$ 278

Fair Value of Financial Instr_7

Fair Value of Financial Instruments - Schedule of Carrying Value and Estimated Fair Value of Financial Instruments Carried at Other Than Fair Value (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Assets
Investments in unconsolidated affiliates	$ 3,874	$ 3,334
Trade and notes receivables, net of allowance	443	442
Total
Total Estimated Fair Value
Assets
FHLB common stock	153	138
Commercial mortgage loans	2,342	2,253
Residential mortgage loans	2,830	2,545
Investments in unconsolidated affiliates	3,394	2,786
Policy loans	94	71
Other invested assets	69	397
Company-owned life insurance	426	59
Trade and notes receivables, net of allowance	443	442
Total	9,751	8,691
Liabilities
Investment contracts, included in contractholder funds	44,762	40,229
Debt	3,986	3,568
Total	48,748	43,797
Carrying Amount
Assets
FHLB common stock	153	138
Commercial mortgage loans	2,572	2,538
Residential mortgage loans	3,054	2,798
Investments in unconsolidated affiliates	3,394	2,786
Policy loans	94	71
Other invested assets	69	397
Company-owned life insurance	426	59
Trade and notes receivables, net of allowance	443	442
Total	10,205	9,229
Liabilities
Investment contracts, included in contractholder funds	55,057	44,540
Debt	4,186	3,887
Total	59,243	48,427
Level 1
Assets
FHLB common stock	0	0
Commercial mortgage loans	0	0
Residential mortgage loans	0	0
Investments in unconsolidated affiliates	0	0
Policy loans	0	0
Other invested assets	22	0
Company-owned life insurance	0	17
Trade and notes receivables, net of allowance	0	0
Total	22	17
Liabilities
Investment contracts, included in contractholder funds	0	0
Debt	0	0
Total	0	0
Level 2
Assets
FHLB common stock	153	138
Commercial mortgage loans	0	0
Residential mortgage loans	0	0
Investments in unconsolidated affiliates	0	0
Policy loans	0	0
Other invested assets	0	0
Company-owned life insurance	0	0
Trade and notes receivables, net of allowance	0	0
Total	153	138
Liabilities
Investment contracts, included in contractholder funds	0	0
Debt	3,986	3,568
Total	3,986
Level 3
Assets
FHLB common stock	0	0
Commercial mortgage loans	2,342	2,253
Residential mortgage loans	2,830	2,545
Investments in unconsolidated affiliates	4	7
Policy loans	94	71
Other invested assets	0	397
Company-owned life insurance	426	0
Trade and notes receivables, net of allowance	443	442
Total	6,139	5,715
Liabilities
Investment contracts, included in contractholder funds	44,762	40,229
Debt	0	0
Total	44,762	40,229
NAV
Assets
Investments in unconsolidated affiliates	3,390	2,779
Other invested assets	47	42
Total	$ 3,437	$ 2,821

Investments - Schedule of Conso

Investments - Schedule of Consolidated Investments (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Available-for-sale securities
Amortized Cost	$ 51,070	$ 45,606
Allowance for Expected Credit Losses	(67)	(42)
Gross Unrealized Gains	822	457
Gross Unrealized Losses	(2,885)	(3,648)
Fair Value/Carrying Value	48,940	42,373
Asset-backed securities
Available-for-sale securities
Amortized Cost	15,986	14,631
Allowance for Expected Credit Losses	(12)	(11)
Gross Unrealized Gains	264	191
Gross Unrealized Losses	(275)	(469)
Fair Value/Carrying Value	15,963	14,342
Commercial mortgage-backed securities
Available-for-sale securities
Amortized Cost	5,359	4,797
Allowance for Expected Credit Losses	(49)	(22)
Gross Unrealized Gains	61	23
Gross Unrealized Losses	(192)	(323)
Fair Value/Carrying Value	5,179	4,475
Corporates
Available-for-sale securities
Amortized Cost	23,673	20,133
Allowance for Expected Credit Losses	(5)	(6)
Gross Unrealized Gains	396	186
Gross Unrealized Losses	(2,092)	(2,417)
Fair Value/Carrying Value	21,972	17,896
Hybrids
Available-for-sale securities
Amortized Cost	609	668
Allowance for Expected Credit Losses	0	0
Gross Unrealized Gains	6	3
Gross Unrealized Losses	(19)	(53)
Fair Value/Carrying Value	596	618
Municipals
Available-for-sale securities
Amortized Cost	1,682	1,826
Allowance for Expected Credit Losses	0	0
Gross Unrealized Gains	20	14
Gross Unrealized Losses	(187)	(229)
Fair Value/Carrying Value	1,515	1,611
Residential mortgage-backed securities
Available-for-sale securities
Amortized Cost	2,617	2,507
Allowance for Expected Credit Losses	(1)	(3)
Gross Unrealized Gains	61	29
Gross Unrealized Losses	(77)	(104)
Fair Value/Carrying Value	2,600	2,429
U.S. Government
Available-for-sale securities
Amortized Cost	800	679
Allowance for Expected Credit Losses	0	0
Gross Unrealized Gains	9	8
Gross Unrealized Losses	(6)	(9)
Fair Value/Carrying Value	803	678
Foreign Governments
Available-for-sale securities
Amortized Cost	344	365
Allowance for Expected Credit Losses	0	0
Gross Unrealized Gains	5	3
Gross Unrealized Losses	(37)	(44)
Fair Value/Carrying Value	$ 312	$ 324

Investments - Narrative (Detail

Investments - Narrative (Details)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024 USD ($) loan	Sep. 30, 2023 USD ($)	Sep. 30, 2024 USD ($) loan	Sep. 30, 2023 USD ($)	Dec. 31, 2023 USD ($) loan
Debt Securities, Available-for-sale [Line Items]
Investment, non-income producing, greater than twelve months	$ 29,000,000		$ 29,000,000		$ 47,000,000
Accrued interest receivable	531,000,000		531,000,000		481,000,000
FHLB collateral pledged	5,123,000,000		5,123,000,000		4,345,000,000
Fixed maturity securities, available-for-sale securities, allowance for credit losses	67,000,000		67,000,000		$ 42,000,000
Allowance for credit loss for securities in an unrealized loss position	$ 0		$ 0
Commercial mortgage loans, percentage of investments	4%		4%		5%
DSC ratio, amortization period			25 years
Amortized cost of loans on non-accrual	$ 74,000,000		$ 74,000,000		$ 57,000,000
Loans in process of foreclosure	73,000,000		73,000,000		$ 41,000,000
Gross investment income	891,000,000	$ 749,000,000	2,526,000,000	$ 2,103,000,000
Reinsurance agreement, recognized gains (losses)	(177,000,000)	43,000,000	(186,000,000)	42,000,000
Funds Withheld, Reinsurance Agreements
Debt Securities, Available-for-sale [Line Items]
Gross investment income	$ 181,000,000	$ 102,000,000	$ 463,000,000	$ 236,000,000
United States
Debt Securities, Available-for-sale [Line Items]
Residential mortgage loans, location percentage			100%
Commercial Mortgage Loans
Debt Securities, Available-for-sale [Line Items]
Mortgage loans delinquent in principal or interest | loan	1		1		0
Charge offs			$ 0		$ 3,000,000
Amortized cost of loans on non-accrual	$ 0		$ 0		$ 0
Commercial Mortgage Loans | Mortgage loans
Debt Securities, Available-for-sale [Line Items]
Allowance for expected credit loss, probability of loss/default model, projected loss, using reasonable forecast period			2 years
Allowance for credit loss, probability of loss/default, using market historical loss experience, period			3 years
Residential Mortgage Loans
Debt Securities, Available-for-sale [Line Items]
Residential mortgage loans, percentage of total investments	5%		5%		5%
Charge offs			$ 0		$ 0
Amortized cost of loans on non-accrual	$ 74,000,000		$ 74,000,000		57,000,000
Residential Mortgage Loans | Mortgage loans
Debt Securities, Available-for-sale [Line Items]
Allowance for expected credit loss, probability of loss/default model, projected loss, using reasonable forecast period			2 years
Allowance for credit loss, probability of loss/default, using market historical loss experience, period			3 years
Fixed maturity securities, available-for-sale
Debt Securities, Available-for-sale [Line Items]
Assets held by insurance regulators	$ 150,000,000		$ 150,000,000		$ 141,000,000

Investments - Schedule of Amort

Investments - Schedule of Amortized Cost and Fair Value of Fixed Maturity Available-for-Sale Securities (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Amortized Cost
Other securities which provide for periodic payments, Amortized Cost	$ 23,962	$ 21,935
Amortized Cost	51,070	45,606
Fair Value
Other securities which provide for periodic payments, Fair Value	23,742	21,246
Total fixed maturity available-for-sale securities, Fair Value	48,940	42,373
Corporates, Non-structured Hybrids, Municipal and Government securities:
Amortized Cost
Due in one year or less	890	703
Due after one year through five years	4,996	4,320
Due after five years through ten years	4,975	3,195
Due after ten years	16,247	15,453
Subtotal, Amortized Cost	27,108	23,671
Fair Value
Due in one year or less	885	687
Due after one year through five years	4,985	4,209
Due after five years through ten years	4,981	3,048
Due after ten years	14,347	13,183
Subtotal, Fair Value	25,198	21,127
Asset-backed securities
Amortized Cost
Other securities which provide for periodic payments, Amortized Cost	15,986	14,631
Amortized Cost	15,986	14,631
Fair Value
Other securities which provide for periodic payments, Fair Value	15,963	14,342
Total fixed maturity available-for-sale securities, Fair Value	15,963	14,342
Commercial mortgage-backed securities
Amortized Cost
Other securities which provide for periodic payments, Amortized Cost	5,359	4,797
Amortized Cost	5,359	4,797
Fair Value
Other securities which provide for periodic payments, Fair Value	5,179	4,475
Total fixed maturity available-for-sale securities, Fair Value	5,179	4,475
Residential mortgage-backed securities
Amortized Cost
Other securities which provide for periodic payments, Amortized Cost	2,617	2,507
Amortized Cost	2,617	2,507
Fair Value
Other securities which provide for periodic payments, Fair Value	2,600	2,429
Total fixed maturity available-for-sale securities, Fair Value	$ 2,600	$ 2,429

Investments - Schedule of Fair

Investments - Schedule of Fair Value and Gross Unrealized Losses of Available-for-Sale Securities (Details) $ in Millions	Sep. 30, 2024 USD ($) security	Dec. 31, 2023 USD ($) security
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Value, Less than 12 months	$ 2,782	$ 5,841
Gross Unrealized Losses Less than 12 months	(40)	(302)
Fair Value, 12 months or longer	18,056	20,908
Gross Unrealized Losses, 12 months or longer	(2,802)	(3,291)
Total Fair Value	20,838	26,749
Total Gross Unrealized Losses	$ (2,842)	$ (3,593)
Total number of available-for-sale securities in an unrealized loss position less than twelve months | security	585	1,035
Total number of available-for-sale securities in an unrealized loss position twelve months or longer | security	2,393	2,846
Total number of available-for-sale securities in an unrealized loss position | security	2,978	3,881
Asset-backed securities
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Value, Less than 12 months	$ 583	$ 1,707
Gross Unrealized Losses Less than 12 months	(19)	(56)
Fair Value, 12 months or longer	3,447	5,835
Gross Unrealized Losses, 12 months or longer	(237)	(404)
Total Fair Value	4,030	7,542
Total Gross Unrealized Losses	(256)	(460)
Commercial mortgage-backed securities
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Value, Less than 12 months	209	819
Gross Unrealized Losses Less than 12 months	(5)	(53)
Fair Value, 12 months or longer	1,682	1,922
Gross Unrealized Losses, 12 months or longer	(168)	(235)
Total Fair Value	1,891	2,741
Total Gross Unrealized Losses	(173)	(288)
Corporates
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Value, Less than 12 months	1,382	2,387
Gross Unrealized Losses Less than 12 months	(8)	(134)
Fair Value, 12 months or longer	10,698	10,739
Gross Unrealized Losses, 12 months or longer	(2,084)	(2,283)
Total Fair Value	12,080	13,126
Total Gross Unrealized Losses	(2,092)	(2,417)
Hybrids
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Value, Less than 12 months	47	60
Gross Unrealized Losses Less than 12 months	(1)	(2)
Fair Value, 12 months or longer	393	483
Gross Unrealized Losses, 12 months or longer	(18)	(51)
Total Fair Value	440	543
Total Gross Unrealized Losses	(19)	(53)
Municipals
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Value, Less than 12 months	82	399
Gross Unrealized Losses Less than 12 months	(1)	(49)
Fair Value, 12 months or longer	1,089	920
Gross Unrealized Losses, 12 months or longer	(186)	(179)
Total Fair Value	1,171	1,319
Total Gross Unrealized Losses	(187)	(228)
Residential mortgage-backed securities
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Value, Less than 12 months	188	336
Gross Unrealized Losses Less than 12 months	(3)	(5)
Fair Value, 12 months or longer	447	662
Gross Unrealized Losses, 12 months or longer	(68)	(89)
Total Fair Value	635	998
Total Gross Unrealized Losses	(71)	(94)
U.S. Government
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Value, Less than 12 months	268	84
Gross Unrealized Losses Less than 12 months	(1)	0
Fair Value, 12 months or longer	130	159
Gross Unrealized Losses, 12 months or longer	(5)	(9)
Total Fair Value	398	243
Total Gross Unrealized Losses	(6)	(9)
Foreign Governments
Debt Securities, Available-for-sale, Unrealized Loss Position [Line Items]
Fair Value, Less than 12 months	23	49
Gross Unrealized Losses Less than 12 months	(2)	(3)
Fair Value, 12 months or longer	170	188
Gross Unrealized Losses, 12 months or longer	(36)	(41)
Total Fair Value	193	237
Total Gross Unrealized Losses	$ (38)	$ (44)

Investments - Schedule of Comme

Investments - Schedule of Commercial Mortgage Loan Investment (Details) - USD ($) $ in Millions	Sep. 30, 2024	Jun. 30, 2024	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Dec. 31, 2022
Schedule of Investments [Line Items]
Allowance for expected loan loss	$ (69)	$ (64)	$ (66)	$ (64)	$ (64)	$ (42)
Total commercial mortgage loans, net of valuation allowance	5,626		5,336
Commercial Mortgage Loans
Schedule of Investments [Line Items]
Total commercial mortgage loans, gross of valuation allowance	2,590		2,550
Allowance for expected loan loss	(18)	$ (14)	(12)	$ (15)	$ (13)	$ (10)
Total commercial mortgage loans, net of valuation allowance	$ 2,572		$ 2,538
% of Total	100%		100%
East North Central | Commercial Mortgage Loans
Schedule of Investments [Line Items]
Total commercial mortgage loans, gross of valuation allowance	$ 98		$ 151
% of Total	4%		6%
East South Central | Commercial Mortgage Loans
Schedule of Investments [Line Items]
Total commercial mortgage loans, gross of valuation allowance	$ 75		$ 75
% of Total	3%		3%
Middle Atlantic | Commercial Mortgage Loans
Schedule of Investments [Line Items]
Total commercial mortgage loans, gross of valuation allowance	$ 354		$ 354
% of Total	14%		14%
Mountain | Commercial Mortgage Loans
Schedule of Investments [Line Items]
Total commercial mortgage loans, gross of valuation allowance	$ 409		$ 352
% of Total	16%		14%
New England | Commercial Mortgage Loans
Schedule of Investments [Line Items]
Total commercial mortgage loans, gross of valuation allowance	$ 164		$ 168
% of Total	6%		6%
Pacific | Commercial Mortgage Loans
Schedule of Investments [Line Items]
Total commercial mortgage loans, gross of valuation allowance	$ 713		$ 766
% of Total	27%		30%
South Atlantic | Commercial Mortgage Loans
Schedule of Investments [Line Items]
Total commercial mortgage loans, gross of valuation allowance	$ 595		$ 563
% of Total	23%		22%
West North Central | Commercial Mortgage Loans
Schedule of Investments [Line Items]
Total commercial mortgage loans, gross of valuation allowance	$ 22		$ 4
% of Total	1%		0%
West South Central | Commercial Mortgage Loans
Schedule of Investments [Line Items]
Total commercial mortgage loans, gross of valuation allowance	$ 160		$ 117
% of Total	6%		5%
Hotel | Commercial Mortgage Loans
Schedule of Investments [Line Items]
Total commercial mortgage loans, gross of valuation allowance	$ 17		$ 18
% of Total	1%		1%
Industrial | Commercial Mortgage Loans
Schedule of Investments [Line Items]
Total commercial mortgage loans, gross of valuation allowance	$ 617		$ 616
% of Total	24%		24%
Mixed Use | Commercial Mortgage Loans
Schedule of Investments [Line Items]
Total commercial mortgage loans, gross of valuation allowance	$ 11		$ 11
% of Total	0%		0%
Multifamily | Commercial Mortgage Loans
Schedule of Investments [Line Items]
Total commercial mortgage loans, gross of valuation allowance	$ 1,006		$ 1,012
% of Total	39%		40%
Office | Commercial Mortgage Loans
Schedule of Investments [Line Items]
Total commercial mortgage loans, gross of valuation allowance	$ 356		$ 316
% of Total	14%		13%
Retail | Commercial Mortgage Loans
Schedule of Investments [Line Items]
Total commercial mortgage loans, gross of valuation allowance	$ 99		$ 102
% of Total	4%		4%
Student Housing | Commercial Mortgage Loans
Schedule of Investments [Line Items]
Total commercial mortgage loans, gross of valuation allowance	$ 83		$ 83
% of Total	3%		3%
Other | Commercial Mortgage Loans
Schedule of Investments [Line Items]
Total commercial mortgage loans, gross of valuation allowance	$ 401		$ 392
% of Total	15%		15%

Investments - Schedule of Com_2

Investments - Schedule of Commercial Mortgage Loans Segregated By Aging of Loans and Charge Offs (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Charge-offs
Year one	$ 0	$ 0
Year two	0	0
Year three	0	0
Year four	0	0
Year five	0	0
Commercial Mortgage Loans
Credit Quality Indicator Current Year [Abstract]
2024	140	213
2023	221	288
2022	289	1,256
2021	1,253	512
2020	469	0
Prior	218	259
Total	2,590	2,528
Credit Quality Indicator Prior Year [Abstract]
2023	140	213
2022	221	288
2021	289	1,256
2020	1,253	512
2019	469	0
Prior	218	259
Total	2,590	2,528
Charge-offs
Prior	0	3
Total	0	3
Loans under development, amortized cost	22	22
Loans under development, fair value	22	22
Commercial Mortgage Loans | Current (less than 30 days past due)
Credit Quality Indicator Current Year [Abstract]
2024	140	213
2023	221	288
2022	289	1,256
2021	1,253	512
2020	469	0
Prior	209	259
Total	2,581	2,528
Credit Quality Indicator Prior Year [Abstract]
2023	140	213
2022	221	288
2021	289	1,256
2020	1,253	512
2019	469	0
Prior	209	259
Total	2,581	2,528
Commercial Mortgage Loans | 30-89 days past due
Credit Quality Indicator Current Year [Abstract]
2024	0	0
2023	0	0
2022	0	0
2021	0	0
2020	0	0
Prior	9	0
Total	9	0
Credit Quality Indicator Prior Year [Abstract]
2023	0	0
2022	0	0
2021	0	0
2020	0	0
2019	0	0
Prior	9	0
Total	9	0
Commercial Mortgage Loans | 90 days or more past due
Credit Quality Indicator Current Year [Abstract]
2024	0	0
2023	0	0
2022	0	0
2021	0	0
2020	0	0
Prior	0	0
Total	0	0
Credit Quality Indicator Prior Year [Abstract]
2023	0	0
2022	0	0
2021	0	0
2020	0	0
2019	0	0
Prior	0	0
Total	$ 0	$ 0

Investments - Schedule of Inves

Investments - Schedule of Investment in CMLs by Loan to Value and Debt Service Coverage Ratios (Details) - Commercial Mortgage Loans - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Schedule of Investments [Line Items]
Loans	$ 2,590	$ 2,528
% of Total	100%	100%
Credit Quality Indicator Current Year [Abstract]
2024	$ 140	$ 213
2023	221	288
2022	289	1,256
2021	1,253	512
2020	469	0
Prior	218	259
Total	2,590	2,528
Credit Quality Indicator Prior Year [Abstract]
2023	140	213
2022	221	288
2021	289	1,256
2020	1,253	512
2019	469	0
Prior	218	259
Total	2,590	2,528
Loans under development, amortized cost	22	22
Loans under development, fair value	22	22
Fair Value
Schedule of Investments [Line Items]
Loans	$ 2,342	$ 2,231
% of Total	100%	100%
Credit Quality Indicator Current Year [Abstract]
Total	$ 2,342	$ 2,231
Credit Quality Indicator Prior Year [Abstract]
Total	2,342	2,231
Less than 50.00%
Schedule of Investments [Line Items]
Loans	$ 516	$ 533
% of Total	20%	21%
Credit Quality Indicator Current Year [Abstract]
2024	$ 58	$ 85
2023	93	17
2022	18	77
2021	74	232
2020	189	0
Prior	84	122
Total	516	533
Credit Quality Indicator Prior Year [Abstract]
2023	58	85
2022	93	17
2021	18	77
2020	74	232
2019	189	0
Prior	84	122
Total	516	533
Less than 50.00% | Fair Value
Schedule of Investments [Line Items]
Loans	$ 501	$ 510
% of Total	21%	23%
Credit Quality Indicator Current Year [Abstract]
Total	$ 501	$ 510
Credit Quality Indicator Prior Year [Abstract]
Total	501	510
50.00% to 59.99%
Schedule of Investments [Line Items]
Loans	$ 820	$ 764
% of Total	31%	30%
Credit Quality Indicator Current Year [Abstract]
2024	$ 59	$ 53
2023	53	149
2022	149	267
2021	267	158
2020	158	0
Prior	134	137
Total	820	764
Credit Quality Indicator Prior Year [Abstract]
2023	59	53
2022	53	149
2021	149	267
2020	267	158
2019	158	0
Prior	134	137
Total	820	764
50.00% to 59.99% | Fair Value
Schedule of Investments [Line Items]
Loans	$ 752	$ 679
% of Total	32%	30%
Credit Quality Indicator Current Year [Abstract]
Total	$ 752	$ 679
Credit Quality Indicator Prior Year [Abstract]
Total	752	679
60.00% to 74.99%
Schedule of Investments [Line Items]
Loans	$ 1,239	$ 1,216
% of Total	48%	48%
Credit Quality Indicator Current Year [Abstract]
2024	$ 23	$ 69
2023	69	113
2022	113	912
2021	912	122
2020	122	0
Prior	0	0
Total	1,239	1,216
Credit Quality Indicator Prior Year [Abstract]
2023	23	69
2022	69	113
2021	113	912
2020	912	122
2019	122	0
Prior	0	0
Total	1,239	1,216
60.00% to 74.99% | Fair Value
Schedule of Investments [Line Items]
Loans	$ 1,074	$ 1,028
% of Total	46%	46%
Credit Quality Indicator Current Year [Abstract]
Total	$ 1,074	$ 1,028
Credit Quality Indicator Prior Year [Abstract]
Total	1,074	1,028
75.00% to 84.99%
Schedule of Investments [Line Items]
Loans	$ 15	$ 15
% of Total	1%	1%
Credit Quality Indicator Current Year [Abstract]
2024	$ 0	$ 6
2023	6	9
2022	9	0
2021	0	0
2020	0	0
Prior	0	0
Total	15	15
Credit Quality Indicator Prior Year [Abstract]
2023	0	6
2022	6	9
2021	9	0
2020	0	0
2019	0	0
Prior	0	0
Total	15	15
75.00% to 84.99% | Fair Value
Schedule of Investments [Line Items]
Loans	$ 15	$ 14
% of Total	1%	1%
Credit Quality Indicator Current Year [Abstract]
Total	$ 15	$ 14
Credit Quality Indicator Prior Year [Abstract]
Total	15	14
Greater than 1.25
Schedule of Investments [Line Items]
Loans	2,430	2,443
Credit Quality Indicator Current Year [Abstract]
2024	72	154
2023	161	276
2022	278	1,256
2021	1,241	512
2020	469	0
Prior	209	245
Total	2,430	2,443
Credit Quality Indicator Prior Year [Abstract]
2023	72	154
2022	161	276
2021	278	1,256
2020	1,241	512
2019	469	0
Prior	209	245
Total	2,430	2,443
Greater than 1.25 | Less than 50.00%
Schedule of Investments [Line Items]
Loans	499	519
Credit Quality Indicator Current Year [Abstract]
Total	499	519
Credit Quality Indicator Prior Year [Abstract]
Total	499	519
Greater than 1.25 | 50.00% to 59.99%
Schedule of Investments [Line Items]
Loans	749	764
Credit Quality Indicator Current Year [Abstract]
Total	749	764
Credit Quality Indicator Prior Year [Abstract]
Total	749	764
Greater than 1.25 | 60.00% to 74.99%
Schedule of Investments [Line Items]
Loans	1,182	1,160
Credit Quality Indicator Current Year [Abstract]
Total	1,182	1,160
Credit Quality Indicator Prior Year [Abstract]
Total	1,182	1,160
Greater than 1.25 | 75.00% to 84.99%
Schedule of Investments [Line Items]
Loans	0	0
Credit Quality Indicator Current Year [Abstract]
Total	0	0
Credit Quality Indicator Prior Year [Abstract]
Total	0	0
Greater than 1.00 but less than 1.25
Schedule of Investments [Line Items]
Loans	130	66
Credit Quality Indicator Current Year [Abstract]
2024	67	59
2023	60	3
2022	3	0
2021	0	0
2020	0	0
Prior	0	4
Total	130	66
Credit Quality Indicator Prior Year [Abstract]
2023	67	59
2022	60	3
2021	3	0
2020	0	0
2019	0	0
Prior	0	4
Total	130	66
Greater than 1.00 but less than 1.25 | Less than 50.00%
Schedule of Investments [Line Items]
Loans	8	4
Credit Quality Indicator Current Year [Abstract]
Total	8	4
Credit Quality Indicator Prior Year [Abstract]
Total	8	4
Greater than 1.00 but less than 1.25 | 50.00% to 59.99%
Schedule of Investments [Line Items]
Loans	59	0
Credit Quality Indicator Current Year [Abstract]
Total	59	0
Credit Quality Indicator Prior Year [Abstract]
Total	59	0
Greater than 1.00 but less than 1.25 | 60.00% to 74.99%
Schedule of Investments [Line Items]
Loans	57	56
Credit Quality Indicator Current Year [Abstract]
Total	57	56
Credit Quality Indicator Prior Year [Abstract]
Total	57	56
Greater than 1.00 but less than 1.25 | 75.00% to 84.99%
Schedule of Investments [Line Items]
Loans	6	6
Credit Quality Indicator Current Year [Abstract]
Total	6	6
Credit Quality Indicator Prior Year [Abstract]
Total	6	6
Less than 1.00
Schedule of Investments [Line Items]
Loans	30	19
Credit Quality Indicator Current Year [Abstract]
2024	1	0
2023	0	9
2022	8	0
2021	12	0
2020	0	0
Prior	9	10
Total	30	19
Credit Quality Indicator Prior Year [Abstract]
2023	1	0
2022	0	9
2021	8	0
2020	12	0
2019	0	0
Prior	9	10
Total	30	19
Less than 1.00 | Less than 50.00%
Schedule of Investments [Line Items]
Loans	9	10
Credit Quality Indicator Current Year [Abstract]
Total	9	10
Credit Quality Indicator Prior Year [Abstract]
Total	9	10
Less than 1.00 | 50.00% to 59.99%
Schedule of Investments [Line Items]
Loans	12	0
Credit Quality Indicator Current Year [Abstract]
Total	12	0
Credit Quality Indicator Prior Year [Abstract]
Total	12	0
Less than 1.00 | 60.00% to 74.99%
Schedule of Investments [Line Items]
Loans	0	0
Credit Quality Indicator Current Year [Abstract]
Total	0	0
Credit Quality Indicator Prior Year [Abstract]
Total	0	0
Less than 1.00 | 75.00% to 84.99%
Schedule of Investments [Line Items]
Loans	9	9
Credit Quality Indicator Current Year [Abstract]
Total	9	9
Credit Quality Indicator Prior Year [Abstract]
Total	$ 9	$ 9

Investments - Schedule of Distr

Investments - Schedule of Distribution of Residential Mortgage Loans by State (Details) - USD ($) $ in Millions	Sep. 30, 2024	Jun. 30, 2024	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Dec. 31, 2022
Schedule of Investments [Line Items]
Allowance for expected loan loss	$ (69)	$ (64)	$ (66)	$ (64)	$ (64)	$ (42)
Total commercial mortgage loans, net of valuation allowance	5,626		5,336
Residential Mortgage Loans
Schedule of Investments [Line Items]
Amortized Cost	$ 3,105		$ 2,852
% of Total	100%		100%
Allowance for expected loan loss	$ (51)	$ (50)	$ (54)	$ (49)	$ (51)	$ (32)
Total commercial mortgage loans, net of valuation allowance	3,054		2,798
Florida | Residential Mortgage Loans
Schedule of Investments [Line Items]
Amortized Cost	$ 160		$ 163
% of Total	5%		6%
New York | Residential Mortgage Loans
Schedule of Investments [Line Items]
Amortized Cost			$ 129
% of Total			5%
Texas | Residential Mortgage Loans
Schedule of Investments [Line Items]
Amortized Cost			$ 129
% of Total			5%
All other states | Residential Mortgage Loans
Schedule of Investments [Line Items]
Amortized Cost	$ 2,945		$ 2,431
% of Total	95%		84%

Investments - Schedule of Resid

Investments - Schedule of Residential Mortgage Loans with Credit Quality Indicators, Performing or Nonperforming (Details) - USD ($) $ in Millions	Sep. 30, 2024	Jun. 30, 2024	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Dec. 31, 2022
Schedule of Investments [Line Items]
Allowance for expected loan loss	$ (69)	$ (64)	$ (66)	$ (64)	$ (64)	$ (42)
Total commercial mortgage loans, net of valuation allowance	5,626		5,336
Residential Mortgage Loans
Schedule of Investments [Line Items]
Amortized Cost	$ 3,105		$ 2,852
% of Total	100%		100%
Allowance for expected loan loss	$ (51)	$ (50)	$ (54)	$ (49)	$ (51)	$ (32)
Total commercial mortgage loans, net of valuation allowance	3,054		2,798
Performing | Residential Mortgage Loans
Schedule of Investments [Line Items]
Amortized Cost	$ 3,031		$ 2,795
% of Total	98%		98%
Non-performing | Residential Mortgage Loans
Schedule of Investments [Line Items]
Amortized Cost	$ 74		$ 57
% of Total	2%		2%

Investments - Schedule of Res_2

Investments - Schedule of Residential Loans Segregated by Aging of Loans (By Year of Origination) and Non-accrual Loans by Amortized Cost (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Amortized Cost of Non-Accrual Loans [Abstract]
Amortized cost of loans on non-accrual	$ 74	$ 57
Residential Mortgage Loans
Credit Quality Indicator Current Year [Abstract]
2024	393	373
2023	377	995
2022	946	877
2021	858	208
2020	182	204
Prior	349	195
Credit Quality Indicator Prior Year [Abstract]
2023	393	373
2022	377	995
2021	946	877
2020	858	208
2019	182	204
Prior	349	195
Total	3,105	2,852
Amortized Cost of Non-Accrual Loans [Abstract]
Amortized cost of loans on non-accrual	74	57
Commercial Mortgage Loans
Credit Quality Indicator Current Year [Abstract]
Total	2,590	2,528
Credit Quality Indicator Prior Year [Abstract]
Total	2,590	2,550
Amortized Cost of Non-Accrual Loans [Abstract]
Amortized cost of loans on non-accrual	0	0
Current (less than 30 days past due) | Residential Mortgage Loans
Credit Quality Indicator Current Year [Abstract]
2024	387	373
2023	372	985
2022	928	854
2021	822	192
2020	168	183
Prior	317	192
Credit Quality Indicator Prior Year [Abstract]
2023	387	373
2022	372	985
2021	928	854
2020	822	192
2019	168	183
Prior	317	192
Total	2,994	2,779
Current (less than 30 days past due) | Commercial Mortgage Loans
Credit Quality Indicator Current Year [Abstract]
Total	2,581	2,528
30-89 days past due | Residential Mortgage Loans
Credit Quality Indicator Current Year [Abstract]
2024	6	0
2023	3	4
2022	9	7
2021	8	3
2020	4	0
Prior	7	2
Credit Quality Indicator Prior Year [Abstract]
2023	6	0
2022	3	4
2021	9	7
2020	8	3
2019	4	0
Prior	7	2
Total	37	16
30-89 days past due | Commercial Mortgage Loans
Credit Quality Indicator Current Year [Abstract]
Total	9	0
90 days or more past due | Residential Mortgage Loans
Credit Quality Indicator Current Year [Abstract]
2024	0	0
2023	2	6
2022	9	16
2021	28	13
2020	10	21
Prior	25	1
Credit Quality Indicator Prior Year [Abstract]
2023	0	0
2022	2	6
2021	9	16
2020	28	13
2019	10	21
Prior	25	1
Total	74	57
90 days or more past due | Commercial Mortgage Loans
Credit Quality Indicator Current Year [Abstract]
Total	$ 0	$ 0

Investments - Schedule of Chang

Investments - Schedule of Changes in Allowance for Expected Credit Losses on Mortgage Loans (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning Balance	$ (64)	$ (64)	$ (66)	$ (42)
Provision (expense) benefit for loan losses	(5)	0	(3)	(22)
Ending Balance	(69)	(64)	(69)	(64)
Residential Mortgage Loans
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning Balance	(50)	(51)	(54)	(32)
Provision (expense) benefit for loan losses	(1)	2	3	(17)
Ending Balance	(51)	(49)	(51)	(49)
Commercial Mortgage Loans
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Beginning Balance	(14)	(13)	(12)	(10)
Provision (expense) benefit for loan losses	(4)	(2)	(6)	(5)
Ending Balance	$ (18)	$ (15)	$ (18)	$ (15)

Investments - Schedule of Inter

Investments - Schedule of Interest and Investment Income (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Schedule of Investments [Line Items]
Gross investment income	$ 891	$ 749	$ 2,526	$ 2,103
Investment expense	(76)	(63)	(218)	(188)
Interest and investment income	815	686	2,308	1,915
Fixed maturity securities, available-for-sale
Schedule of Investments [Line Items]
Gross investment income	583	493	1,679	1,405
Equity securities
Schedule of Investments [Line Items]
Gross investment income	8	8	26	24
Preferred securities
Schedule of Investments [Line Items]
Gross investment income	7	12	25	39
Mortgage loans
Schedule of Investments [Line Items]
Gross investment income	69	59	200	167
Invested cash and short-term investments
Schedule of Investments [Line Items]
Gross investment income	72	39	172	106
Limited partnerships
Schedule of Investments [Line Items]
Limited partnerships	84	69	234	171
Tax deferred property exchange income
Schedule of Investments [Line Items]
Gross investment income	36	44	102	128
Other investments
Schedule of Investments [Line Items]
Gross investment income	$ 32	$ 25	$ 88	$ 63

Investments - Schedule of Recog

Investments - Schedule of Recognized Gains (Losses), net (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Schedule of Investments [Line Items]
Net realized (losses) gains on fixed maturity available-for-sale securities	$ (1)	$ (32)	$ 3	$ (137)
Net realized/unrealized gains (losses) on other invested assets	3	9	73	(20)
Change in allowance for expected credit losses	0	(7)	(32)	(30)
Realized gains (losses) on certain derivative instruments	30	(30)	65	(184)
Unrealized gains (losses) on certain derivative instruments	347	(297)	450	14
Change in fair value of other derivatives and embedded derivatives	3	(3)	6	0
Realized gains (losses) on derivatives and embedded derivatives	202	(294)	335	(136)
Recognized gains and losses, net	269	(356)	456	(367)
Reinsurance related embedded derivatives
Schedule of Investments [Line Items]
Change in fair value of reinsurance related embedded derivatives	(178)	36	(186)	34
Equity securities
Schedule of Investments [Line Items]
Net realized/unrealized gains (losses) on equity securities and gains (losses) on preferred securities	48	(33)	48	(37)
Valuation gains (losses)	31	(22)	(42)	(12)
Preferred securities
Schedule of Investments [Line Items]
Net realized/unrealized gains (losses) on equity securities and gains (losses) on preferred securities	17	1	29	(7)
Valuation gains (losses)	$ 18	$ 2	$ 30	$ 52

Investments - Schedule of Proce

Investments - Schedule of Proceeds From the Sale of Fixed-Maturity Available-For-Sale Securities (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Investments, Debt and Equity Securities [Abstract]
Proceeds	$ 1,476	$ 880	$ 2,638	$ 1,978
Gross gains	18	0	36	7
Gross losses	$ (20)	$ (27)	$ (52)	$ (109)

Investments - Schedule of VIE (

Investments - Schedule of VIE (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Schedule of Investments [Line Items]
Carrying Value	$ 27,009	$ 23,908
Maximum Loss Exposure	28,934	27,152
Investment in unconsolidated affiliates
Schedule of Investments [Line Items]
Carrying Value	3,666	3,071
Maximum Loss Exposure	4,814	4,806
Fixed maturity securities
Schedule of Investments [Line Items]
Carrying Value	23,343	20,837
Maximum Loss Exposure	$ 24,120	$ 22,346

Derivative Financial Instrume_3

Derivative Financial Instruments - Schedule of Carrying Amount of Derivative Instruments (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Derivative [Line Items]
Total asset derivatives	$ 1,435	$ 977
Total liability derivatives	5,449	4,259
Derivative investments: | Equity options
Derivative [Line Items]
Total asset derivatives	1,293	739
Derivative investments: | Interest rate swaps
Derivative [Line Items]
Total asset derivatives	108	57
Derivative investments: | Other derivative investments
Derivative [Line Items]
Total asset derivatives	0	1
Other embedded derivatives | Other embedded derivatives
Derivative [Line Items]
Total asset derivatives	34	28
Prepaid expenses and other assets: | Reinsurance related embedded derivatives
Derivative [Line Items]
Total asset derivatives	0	152
Contractholder funds: | Indexed annuities/indexed universal life insurance ("IUL") embedded derivatives, included in contractholder funds
Derivative [Line Items]
Total liability derivatives	5,411	4,258
Accounts payable and accrued liabilities: | Equity options
Derivative [Line Items]
Total liability derivatives	4	1
Accounts payable and accrued liabilities: | Reinsurance related embedded derivatives
Derivative [Line Items]
Total liability derivatives	$ 34	$ 0

Derivative Financial Instrume_4

Derivative Financial Instruments - Schedule of Change in Fair Value of Derivative Instruments (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Equity options
Derivative [Line Items]
Change in fair value of derivatives	$ 260	$ (308)	$ 487	$ (155)
Interest rate swaps
Derivative [Line Items]
Change in fair value of derivatives	114	(19)	9	(19)
Futures contracts
Derivative [Line Items]
Change in fair value of derivatives	7	(4)	18	1
Other derivative investments
Derivative [Line Items]
Change in fair value of derivatives	(4)	4	1	3
Other embedded derivatives
Derivative [Line Items]
Change in fair value of derivatives	3	(3)	6	0
Reinsurance related embedded derivatives
Derivative [Line Items]
Change in fair value of derivatives	(178)	36	(186)	34
Total net investment gains (losses)
Derivative [Line Items]
Change in fair value of derivatives	202	(294)	335	(136)
Indexed annuities/IUL embedded derivatives increase
Derivative [Line Items]
Change in fair value of derivatives	$ 563	$ (265)	$ 1,153	$ 441

Derivative Financial Instrume_5

Derivative Financial Instruments - Narrative (Details) $ in Millions	9 Months Ended
	Sep. 30, 2024 USD ($) contract counterparty	Dec. 31, 2023 USD ($) contract
Derivative [Line Items]
Number of counterparties, net exposure threshold set to zero | counterparty	1
Counterparties, collateral required threshold	0%
Other embedded derivatives
Derivative [Line Items]
Term of contract, term one	1 year
Term of contract, term two	2 years
Term of contract, term three	3 years
Term of contract, term five	5 years
Term of contract, term six	6 years
Call options and interest rate swaps | Derivatives for Trading and Investment | Not Designated as Hedging Instrument
Derivative [Line Items]
Collateral posted	$ 1,351	$ 775
Net Credit Risk	53	39
Call options and interest rate swaps | Cash and Cash Equivalents | Not Designated as Hedging Instrument
Derivative [Line Items]
Collateral posted	$ 1,133	$ 588
Futures contracts
Derivative [Line Items]
Number of instruments held | contract	392	439
Collateral held	$ 5	$ 4

Derivative Financial Instrume_6

Derivative Financial Instruments - Schedule of Exposure to Credit Loss on Call Options Held (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Derivatives, Fair Value [Line Items]
Fair Value	$ 1,435	$ 977
Not Designated as Hedging Instrument | Derivative instruments excluding futures contracts
Derivatives, Fair Value [Line Items]
Notional Amount	35,561	29,968
Fair Value	1,393	796
Collateral	1,351	775
Net Credit Risk	$ 53	$ 39

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) $ in Millions	Jan. 11, 2024 USD ($)	Sep. 07, 2023 lawsuit	Sep. 30, 2024 USD ($) lawsuit	Jan. 02, 2024 USD ($)	Dec. 31, 2023 USD ($)
Other Commitments [Line Items]
Estimated litigation liability | $			$ 17		$ 10
Roar | Maximum | Loan Commitment
Other Commitments [Line Items]
Loan commitment (up to) | $			$ 6	$ 40
6.875% Series A Mandatory Convertible Preferred Stock
Other Commitments [Line Items]
Issuance of preferred stock | $	$ 250
Preferred stock, dividend rate, percentage	6.875%
Damages from Product Defects
Other Commitments [Line Items]
Number of similar lawsuits filed against other entities (over) | lawsuit			150
Cooper v. Progress Software Corp., No. 1:23-cv-12067
Other Commitments [Line Items]
Number of defendants | lawsuit		5
Pending Litigation | Damages from Product Defects
Other Commitments [Line Items]
Number of class action lawsuits | lawsuit			2

Commitments and Contingencies_2

Commitments and Contingencies - Schedule of Investment Commitments (Details) - Commitment to Invest $ in Millions	Sep. 30, 2024 USD ($)
Other Commitments [Line Items]
Total	$ 3,105
Limited partnerships
Other Commitments [Line Items]
Total	1,148
Whole loans
Other Commitments [Line Items]
Total	949
Fixed maturity securities, ABS
Other Commitments [Line Items]
Total	359
Direct Lending
Other Commitments [Line Items]
Total	273
Other fixed maturity securities, AFS
Other Commitments [Line Items]
Total	43
Commercial mortgage loans
Other Commitments [Line Items]
Total	79
Other assets
Other Commitments [Line Items]
Total	145
Other invested assets
Other Commitments [Line Items]
Total	$ 109

Dividends (Details)

Dividends (Details) - $ / shares		3 Months Ended		9 Months Ended
	Nov. 06, 2024	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Subsequent Event [Line Items]
Cash dividend per common share (in usd per share)		$ 0.48	$ 0.45	$ 1.44	$ 1.35
Subsequent Event
Subsequent Event [Line Items]
Cash dividend per common share (in usd per share)	$ 0.50

Segment Information - Schedule

Segment Information - Schedule of Segment Reporting Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Segment Reporting Information [Line Items]
Title premiums	$ 1,360	$ 1,252	$ 3,741	$ 3,484
Other revenues	1,159	1,196	3,555	3,288
Revenues from external customers	2,519	2,448	7,296	6,772
Interest and investment income, including recognized gains and losses, net	1,084	330	2,764	1,548
Total revenues	3,603	2,778	10,060	8,320
Depreciation and amortization	189	153	545	438
Interest expense	56	44	152	129
Earnings (loss) before income taxes and equity in earnings of unconsolidated affiliates	313	603	1,102	861
Income tax expense (benefit)	44	141	223	245
Earnings before equity in earnings of unconsolidated affiliates	269	462	879	616
Equity in earnings of unconsolidated affiliates	2	15	4	16
Net earnings (loss) from continuing operations	271	477	883	632
Assets	94,672	74,002	94,672	74,002	$ 80,614
Goodwill	5,272	4,830	5,272	4,830	$ 4,830
Operating Segments | Title
Segment Reporting Information [Line Items]
Title premiums	1,360	1,252	3,741	3,484
Other revenues	581	577	1,636	1,629
Revenues from external customers	1,941	1,829	5,377	5,113
Interest and investment income, including recognized gains and losses, net	155	46	313	178
Total revenues	2,096	1,875	5,690	5,291
Depreciation and amortization	35	39	106	115
Interest expense	0	0	0	0
Earnings (loss) before income taxes and equity in earnings of unconsolidated affiliates	372	248	825	638
Income tax expense (benefit)	73	73	190	165
Earnings before equity in earnings of unconsolidated affiliates	299	175	635	473
Equity in earnings of unconsolidated affiliates	2	15	4	16
Net earnings (loss) from continuing operations	301	190	639	489
Assets	8,046	8,136	8,046	8,136
Goodwill	2,800	2,789	2,800	2,789
Operating Segments | F&G
Segment Reporting Information [Line Items]
Title premiums	0	0	0	0
Other revenues	526	582	1,772	1,523
Revenues from external customers	526	582	1,772	1,523
Interest and investment income, including recognized gains and losses, net	918	269	2,413	1,365
Total revenues	1,444	851	4,185	2,888
Depreciation and amortization	147	108	417	302
Interest expense	36	24	94	71
Earnings (loss) before income taxes and equity in earnings of unconsolidated affiliates	(30)	380	366	340
Income tax expense (benefit)	(25)	74	51	99
Earnings before equity in earnings of unconsolidated affiliates	(5)	306	315	241
Equity in earnings of unconsolidated affiliates	0	0	0	0
Net earnings (loss) from continuing operations	(5)	306	315	241
Assets	84,110	63,596	84,110	63,596
Goodwill	2,179	1,749	2,179	1,749
Operating Segments | Corporate and Other
Segment Reporting Information [Line Items]
Title premiums	0	0	0	0
Other revenues	52	37	147	136
Revenues from external customers	52	37	147	136
Interest and investment income, including recognized gains and losses, net	37	37	118	48
Total revenues	89	74	265	184
Depreciation and amortization	7	6	22	21
Interest expense	20	20	58	58
Earnings (loss) before income taxes and equity in earnings of unconsolidated affiliates	(3)	(3)	(9)	(74)
Income tax expense (benefit)	(4)	(6)	(18)	(19)
Earnings before equity in earnings of unconsolidated affiliates	1	3	9	(55)
Equity in earnings of unconsolidated affiliates	0	0	0	0
Net earnings (loss) from continuing operations	1	3	9	(55)
Assets	2,516	2,270	2,516	2,270
Goodwill	293	292	293	292
Consolidation, Eliminations
Segment Reporting Information [Line Items]
Title premiums	0	0	0	0
Other revenues	0	0	0	0
Revenues from external customers	0	0	0	0
Interest and investment income, including recognized gains and losses, net	(26)	(22)	(80)	(43)
Total revenues	(26)	(22)	(80)	(43)
Depreciation and amortization	0	0	0	0
Interest expense	0	0	0	0
Earnings (loss) before income taxes and equity in earnings of unconsolidated affiliates	(26)	(22)	(80)	(43)
Income tax expense (benefit)	0	0	0	0
Earnings before equity in earnings of unconsolidated affiliates	(26)	(22)	(80)	(43)
Equity in earnings of unconsolidated affiliates	0	0	0	0
Net earnings (loss) from continuing operations	(26)	(22)	(80)	(43)
Assets	0	0	0	0
Goodwill	$ 0	$ 0	$ 0	$ 0

Supplemental Cash Flow Inform_3

Supplemental Cash Flow Information - Schedule of Supplemental Cash Flow Information (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash paid for:
Interest	$ 154	$ 122
Income taxes	153	140
Deferred sales inducements	219	113
Non-cash investing and financing activities:
Change in proceeds of sales of investments available for sale receivable in period	(69)	53
Change in purchases of investments available for sale payable in period	639	145
Lease liabilities recognized in exchange for lease right-of-use assets	35	29
Remeasurement of lease liabilities	55	53
Liabilities assumed in connection with acquisitions
Fair value of assets acquired	771	304
Less: Total Purchase price	570	299
Liabilities and noncontrolling interests assumed	$ 201	$ 5

Revenue Recognition - Schedule

Revenue Recognition - Schedule of Disaggregation of Revenue (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Disaggregation of Revenue [Line Items]
Revenue from contract with customer	$ 506	$ 501	$ 1,431	$ 1,433
Interest and investment income	815	686	2,308	1,915
Recognized gains and losses, net	269	(356)	456	(367)
Total revenues	3,603	2,778	10,060	8,320
Title
Disaggregation of Revenue [Line Items]
Loan subservicing revenue	68	71	197	200
Title | Direct title insurance premiums
Disaggregation of Revenue [Line Items]
Revenue from contract with customer	571	524	1,575	1,493
Title | Agency title insurance premiums
Disaggregation of Revenue [Line Items]
Revenue from contract with customer	789	728	2,166	1,991
Title | Home warranty
Disaggregation of Revenue [Line Items]
Revenue from contract with customer	42	43	114	110
Title | Insurance contracts
Disaggregation of Revenue [Line Items]
Revenue from contract with customer	1,928	1,877	5,627	5,117
Title | Escrow fees
Disaggregation of Revenue [Line Items]
Revenue from contract with customer	219	211	609	590
Title | Other title-related fees and income
Disaggregation of Revenue [Line Items]
Revenue from contract with customer	169	167	479	482
Title | ServiceLink, excluding title premiums, escrow fees, and subservicing fees
Disaggregation of Revenue [Line Items]
Revenue from contract with customer	83	85	237	247
F&G | Life insurance premiums, insurance and investment product fees, and other
Disaggregation of Revenue [Line Items]
Revenue from contract with customer	526	582	1,772	1,523
Corporate and other | Real estate technology
Disaggregation of Revenue [Line Items]
Revenue from contract with customer	35	38	106	114
Corporate and other | Other
Disaggregation of Revenue [Line Items]
Revenue from contract with customer	$ 17	$ (1)	$ 41	$ 22

Revenue Recognition - Narrative

Revenue Recognition - Narrative (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023	Dec. 31, 2022
Disaggregation of Revenue [Line Items]
Home warranty contract, period		1 year
Policy period		1 year
Revenue recognized	$ 40	$ 76
URL	94	94	$ 91
URL
Disaggregation of Revenue [Line Items]
URL	$ 366	$ 366	$ 270	$ 241	$ 166

Revenue Recognition - Schedul_2

Revenue Recognition - Schedule of Information about Trade Receivables and Deferred Revenue (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Revenue Recognition and Deferred Revenue [Abstract]
Trade receivables	$ 336	$ 317
Deferred revenue (contract liabilities)	$ 94	$ 91

Revenue Recognition - Schedul_3

Revenue Recognition - Schedule of Rollforward of Unearned Revenue Liabilities (URL) (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Contract With Customer Liability [Roll Forward]
Balance, beginning	$ 91
Balance, ending	94
URL
Contract With Customer Liability [Roll Forward]
Balance, beginning	270	$ 166
Capitalization	110	87
Amortization	(14)	(12)
Balance, ending	$ 366	$ 241

Value of Business Acquired, D_3

Value of Business Acquired, Deferred Acquisition Costs and Deferred Sales Inducements - Schedule of Reconciliation of Other Intangibles to Balance Sheet (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Value of business acquired	$ 1,389	$ 1,446	$ 1,487	$ 1,615
Deferred acquisition costs	2,857	2,215
Deferred sales inducements	538	346
Total Other intangible assets, net	5,758	4,627
Customer relationships and contracts
Finite-Lived Intangible Assets [Line Items]
Definite lived	440	174
Value of distribution asset
Finite-Lived Intangible Assets [Line Items]
Definite lived	76	86
Computer software
Finite-Lived Intangible Assets [Line Items]
Definite lived	282	266
Trademarks, tradenames, and other
Finite-Lived Intangible Assets [Line Items]
Definite lived	$ 176	$ 94

Value of Business Acquired, D_4

Value of Business Acquired, Deferred Acquisition Costs and Deferred Sales Inducements - Schedule of VOBA (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
VOBA
VOBA at beginning of period	$ 1,446	$ 1,615
Amortization	(120)	(128)
Actuarial model updates and refinements	63
VOBA at end of period	1,389	1,487
Amortization	15
Indexed Annuities
VOBA
VOBA at beginning of period	1,025	1,166
Amortization	(101)	(106)
Actuarial model updates and refinements	0
VOBA at end of period	924	1,060
Fixed rate annuities
VOBA
VOBA at beginning of period	27	32
Amortization	(4)	(4)
Actuarial model updates and refinements	0
VOBA at end of period	23	28
Immediate Annuities
VOBA
VOBA at beginning of period	191	201
Amortization	(5)	(8)
Actuarial model updates and refinements	0
VOBA at end of period	186	193
Universal Life
VOBA
VOBA at beginning of period	134	143
Amortization	(5)	(7)
Actuarial model updates and refinements	0
VOBA at end of period	129	136
Traditional Life
VOBA
VOBA at beginning of period	69	73
Amortization	(5)	(3)
Actuarial model updates and refinements	63
VOBA at end of period	$ 127	$ 70

Value of Business Acquired, D_5

Value of Business Acquired, Deferred Acquisition Costs and Deferred Sales Inducements - Narrative (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
VOBA amortization including actuarial model updates and refinements	$ 135
VOBA amortization	120	$ 128
DAC amortization	200	135
Indexed annuities
Goodwill and Intangible Assets Disclosure [Abstract]
VOBA amortization	101	106
DAC amortization	112	75
Finite-Lived Intangible Assets [Line Items]
DSI amortization	$ 27	$ 15

Value of Business Acquired, D_6

Value of Business Acquired, Deferred Acquisition Costs and Deferred Sales Inducements - Schedule of DAC (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
DAC
DAC at beginning of period	$ 2,211	$ 1,402
Capitalization	842	657
Amortization	(200)	(135)
Reinsurance related adjustments		79
DAC at end of period	2,853	2,003
Indexed Annuities
DAC
DAC at beginning of period	1,378	971
Capitalization	496	371
Amortization	(112)	(75)
Reinsurance related adjustments		0
DAC at end of period	1,762	1,267
Fixed Rate Annuities
DAC
DAC at beginning of period	288	83
Capitalization	147	119
Amortization	(61)	(35)
Reinsurance related adjustments		79
DAC at end of period	374	246
Universal Life
DAC
DAC at beginning of period	545	348
Capitalization	199	167
Amortization	(27)	(25)
Reinsurance related adjustments		0
DAC at end of period	$ 717	$ 490

Value of Business Acquired, D_7

Value of Business Acquired, Deferred Acquisition Costs and Deferred Sales Inducements -Schedule of DAC Reconciliation to Balance Sheet (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Deferred acquisition costs	$ 2,857	$ 2,215
Indexed Annuities
Finite-Lived Intangible Assets [Line Items]
Deferred acquisition costs	1,762	1,378
Fixed rate annuities
Finite-Lived Intangible Assets [Line Items]
Deferred acquisition costs	374	288
Universal Life
Finite-Lived Intangible Assets [Line Items]
Deferred acquisition costs	717	545
Funding Agreements
Finite-Lived Intangible Assets [Line Items]
Deferred acquisition costs	$ 4	$ 4

Value of Business Acquired, D_8

Value of Business Acquired, Deferred Acquisition Costs and Deferred Sales Inducements - Schedule of DSI (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
DSI
DSI at beginning of period	$ 346
DSI at end of period	538
Indexed annuities
DSI
DSI at beginning of period	346	$ 200
Capitalization	219	112
Amortization	(27)	(15)
DSI at end of period	$ 538	$ 297

Value of Business Acquired, D_9

Value of Business Acquired, Deferred Acquisition Costs and Deferred Sales Inducements - Schedule of Estimated Amortization Expense for VOBA in Future Fiscal Periods (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023	Sep. 30, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
2024	$ 38
2025	143
2026	130
2027	119
2028	108
Thereafter	851
Total	$ 1,389	$ 1,446	$ 1,487	$ 1,615

F&G Reinsurance - Schedule of E

F&G Reinsurance - Schedule of Effect of Reinsurance on Premiums Earned, Benefits Incurred and Reserve Changes (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Net Benefits Incurred
Net	$ 61	$ 57	$ 168	$ 157
Traditional Life Insurance Premiums
Net Premiums Earned
Direct	363	508	1,340	1,319
Ceded	(23)	(26)	(71)	(79)
Net	340	482	1,269	1,240
Net Benefits Incurred
Direct	1,127	323	2,999	2,057
Ceded	(32)	(31)	(135)	(136)
Net	$ 1,095	$ 292	$ 2,864	$ 1,921

F&G Reinsurance - Schedule of R

F&G Reinsurance - Schedule of Reinsurance Recoverable (Details) - USD ($) $ in Millions	1 Months Ended				5 Months Ended	12 Months Ended
	Sep. 30, 2024	Aug. 31, 2024	Jul. 31, 2024	Jun. 30, 2024	May 31, 2024	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Dec. 31, 2022
Effects of Reinsurance [Line Items]
Allowance for expected credit loss	$ (21)			$ (21)		$ (21)	$ (10)	$ (9)	$ (10)
Reinsurance recoverable, net of allowance for credit losses	$ 12,409					$ 8,977
Reinsurance, retrocession, quota share basis, percentage	90%	90%	30%	30%	90%	90%
F&G
Effects of Reinsurance [Line Items]
Reinsurance recoverable, gross of allowance for credit losses	$ 12,425					$ 8,981
Allowance for expected credit loss	(21)					(21)
Reinsurance recoverable, net of allowance for credit losses	12,404					8,960
Aspida Life Re Ltd | Certain MYGA | F&G
Effects of Reinsurance [Line Items]
Reinsurance recoverable, gross of allowance for credit losses	7,543					6,128
Somerset Reinsurance Ltd (c) | Certain MYGA and DA | F&G
Effects of Reinsurance [Line Items]
Reinsurance recoverable, gross of allowance for credit losses	2,181					716
Everlake Life Insurance Company | Certain MYGA | F&G
Effects of Reinsurance [Line Items]
Reinsurance recoverable, gross of allowance for credit losses	1,120					509
Wilton Reassurance Company | Block of traditional, IUL and UL | F&G
Effects of Reinsurance [Line Items]
Reinsurance recoverable, gross of allowance for credit losses	1,073					1,092
Other | F&G
Effects of Reinsurance [Line Items]
Reinsurance recoverable, gross of allowance for credit losses	$ 508					$ 536

F&G Reinsurance - Narrative (De

F&G Reinsurance - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Reinsurance Disclosures [Abstract]
Deposit assets	$ 10,500		$ 10,500		$ 7,500
Reinsurance risk charge fee	$ 10	$ 10	$ 32	$ 30

F&G Reinsurance - Schedule of C

F&G Reinsurance - Schedule of Credit Loss (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Reinsurance Recoverable, Allowance for Credit Loss [Roll Forward]
Balance at beginning of period	$ (21)	$ (9)	$ (21)	$ (10)
Changes in the expected credit loss reserve	0	(1)	0	0
Balance at end of period	$ (21)	$ (10)	$ (21)	$ (10)

F&G Insurance Subsidiary Fina_3

F&G Insurance Subsidiary Financial Information and Regulatory Matters - Schedule of Statutory Accounting Practices Disclosure (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
IOWA
Statutory Accounting Practices [Line Items]
Statutory capital surplus (deficit)	$ 1,704		$ 1,704		$ 2,009
IOWA | F&G
Statutory Accounting Practices [Line Items]
Statutory net income (loss)	(6)	$ 94	71	$ 54
New York
Statutory Accounting Practices [Line Items]
Statutory capital surplus (deficit)	95		95		86
New York | F&G
Statutory Accounting Practices [Line Items]
Statutory net income (loss)	1	(1)	7	4
Vermont | Raven Reinsurance Company
Statutory Accounting Practices [Line Items]
Statutory capital surplus (deficit)	156		156		140
Vermont | Raven Reinsurance Company | F&G
Statutory Accounting Practices [Line Items]
Statutory net income (loss)	13	14	41	42
Vermont | Corbeau Re
Statutory Accounting Practices [Line Items]
Statutory capital surplus (deficit)	139		139		171
Vermont | Corbeau Re | F&G
Statutory Accounting Practices [Line Items]
Statutory net income (loss)	5	0	(394)	0
Cayman Islands
Statutory Accounting Practices [Line Items]
Statutory net income (loss)	(11)	6	(27)	13
Statutory capital surplus (deficit)	625		625		543
Bermuda
Statutory Accounting Practices [Line Items]
Statutory net income (loss)	102	$ (80)	181	$ (6)
Statutory capital surplus (deficit)	$ 195		$ 195		$ 11

F&G Insurance Subsidiary Fina_4

F&G Insurance Subsidiary Financial Information and Regulatory Matters - Narrative (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Insurance [Abstract]
Permitted practice, statutory surplus	$ 29	$ 102

Acquisitions - Narrative (Detai

Acquisitions - Narrative (Details) - USD ($) $ in Millions				3 Months Ended	9 Months Ended
	Jul. 18, 2024	Jul. 17, 2024	Jan. 02, 2024	Sep. 30, 2024	Sep. 30, 2024
Roar
Business Acquisition [Line Items]
Ownership interests acquired			70%
Contingent consideration arrangements, payments			$ 90
Contingent consideration liability payment period			3 years
Revenue of acquiree				$ 19	$ 60
Earnings of acquiree				2	6
PALH LLC
Business Acquisition [Line Items]
Ownership interests acquired	70%
Ownership interest including subsequent acquisition, percentage	100%
Ownership interest prior to acquisition		30%
Acquisition date fair value of previously held interests	$ 92	$ 92
Remeasurement gain				$ 2	$ 2
PALH LLC | PALH LLC
Business Acquisition [Line Items]
Ownership percentage, of acquiree prior to acquisition		70%

Acquisitions - Schedule of Init

Acquisitions - Schedule of Initial Purchase Price -Roar (Details) - Roar $ in Millions	Jan. 02, 2024 USD ($)
Business Acquisition [Line Items]
Ownership interests acquired	70%
Cash paid for 70% majority interest of Roar shares	$ 269
Less: Cash acquired net of noncontrolling interests	1
Net cash paid	268
Initial fair value of contingent consideration	48
Total initial consideration	$ 316

Acquisitions - Schedule of Prel

Acquisitions - Schedule of Preliminary Fair Value Amounts for Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Millions	Sep. 30, 2024	Jul. 18, 2024	Jan. 02, 2024	Dec. 31, 2023	Sep. 30, 2023
Business Acquisition [Line Items]
Goodwill	$ 5,272			$ 4,830	$ 4,830
Roar
Business Acquisition [Line Items]
Goodwill			$ 268
Prepaid expenses and other assets			3
Other intangible assets			183
Total assets acquired			454
Accounts payable and accrued liabilities			2
Total liabilities assumed			2
Noncontrolling interests (fair value determined using income approach)			136
Total liabilities assumed and non-controlling interests			138
Net assets acquired			$ 316
PALH LLC
Business Acquisition [Line Items]
Goodwill		$ 162
Prepaid expenses and other assets		5
Other intangible assets		149
Total assets acquired		316
Accounts payable and accrued liabilities		2
Total liabilities assumed		2
Net assets acquired		$ 314

Acquisitions - Schedule of Gros

Acquisitions - Schedule of Gross Carrying Value and Weighted Average Estimated Useful Lives of Other Intangible Assets (Details) - USD ($) $ in Millions	Jul. 18, 2024	Jan. 02, 2024
Roar
Acquired Finite-Lived Intangible Assets [Line Items]
Gross Carrying Value		$ 183
Roar | Customer relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Gross Carrying Value		$ 179
Estimated Useful Life		12 years
Roar | Definite lived trademarks, tradenames, and other
Acquired Finite-Lived Intangible Assets [Line Items]
Gross Carrying Value		$ 4
Estimated Useful Life		10 years
PALH LLC
Acquired Finite-Lived Intangible Assets [Line Items]
Gross Carrying Value	$ 149
PALH LLC | Customer relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Gross Carrying Value	$ 131
Estimated Useful Life	20 years
PALH LLC | Definite lived trademarks, tradenames, and other
Acquired Finite-Lived Intangible Assets [Line Items]
Gross Carrying Value	$ 18
PALH LLC | Minimum | Definite lived trademarks, tradenames, and other
Acquired Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life	5 years
PALH LLC | Maximum | Definite lived trademarks, tradenames, and other
Acquired Finite-Lived Intangible Assets [Line Items]
Estimated Useful Life	10 years

Acquisitions - Schedule of In_2

Acquisitions - Schedule of Initial Purchase Price - PAHL (Details) - PALH LLC - USD ($) $ in Millions	Jul. 18, 2024	Jul. 17, 2024
Business Acquisition [Line Items]
Cash consideration	$ 215
Less: Cash acquired	1
Net cash paid	214
Settlement of prepaid asset	8
Acquisition date fair value of previously held interests	92	$ 92
Total consideration	$ 314

Notes Payable - Schedule of Lon

Notes Payable - Schedule of Long Term Debt (Details) - USD ($) $ in Millions	Sep. 30, 2024	Jun. 04, 2024	Apr. 23, 2024	Dec. 31, 2023	Dec. 06, 2023	Jan. 13, 2023	Nov. 22, 2022	Sep. 17, 2021	Sep. 15, 2020	Jun. 12, 2020	Aug. 13, 2018
Debt Instrument [Line Items]
Notes payable	$ 4,186			$ 3,887
4.50% Notes, net of discount
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage											4.50%
4.50% Notes, net of discount | Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	4.50%		4.50%								4.50%
Notes payable	$ 446			446
3.40% Notes, net of discount
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage										3.40%
3.40% Notes, net of discount | Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	3.40%		3.40%
Notes payable	$ 645			644
2.45% Notes, net of discount
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage									2.45%
2.45% Notes, net of discount | Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	2.45%		2.45%
Notes payable	$ 595			594
3.20% Notes, net of discount
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage								3.20%
3.20% Notes, net of discount | Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	3.20%		3.20%
Notes payable	$ 444			444
Revolving Credit Facility | Line of Credit | Revolving Credit Facility
Debt Instrument [Line Items]
Notes payable	4			2
F&G Credit Agreement
Debt Instrument [Line Items]
Notes payable	$ 358			362
6.50% F&G Notes, net of discount | Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	6.50%	6.50%
Notes payable	$ 544			0
7.40% F&G Notes, net of discount | Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	7.40%					7.40%
Notes payable	$ 496			495
5.50% F&G Notes, net of discount | Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	5.50%	5.50%					5.50%
Notes payable	$ 304			561
7.95% F&G Notes, net of discount | Senior Notes
Debt Instrument [Line Items]
Debt instrument, interest rate, stated percentage	7.95%				7.95%
Notes payable	$ 336			336
Other
Debt Instrument [Line Items]
Notes payable	$ 22			$ 7

Notes Payable - Narrative (Deta

Notes Payable - Narrative (Details) - USD ($)

9 Months Ended

Jun. 04, 2024

Feb. 21, 2023

Nov. 22, 2022

Sep. 17, 2021

Sep. 15, 2020

Jun. 12, 2020

Apr. 20, 2018

Sep. 30, 2024

Sep. 30, 2023

Apr. 23, 2024

Feb. 16, 2024

Feb. 15, 2024

Dec. 31, 2023

Dec. 06, 2023

Jan. 13, 2023

Jun. 01, 2020

Aug. 13, 2018

Debt Instrument [Line Items]

Debt service payments

$ 250,000,000

$ 8,000,000

Outstanding debt

4,186,000,000

$ 3,887,000,000

Outstanding principal

$ 4,235,000,000

6.50% F&G Notes, net of discount | Senior Notes

Debt Instrument [Line Items]

Aggregate principal amount

$ 550,000,000

Debt instrument, interest rate, stated percentage

6.50%

6.50%

Price as percent of par on offering of unsecured notes

99.74%

Debt issuance costs, net

$ 6,000,000

Outstanding debt

$ 544,000,000

0

5.50% F&G Senior Notes | F&G

Debt Instrument [Line Items]

Aggregate principal amount

$ 550,000,000

Debt instrument, interest rate, stated percentage

5.50%

Price as percent of par on offering of unsecured notes

99.50%

Proceeds from issuance of senior notes

$ 547,000,000

5.50% F&G Senior Notes | Senior Notes

Debt Instrument [Line Items]

Debt instrument, interest rate, stated percentage

5.50%

5.50%

5.50%

Debt service payments

$ 250,000,000

Outstanding debt

$ 304,000,000

561,000,000

7.95% F&G Notes, net of discount | Senior Notes

Debt Instrument [Line Items]

Aggregate principal amount

$ 345,000,000

Debt instrument, interest rate, stated percentage

7.95%

7.95%

Debt issuance costs, net

$ 9,000,000

Outstanding debt

$ 336,000,000

336,000,000

7.40% F&G Senior Notes | Senior Notes

Debt Instrument [Line Items]

Aggregate principal amount

$ 500,000,000

Debt instrument, interest rate, stated percentage

7.40%

7.40%

Outstanding debt

$ 496,000,000

495,000,000

F&G Credit Agreement

Debt Instrument [Line Items]

Outstanding debt

$ 358,000,000

362,000,000

F&G Credit Agreement | Revolving Credit Facility

Debt Instrument [Line Items]

Basis spread on variable rate (as percent)

1%

F&G Credit Agreement | Revolving Credit Facility | Fed Funds Rate

Debt Instrument [Line Items]

Basis spread on variable rate (as percent)

0.50%

F&G Credit Agreement | Senior Notes

Debt Instrument [Line Items]

Maturity date, principal amount, maximum

$ 150,000,000

F&G Credit Agreement | Line of Credit | Revolving Credit Facility

Debt Instrument [Line Items]

Line of credit facility

$ 665,000,000

$ 550,000,000

$ 750,000,000

$ 665,000,000

Debt, period prior to maturity date (days)

91 days

Prior debt redeemed or paid and any refinancing of debt incurred matures period (at least)

91 days

Period from effective date

3 years

Credit facility, increase in borrowing commitments

$ 115,000,000

F&G Credit Agreement | Line of Credit | Revolving Credit Facility | Condition One | Minimum

Debt Instrument [Line Items]

Basis spread on variable rate (as percent)

0.30%

F&G Credit Agreement | Line of Credit | Revolving Credit Facility | Condition One | Maximum

Debt Instrument [Line Items]

Basis spread on variable rate (as percent)

0.80%

F&G Credit Agreement | Line of Credit | Revolving Credit Facility | Condition Two | Minimum

Debt Instrument [Line Items]

Basis spread on variable rate (as percent)

1.30%

F&G Credit Agreement | Line of Credit | Revolving Credit Facility | Condition Two | Maximum

Debt Instrument [Line Items]

Basis spread on variable rate (as percent)

1.80%

3.20% Senior Notes

Debt Instrument [Line Items]

Aggregate principal amount

$ 450,000,000

Debt instrument, interest rate, stated percentage

3.20%

Proceeds from issuance debt

$ 443,000,000

3.20% Senior Notes | Senior Notes

Debt Instrument [Line Items]

Debt instrument, interest rate, stated percentage

3.20%

3.20%

Outstanding debt

$ 444,000,000

444,000,000

Revolving Credit Facility | Line of Credit | Revolving Credit Facility

Debt Instrument [Line Items]

Debt issuance costs, net

4,000,000

Outstanding debt

4,000,000

2,000,000

Line of credit facility

$ 800,000,000

Outstanding principal

0

Remaining borrowing capacity

$ 800,000,000

2.45% Notes, net of discount

Debt Instrument [Line Items]

Aggregate principal amount

$ 600,000,000

Debt instrument, interest rate, stated percentage

2.45%

Proceeds from issuance debt

$ 593,000,000

2.45% Notes, net of discount | Senior Notes

Debt Instrument [Line Items]

Debt instrument, interest rate, stated percentage

2.45%

2.45%

Outstanding debt

$ 595,000,000

594,000,000

Term Loan | Term Loan

Debt Instrument [Line Items]

Repayments of all outstanding indebtedness under term loan credit agreement

$ 260,000,000

Repayment of principal borrowed

$ 640,000,000

3.40% Notes, net of discount

Debt Instrument [Line Items]

Aggregate principal amount

$ 650,000,000

Debt instrument, interest rate, stated percentage

3.40%

Proceeds from issuance debt

$ 642,000,000

3.40% Notes, net of discount | Senior Notes

Debt Instrument [Line Items]

Debt instrument, interest rate, stated percentage

3.40%

3.40%

Outstanding debt

$ 645,000,000

644,000,000

4.50% unsecured notes due August 2028

Debt Instrument [Line Items]

Debt instrument, interest rate, stated percentage

4.50%

Price as percent of par on offering of unsecured notes

99.252%

Annual interest rate

4.594%

4.50% unsecured notes due August 2028 | Senior Notes

Debt Instrument [Line Items]

Aggregate principal amount

$ 450,000,000

Debt instrument, interest rate, stated percentage

4.50%

4.50%

4.50%

Outstanding debt

$ 446,000,000

$ 446,000,000

Notes Payable - Schedule of Pri

Notes Payable - Schedule of Principal Maturities of Notes Payable (Details) $ in Millions	Sep. 30, 2024 USD ($)
Maturities of Long-term Debt [Abstract]
2024 (remaining)	$ 365
2025	303
2026	22
2027	0
2028	950
Thereafter	2,595
Total long term debt	$ 4,235

Market Risk Benefits - Schedule

Market Risk Benefits - Schedule of Balances and Changes in Market Risk Benefit (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Indexed annuities
Market Risk Benefit [Line Items]
Balance beginning of period	$ 314	$ 164
Balance, beginning of period, before effect of changes in the instrument-specific credit risk	209	102
Issuances and benefit payments	78	(10)
Attributed fees collected and interest accrual	103	131
Actual policyholder behavior different from expected	8	27
Changes in assumptions and other	32	29
Effects of market related movements	(31)	(70)
Balance, end of period, before effect of changes in the instrument-specific credit risk	399	209
Issuances and benefit payments	78	(10)
Attributed fees collected and interest accrual	103	131
Actual policyholder behavior different from expected	8	27
Changes in assumptions and other	32	29
Effects of market related movements	(31)	(70)
Effect of changes in the instrument-specific credit risk	112	105
Balance, end of period	511	314
Less: reinsured market risk benefits	43	0
Balance, end of period, net of reinsurance	$ 468	$ 314
Weighted-average attained age of policyholders weighted by total AV (years)	68 years 14 days	68 years 3 months 10 days
Net amount at risk	$ 1,390	$ 1,059
Fixed rate annuities
Market Risk Benefit [Line Items]
Balance beginning of period	1	1
Balance, beginning of period, before effect of changes in the instrument-specific credit risk	1	1
Issuances and benefit payments	0	0
Attributed fees collected and interest accrual	0	0
Actual policyholder behavior different from expected	0	0
Changes in assumptions and other	0	0
Effects of market related movements	0	0
Balance, end of period, before effect of changes in the instrument-specific credit risk	1	1
Issuances and benefit payments	0	0
Attributed fees collected and interest accrual	0	0
Actual policyholder behavior different from expected	0	0
Changes in assumptions and other	0	0
Effects of market related movements	0	0
Effect of changes in the instrument-specific credit risk	0	0
Balance, end of period	1	1
Less: reinsured market risk benefits	0	0
Balance, end of period, net of reinsurance	$ 1	$ 1
Weighted-average attained age of policyholders weighted by total AV (years)	72 years 5 months 19 days	72 years 7 months 2 days
Net amount at risk	$ 2	$ 2

Market Risk Benefits - Schedu_2

Market Risk Benefits - Schedule of Reconciliation of Asset and Liability (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Market Risk Benefit [Line Items]
Market risk benefits asset	$ 134	$ 88
Market risk benefits liability	603	403
Direct
Market Risk Benefit [Line Items]
Market risk benefits asset	91	88
Market risk benefits liability	603	403
Reinsured
Market Risk Benefit [Line Items]
Market risk benefits asset	43	0
Market risk benefits liability	0	0
Indexed annuities
Market Risk Benefit [Line Items]
Market risk benefits asset	134	88
Market risk benefits liability	602	402
Indexed annuities | Direct
Market Risk Benefit [Line Items]
Market risk benefits asset	91	88
Market risk benefits liability	602	402
Indexed annuities | Reinsured
Market Risk Benefit [Line Items]
Market risk benefits asset	43	0
Market risk benefits liability	0	0
Fixed rate annuities
Market Risk Benefit [Line Items]
Market risk benefits liability	1	1
Fixed rate annuities | Direct
Market Risk Benefit [Line Items]
Market risk benefits liability	1	1
Fixed rate annuities | Reinsured
Market Risk Benefit [Line Items]
Market risk benefits liability	$ 0	$ 0

Contractholder Funds - Schedule

Contractholder Funds - Schedule of Balances and Changes in Contractholder Funds (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Policyholder Account Balance [Roll Forward]
Balance, beginning of year			$ 48,798
Balance, end of period	$ 55,468		55,468		$ 48,798
Embedded derivative adjustment	3	$ (3)	6	$ 0
Gross Liability, end of period	55,468		55,468		48,798
Reinsurance recoverable, net of allowance for credit losses	12,409		12,409		8,977
Indexed annuities
Policyholder Account Balance [Roll Forward]
Balance, beginning of year			27,164	24,766	24,766
Issuances			4,829		4,722
Premiums received			85		103
Policy charges			(140)		(182)
Surrenders and withdrawals			(2,807)		(2,005)
Benefit payments			(368)		(526)
Interest credited			488		270
Other			5		16
Balance, end of period	29,256		29,256		27,164
Issuances			4,829		4,722
Premiums received			85		103
Policy charges			(140)		(182)
Surrenders and withdrawals			(2,807)		(2,005)
Benefit payments			(368)		(526)
Interest credited			488		270
Other			5		16
Embedded derivative adjustment			790		243
Gross Liability, end of period	30,046		30,046		27,407
Reinsurance recoverable, net of allowance for credit losses	410		410		17
Net Liability, after Reinsurance	$ 29,636		$ 29,636		$ 27,390
Weighted-average crediting rate	2.33%		2.33%		1.40%
Cash surrender value	$ 26,985		$ 26,985		$ 25,099
Fixed rate annuities
Policyholder Account Balance [Roll Forward]
Balance, beginning of year			13,443	9,358	9,358
Issuances			4,476		5,061
Premiums received			1		1
Policy charges			0		0
Surrenders and withdrawals			(1,184)		(1,142)
Benefit payments			(233)		(240)
Interest credited			476		405
Other			0		0
Balance, end of period	16,979		16,979		13,443
Issuances			4,476		5,061
Premiums received			1		1
Policy charges			0		0
Surrenders and withdrawals			(1,184)		(1,142)
Benefit payments			(233)		(240)
Interest credited			476		405
Other			0		0
Embedded derivative adjustment			0		0
Gross Liability, end of period	16,979		16,979		13,443
Reinsurance recoverable, net of allowance for credit losses	10,471		10,471		7,520
Net Liability, after Reinsurance	$ 6,508		$ 6,508		$ 5,923
Weighted-average crediting rate	4.26%		4.26%		4.85%
Cash surrender value	$ 15,815		$ 15,815		$ 12,505
Universal Life
Policyholder Account Balance [Roll Forward]
Balance, beginning of year			2,391	2,112	2,112
Issuances			157		199
Premiums received			361		382
Policy charges			(231)		(261)
Surrenders and withdrawals			(75)		(90)
Benefit payments			(13)		(27)
Interest credited			108		76
Other			0		0
Balance, end of period	2,698		2,698		2,391
Issuances			157		199
Premiums received			361		382
Policy charges			(231)		(261)
Surrenders and withdrawals			(75)		(90)
Benefit payments			(13)		(27)
Interest credited			108		76
Other			0		0
Embedded derivative adjustment			119		84
Gross Liability, end of period	2,817		2,817		2,475
Reinsurance recoverable, net of allowance for credit losses	883		883		894
Net Liability, after Reinsurance	$ 1,934		$ 1,934		$ 1,581
Weighted-average crediting rate	5.84%		5.84%		3.44%
Net amount at risk	$ 70,859		$ 70,859		$ 60,389
Cash surrender value	2,088		2,088		1,872
FABN
Policyholder Account Balance [Roll Forward]
Balance, beginning of year			2,613	2,613	2,613
Issuances			599		0
Premiums received			0		0
Policy charges			0		0
Surrenders and withdrawals			0		0
Benefit payments			(791)		(53)
Interest credited			51		54
Other			(1)		(1)
Balance, end of period	2,471		2,471		2,613
Issuances			599		0
Premiums received			0		0
Policy charges			0		0
Surrenders and withdrawals			0		0
Benefit payments			(791)		(53)
Interest credited			51		54
Other			(1)		(1)
Embedded derivative adjustment			0		0
Gross Liability, end of period	2,471		2,471		2,613
Reinsurance recoverable, net of allowance for credit losses	0		0		0
Net Liability, after Reinsurance	2,471		2,471		2,613
FHLB
Policyholder Account Balance [Roll Forward]
Balance, beginning of year			2,539	$ 1,982	1,982
Issuances			1,803		1,256
Premiums received			0		0
Policy charges			0		0
Surrenders and withdrawals			0		0
Benefit payments			(1,576)		(763)
Interest credited			89		64
Other			(2)		0
Balance, end of period	2,853		2,853		2,539
Issuances			1,803		1,256
Premiums received			0		0
Policy charges			0		0
Surrenders and withdrawals			0		0
Benefit payments			(1,576)		(763)
Interest credited			89		64
Other			(2)		0
Embedded derivative adjustment			0		0
Gross Liability, end of period	2,853		2,853		2,539
Reinsurance recoverable, net of allowance for credit losses	0		0		0
Net Liability, after Reinsurance	$ 2,853		$ 2,853		$ 2,539

Contractholder Funds - Schedu_2

Contractholder Funds - Schedule of Reconciliation to Condensed Consolidated Balance Sheets (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023
Policyholder Account Balance [Line Items]
Contractholder funds	$ 55,468	$ 48,798
Indexed annuities
Policyholder Account Balance [Line Items]
Contractholder funds	30,046	27,407
Fixed rate annuities
Policyholder Account Balance [Line Items]
Contractholder funds	16,979	13,443
Immediate Annuities
Policyholder Account Balance [Line Items]
Contractholder funds	292	311
Universal Life
Policyholder Account Balance [Line Items]
Contractholder funds	2,817	2,475
Traditional Life
Policyholder Account Balance [Line Items]
Contractholder funds	5	5
FABN
Policyholder Account Balance [Line Items]
Contractholder funds	2,471	2,613
FHLB
Policyholder Account Balance [Line Items]
Contractholder funds	2,853	2,539
PRT
Policyholder Account Balance [Line Items]
Contractholder funds	$ 5	$ 5

Contractholder Funds - Narrativ

Contractholder Funds - Narrative (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Insurance [Abstract]
Change in total benefits and other changes in policy reserves increase (decrease)	$ (79)	$ 73

Contractholder Funds - Schedu_3

Contractholder Funds - Schedule of Account Values by Range of Guaranteed Minimum Credit Rating (Details) $ in Millions	Sep. 30, 2024 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)
Policyholder Account Balance [Line Items]
Contractholder funds	$ 55,468	$ 48,798
Indexed annuities
Policyholder Account Balance [Line Items]
Contractholder funds	29,256	27,164	$ 24,766
Indexed annuities | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Contractholder funds	24,112	22,965
Indexed annuities | Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Contractholder funds	1,288	1,446
Indexed annuities | Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Contractholder funds	962	550
Indexed annuities | Greater Than 0150
Policyholder Account Balance [Line Items]
Contractholder funds	2,894	2,203
Indexed annuities | 0.00%-1.50%
Policyholder Account Balance [Line Items]
Contractholder funds	26,729	26,315
Indexed annuities | 0.00%-1.50% | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Contractholder funds	23,095	22,392
Indexed annuities | 0.00%-1.50% | Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Contractholder funds	1,285	1,444
Indexed annuities | 0.00%-1.50% | Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Contractholder funds	502	526
Indexed annuities | 0.00%-1.50% | Greater Than 0150
Policyholder Account Balance [Line Items]
Contractholder funds	1,847	1,953
Indexed annuities | 1.51%-2.50%
Policyholder Account Balance [Line Items]
Contractholder funds	2,207	471
Indexed annuities | 1.51%-2.50% | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Contractholder funds	700	196
Indexed annuities | 1.51%-2.50% | Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Contractholder funds	1	1
Indexed annuities | 1.51%-2.50% | Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Contractholder funds	460	24
Indexed annuities | 1.51%-2.50% | Greater Than 0150
Policyholder Account Balance [Line Items]
Contractholder funds	1,046	250
Indexed annuities | Greater than 2.50%
Policyholder Account Balance [Line Items]
Contractholder funds	320	378
Indexed annuities | Greater than 2.50% | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Contractholder funds	317	377
Indexed annuities | Greater than 2.50% | Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Contractholder funds	2	1
Indexed annuities | Greater than 2.50% | Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Contractholder funds	0	0
Indexed annuities | Greater than 2.50% | Greater Than 0150
Policyholder Account Balance [Line Items]
Contractholder funds	1	0
Fixed rate annuities
Policyholder Account Balance [Line Items]
Contractholder funds	16,979	13,443	9,358
Fixed rate annuities | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Contractholder funds	876	921
Fixed rate annuities | Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Contractholder funds	30	35
Fixed rate annuities | Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Contractholder funds	948	1,559
Fixed rate annuities | Greater Than 0150
Policyholder Account Balance [Line Items]
Contractholder funds	15,125	10,928
Fixed rate annuities | 0.00%-1.50%
Policyholder Account Balance [Line Items]
Contractholder funds	14,847	11,851
Fixed rate annuities | 0.00%-1.50% | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Contractholder funds	46	23
Fixed rate annuities | 0.00%-1.50% | Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Contractholder funds	21	25
Fixed rate annuities | 0.00%-1.50% | Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Contractholder funds	925	1,532
Fixed rate annuities | 0.00%-1.50% | Greater Than 0150
Policyholder Account Balance [Line Items]
Contractholder funds	13,855	10,271
Fixed rate annuities | 1.51%-2.50%
Policyholder Account Balance [Line Items]
Contractholder funds	491	489
Fixed rate annuities | 1.51%-2.50% | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Contractholder funds	4	5
Fixed rate annuities | 1.51%-2.50% | Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Contractholder funds	7	8
Fixed rate annuities | 1.51%-2.50% | Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Contractholder funds	20	23
Fixed rate annuities | 1.51%-2.50% | Greater Than 0150
Policyholder Account Balance [Line Items]
Contractholder funds	460	453
Fixed rate annuities | Greater than 2.50%
Policyholder Account Balance [Line Items]
Contractholder funds	1,641	1,103
Fixed rate annuities | Greater than 2.50% | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Contractholder funds	826	893
Fixed rate annuities | Greater than 2.50% | Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Contractholder funds	2	2
Fixed rate annuities | Greater than 2.50% | Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Contractholder funds	3	4
Fixed rate annuities | Greater than 2.50% | Greater Than 0150
Policyholder Account Balance [Line Items]
Contractholder funds	810	204
Universal Life
Policyholder Account Balance [Line Items]
Contractholder funds	2,698	2,391	$ 2,112
Universal Life | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Contractholder funds	2,669	2,348
Universal Life | Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Contractholder funds	6	21
Universal Life | Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Contractholder funds	1	1
Universal Life | Greater Than 0150
Policyholder Account Balance [Line Items]
Contractholder funds	22	21
Universal Life | 0.00%-1.50%
Policyholder Account Balance [Line Items]
Contractholder funds	2,331	2,013
Universal Life | 0.00%-1.50% | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Contractholder funds	2,303	1,987
Universal Life | 0.00%-1.50% | Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Contractholder funds	6	5
Universal Life | 0.00%-1.50% | Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Contractholder funds	0	0
Universal Life | 0.00%-1.50% | Greater Than 0150
Policyholder Account Balance [Line Items]
Contractholder funds	22	21
Universal Life | Greater than 2.50%
Policyholder Account Balance [Line Items]
Contractholder funds	367	378
Universal Life | Greater than 2.50% | At Guaranteed Minimum
Policyholder Account Balance [Line Items]
Contractholder funds	366	361
Universal Life | Greater than 2.50% | Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Contractholder funds	0	16
Universal Life | Greater than 2.50% | Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Contractholder funds	1	1
Universal Life | Greater than 2.50% | Greater Than 0150
Policyholder Account Balance [Line Items]
Contractholder funds	$ 0	$ 0
Minimum | Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Policyholder account balance, above guaranteed minimum crediting rate	0.0001	0.0001
Minimum | Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Policyholder account balance, above guaranteed minimum crediting rate	0.0051	0.0051
Minimum | Greater Than 0150
Policyholder Account Balance [Line Items]
Policyholder account balance, above guaranteed minimum crediting rate	0.0150	0.0150
Maximum | Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Policyholder account balance, above guaranteed minimum crediting rate	0.0050	0.0050
Maximum | Range from 0051 to 0150
Policyholder Account Balance [Line Items]
Policyholder account balance, above guaranteed minimum crediting rate	0.0150	0.0150

Future Policy Benefits - Schedu

Future Policy Benefits - Schedule of Balances and Changes in the Present Value of Expected Net Premiums and Present Value (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Net liability for future policy benefits	$ 8,268	$ 7,050
Traditional Life
Liability for Future Policy Benefit, Expected Net Premium [Roll Forward]
Balance, beginning of year	722	797
Beginning balance of original discount rate	874	974
Effect of actual variances from expected experience		(4)	$ (1)
Balance adjusted for variances from expectation		870	973
Interest accrual	13	19
Net premiums collected	(82)	(118)
Ending Balance at original discount rate	801	874
Effect of actual variances from expected experience		(4)	(1)
Effect of changes in discount rate assumptions	(128)	(152)
Balance, end of year	673	722
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Balance, beginning of year	2,071	2,151
Beginning balance of original discount rate	2,492	2,665
Effect of actual variances from expected experience		48	(24)
Balance adjusted for variances from expectation		2,540	2,641
Interest accrual	41	56
Benefits payments	(165)	(205)
Ending Balance at original discount rate	2,416	2,492
Effect of actual variances from expected experience		48	(24)
Balance adjusted for variances from expectation		2,540	2,641
Interest accrual	41	56
Benefits payments	(165)	(205)
Effect of changes in discount rate assumptions	(358)	(421)
Balance, end of period	2,058	2,071
Net liability for future policy benefits	1,385	1,349
Less: Reinsurance recoverable	525	413
Net liability for future policy benefits, after reinsurance recoverable	$ 860	$ 936
Weighted-average duration of liability for future policyholder benefits (years)	6 years 10 months 13 days	7 years 4 months 9 days
Immediate Annuities
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Balance, beginning of year	$ 1,415	$ 1,429
Beginning balance of original discount rate	1,788	1,858
Effect of changes in cash flow assumptions		0	0
Effect of actual variances from expected experience		(26)	(15)
Balance adjusted for variances from expectation		1,762	1,843
Issuances	27	22
Interest accrual	46	51
Benefits payments	(88)	(128)
Ending Balance at original discount rate	1,747	1,788
Effect of changes in cash flow assumptions		0	0
Effect of actual variances from expected experience		(26)	(15)
Balance adjusted for variances from expectation		1,762	1,843
Issuances	27	22
Interest accrual	46	51
Benefits payments	(88)	(128)
Effect of changes in discount rate assumptions	(354)	(373)
Balance, end of period	1,393	1,415
Net liability for future policy benefits	1,393	1,415
Less: Reinsurance recoverable	115	116
Net liability for future policy benefits, after reinsurance recoverable	$ 1,278	$ 1,299
Weighted-average duration of liability for future policyholder benefits (years)	12 years 10 months 20 days	12 years 5 months 19 days
PRT
Liability for Future Policy Benefit, Expected Future Policy Benefit [Roll Forward]
Balance, beginning of year	$ 4,189	$ 2,165
Beginning balance of original discount rate	4,351	2,475
Effect of changes in cash flow assumptions		4	(9)
Effect of actual variances from expected experience		(20)	(7)
Balance adjusted for variances from expectation		4,335	2,459
Issuances	1,300	2,041
Interest accrual	168	109
Benefits payments	(346)	(258)
Ending Balance at original discount rate	5,457	4,351
Effect of changes in cash flow assumptions		4	(9)
Effect of actual variances from expected experience		(20)	(7)
Balance adjusted for variances from expectation		4,335	$ 2,459
Issuances	1,300	2,041
Interest accrual	168	109
Benefits payments	(346)	(258)
Effect of changes in discount rate assumptions	(63)	(162)
Balance, end of period	5,394	4,189
Net liability for future policy benefits	5,394	4,189
Less: Reinsurance recoverable	0	0
Net liability for future policy benefits, after reinsurance recoverable	$ 5,394	$ 4,189
Weighted-average duration of liability for future policyholder benefits (years)	8 years 10 days	8 years 2 months 23 days

Future Policy Benefits - Sche_2

Future Policy Benefits - Schedule of Balances and Changes in the Deferred Profit Liability (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Immediate Annuities
Deferred Profit Liability Rollforward [Roll Forward]
Balance, beginning of year	$ 87	$ 69
Effect of modeling changes		0	$ 4
Effect of changes in cash flow assumptions		0	0
Effect of actual variances from expected experience		6	16
Balance adjusted for variances from expectation		93	89
Issuances	2	3
Interest accrual	1	2
Amortization	(6)	(7)
Balance, end of period	90	87
Effect of modeling changes		0	4
Effect of changes in cash flow assumptions		0	0
Effect of actual variances from expected experience		6	16
PRT
Deferred Profit Liability Rollforward [Roll Forward]
Balance, beginning of year	10	4
Effect of modeling changes		0	0
Effect of changes in cash flow assumptions		(7)	1
Effect of actual variances from expected experience		0	5
Balance adjusted for variances from expectation		3	10
Issuances	0	0
Interest accrual	4	1
Amortization	(1)	(1)
Balance, end of period	$ 6	10
Effect of modeling changes		0	0
Effect of changes in cash flow assumptions		(7)	1
Effect of actual variances from expected experience		$ 0	$ 5

Future Policy Benefits - Sche_3

Future Policy Benefits - Schedule of Reconciliation of Net FPB to the Condensed Consolidated Balance Sheets (Details) - USD ($) $ in Millions	Sep. 30, 2024	Dec. 31, 2023	Dec. 31, 2022
Liability for Future Policy Benefit, Activity [Line Items]
Future policy benefits	$ 8,268	$ 7,050
Traditional Life
Liability for Future Policy Benefit, Activity [Line Items]
Future policy benefits	1,385	1,349
Immediate Annuities
Liability for Future Policy Benefit, Activity [Line Items]
Future policy benefits	1,393	1,415
Deferred profit liability	90	87	$ 69
PRT
Liability for Future Policy Benefit, Activity [Line Items]
Future policy benefits	5,394	4,189
Deferred profit liability	6	10	$ 4
Immediate annuities DPL
Liability for Future Policy Benefit, Activity [Line Items]
Deferred profit liability	90	87
PRT DPL
Liability for Future Policy Benefit, Activity [Line Items]
Deferred profit liability	$ 6	$ 10

Future Policy Benefits - Sche_4

Future Policy Benefits - Schedule of Liability For Future Policy Benefit Expected Future Policy Benefit Undiscounted (Details) - USD ($) $ in Millions	Sep. 30, 2024	Sep. 30, 2023
Traditional Life
Liability for Future Policy Benefit, Expected Future Policy Benefit, Undiscounted [Abstract]
Expected future benefit payments	$ 2,843	$ 2,996
Expected future gross premiums	978	1,116
Liability for Future Policy Benefit, Expected Future Policy Benefit, Discounted [Abstract]
Expected future benefit payments	2,073	1,984
Expected future gross premiums	728	772
Immediate Annuities
Liability for Future Policy Benefit, Expected Future Policy Benefit, Undiscounted [Abstract]
Expected future benefit payments	3,212	3,227
Expected future gross premiums	0	0
Liability for Future Policy Benefit, Expected Future Policy Benefit, Discounted [Abstract]
Expected future benefit payments	1,392	1,313
Expected future gross premiums	0	0
PRT
Liability for Future Policy Benefit, Expected Future Policy Benefit, Undiscounted [Abstract]
Expected future benefit payments	8,449	5,445
Expected future gross premiums	0	0
Liability for Future Policy Benefit, Expected Future Policy Benefit, Discounted [Abstract]
Expected future benefit payments	5,470	3,605
Expected future gross premiums	$ 0	$ 0

Future Policy Benefits - Sche_5

Future Policy Benefits - Schedule of Gross Premium Income and Interest Expense (Details) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Liability for Future Policy Benefit, Activity [Line Items]
Gross premium income	$ 1,340	$ 1,319
Interest expense	242	149
Traditional Life
Liability for Future Policy Benefit, Activity [Line Items]
Gross premium income	84	94
Interest expense	28	28
Immediate Annuities
Liability for Future Policy Benefit, Activity [Line Items]
Gross premium income	16	18
Interest expense	46	42
PRT
Liability for Future Policy Benefit, Activity [Line Items]
Gross premium income	1,240	1,207
Interest expense	$ 168	$ 79

Future Policy Benefits - Sche_6

Future Policy Benefits - Schedule of Weighted Average Rates (Details)	Sep. 30, 2024	Dec. 31, 2023
Traditional Life
Liability for Future Policy Benefit, Activity [Line Items]
Interest accretion rate	2.34%	2.33%
Current discount rate	4.95%	5.03%
Immediate Annuities
Liability for Future Policy Benefit, Activity [Line Items]
Interest accretion rate	3.17%	3.14%
Current discount rate	4.90%	4.98%
PRT
Liability for Future Policy Benefit, Activity [Line Items]
Interest accretion rate	4.70%	4.61%
Current discount rate	4.85%	5.03%

Future Policy Benefits - Sche_7

Future Policy Benefits - Schedule of Actual Experience and Expected Experience for Mortality and Lapses (Details)	Sep. 30, 2024	Dec. 31, 2023
Actual experience | Traditional Life
Liability for Future Policy Benefit, Activity [Line Items]
Mortality rate	1.40%	1.70%
Lapse rate	0.10%	0%
Actual experience | Immediate Annuities
Liability for Future Policy Benefit, Activity [Line Items]
Mortality rate	2.70%	3.20%
Lapse rate	0%	0%
Actual experience | PRT
Liability for Future Policy Benefit, Activity [Line Items]
Mortality rate	3%	3.20%
Lapse rate	0%	0%
Expected experience | Traditional Life
Liability for Future Policy Benefit, Activity [Line Items]
Mortality rate	1.50%	1.40%
Lapse rate	0.50%	0.30%
Expected experience | Immediate Annuities
Liability for Future Policy Benefit, Activity [Line Items]
Mortality rate	1.90%	1.80%
Lapse rate	0%	0%
Expected experience | PRT
Liability for Future Policy Benefit, Activity [Line Items]
Mortality rate	2.50%	2.30%
Lapse rate	0%	0%

Future Policy Benefits - Sche_8

Future Policy Benefits - Schedule of Additional Information, Cohort NPR (Details) $ in Millions	9 Months Ended
	Sep. 30, 2024 USD ($)
Insurance [Abstract]
NPR before capping	109%
Reserves before NPR capping	$ 1,219
Reserves after NPR capping	1,250
Loss Expense	$ 31